endocarditis	primary repair	the right pulmonary artery	short-term occlusions	the erosion	para-anastomotic pseudoaneurysm	hypertensive intracerebral hemorrhage	acute coronary syndrome	a large thrombus	the right middle cerebral artery	embolization shows disappearance	a large left sinus	co- existent coarctation	Aortic coarctation	the membranous ventricular septum	:1474 –81 .10.1016/0735-1097	a subarachnoid hemorrhage	interventricular septum Annals	connective disease patient populations	the basilar artery	arteriosclerosis	the coronary artery	complete exclusion	the nidus	the aortomitral intervalvular fibrosa	aortic root	ventricular septal defects	the walls	basilar meningitis	coexistent coarctation	the cerebellopontin angle	membranous septum	circumflex artery	a congenital bicuspid aortic valve	tricuspid valve	hemopericardium	diastole	subclavian artery	stent	the initial size	different approaches	No stent fracture	duct occluder	wall motion abnormalities	recurrent embolism	the anterior communicating artery	infective endarteritis	ventricular thrombus	laterality	circulatory collapse	a linear repair	aortic pathology	ventricular noncompaction	the vascular pain	congenital sinus	the ruptured sinus	dilation	endarteritis	intracranial arteries	a left internal carotid artery	upon rupture	a giant anterior communicating artery	left sinus	aorta-to-left atrial fistula	brief review	the right side	anterior myocardial infarction	vascular malformation	the left-side sinus	coronary artery ectasia	therapeutic strategy	a large left-side sinus	intravenous anesthesia	valve prolapse	right internal carotid	renal cysts	late enhancement	multiple openings	An left sinus	a size	either direct pressure	a sinus	left renal infarction	cervical artery dissections	the left sinus	accessory mitral valvar tissue	post	the resiliency	excellent multi-planar	any indications	well- recognized clinical entity	the pulmonary artery	the internal carotid arteries	diastolic out-pouching	abnormalities	the abrupt growth	aortic valve replacement	ventricular tunnel	transseptal contrast flow	the fate	risk parameters	group-A streptococcus	mediastinum organs	the viewpoint	any case	coronary artery fistula	the mitral-aortic intervalvular fibrosa	blue arrow	the first report	Interventional treatment	coronary artery stenosis	the atrial appendages	black arrow	the petrous13	internal carotid artery	the noncoronary sinus	The resolution	a coil embolization	temporal lobe	an aortocoronary venous bypass graft	an atrial appendage	the right sinus	a few cases	the anterior circulation	severe mitral insufficiency	a left ventricular	ruptured sinus	dissection	atherosclerosis	thrombosed sinus	the initial right parietal lobe infarct	the mitral aortic intervalvular fibrosa	a polytetrafluoroethylene	hypertensive arterial necrosis	endovascular repair	inferior vena cava	:1290	fibrotic intimal peel	main pulmonary arterysurgical correction	a segment artery	venous malformations	heritable conditions	cerebrovascular embolism	definite diagnosis	oxymetry data	the rapid increase	a 20-year rate	mechanical dyssynchrony	noncompaction	vertebral dissection	sinus	the actual size	the large thrombosed sinus	pericardial effusion	left atrial appendage	coronary artery aneurysms	the right atrial appendage	base	echocardiogram	septum	arrow heads	the arch	the sinus	Aortic root dilatation	the thoracic aorta	intraluminal thrombus	spontaneous thrombosis	Rupture	the spontaneous regression rate	vessel rupture	any suspected case	aorta dilatation	the aortic sinuses	aortic incompetence	basilar artery	cardiac scarring	malapposition	commissures	five-chamber view	dilatation	the abnormality	chamber enlargement	anterior circulation	orifice	the high sensitivity	aorta [ Figure	the apical aneurysm contour	an anterior communicating artery	other source	the corpus callosum	the aortic root	proximal right coronary artery	dyslipidemia	a ruptured sinus	pituitary adenoma	the right posterior	myoardial ischemia	posterior pulmonary valve	aortocoronary vein	central catheters Pediatrics	aneurysms-47 Years	death.17	] arrhythmias	false aneurysm	coarctation endarteritis	an arterial occlusion	low-grade inflammation	right atrial communication	any evidence	subarachnoid hemorrhage	the sigmoid sinus14	Trials	congenital fistulae	arterial dysplasia	a dehiscent	bipolar depression	Vascular malformation	Clipping	abdominal aorta	the aortic valve	lateral wall	The remainder	financial reasons	acute infection	a left sinus	The mechanism	Large extracardiac aneurysm	peripheral artery atherosclerosis	the septal portion	precise localization	other mass	
either mitosis	decreased consciousness	conjunctival injection	recombination	respiratory depression	
a 35-year-old woman	different daily dosages	
the pulmonary arteries	pulmonary venous stenosis	shunt	ovulation	the etiopathogenesis	a discordant arterial connection	reovirus type	valvular lesions	left ventricular-right atrial communication	the natural process	coronary ostium	total anomalous pulmonary venous connection	heart defects	severe infection	the external auditory canal	superior vena cava	critical pulmonary stenosis	hypoplastic left-heart syndrome	implantable systems	myocardial squeezing	bilateral absence	intact septum	a fetal type	great vessels	ostial stenosis	embryonic fourth arch	choanal stenosis	intact ventricular septum	complex pulmonary stenosis	atrioventricular	the embryonic fourth arch	the nasal choanae	severe pulmonary stenosis	ventriculoarterial concordance	atrial outlet	the right-side oval window	continuity	The underlying defects	ventricular septal defect	severe microtia	the atrioventricular connections	valves	the common pulmonary vein	the malleus	left-sided valve	malalignment	double-outlet	theca interna cells transition	complex single ventricle	small atrial communication	pulmonary artery stenosis	multiple anomalies	tricuspid valve abnormality	otitis externa	mitral stenosis	the tunnel	

complex concentrate Circulation	the replacement	
A potential assessment	
The interaction	data	each odds ratio	injury	cigarette pack-years	metals	erionite	exposure	the odds ratio	lung cancer case-control study	a sensitivity	radiographic effect	man-made vitreous fibers	toxic exposure	high concentration levels	kaolinite	lifetime occupational history	work processes	The ill effects	other construction dusts	c.monaco	a method	Pneumoconioses	high level	airborne particulates	man-made fibers	dust	the specifics	the long latency	high ’ levels	initial management	effects	many occupational exposures	aromatic amines	vinyl chloride	The genotoxic effects	All forms	diesel	bleomycin	thorium [	quartz	Reactive oxygen species	rat lung fibroblasts	bronchogenic carcinoma	construction dust	regional differences	ionising radiation	benign pulmonary diseases	diesel exposures	habits	intratracheal instillation	] crystals	interferon-7	alum	the predominant type	a cohort	six-mix ” amphiboles	the workplace	the mining	some exposure	silica	smoke	inflammasome sensing	restriction	beryllium	silicone	a common phenomenon	radiographic evidence	fibrous histiocytoma	inflammation induce activation	asbestosis	man-made vitreous fibres	human carcinogens	prior diagnosis	a multiplicative risk model	‘ high ’ concentrations	the models	the workers	these jobs	profusion	both cigarette smoking	radiation therapy	
Weston-Hurst syndrome	acute hemorrhagic encephalomyelitis	
act	phosphates	
the recipient	technology	human peripheral blood leucocyte	chimera fusion protein	the host erythrocyte.2	µM	
isoprene	ethane	elders	acetone release	
spermine/spermidine acetyl transferase	
non-functional leads	any apparent influence	An association	parenchymal lesion	
imprint	

anti-NMDA receptor antibodies	primary spinal tumors	acute episodes	an isolated symptom	short segment	hemiparesis	intracranial lesions	encephalitis	severe spinal cord injuries	an acute episode	diseases/NMO	a disseminated form	hyperIgEaemia	pleocytosis	meningo-encephalitis	an atypical brain	encephalomyelitis	both optic neuritis	neuralgiform occipital pain	optic neuritis	the periphery	Encephalitis	any clinical signs	water channel	myositis,82	cord	vertebral segments	No oligoclonal bands	tumors	ischemia	severe optic neuritis	the spectrum	flaccid quadriplegia	limited phenotypes	typical optic neuritis	venous sinus thrombosis	recurrent optic neuritis	dystonia	
blood vessels	interventricular septum thickness	equal content	the passive filling	BAV	some limitations	ventricular posterior wall diameter	the blood pools	oblique projection	a shorter pressure half-time	horizontal white lines	different components	pressure gradient	relative wall thickness	deceleration time	posterior wall	limits	Mitral valve	the balloon inflates	an inverse association	desc	this segment	the flow territories	rapid increase	mitral annulus velocities	left ventricular systole	diastolic functions	trans-mitral peak flow rate	a transient inward	inter ventricular septum	mid	unobstructed flow	db/db mice	epicardial length	sagittal view	the angiographic appearances	assess cardiologic systole	cardiac systolic function	redirection	the distal arterial bed	venosus	a reduced rate	solitary nature	inflow propagation velocity	a reservoir	one-third	p=0.0329	The peak mitral flow rate	tissue doppler imaging	a rewritten form	the aortic valve plane	the aberrant release	The mechanical duration	mid-segment	the zero-pressure volume	the following systole	the diameter	The peak trans-mitral inflow velocities	Parasternal long-axis view	p=0.1182	the balloon	systole means contraction	the inflow	diastolic diameter	wall dimensions	the mitral inflow profile	transducer	max	atrial contraction	internal dimensions	internal diameter	a linear dependence	ventricular dimension	full-volume acquisition	±1.7 mm	The short-axis aortic view	the non-ventricular counts	the basal segments	lower-upper limits	the cardiomyocyte relaxation phase	the complex geometry	intraventricular septal wall thickness	the non-TAP group	branch pulmonary arteries	the cardiac cycle	the late phase	an active contractile component	long ones	inflow velocities	The distribution	the descending aorta	a cardiac structure	internal dimension	end-systolic volume	interventricular septal thickness	genuine difficulty	wall thicknesses	overall image quality	amplitudes	single oblique	early systole	a central component	disappearance	the aLV	branch	systole	epicardial area	the systole	image quality	end systole	short axis view	pathological noncompaction	tag	area	color aliasing	a semi-automatic fashion	The velocity	binds myosin	the apical four-chamber view	diastolic blood pressures	males	amplification	coronary perfusion	the following parameters	frames	afterload	sweep volume	ventricular diameter	bottom row	the expected changes	ventricular end-diastolic diameter	a similar orientation	ventricular posterior wall thickness	the transmitral pressure gradient	reflection	the negative ino-tropic action	p=0.0002	epicardial outlines	late filling	diastolic augmentation	millimeters	views	the closure	ventricular internal end-systolic dimension	peak systolic velocity	a quadricuspid aortic valve	the two-dimensional parasternal long-axis view	atrial dimension	•Spirometry	ventricular internal diameter	ventricular strain	dP/dt min	minimal tricuspid	the relative duration	ECG-gated multidetector row	the ejection flow	the ventricular	the ventricular septum deforms	ejection-fraction percentage	thickness	multiple regression models	:1924	new paradigm	myocardial strains	two-chamber apical views	the luminal diameter excursion	ventricular end-diastolic dimension	red arrow	dia	the isovolumetric relaxation phase	The reduced intramyocardial blood pool	the 4-Ch plane	systolic septal flattening	the rapid decline	percentage change	ventricular systole	increased time	vivo cinematographic analysis	the posterior leaflet	the differences	cyclins	both ventricular diastolic function parameters	stills	an anatomic measurement	These communications	pressure half-time	cm2 ]	pressure overload	the cusps closure	The end diastolic	
synthetic materials	polytetrafluoroethylene	a flexible membrane	germanium	oil	The lead	capsule opacification	that different types	a flame	silicone-filled implants	polyester mesh	The symptomatology	linseed	fat	hydrophobic acrylic	silica nanoparticles	safe therapeutic strategy	an IS-1 connector	hydrophilic acrylic material	the cartilaginous framework	Ingestion	polydimethylsiloxane.5–7	a bronchial stent	hydroxyapatite cement	hydrophobic acrylic lenses	porous polyethylene	Allogenic materials	The device	the same airway disease	the optical platform	polydimethylsiloxane antibody	micro-droplets	autologous fat	a compliant layer	bipolar	hyaluronic acid	ceramics	The microvascular clamp	nitinol	polyester	polyurethane	self-expanding retainer	
The influence	Arterial negative logarithm	diastolic blood pressure	pH	
an ammonium sulfate test	The striking co-localization	palm	Figure	choroidal neovascularization	Ring	retinal pigment epithelium	decreased expression	amyloid	
complete blood count	function panel	tissue histology	liver function	urinalysis	blood cell counts	creatinine	dual-energy x-ray absorptiometry	hemotology	inflammatory indices	serologic screening	white cell count	urine analyses	enrollment	transaminase	brain lesions	serology	hematological counts	neurological examination	complete blood cell counts	hematology	mEq/L	gas content measurements	mediastinitis	blood count	coagulation	
proton	al.7	
depigmentation	% fluticasone propionate cream	,20	hypophysitis [	The representative image	autoimmune mechanisms	skin lesions	oral lichen planus	psoriasis vulgaris	chronic autoimmune urticaria	primary gonadal insufficiency	alopecia	
substantial inhibition	mesylate	skeletal-related event	relative potency	the first administration	actions	first-line long-term hormone therapy	nursing implications	The bisphosphonate	the conventional regimen	vivo effects	the anti-resorptive effect	monthly treatment	final 60-month results	the anti-tumor effects	combination therapy	mg/kg i.v	standard therapy versus standard therapy	A single dose	taxotere combination	protein binding	densoumab	holiday	the cortical bone	yearly-pivotal fracture trial	the biphasic material	castration-resistant prostate cancer	Pre-treatment	Stopeck	the potent anti-resorptive bisphosphonate	a novel bisphosphonate	balb/c nude mice	residual invasive tumor size	bone health	affinity	discovery analysis	weekly low-dose	different doses	female metastatic breast cancer patients	mg dose	the side effects	cortical bone density	postmenopausal breast cancer patients	,24,34–55	hormone-sensitive prostate cancer	activin	reduced incidence	the anti-tumor potential	hormone-refractory prostate cancer patients	a weekly low-dose therapy	risedronate	prostate cancer-specific survival	anti-tumor effects	other bone agents	–10825.9724788	μg/kg i.p	the cancer dose	osteosarcoma cells	data show	radiopharmaceuticals	hypophosphatasia	P1NP	bone-marker levels	the potential renal damage	prostate-specific antigen	decreases	the approved dosing schedules	the pharmacology	discussion	biyearly treatment	delayed introduction	direct anticancer activity	bones	cortical bone	ArticleDifferential effect	an initial effect	other solid tumors	the nitrogen-containing bisphosphonates	undergone lung transplant	pamidronate	adjuvant therapy	an incidence	cancer doses	p=0.006	the anti-resorptive antibody denosumab	osteoblasts	denosumab trials	intravenous dose	conventional dosing	weekly low dose	innovations	bone resorption	dosing	pain palliation	The upfront biyearly regimen	consistent benefits	pamidronic acid	subgroup analysis	other treatments	clodronate	oral raloxifene	a conventional dosage	inhibited growth	mg i.v	lung cancer patients	single infusion	conventional arm	clinical effects	Early cancer cell dissemination	achievable dose	powerful bisphosphonate	weeks schedule	morphogenic protein-2	schedules	clodronic acid	further analyses	apoptosis	the early effects	The major benefit	short-term incubation	no postoperative treatment	inhibitory effects	a single infusion	another animal study	metastatic bone disease	-tumour effects	breast cancer.11,26	neoadjuvant chemotherapy	monthly infusions	alendronic acid	mechanical loading	open label	conventional setting	non-vertebral fractures	neoadjuvant therapy	a single administration	the reductions	Clodronate	low-dose weekly regimens	s.c.	breast cancer	ifosfamide	daily oral dosing	raloxifene	denosumab	ibandronate	long-term continuous use	doxorubicin treatment	different schedule	e303	the osteoblastic niche	additional animals	treatment groups	endocrine therapy	improved overall survival	anti-resorptive activity	the bisphosphonate	tumour growth	severe osteoporosis	low bone mineral density	cancer treatment doses	long-term oral bisphosphonate	single intravenous administration	other bisphosphonates	medical oncologists	bone remodeling	repeated administration	renal cancers	mL·min−1	all clinical situations	letrozole	the antiresorptive therapies	pravastatin	14-year old children	tamoxifen	the postoperative use	osteoclasts.27	The anti-tumour effects	a novel bone	the bisphosphonate osteoclast inhibitor	dose ”	pamidronate disodium	all-transretinoic acid	osteoclast activity	the anti-tumor activity	these marginal benefits	the bi-annually regimen	the registered label recommends	wk vs	a tubular lesion	early initiation	the anticancer effects	a single intravenous dose	the bisphosphonates	protective effects	intravenous zoledronate	hypertrophic osteoarthropathy	adjuvant bisphosphonates	the mean risk	doxorubicin	complete pain resolution	previous fracture	teriparatide	the doxorubicin	a subcutaneous injection	double-blind study	
thiazole	high vascular selectivity	pungent	bis	the chemical structure	
a single sample	whereas	

these implants	

Intracerebroventricular treatment	afferent vagal activity	

doxilamine	diamorphine	other comparators	headache impact test	opiate	caffeine and/or	diclofenac	little codeine	acetaminophen	chronic administration	parallel group trials	the majority	dihydrocodeine	effect	plus paracetamole	analgesics	butalbital share indications	drug with- drawal	the dangers	the antitussive efficacy	1/10th potency	no combinations	opium	

healthy women	
The comparison	mg/kg daily dosage	Inhibitors	the dosages	COMB-4 post osteotomy	testing	intracellular cGMP	ambrisentan	a phosphodiesterase-5 inhibitor	tritiated sildenafil	cialis®	inducible nitric oxide synthase	a telomerase vaccine	silodosin	a phosphodiesterase inhibitor	medical therapies	vardenafil	single oral doses	pg/dL	


s lymphoma	
intramedullary tumours	thoracic tuberculosis	an anterolateral extrapleural approach	cold abscess formation	the thoracic spine	instability	hypoestrogenemia	angle	decreased disk heights	duplex kidney	surgical outcomes	current smoking	thoracic scoliosis	The fixation devices	the instrument	Self-reported estrogen use	an alarming increase	multiple rib fractures	an initial angle	% correction	situations	lumbar intervertebral disc herniations	the intervertebral disk spaces	significant scoliosis	ossification	the spinal infection	lung mechanics.78	adult residents	joint deformaties	both bone turnover biomarkers	lordosis	global lesions	gooseneck deformity	pleural effusions	thoracic deformities	shoes	spinal rigidity	a previous fusion	iatrogenic flatback	rib mobility	fragment subluxation	a slight progress	drawn	vertebral collapse	reduced odds	back pain	correction	scoliosis component	Gradual increase	E1395	outcome analysis	thoracoplasty	fracture progression	small size	kyphosis progression	degrees	the other arm	neurologic symptoms	spinal cord compression	height loss	the angle	a question therefore arises	ligaments	ventilatory dysfunction	long lasting correction	seventh	a progression	the progress	overt destruction	growth	the residual wedging	anterior column defects	a final kyphosis	spondylitis	bone turnover	increased mortality rates	the thoracic vertebrae	a final deformity	potential mechanical instability	spinal tuberculosis	scoliosis	pes	
an opening pressure	


the caudal endplate	the trabecular bone	shoulder	Midsagittal section	The endplates	cartilaginous endplates	a low speed	distal radius	safeHFWD	lumbar level	Treament effects	virtual biopsies	epidural collections	total area	distal forearm	humerus	intervertebral discs	the lengths	sternum	Load-displacement curves	the histomorphometric analysis	the middle third	hip	the gradual slippage	tibia epiphysis	rat femur	cord compression	% collapse	vertebral endplate thickening	replicate scans	sacrum	tibia	soft tissue	proximal tibia	tuberculous involvement	normal uptake	micro-CT images	HR-pQCT slice	the first cervical vertebrae	spinal segment	rugger-jersey spine	the cervical spine	the residual load-bearing capacity	the mean values	the experimental values	the right border	the central trabecular region	both sites	initial compression	Whole trabecular volume	anterior osteophytes	each animal	wedging	relative translation	complete destruction	Three-dimensional morphometry	the lumbar level	a slight kyphotic deformity	the cephalad endplate	vertebrae/group	representative micrographs	upper limb	bone volume/tissue volumeC8	
biophysical activity	lung infection	The immunoregulatory roles	allergen-induced airway inflammation	ssRNA	
pedicle screw insertion	d	same age	a deep insertion	The leads	the subcutaneous tissue	same sex	‡significant difference	low signal intensity	Formation	the bullets	
cashive	fish	rerio	
amines	sympathomimetic amine	insulin-treated diabetic Data	tyrosine decarboxylase enzyme activity	hydroxyamphetamine	tryptamine	octopa- mine levels	octopamine	lactose capsules	
chorea	stress test features	the initial attack	Histopathological findings	scarlet fever controls	major criteria	echocardiographic findings	congestive failure	the inter-mountain area	polyarthritis	the mitral and/or	The hallmark	rheumatic fever	the true frequency	arthritis groups	worsened valvular lesion	major manifestations	valvulitis	significant valvular heart disease	congestive cardiac failure	the conduction abnormality	myocardiopathy	first evaluation undergoing	macrophages	block	
clomipramine	muscimol	clon- azepam	diphenhydramine	a decreased performance	levetiracetam	artan	inhibition	escitalopram	the prelimbic cortex	hyperthermia	Muscle relaxants	antispasticity agents	tizanidine	inserted metal probe	agonist	midazolam	other physicians	surface	bromocriptine	trihexylphenidyl	phaclofen treatment	tizanidin	intrathecal administration	phenytoin	phaclofen	the co treatment	selegiline	partial resolution	bid	
drainage	anaerobic microbiology	necrotising/cavitatory infiltrates	atelectatic lung	the typical biochemical profile	severe pain	intractable pneumothorax	sonographic evidence	bacterial pneumonia	The bacteriology	nocardiosis	peritonitis	broncho-pleural fistula	abscess	severe bilateral bronchopneumonia	pleural effusion	intravenous peramivir	parapneumonic effusion	hemophagocytosis	a context	intrapleural catheter placement	multicenter trial	clinical manifestation	the lacrimal sac	parapneumonic effusions	pleurisy	the few reported cases	suppurative lung disease	bronchopleural fistula	hemothorax	overwhelming septic shock	effusions	the first successful treatment	abscesses	empyema Proceedings	a rare causative pathogen	A 76-year-old diabetic man	external agents	ng ml	acute dacryocystitis	the fluid	causes	tenderness	a few case reports	complicated parapneumonic effusion	microscopy	pus	pulmonary edema	
orange juices	tea consumption	

contrast material	iohexol	
inhibitory factor	the disease course	the stimulator	
therapeutic responses	transporter	female adolescents	a primary ciliary dyskinesia	primary cultures	azitromycin treatment	The implementation	long-term antibiotics	abnormality	the mucociliary transport	–5 .10922133	cystic fibrosis genotype	elimination kinetics	hospitalized patients	a genetic mutation	a one-phase exponential decay model	mucoviscidosis	significant risk factors	suggestive	Several decades	poor outcome	the widespread introduction	cepacia empyema necessitatis	musculoskeletal diseases	cystic fibrosis-related diabetes	allergic fungal rhinosinusitis	allergic bronchopulmonary aspergillosis	post-transplant bronchiolitis obliterans	the route	rapid deterioration	arterial oxygen saturation monitoring	old university graduate student	a presentation	p1412	a piglet model	lung transplantation	psoriasis	the lifespan	the setting	aerosolized tobramycin	A.	the serum	bacteria	the respiratory tract	chloride	microlitre plugs	asthma	systemic disorders	remove_FC converted:21.06.2016	water permeabilities	antifungal treatment	heterozygous c.2752-26	special cases	a cell culture model	pilot study	antibiotic resistance amongst	ciliary dyskinesia	peripheral muscle function	Viral detection	hepatic sulphotransferase activities	a possible extracellular role	alpha	dehydroepiandrosterone sulfate	airway neutrophils	5-year survivorship model	tolerability profiles	infants	stable asthma	bronchiectasias	journal	pathophysiological significance	intracerebral hemorrhage	chronic pulmonary disorder	an adult	long‐term effects	specific drug therapies	no intact mucin	the cystic fibrosis transmembrane conductance regulator	signaling	prematurity	species	non-CF bronchiectasis	any other immunocompromised state	a large neutrophilic component	advanced lung disease	non-cystic fibrosis	persistent infection	the long-term therapy	feeding	normal children	% ]	doctors.org.ukSLK	respiratory tract cancer	sodium	aspergilloma	adult men	hypertonic saline	mannose-binding lectin	bronchiectatic disease	veno-arterio-venous cannulation	horizontal lines	congenital airways anomalies	mannitolilytica strains	2789+5G- >	bronchiectatic airways	all adult patients	serum calprotectin	Efficient drug administration	¥¥¥¥	Israeli patients	the multidrug-resistant protein	marked variability	adolescent females	outpatients	protein-chain reaction assay	bloodstream infection	cough clearance	sickle cell anaemia	a pediatric population	chromosomal defects	bronchial asthma	muscular dystrophy deletions	alpha-1-antitrypsindeficiency	ground glass opacities	early features	suitable biomarkers	RSV-seropositive children	antigen gene	mechanical stress	long-term survivors	year olds	clinical trials.4	non-productive inflammation	children	compression	vascular malformations	remarkable homology	kyphoscoliosis	tobramycin	first-degree relatives	Recommendations	multicentric study	AID-PPUL2 >	treatment results	qub.ac.ukJSE	hypercapnic respiratory failure	mild pulmonary impairment	young adults	alternate-day prednisone	lung function decline	aeruginosa infection	an adult patient	congenital adrenal hyperplasia	transplant	future trends	Pulmonary exacerbations	assay	the tale	haemopoietic stem cell transplantation	ureterolithiasis	immunodeficiencies	pneumoniae challenge	pneumoconiosis	pulmonary exacerbations	surface liquid volume	AID-PPUL8 >	phasic shear stress	active mycobacterial disease	fibrosis	database*	meetings	disposition	the rs	volumes	gastrostomy-fed children	male	healthy human lung	a state	study population	chloride transport	regional fractional ventilation	acute infective exacerbation	metabolic disorder	end‐stage patients	n=14	:324 –31	a biomarker	alpha1-antitrypsin deficiency	print	the surface	anti-inflammatory therapies	expression	none	chronic bronchiectasis	chronic use	survival analysis	pediatric inflammatory bowel disease	Chinese children	steroids	eosinophilic granuloma	male patients	bronchopulmonary dysplasia	E‐mail	healthy control	chest	powering	non‐CF bronchiectasis	this inflammatory damage	chronic respiratory diseases	pulmonary graft-versus-host disease	:10 –12	*Division	usual interstitial pneumonia	airflow resistance	an atypical adult presentation	irritants	gene repression	focal endobronchial lesion	future strategies	primary ciliary dyskinesia syndrome	diffusion	exhaled air	interstitial lung diseases	AID-PPUL5 >	:59 –66	chronic lung disease	–50	pan-bronchiolitis	Cystic fibrosis transmembrane conductance regulator	a hallmark	combinations	congenital disease	primary ciliary dyskinesia	diagnostic possibilities	tumour necrosis factor	double-blind trial	asthma [ 13,39-41 ]	Adult patients	preschool children	mucus clearance rates	non-cystic fibrosis bronchiectasis	a striking paucity	cytotoxic peptides	chronic lung diseases	clinical feature	devices	sinus surgery	safety	exhibit mucus overexpression	virulence factors	bronchiectasis	chronic rhinosinusitis	nNO testing	a 14-year-old adolescent	TORPEDO-CF trial	young children	–34	6-year-old children	mannitol powder aerosol	adolescents	–44	an infant	beta-defensin	infections	study patients	respiratory cancer	services	airway liquid	idiopathic pulmonary fibrosis	an increase	patterns	Previous trials	diffuse bronchiectasis	bronchial obstruction	neuromuscular diseases	clinical response	the g551d mutation	a major co-morbidity	lung disease patients	a factor	microbes	tolerability	the art	situ analysis	European recommendations	the pancreas	calprotectin	bronchiectasis sputum	a two-phase exponential decay model	the airway epithelia	adult patients	young infants	clearance index	The diagnosis	available molecular methods	panbronchiolitis	insulin-dependent diabetes mellitus	an age-range	wall deformities	a young man	airway disease	DNA	edn	congenital heart diseases	:191 –201	patient	mucus hypersecretion	bacterial exacerbations	inflammatory biomarkers	pancreatic insufficiency	A clinical practice guideline	Abbreviation	exacerbations141,142	comprehensive standardisation document	whole body vibration exercise	a classic differential diagnosis	receptor	male mouse model	the expected prevalence	comparison	an initial presentation	lung transplantation survival models	novel solution	normal sweat test	An unusual presentation	chronic suppurative lung disease	00150-1	structural markers	other chronic inflammatory	asteroides	noncystic fibrosis bronchiectasis	canadian centers	active malignancy	advanced pulmonary diseases	improved adherence	other chronic respiratory diseases	morbidity	thymidine polymorphism	The efficacy	parent caregivers	the detection	a primary component	nitric oxide levels	intensive care unit care	bronchopulmonary aspergillosis	rheology	clinical diagnosis	clinical variables	retrospective study	congenital chloride-losing diarrhea	adult females	life-threatening pulmonary obstruction	tuberous sclerosis	Clinical manifestations	nucleatum	Adults	–112	sodium absorption	Assessment	immune deficiencies	single lung transplantation	statistical techniques	AID-PPUL7 >	energy requirements	rinsing	channel	disease-control subjects	active pulmonary tuberculosis	bronchogenic lung cancer	Exercise	male subjects	abnormal values	albuterol	–6	polyposis	CFTR-related disorders	muc5b mucins	dry powder	implications	the adult	The association	pediatric patients	a chronic disease	neck diseases	the transepithelial migration	a European/North American multicenter study	the infection	deficient	fumigatus	other immunocompromised settings	predisposition	the nicotinic anti-inflammatory pathway	elevated sweat chloride concentration	a potent	acute air pollution exposure	E11–E14	This phase	evident bronchiectasis	pneumonia	pancreatic function	other centers	A clinical practice guideline*	knockout mice causes	A complex interplay	advanced states	aeruginosa	any other human genetic disease	pulmonary tuberculosis	phospholipase	haematological malignancies	young patients	A five‐year study	cephalometric parameters	specificity	molecular genetic diagnosis	fibromyalgia	the possibilities	extensive bronchiectasis	the respiratory system	the lysosomal cysteine proteinases	bayer.com2015	clearance strategies	pulmonary arterial hypertension	a gastrostomy tube	a mild form	stable adults	metabolism	a few national centres	degenerative processes	nasal epithelial cells	immunosuppressive condition	long term treatment	the proportion	deoxyribonucleic acid	a proteolysis-resistant inhibitor	the lung parenchyma	rhDNase	women	borderline sweat test	vital capacity	coefficient	lymphangioleiomyomatosis	insured people	an adolescent	the original work	an autosomal recessive disorder	the peptide transporter	free granulocyte elastase	other high‐risk children	stroke	identifiable mutations	lung infarction	macrophage activation states	chronic bronchitis.8,9	anti-inflammatory pathways	1440-1843RESPRespirology	functional nasal sinus surgery	the tension-time index	AID-PPUL10 >	a milder phenotype	oxide	chronic hypoxia	human immunodeficiency virus	multi-resistant bacteria	reduces	

dominant inheritance	phenomenologies	spinocerebellar ataxias	Movement disorders	baclofen	mild involuntary orofacial movements	a wide variety	orofaciolingual dyskinesia	Improvement	ballism	orofacial dyskinesias	hypothyroidism	motor function	the TTF-1 gene	incoordination	athetosis	akathisia	seizures	amongst others	ropinirole treatment	:222	nervous system	cervical dystonia	brain/lung involvement	early onset gait abnormalities	valvular heart disease	the abnormal movements	myoclonus	hyperkinetic movement disorders	an isolated manifestation	Other PolyQ-disorders	various hyperkinetic disorders	the big joints	a special type	oculomotor apraxia	behavioral changes	different causes	irregular gait	any disease	sensorium	basal ganglia encephalitis	hemiballismus	distal athetosis	tongue protrusion dystonia	subclinical carditis	epidemiological study	pains	These neurons	cranial neuropathies	trunk involvement	choreoathetosis	ballismus	early postimplantation development	autoantibody disorders	a suspected diagnosis	the cases	a neurological condition	gait ataxia	levodopa	short stature	dyskinesia	tocotrienol supplementation	impaired surfactant protein production	carditis	subclinical valvulitis	hypotonia	anatomy	simplex encephalitis relapse	erythema marginatum	marginatum	early onset hypotonia	dyskinesias	tics	autoantibodies	A number	writhing	carditis/valvulitis	tremor ”	the box	cognitive disturbances	retinitis pigmentosa	amphetamine addiction	permanent phenotype	
retroperitoneal bleeding	intra-peritoneal bleeding	biliary obstruction	hepatic abscess	

upper eyelid	dribbling	glabella	periocular lines	
miR-499 protects cardiomyocytes	Vascular endothelium	microscopic view	The reversibility	the deleterious effect	cell carcinoma	The functional improvement	depletion	β-adrenergic blockade	
protrudingears	the tendon graft	the brachial plexus	intercalated disks	the auricle	anti-interleukin-1 therapy	paraspinal muscles	tendons	a blood vessel	subepicardial hematoma	control nerves	the lead	a vitreous hemorrhage	cervical root	years post-injury	intermediate disc	cervical roots	
Average duration	physical injury	crazy laughter	central disruption	post- drome	photopsia	The premonitory phase	postdrome symptoms	postdrome	The premonitory symptoms	the “ fou rire prodromique	
steroid therapy	new medicines	recurrent cases	These disorders	supportive care.3	this tremor	the important role	specialized centers	aversive aspects	important therapeutic step	a dose reduction	the fourth day	this regimen	

the circumflex artery	the maxillary artery	scar	a hybrid approach	epithelial ovarian cancer cells	the ipsilateral common carotid artery	bax	a historical perspective	All rCBF time courses	the hemorrhoidal artery	the ureter	the vertical vein	indocin therapy	carotid artery angioplasty	Suppression	Recombinant adenoviruses	a patent ductus arteriosus	plain sutures	AID-IMMU3815 >	department	triple cervical corpectomy	puncture lead	negative selection	different suppression adaptors	this receptor	exogenous stimuli	apoptotic triggers	a patent duct.16	transantral presentation	coronary arterial pressure response	removal	the costimulatory molecule	bilateral common carotid arteries	The surgical intervention group	the seventh postoperative day	crosslinks	the placebo effect	the middle cerebral artery	a plain suture	tumor development	A cardiectomy	the artery	the internal mammary artery	left coronary artery	the shoulder	the left pulmonary artery	blue	developmental cues	the brachial arteries	The regulation	a patent	origin	the thoraci lymph flow	annuloplasty/replacement	co-inhibitory molecules	systemic drainage	these side branches	NF-ĸB nuclear translocation	patent ducts	a tandem occlusion model	atrial appendage	the long-term hypoperfusion phase	double puncture	collateral	electrocoagulation	postHI recovery	pericardiectomy	resection	death-receptors	a microvascular clamp	the arterial duct	aortic arch repair	chylothorax	local excision	costimulatory molecules	peratrial device closure	closure	an artificial-tubing system	prior vein stripping	neuronal activity	silk sutures	the functional activation	superior vena	aortic arch	Atrial septectomy	the thoracic duct	*Glenn shunt anastamosis site stenosis	the internal mammary	dividing	vascular injury	a bidirectional cavopulmonary shunt	portal vein embolization	the maxillary sinus	heavy neutrophils infiltration	clone	indomethacin	clipping	severe varicosities	meningeal diverticula	blood supply	the percutaneous closed-chest model	p-rCrU-Cy/dye	other stimuli	interleukin-17 induction	resistant	the thoracic duct proximal	immunity	conjugation	banding	bilateral vertebral arteries	left pulmonary artery	because	the patent ductus	receptor complex	the hearts	a Blalock-Taussig shunt	drainage group	foramen	promising results	the anterior ethmoid artery	the ductus arteriosus	intracellular calcium influx	mg/kg i.p	the vertebral artery	5'-AATGTACGACGCCAAAGAT-3 '	a clear shift	the sphenopalatine artery	great cardiac veins	the aortico-left atrial fistula	heterodimeric proteins	atrial septectomy	the common carotid artery	receptor enhances	ostial closure	antigen	common carotid artery	polymerase gap filling	gap	potential causes	kinase-dependent pathway	the critical role	reconstruction	the receptor	Structure	the left coronary artery	the engagement	no third needle prick	spinal nerves	the apical surface	sRAGE	sham operation group	

soybeans	ganglia deposition	carboxylase	the metaloenzymes	the intact brain	gritty urine	cadmium	the tracer methods	the voxels	a preferential catecholamine	both cadmium	the determination	accumulation	low blood levels	the metals cadmium	the biologic half-life	

chest wall implantation	tissue-core biopsy	
– yolk sac tumor	necrosis/fibrosis	the way	magnification	cylindroma	the prognosis	fibroma	malignant teratoma	fibromas	a formation	lymphoma	neuroblastoma	germ cell tumors	renal differentiation–a	fig	all cases notes	other non-seminomatous histologies	Review	somatic malignant transformation	tumor formation	primary benign germ cell tumor	

assist device	renal replacement therapy	return	general anesthesia	an alternative means	vasopressors	similar models.184	this term	−0.836	pediatric cardiac support	Another case	activated factor	Interventional procedure overview	veno-arterial configuration	the intra-aortic balloon pump	a ventricular assist device	life support registry report	such conventional mechanical cardiopulmonary support devices	early institution	the desirable effects	a risk adjustment model	lung failure	acute heart failure	blood pump	the simultaneous deployment	pediatric heart transplantation	AID-CCD13 >	The use	−0.599	the clinical use	ice-water submersions	abusive head trauma	this juncture	high flow oxygen therapy	pump	neuron-specific enolase	systemic corticosteroid treatment	cardiopulmonary resuscitation	nitric oxide inhalation	intra-aortic balloon pump	a single-center experience	minimal ventilatory support	main trunk	p-ECMO	other ventricular assist devices	a bridge	conduit	An international survey Annals	Introduction	circulatory assistance	ventricular assist devices	imbalanced ventricles	many died.5,6	peramivir	dogs	open heart surgery	immediate cardiovascular support	on-pump coronary surgery	severity level	a medical center	inconclusive evidence	continuous renal replacement therapy	application	article	neonates	primary graft dysfunction	circulatory support	extracorporeal life support	high positive end-expiratory pressure	Myocarditis	neuromuscular blockade	pump servo-regulation	long-term extracorporeal support	takotsubo cardiomyopathy—a	an extrcorporeal life support	oxygen dependent	usage	intra-aortic balloon counter pulsation	the outcome	an extracorporeal cardiopulmonary resuscitation simulation program reduces	acute pulmonary embolism	dialysis	paediatric heart transplantation	Follow-up echocardiography	ventricular assist device	cardiac arrest patients	pediatric cardiac intensive care unit patients	operative repair	the extracorporeal circuit	intraaortic ballon pump	advanced respiratory assistance	support	ventilation duration	cardiac surgery	:2943	A large number	prone positioning	the right internal carotid artery	septic shock	intraluminal tracheal stenting	:216	genetic screening	competition	

involuntary jerky movements	skeletal abnormalities	a seizure disorder	live births	large head	neuroregression	full scale intelligence quotient	A 5-month-old boy	non consanguineous parentage	sociable personality	abnormal hand movements	these kindreds	affected children	progressive ataxia	A 5-month-old male patient	aspect	central hypotonia	first degree cousins	old girl	a background	autistic characteristics	developmental dysphasia	array	old male baby	hemimegalencephaly	pervasive developmental disorder	regression	other developmental problems	a 2.5-year-old male	the sites	early-onset pendular nystagmus	fair skin	lamotrigine	spastic quadriplegia	generalized looseness	learning difficulties	
No intracranial large- vessel atherothrombosis	valvar dysfunction	atherosclerotic extracranial internal carotid artery	endothelial cell	vessel wall degeneration	the suboptimal temporal bone window	the donor innominate vein	granular osmiophilic material	vertebral axis	enzyme inhibitor	a clear precipitating cause	the distal location	irregular areas	the arteriolar level	graft	ischemic stroke	sagittal projection	stent deployment	% resolution	a lesion	a selective cerebral angiography	carotid atherosclerosis	right ventricle	stent characteristics	the neonatal period	In-stent thrombosis	arteriosclerotic changes	right bronchial anastomosis	the low incidence rate	% diameter	the anastamosis site	carotid plaques characteristics	Sex	goals	restricted movement	al.61	right internal carotid artery	the clinical significance	segments	left circumflex	bicuspid aorta	view ”	recent advances	the coronary lumen	high quality images	moderate tubular aortic arch hypoplasia	vulnerability	degenerative spondylolisthesis	descriptive terms	vaginal shortening	gastrointestinal angiodysplasia	maneuver	Aortic insufficiency	thrombi	crossing	The anatomical data	atherosclerotic occlusion	segment consistent	Significant stenosis	moderate tricuspid insufficiency	an unexpected evolution	the lacrimal duct	lesion classification	synovial cyst	No intracranial large-vessel atherothrombosis	aneurysm	the upright position	overall plaque burden	common valvular heart disease	great cerebral arteries	intervertebral disc herniation	single-vessel coronary artery disease	regurgitation	gastrointestinal haemorrhage	the maximal degree	the initial evaluation	coronary ostial isolation	a nasopharyngeal insufficiency	Aortic calcification	degenerative disk disease	supravalvar	The tip	The harms	coronary vessels	mL vs	valvular regurgitation	atherothrombotic events	vessel dilatation	significant regurgitation	mean gradient	mitral valvular insufficiency	auditory canal atresia	coronary arteries occlusion	aortic valve sclerosis	focal areas	myocardial ischemia	the long penetrating cerebral arteries	gradient	osteopontin	the grade	a major challenge	stenting	multiple vessel disease	vertebral artery origin	tube oesophagus	a cross-sectional area	many ventilator	myocardial dysfunction	a semi-quantitative method	the third criterion	a random population sample	optimal medical management	necrosis	Unilateral stenosis	chi-square =	the exact degree	coronary arteries	lumbar spondylosis	the same clinical course	coronary artery calcification	consistent conduit	anatomic abnormality	previous mechanical dilatation	the atrio-pericardial anastomotic technique	coronary angiography	pulmonary venous obstruction	the channel	branch pulmonary artery	serious obstruction	stenotic lesions	relevant blood investigations	no other neural tube malformation	main+3-vessel disease	mucus plugs	the pulmonary artery bifurcation	several coronary arteries	a mean transvalvular gradient	an acute coronary syndrome	discontinuity	pulmonic valve	postnatal day	echocardiographic criteria	tricuspid valves	−0.30	the targeted segment	arterial dissection	sub-axial instability	the pulmonary veins	marked degeneration	the grading	occlusions	blocking	Events	aneurysms	*13/68	angiogram	recent coronary angiography	important prognostic predictors	further testing	the aqueduct	the valve	any regurgitation	regional airway obstruction	Interventional dilatation	wall irregularities	invasive treatment	mixed regurgitation	severe degree	structural abnormalities	the root	symptomatic vertebrobasilar stenosis	occlusion aDependent variable	other cerebral venous drainage abnormalities	ultrasonographic study	subannular hypoplasia	pre-test probability	the subclavian artery	equivalent	cor triatiatum	the cervical spinal canal	physiologic assessment	desobstruction	decreased valve elasticity	relevant	systemic veins	retrograde wire sounding	coronary stenosis	valve regurgitation	insufficiencies	the aortic anastomosis	post-operative parameters	membrane-like obstructions	the predominant underlying pathology	post-ablation	insufficiency	the target vessel	multidetector spiral	the neoPA and/or	endobronchial involvement	scarring	mild coronary arteries	irregularity	pink	the carotid bifurcation	the proximal coronary pressure	the intracranial segment	synechia	different criteria	intramural hematoma	interspinous bursitis	position	intimal flap	neopulmonary arteries	Recurrence	webs	a major coronary artery	tortuosity	degeneration	in-stent thrombosis	regurgitation ”	echocardiographic evidence suggestive	Forty-seven patients	–62	both modalities	no plaques	today	lesion type	the renal arteries	an unusual clinical presentation	Access-related re-intervention procedures	external auditory canal	Progression	aortic valve morphology	fourth ventricle	dissections	particular location	Participants	mucosal tumor infiltration	gradient echo	bronchial wall instability	the carotid arteries	severe valvular regurgitation	This index	other major defects	Silent subcortical infarction	the capillary lumen	the proximal part	the blockage	extrinsic compression	synovial cysts	the left	the collateral vessels	ileum	forme fruste	the caudate head lesion	concurrent stroke	external compression	a right internal carotid artery	the high risk	cm/s confirms	middle cerebral artery	new-born babies	basilar artery branch disease	Coartaction	the main parts	the neopulmonary artery	the lenticular nucleus	an indicator	the remained lesion	serious complications	that calcification	ECD findings	a definite explanation	the hemodynamic state	significant atrioventricular valve regurgitation	non-operable patients.2–4	severe coronary 2-vessel disease	all non-cardioembolic strokes	the interlobular spur	narrow pulmonary valve annulus	alveolar-bronchiolar attachments	lumbar fusions	factor levels.94	bending	The proximal location	urokinase infusion	% stenosis	cm/m2	both branch	the ostium	the nostril	no plaque	restricted leaflet motion	an angiographic sequence	grafts	lacunar infarcts	the major coronary vessels	coronary angiographic evidence	relative changes	% diameter reduction	mucosal atrophy	a 3.87-fold increased risk	multicenter study	life expectancy	coronary lesions	carotid artery disease	venous anastomosis	the neoPA	the peripheral pulmonary artery	leukoaraiosis	plaques characteristics	The patient underwent percutaneous transluminal angioplasty	pulmonary vessels	physiological derangement	mild coronary artery disease	the middle meatus	ventricular systolic dysfunction	EF	septum deviation	graft occlusion	malformation	disc	plaque	] degree	valvular disease	parenchyma injury	aortic valve hypoplasia	Mixed congenital mitral regurgitation	The evolution	the nonculprit lesions	self-expandable metallic stent	either branch	constricted patent ductus arteriosus	intracranial atherosclerosis	140-209 cm/s	increased scarring	pulmonary arteries	native vessels35	a pulmonary artery embolism	ectasia	acute lacunar infarcts	invasive indices	reduced vascular elasticity	the clinical condition	renovascular hypertension	unspecified occlusion	informative model	other coronary artery segments	pseudo aneurysm	any degree	evolution	occlusion	secondary stroke-prevention	coronary pressure measurement	stroke recurrence	vessel	prolapse	the middle ear	a flow-volume curve	malacia	clinical attention	pulmonary artery branch stenosis	subclavian arteries	movie	the non-predictable significant tendency	patient discomfort	pulmonary artery	a rheumatic process	thrombogenic plaque characteristics	cardiac valves	the actual midascending diameter	aortic coarctation	semilunar valve insufficiency	right middle cerebral artery	the branches	any grade	significant between-study heterogeneity	diameter	Correct diagnosis	asymptomatic atherosclerotic carotid arteries	vascular events	no stenosis	widespread cardiovascular disease	eventual calcification	pre-cerebral arteries	significant pul-monary vein	a high incidence	concurrent vertebrobasilar	the dynamic progression	irregular lumen	the arteries	fistulation	the following inclusion criteria	ileo-ureteric anastomotic stricture	b-blocker drug	native valve diseases	all degrees	calcific aortic valve stenosis—fact	spectrum analyses	active tuberculosis infection	a local degree	the accurate evaluation	deformity	plaque characteristics	leakage	stents	neoostial orifice	the intrauterine	disease guidelines	plaque extent	previous report	interpretations	intracranial extension	major cerebral artery occlusion	popular assessment tools	the posterior circulation	aortic valve calcification	chronic coronary artery aneurysm	angiographic assessment	genotype carriers	microvascular brain damage	a leading cause	the distal arteriotomy	medical treatment Patients	distal occlusion	balloon angioplasty	a restriction	mean	the outreach clinic	intracranial arterial stenosis	an early myelographic study	coronary disease	the formulas	% versus stenosis	the high grade	distal internal carotid arteries	avoid descriptive terms	cardiovascular events	neurovascular compression	any displacement	the supraclinoid	Level	The percentage diameter	flow reserve	lipid-rich necrotic core plaque	the mitral valve	the final combination	wm	The degree	Such findings	the vessel	Echocardiographic findings suggestive	a high degree	the asymptomatic patients	the noninvasive detection	left ventricular outflow obstruction	ventriculomegaly	good sensitivity	arrows	cerebral atherosclerosis	a web formation	draining	the cavernous portion	immediate angiographic documentation	a bypass graft	no other apparent neural tube malformations	previous population-based studies	orthothopic heart transplantation	anastomosis	plaques	outflow obstruction	anatomical high risk	the present	artery	the mitral prosthesis	Reversible cerebral segmental vasoconstriction	plaque rupture	stenosis grade	main pancreatic duct	revision	the alar	invasive coronary angiography	intraplaque hemorrhage	Procedural success	the symptomatic status	the anomaly	osteoneogensis	the nasal valve	artery origin	any pulmonary hypertensive changes	the various risks	early mortality	carotid occlusive arterial disease	the median degree	findings suggestive	success	extracranial vessels	a cavography	Vessels	a silent asymptomatic course	Predictors	annual rate	the posterior inferior cerebellar artery	calcification	The ultrasound grading	No reclassification	the renal artery	isolated left-sided papillary muscles	an occlusion	cerebral arteries	% degree	severe innominate vein	the maxillary sinus opening	the internal jugular veins	iliac limb thrombosis	a second view	congenital	the angiographic degree	mitral valve hypoplasia	mitral valve regurgitation	internal carotid	congruent	the causes	right subclavian arteries	grading	no right	further spinal cord decompression	leak	3-vessel disease	the carotid artery	intramural thrombus	the cognitive function	both carotid arteries	a degenerative valvular disease	minimal plaques	the lumen	aortic valve regurgitation	Aortic regurgitation	the canaliculi	stenosis characteristics	The past medical history	stroke patients	aortic valves	the alveolar component	the rectal wall	cerebral hypoperfusion Treatments	systemic venous baffle	invasive quantitative coronary angiography	the internal carotid artery	venovenous vessel	the anomalous pulmonary veins	common area	Occlusion	the arch vessels	circumflex	the cut-off diameters	cardiovascular pathology	cervical vessels	web	a stent	transthoracic echocardiography	vulnerable plaques	the fragile nature	bicuspid valve	reactive right ventricular hypertrophy	A 7-Fr sheath	the urinary tract	the branch	pseudo-aneurysms	
3-dimensional echocardiographic study	
the treatment summary	beneficiaries	the follow-up strategy	a treatment summary	
small doses	intravenous infusion	
several factors	s law relating volume	percutaneous interventions Circulation	pinprick	velocity time	chocolate	an inflammatory phenotype	volume load	attenuation	30-40 mmHg	equation	a series	deferrals	heart rate variabilities	pain radiation	normal highlanders	the defects	the intra-compartmental differences	mechanical stimuli	neck movement	diastolic factors	volume	both peak	noninvasive methods	inspiratory flow	retinal arteriolar narrowing	iv	low cere- brospinal fluid	a pressure transducer	temperature regulation	the shear	low-pressure conditions	strain	any build-up	algometry	the mid-diaphysis	increased end	volume loading	a generalization	blood flow curves	contraction	No significant effect	matrix strain	aortic pulse wave	heat-	flow	drainage volume	volume-regulated ventilator	the appli- cation	Questions	ureters	reduced compliance	aortic pulse pressure	significant elevation	a multidisciplinary treatment	aortic valve leaflets	L-malposed aorta	venous backflow	a similar degree	some shortcomings	systolic pulmonary artery	baseline value	a revisit	the esophagus	sinus pressure	no major differences	0.35-1.3	a routine annual examination	aid	Each day	The prosthesis	body center	cardiovascular risks	post-CPAP treatment	+14±5 mmHg	the loss	ventricular hypertrophy	total lung capacity	sharp shooting	a condenser humidifier	intake	volume preset	This phenomenon	experimental atrial fibrillation	the body box	alternative indices	the tympanic membrane rapture	specific contribution	the future.Fig	noxious mechanical stimuli	intracardiac volume	the corresponding change	the renal collecting system	the discrepancy	apparatus	the local speed	the ventricular septum	heart rate responses	effective pressure level	the demand	a few hours	aasta trendid	normal protein	peripheral arterial occlusive disease	intravasal pressures	tube removal	0-60 mmH2O	the cardiovascular system consist	midface pain	Oligoclonal bands	a gradient	coronary flow velocity	the passive upper airways	vessel recanalisation	the pulmonary vasculature	deviatoric stress	Antithrombotic Trialists	these secondary indices	each evaluation site	rapid vibrations	the cutoff pressure	paraformaldehyde	a significant epicardial coronary stenosis	diastolic elastance	type mixt	awkward head positions	a normal pulmonary artery	paroxysmal pain	atmospheres	the overestimation	cardiac parameters	lipid levels	mmH2O	the initial radius	ventricular contraction	the sheath	the stomach	unjustified antibiotic prescriptions	a saline-filled catheter	the endosteal surface	air bag body temperature	the recording	patient expectations	non-uniform distribution	oxygen concentration	direct catheter measurements	the catheter tip	mm/hg	nonevanescent waves	−0.119−3	clinical care	caution	traction	triacylglycerol	no clear explanation	a ligature	aortic stiffness	hyposmia	high-sensitive C-reactive protein	upper esophageal sphincter	consent √	intraluminal flow	shear stress	an estimation	the circulation	interstitial flow	lung volume change	Pressure	an epicardial obstructive stenosis	the temperature	abdominal content	bilateral small subdural fluid collection	‘ hearing aid stigma	perfusion pressure	the peak rate	level correlates	touch	iii	0.38-0.9	blood oxygenation	thermal pain hyperalgesia	focal cerebral ischemia	strict control	a randomised parallel trial	balloon volume	electrolyte excretion	emergency admissions	gases	an evidence-based medicine perspective	visual field	sinus massage	proinflammatory gene expression	this pressure	retinal venous distension	] i.e	intracranial blood volume	multivariate logistic regression model	the same temperature	a negative correlation	standard sphygmomanometer	hepatic venous pressure	the biological response	p6	pressure variation,142,143	adult cIMT	antitussive effect	trajectories	p-Value	the resulting increase	atrial septum	body temperature	the right arm	one-dimensional models	factor kappa beta	plethysmographic volume	80-100 mmHg	dP/dt+	shear stress regulate matrix metalloproteinases	the infant	thrombus	pressure transducer	the principal manifestation	rapid eye movement	each respective patient	a low cerebrospinal fluid	individualised observations	Estimation	Intraoperative monitoring	the minimal amount	a pulsatile behavior	.44	antegrade route	complete blood cell count	the cut-off values	fluid flow	glucose independent renoprotective effects	catheterization recordings	voltage signals	direct application	the diseased cases	arterial carbon dioxide	complete revascularization	important factor	the result	expiratory	inflations/min	high temperature	a flow rate	cuff sphygmomanometer	pathogens	intracranial elastance	Preoperative hemodynamics	parameter line	quick rise	dp/dt	the intra-ventricular balloon recordings	other trauma patterns	continuous analysis	ischaemia	the range	A radio telemeter	the device	orthostatic headaches	employee	autonomic responses	pO2	hospitals	dysfunction	an estimate	measuring	coronary artery disease	millimeter	an electronic blood pressure monitor	whole body centre	aortic flow	intra-tracheal catheters	poststenotic hyperemic coronary flow velocity	arterial blood	any patient	concerted cycles	inflow	chest heaviness	haemoglobin	inspiratory reserve volume	systemic blood pressure	compliance and/or efficiency	vascular strain.32,33	malformations	the banding	a non-linear shock	pulsatile tinnitus	right ventricular	aid stigma	the entire reduction	heart rates	pinprick etc	Airways resistance	no evi- dence	the monkeys	spatial variations	a blast	peak exercise pressure	indices	tension reception	The left pulmonary artery	applica- tion	Mechanical strain	flow rates	continuous airflow	non-culprit lesions	Ventilator pressures	high arterial perfusion pressure	blast wind ”	possible leakage	the plantar reflexes	a first sensation	The right ventricular volume	direct measurement	pulse rate	arterial compliance	mean anteroposterior centre	a complex interplay	volume waveforms	an abrupt drop	temporal evolution	plateau pressure	mean values	an automatic recorder	morphogenic protein-dependent manner	high-density lipoprotein	The interrelationships	infra	the vessels	outflow tract obstruction	right atrial	dull ache	hypertensives	mmhg	seep	the absence/presence	any side effects	this vessel	a multiple logistic regression model	a recent small study	a potent inhibitory effect	no load	important role	echocardiographic estimation	abnormal stress	cardiac oxidative stress	ml air increments	pulse oximeter	closing	pulse pressure	different levels	diabetic hypertensive patients	the various stimulus modalities	small subdural fluid collection	the radial artery	trigeminal nerve fibers	bioelectrical impedance	cardiac performance	The recovery	the individual components	the anterior optic nerve	lipid profile targets	transpulmonary gradient	the patient valve structures	vibration perception	The target expiratory flow	dietary salt	cyclic stretch	the experimental difficulty	regional lung overdistension	Right ventricle	rises	h	average mediolateral centre	fluid velocity	the pons	radius	a 26-gauge needle	end-inspiratory plateau pressure	the intracranial blood compartment	invasive determination	data acquisition card	supraorbital axial planes	cIMT	mean pulmonary artery	a consensus approach	the flow range	phases	kV	the advanced auto-inflate blood pressure monitor	intramedullary pressure	the right ventricular function	fluid volume	cmH2O pressure support	the proper choice	occipital headaches	n=7	velocity	white-matter disease progression	circulation	residual volume	both cIMT	the tracheostomy	extracephalic locations	mechanical allodynia	coma scale	time/Pulmonary artery	hypokinesis	footprint contact area	flow distal	routine blood work	flow pulsatility	zero reference	all directions	the eye	taste	kHz	inhaled air volume	excessive volume	red line	arterial oxygen	constriction	the so-called deceleration time	Low cerebrospinal fluid	this measurement	any increase	the tricuspid valve regurgitant jet	esophageal sphincter	anonymity	time-lapse images	the upper airways	manoeuvre	The inflammatory response	air friction	flow rate	semi-lunar valves	a hepatic vein	volume values	ways	final assessments	pressure blood flow	the pressure	cm2	ratio12	arterial stiffness	the momentum changes	any object	a mercury sphygmomanometer	0.15-0.71	normal right atrial	low vacuum mode	the spinal cord	planimetry	glycaemic effects	flow velocity measurement	the ventricle	no burning	A statement	+dP/dt	girls	side-locked headaches	intravascular flow velocity	piston	pulmonary artery occlusion pressure	ventricular ejection fraction	check	overall cardiac output	↑ volume	surface expansion	diffuse pachymeningeal enhancement	height	The absence	local tender- ness	Altruism	metabolic efficacy	the arterial gases	central hemodynamic measures	disease diagnosis	7-8 mmHg	aortic cross clamping	calcium channel blocker	ventricular volume	pulmonary artery anatomy	the peak velocity	no definition	the compartment syndromes	the effective pressure level	lung lavage	systemic vascular resistances	late-life cognitive function change	applied pressure	dimension	Treatment conditions	anterior chamber depth	the other line	the vertebra	q.o.l	Measurements	point	longitudinal assembling	spinal cord injury	5-8 minutes	a reduced cardiac output	moderate local tenderness	oscillometric blood pressure device	Pain thresholds	the vertebral body	the appropriate frequency	low values	inferior vena	pulse-wave velocity	path length	arterial elastance	care unit	peak rates	thoracic epidural analgesia	standard temperature	a peak pressure	tidal volume	infection/ear problems	myofascial trigger points	increased pulmonary artery	optic nerve diameter	a diastolic pressure gradient	careful application	intraorbital increase	a deep sensation	this assumption	a side port	Various Clinical Parameters	sequor	collateral flow	congested veins	volume overload disease	alters	sterile pericarditis	a certain amount	the combined effect	an uneven distribution	weight gain	the only cause	the free wall	hear rate	palpation	the cerebrospinal fluid	reduces pressure consumption	dP/dt	the hearing aid rehabilitation questionnaire scales aid stigma	and/or sensation	gentle finger rubbing	ventricular	jaw movements	cyclic mechanical strain	The low sensation	pain trigger points	ejection fraction changes	air flow	cerebral white matter share	s equation	distending	inflammatory endpoints	a function	C-reactive protein	Images	atm	myocardial performance prolongation	mitral anulus	convective component	cortical activation	the postoperative right ventricle	the right atrial	citizens	blood flow	the declaration	the mean ratio	trochanter	electrocardiographic tracing	ligamentous laxity	manual sphygmomanometer	the oxygen source	hydrochlorothiazide	human leukocyte antigen class	the obstruction	polygraphy	the law	a major determinant	low sugars	atrial volume	suprapubic pain	minute intervals	the absolute value	lactate concentrations	hypertrophy	The respiratory system	pin prick	resveratrol-treated groups	atrial natriuretic peptide	clinical presentation	public awareness	anthropometric data	local tenderness	Volume	a diagnostic lumbar	right	a hard copy	throbbing	coronary heart disease	colour maps	long-term deleterious effects	Routine investigations	190/0-6 mmHg	End-Systolic Pressure	actual flow rate	cardiac contractility	pontine flattening	total correction	the same amount	.15	low cerebral spinal fluid	cardiac output	inspection	stroke risk	the leak	collapsibility	handle	antihypertensive treatment	systolic pressure	the posterior ciliary arteries	diastolic function	a similar appearance	end-stage renal disease	the first minutes	a transient rise	the isovolumic relaxation period	friction	pain detection thresholds	26-gauge needle	mercury	the needle	all prong sizes	the proximal	a face mask	obligation	repeat donors	secondary indices	the inferior wall	airway pressure	adaptability/ability	the measurements	the stress	the abrasive water jets	arachnoid membrane becomes	positive airway pressure	stretches	protamine administration	the great cross-sectional area	Systolic elastance	a substantial blood pressure response	ARC	abdominal compartment expansion	a specific therapy	ill premature infants	the combined effects	signal reappears	facial heat	a suspicion	cmH2O	chlorhexidene	a hearing aid	barotrauma	frequent repositioning	peak velocity	the skull base	constant ”	flow velocity	vascular risk management	the spatiotemporal maps	site	any elevation	pulse	several flow	waveforms	airway resistance	timing	low levels	a random	levels	the inability	Ascites	pulse wave velocity	a rise	the maximal altitude	branches	slab thickness	Reduction	a slight change	a pressure/volume ventilator	unilateral diaphragmatic paralysis	antihypertensive drug treatment	a tumour mass	sexual dysfunction	respect	body mass	volume shifts	molecular mechanisms	sternotomy	ureteral contractility	convection	pharyngeal pressure	a ventilation mode	transducers	the atrium	insufflation pressure	a surrogate	diastolic measure	an “ umbrella handle ”	high filling pressures	a modest gradient	paralytic patients	vivo measurements	suture retention	an immediate intervention	the occipital nerves	the load	stretch	the interventricular septum	positive end-expiratory pressure	The school environment	traumatic brain injury	a healthy volunteer	The blast shock wave	active myofascial trigger points	the approach	intracranial volume	any further elevation	cm	hormone-replacement therapy	high saturations	device	the cylinder	stabbing	the collateral perfusion	the entire population	cwp	systemic cause	pulsation	opening time	Structural changes	a certain point	left ventricular	a new formula	the automatic oscillometric method	normal transduction	personal distress	respiratory exchange ratio	diurnal blood pressure variation	active renin	the provision	formalin	inflammatory kers	a preset respiratory rate	the spatial gradient	long-term durability	compensation unit	aids	neurofilament-heavy chain	future experimental studies	the Australian trial	the sudden increase	the low resistance	normal cerebrospinal fluid	expiratory pressure	systolic blood pressure/DBP	heat	sub-atmospheric levels	aortic input impedance	the outlet	second peak	positive-negative pressure	a volume	high-frequency	systolic aortic pressure	path measurement	the left ventricular end-diastolic diameter index	flows	emboli	Pathophysiology	no papilloedema	elastance	volume status	gastric	the woman	differential flow	a low ejection fraction	contractility	other cardiovascular comorbidities	estimate	flow resistance	these cavities	that port	retinal vessel signs	a radioimmunoassay	the node	the mean time difference	an inadequate equalization	mmHg	
an optical light	corrosion casts	The histology	a combined light	intrabronchial growth	the mossy fibers	the central nervous system-a light	the thalamostriatal projection	a light	mast cells	hibernation	light microscopic	vivo	
protozoan infections	oral squamous cell carcinoma	
The sigmoidoscopic picture	CD	top	reliable experimental acute	% sensitivity	chronic diarrhea	
prospective comparison	jejunostomy	percutaneous endoscopic gastrostomy stoma metastases	tube placement	Fiberoptic endoscopic evaluation	nasogastric tube	gastropexy –	-Syndrom	nasogastric tube feeding	
mineral imbalances	metallothioneins	adaptive immunity	[ 61-64 ]	severe clinical manifestations	low level mercury exposures	immune activation	tartrazine	maternal dietary zinc deficiency	niger	further research	zinc toxicity	copper gain	these food color additives	


the support	31ser-arg polymorphism	prostate cancer metastasis	

competitive electrochemiluminescence immunoassay	synthetic glucocorticoids	nora- drenaline	no concentrations	enhances	circadian variations	the major active glucocorticoid	the luteal	group comparison	high blood levels	the MR	the synthesis	carbenoxolone	this paper	plasma catecholamine levels	small aldosterone	free concentrations	proatrial natriuretic peptide	This relationship	haptoglobin	apical hypokinesia	the augmented release	testosterone levels	the systemic inflammatory markers	subtle autonomous production	other dependent variables	circadian rhythmicity	brain oscillations	thyroid hormones	open-heart cardiac surgery	substance	daily biosynthesis	ACTH-stimulated adrenocortical cells	lowered production	aldosterone	increased secretion	renal-specific 11β-hydroxysteroid dehydrogenase type	mmol/L	salivary flow rate whereas	hormone	stimulation test	leptin secretion	plasma platelet levels	serum intact parathyroid hormone level	each allocated time point	subjective responses	These rhythmic oscillations	the actions	free cortisol	chemiluminescence assays	The serum levels	ng/dL	the neuroendocrine system	prostaglandin	growth hormone	copeptine	dependent variables	increased concentrations	this rhythm	no gen- der differences	plasma cate- cholamine	free thyroxine	fetal protection	µg/dL Non-survivors Survivors	The concentration	gm/L	the deregulation	plas- ma	prolactin levels	non survivors	a high tetrahydrocortisol	neurophysiologic data	glucocorticoid receptors	the prevalent glucocorticoid	a high level	DHEA-S	psychosocial stress	μg/dL	an interactive effect	an aldosterone mimic	the hip	The secretion	adrenaline	ug/dl	an adrenal mass	qualified profiles	urine screen	immunoreac- tive insulin concentrations	the adrenal glands	One-year post-resection	corticosterone	minutes cycle	thirty minute intervals	regional cerebral blood flow	neurohormonal systems	glucagon	Experimental equivalence	pre-simulated flight	pituitary/ectopic tumors	optimize function	monthly plasma concentrations	facial thermo-images	the secretion	total concentrations	adrenocorticotropic hormone	thromboxane	day-5	catecholamines	urinary metabolites	gonadal hormones	different intervals	session	prolactin	The mean serum level	diminished release	serum ferritin	testosterone hormones	hormones	lead	pg/ml	the adrenal cortex	The catecholamine	the increased release	hor- mone	the pathogenetic role	the paired samples	metabolic markers	testosterone	salivary prostaglandin	the noise	the enzyme 11β-hydroxysteroid dehydrogenase type	hormone levels	parathyroid hormone	the rhythm	salivary testosterone	selectivity	noradrenalin	blood parameters	serum levels	regression coefficients	
any episode	multiple bouts	ventricle	Example	any triplets	no significant increase	surgical management	clinical risk factors	5-beat runs	the recovery	multiple factors	incidence	arrhythmogenic CD	prolonged bursts	
coronary microvessel dysfunction	asymptomatic atherosclerotic carotid plaques	carotid stenosis	Wackers	a speech stressor	overt atherosclerosis	asymptomatic coronary artery disease	coronary artery disease status	non	opioid receptor activity	renal transplant recipients	restenotic process	the non diabetic population	the diabetic patients	endorphin responses	a p value	no coronary artery disease	stable angina pectoris	sexual activity varies	
premature loss	residents	enamel hypoplasia	acute health disorders	molar tooth development	acute health effects	tooth maturity	early health effects	ash	observational epidemiological studies	
the rapid injection	autoimmune encephalitis	statin	the medium	both low dose	serelaxin	the immune response	the limited ability	Oral ns-NSAIDs overall low dose	a continuous infusion	cardiotoxic	cerebral activity	repeated doses	the survival rates	any clinical benefit	the smoke exposure	residual tumor	capsaicin	toxicity	the thalidomide	μg/kg/day	methyl prednisolone	The lungs	abrupt discontinuation	iv anticonvulsants	mg/kg body	a dose	medium dose	phenobarbital	lung	a marginal level	the instillation	death [	an isogenic mutant	adrenal insufficiency	a cardiomyocyte-specific knockout	os	toll-like receptor	adefovir	other steroid	The seizure control	bacterial load studies	the bladder	stay	Perinatal neuroprotection	gamma irradiation	inotropic support	IL-8 production	opioids	μg/Kg/min	stereotactic radiosurgery	a proportion	antigenic stimulus	comparable anti-inflammatory activity	fluticasone	leukotriene modifier/theophylline	mr-2	These animals	corticosteroids	effective doses	these drugs	Other lipid-lowering agents	some leeway	a useful use	Co-treatment	pentobarbital	Parenteral ns-NSAIDs overall low dose	post-immunization	norepinephrine	paw volume	vaccine	carbohydrate	repeated local injection	tuberculosis-polymerase chain reaction results	preoperative statins	ethanol	any dietary effects	a multivitamin	.7,122–125	phospho-specific antibodies	low dose	near-continuous oral corticosteroids	an acute	m-2	immunosuppressive therapy	pyridoxine	the strength	preliminary studies	cocaine	

pathological features	both breasts	the inflammatory response	a 25-year experience	a mouse model	duct ectasia	infectious forms	The interrelationship	breast mastitis	a potential treatment	nipple discharge	lactation insufficiency	chronic mastitis	breast disease	women—Indiana	benign breast diseases	
hyperosto- sis	cranial nerve palsy	osteonecrosis	periostitis	hyperostosis	Synovitis	generalized pustulosis	skull base	synovitis	
strenuous exercise	airway constriction	enhancement	respiratory heat exchange	altitudes	biathlon	hyperventilation	spicy foods	fumes	nose	a variety	bronchial responsiveness	−15°C	
induces	the presentation	lumbricoides	a reaction	the initial dose	inhalable pollutant	both inhalable pollutants	FEV1+sensitisation	an adverse pathogen	mice	function changes	epithelia-dendritic cell communication	an event	saline	the actual levels	trafficking	enhanced cytokine production	shift	challenge	Animals	eosinophil recruitment	unbalanced challenges	animal approaches	the cross-linking	an additional moderate-level challenge	postnatal Lgl1+/- mice	the late asthmatic reaction	the mucosa	diesel exhaust	the action	Co-administration	cross-linking	activity differs	FVC+sensitisation	eosinophil infiltration	penetration	saline challenge	a systematic objective analysis	individualized doses	a controlled exposure study	anti-asthmatic effects	culturable fungal concentrations	a complex mixture	windows	
noise	sign	retroclival hematoma	meningitis	




overload	


Another potential limitation	an educational approach	novel immunomodulatory agents	the Departments	10th edition	cognitive behavioural therapy	co-transplantation	both infusion rates	the induction phase	viral shedding	psoralen-UVA	revision surgery,4,8,17,20	tissue engineering	a plateau	non-ICD therapy groups	rituximab	breast cancer risk	the respective diagnostics	human pituitary-adrenal function	significance	differences	swine pulmonary surfactant	top right	polysulfated glycosaminoglycan treatment	these preconditions	Granelli-Piperno	negligible value	a prolonged course	oophorectomy	cardiac rhythm abnormalities	contrast	e9	focus groups	occupational therapy	Chemoradiotherapy	the mainstay	autologous stem cell transplant	randomized clinical trial	poor oral hygiene	recombinant porcine	anti-tumor necrosis factor antibody therapy	acetylsalicylic acid	these antibodies	basiliximab	this rare condition	• Adherence	guidelines.1,86	sachet counts	breakdown products	an appropriate choice	rational use	early echocardiographic assessment	a bleomycin-containing regimen	correctors	clinical indications	repeat echocardiography	efficacy data	al7 described	specific disease histology	each cycle phase	electrolyte substitution	The challenges	lung inflammation	first year	other treatment techniques	a second dose	physicians	pre- versus	early discontinuation	mutation carriers	waist circumference	POPULATIONS	a fluctuation	the urinary pH	oxaliplatin	the favorable outcomes	room air	project	embolic complications	the aid	bubble technique	liposomal formulations	study series	molecular basis	the announcement	endometriosis	general activity	bevacizumab	consecutive increases	a target	a promising agent	serum creatine kinase levels	chromatin immunoprecipitation	significant diarrhea	mainstream treatment	Quality-of-life improvements	no clinical benefit	a common form	gemcitabine	tailoring	and/or severity	cranial paralysis	increased attention	the second year	immunocompetent model	Satisfaction	exploratory analysis	cardiac risk factors	rheumatoid arthritis patients	treatment recommendations	no long-term randomised trials	cancer prevention	the above retrospective database studies	antitumor immunity	different bacteria	nature	cost-effectiveness	study drug treatment	tailored management	positive women	an increased perception	maturation	the machine	thrombotic thrombocytopenic purpura	the tongue base	hormone therapy	siRNA-DOPC	candesartan cilexetil	ventilation	confers	mortality benefits	progressive muscle relaxation	syndrome phenotype	coronary interventions	any potential immune aberrations	thymidylate synthase	a six-month course	the cumulative effect	vasoactive medications	topiramate	diagnostic hypotheses	carfilzomib	cellular effects	the study drug	cryptorchid infants	a meta-analysis	ineligible patients	subclinical tests	molecular diagnosis	∗Shock index	turbulent flow	Rapid tapering	restrictive cardiomyopathy	the positive effect	congenital peripheral pulmonary aneurysm Annals	the 90th day	Duration	cytokine receptor pleiotropy	the initial course	metastatic disease	clinical practice guidelines	acebutolol	either inappropriate	surgical therapy	other professionals	these clinical conditions	lobe	a further therapeutic option	the antihypertensive efficacy	the classic effect	low-dose glucocorticoid	third day	fibrillation	human umbilical cord blood cells	the serum level	viral hepatitis	clinical prediction guides	placebo-controlled trial	The new headache pathogen	streptokinase stimulates	idiopathic causes	chronic cluster headache refractory	a prolonged titration	localized prostatic cancer	physical health problems	large numbers	document	rTFPI	long term survival	partial obstruction	nilotinib	acute T-lymphoblastic leukemia	myocardial angiogenesis	action	bosentan	specific aspects	aureus	chromosomes	cardiac resynchronization therapy-defibrillator	the therapists	tumor-associated antigens	thyroiditis	a 74-yr old patient	the clinical investigation	steady-state concentrations	choral speech	p.	conduct disorder	median spot	hence control	long-term persistence	the average headache	disappear	individual neuropsychiatric disorders	additional chemo–	:1 –7	cellular dehydration	healthcare utilization measures	Basics Principles	an all-trans retinoic acid	Innovation	a current case	the thyroid cancer	benazepril	radiofrequency ablation	the major focus	steroid treatment	the left periadrenal region	clinical failure	vestibular diagnostics	normocapnia	oncolytic adenoviruses	the first-line	accessible tumor	calciunerin inhibitors	multiple cerebral areas	pLADD	an integral component	medication possession ratio	long-term anticoagulation treatment post-stenting	an adverse clinical course	busulfan	prognosticating	progression	.Patient satisfaction	the future application	ventricular arrhythmia	opioid physiology	ambulance	reperfused hearts	neurotransmitter systems	important treatment outcomes	autoimmunity	this combined method	annual periods	mild chronic obstructive pulmonary disease	the taciturn apothecary	pg/mL	an implantable defibrillator	possible infections	relevant prescriptions	the current literature	cells prevents	antihistamines	the rejection	the cohort	etc	score change	systemic chemotherapy	pathological characteristics	neurotological diagnostics	time delay	a significant reduction	sleep-related disorders	multifocal prostate cancer	reduced mortality	the blood pressure goal	the raised neural activity	treatment adherence	age-related macular disease	bite adjustments	Consortium	cough-related headache	anti-tumor efficacy	Various methods	anti-epileptic drugs	this era	tendinitis	the aminoadamantanes	significant increases	neuropsychological tests	the lung biopsy samples	the surveillance algorithms	the frequent occurrence	a program	common side effect	scale response	the evolution	no prior study	unnecessary investigations	clinical manifestations	any nausea	clinical rating scale	syncytial virus prevention	future role	potassium	hs-CRP levels	ampicillin	clinical events	prostate cancer imaging	] treatment	8-week post-therapy visits	this effect	inhalers	These benefits	a rapid evolution	re-institution	red blood cell transfusion policies	:213–20	Median duration	many non-pharmacological therapeutic interventions	cladribine	grant	α-blockers	hr	thromboxane biosynthesis	behavior	epoetin	a hypomethylating agent	transfer	This combination	cardiac death	classical gene therapy	inflammation-associated colon cancer	death	a single agent	antiangiogenic treatment	mL	Microperimetry	a descriptive study	frequent circumstance	prolonged myelosuppression	serum creatinine level	adaptive servo-ventilation	periodical limb movements	the general strategies	several other modalities	peripartum cardiomyopathy	both pharmacologic	indicus pranii	Afterwards	a key component	maintenance doses results	azilsartan/chlorthalidone	this range	immunocompromised hosts	temporary side effects	limited information exists	dosages	responders	betalapachone	the third week	skeletal metastasis	end	symptomless	length	interesting models	aromatase inhibitors	the 6-month readmission rates	routine ultrasound examination	stone removal	influence	sleepiness	medications	unnecessary invasive procedures	a pilot	the usual tension pneumocephalus	appropriate antibiotics	a previous study	9-12 months	8-13	bisphosphonate-related osteonecrosis	the curative potential	no severe side effects	c.867	lines	alpha antagonists	the conventional therapy	consent	Optimal length	force	subsequent weaning	treatment guidelines	funding	intravenous amiodarone	EuroIntervention	discontinuation	des	A good example	mitogen stimula-	azacitidine vs induction chemotherapy	early treatment	inadequate responses	recurrent disease	the clinical outcome	intrathoracic impedance monitoring	adjunctive drugs	underlying illness	tiotropium bromide	low compliance	delamanid	tetraspanin	nonmetastatic disease	shunt procedures	the potential	related cases	the common beta chain	current management	genetic basis	the intention	refractory heart failure	Primary goals	important obstacles	the instigating factor	Comparative studies	this syndrome	the recommended duration	severe deficiency	The time	these physicians	the absolute behavioural gain	multiple myeloma	metastatic gastroesophageal adenocarcinoma	These modifications	intracardiac hemodynamics	oral corticosteroid	inflammatory infiltrates	End	per-protocol population	one-way analysis	the desired outcome	a way	results	physical therapists	The current status	successful element	disease-free time intervals	deficient mice	infant primates	recombinant tissue-type plasminogen activator	evolution immune competition	The inadequate persistence	any drugs	psoriasis Nature	recruit patients postcompletion	the initial mode	aggressive supportive care	the high cost	day	these new agents	the pilot study	2-5 minutes	many parameters	basal cortisol	platform therapy	oral anticoagulant	cancer biology	this case	ipratropium	beta-agonists	david.woods	related side-effects	infective endocarditis	≤6 doses	long-acting bronchodilators	acute otitis media	trade name	the vasculature	autologous hematopoietic transplantation	the switch	inserted needles differs	cardiorenal syndrome	progressive disease	short-acting β2-agonist	autologous bone marrow transplantation	coronary arterial aneurysm	major limitation	the financial implications	human hepatocellular carcinoma	an important part	physical maneuvers	a 14-day interval	valve	an attempt	protease inhibitors	imatinib.30	significant renal insufficiency	The promising potential	clinical statements	different subpopulations	hemosiderosis	polypharmacy	coronary artery bypass	cross-over group	many authors	an avenue	platelet dysfunction	stable asthma control	week block	centre	the overall duration	elderly heart failure patients	reduced numbers	socioeconomic	demographic data	the brain-dead organ donor	varuna	diagnostic imaging methods	no therapeutic trials	radionuclides	clues	Prevention	the protease inhibitors	Taiwanese aborigines community	a change	eosinophil chemotaxis	low bleeding risk	lupus	guide features	steroid-induced osteoporosis	the step-up sample	All other forms	sub-components	recombinant factor	0.393-1.833	hospital system	patient education	safe strategy	these diagnoses	migraine- preventive therapy	high-risk lipid abnormalities	donor infection	reliable diagnostic strategies	the arbitrary nature	These data support	vocal fold paralysis	ezetimibe	The backbone	intraperitoneal	alpha 1-antitrypsin deficiency	secondary prevention	the current era	The prognostic impact	further hospital admissions	revised form	customization	new oral anticoagulants	program	the only independent predictor	β-blocker dosage titration	severe renal impairment	Papillitis	inadequate adherence	nonresponders	blood sampling	a future transplant	effective care	no seizure recurrence	An increase	interruption	non responders	//www.fda.gov/Safety/Med-Watch/ %	the anti-tumor effect	BRCA1-mutated tumors	The administered venotonic	improved multiple myeloma	alert cards	the schemes	antihypertensive agents	tumor diagnosis	The toxicities	the formal pathogenesis	Issue	enhanced tumor-specific immune response	decrease	other chronic illnesses	a multi-institutional experience	the group	no respiratory symptoms	personalization	outcome inferiority	conjugate	calcium	therapy reduces	advanced melanoma	colitis	the availability	Boards	al8	malignant growth	early predictors	biomechanical responses	ventricular tachyarrhythmias	the intensive induction phase	The mutational spectrum	the anemic condition Abbreviation	Cognitive function	test results	biological activity	Intramuscular anti-HER2 antibody gene transfer	trastuzumab	treprostinil	weaken others	the place	immune homeostasis	appropriate applications	chemoimmunotherapy	increased length	both diseases	different nifedipine formulations	several steps	acute airway infections	cardiac serum biomarkers	botulinum toxin type	a large randomised trial	symptomatic partial upper airway obstruction respond	Yates	molecular weight heparin	intraocular corticosteroid	relevant evidence	poor adherence	flu-like symptoms	manufacturer	high concentration	the primary goals	complete surgery	ventilatory response	anti-tumor necrosis factor	killer cells	liaison	consistent	phase cyclins	a comprehensive search	further evaluation	simplification	undesirable systemic side effects.5,8,21,22	implementation research	the physiology	The adequacy	odds ratio=6.16	postoperative atrial fibrillation	the advanced stage	the cardiac catheterization lab	antiplatelet therapy	electromagnetic field	common bacterial infections	effective continuous positive airway pressure	painful metastatic bone disease	choanal atresia	This difference	advantages	these deleterious health consequences	the maturity	cutaneous melanoma	the relative decrease	:225	all lines	poor clinical outcomes.32–34	an intervention	% i.v	implant devices	additional part	a systematic comparison	vincristine-aspirin-ticlopidine	nonpsoriatic patients	% patients	retinopathy	directive counseling	some weeks	immune responses	right atrial catheter ablation	the only possibility	other global initiatives	the active tinnitus desensitization therapy	the so-called contact headache	specific classes	% interrupt	ventricular assist	underlying disease mechanisms	exercise therapy	diagno- sis	augmentation	A reduction	therapeutic strategies	observational cohort study	a chronic metastatic disease	neurological death	an accompanying	additional dimensions	g/kg/day	the herbal drug	either maintenance	Each form	the course	care edn	a cognitive behavioral group therapy	immunosuppressive history	iron therapy	small airway inflammation	anti–tumor necrosis factor	speech	superficial bladder	modifiable factors	each mouse	internal radiation therapy	zidovudine	clinical/conservative control	carnitine supplementation	cervical cancer	p=0.023	terminal renal failure	a substantial improvement	days	:37	extracorporeal circulation	counseling	stem cells	that particular drug	pacing rates	biological validation	pts	normative database	sublethal	vertigo/nystagmus	no primary care consultations	therapy regimen	The goals	//www.egms.de/en/journals/cto/2012-10/cto000078.shtmlVestibular diagnostics	human health	morphological type	//clinicaltrials.gov/show/NCT02099123	successful therapy	initial medical therapy	control group	favor p.o	the entire course	several side-effects	initial improvements	rFVIIa use	the left brain	autoimmune disorders	definitive form	intravesical agents	trastuzumab monotherapy	radiosurgery	a β blocker	healthcare utilisation	acquired mechanisms	a good reason	veterinary medicine	inactivity	recur	venovenous extracorporeal membrane oxygenation	many questions	a few case reports/series	The total duration	real-world populations	Chemo-	heated humidification	tumor hypoxia	salmeterol/fluticasone propionate	likely achieving	an inhaled corticosteroid	current status	oral voriconazole	.4	the gain	pulsed electromagnetic fields	high-dose interleukin-2	the maladaptive plasticity	anti-PD-1 antibodies	patients	Median diastolic blood pressure	the alternate arm	cardiac amyloidosis	direct reprogramming	prednisolone	placebo-controlled trials	atherothrombosis	an exploratory analysis	cPAP	acute promyelocytic leukemia	ramipril	several other methods	both infants	osteocyte-derived insulin-like growth factor i	the bronchoscope	pharyngeal carcinoma	Initiation	a prognostic yard stick	the mean duration	postmenopausal women	underlying lung abnormalities	breast cancer patients	the initial week	in-stent restenosis	the procedures	a real risk	effect size size	optimal medical therapy	adjuvant S-1 monotherapy	a large percentage	the concurrent administration	α=.82 Expectations	helper	cell transfer	previous line	pathophysiological basis	comparative study	used form	paclitaxel infusions	an acquired factor	a superior benefit	periodontitis group	mg/d	ideal combination strategies	individual progenitor colonies	idiopathic pulmonary hemosiderosis	a first-in-field non-blocking antibody	high-intensity	radioimmunolocalisation	enzyme inhibitors	other therapies	the fractions	the timing	p <	registration	cisplatin-induced kidney injury	the cardiac toxicity	systemic corticosteroid	vasopressor therapy∗∗	significant unwanted side effects	immunostimulatory strategies	retinitis	the nematode	response assessment	sputum	non-hip joints	revision surgery –	diuretic use	brain structures	familial hypercholesterolemia	possible molecular targets	pars	overall therapy	inverted papillomas	any respiratory support	second cycle	delirious pitfall	fails	poor persistence	Cardiovascular drugs	biology	the Long-Term Intervention	gefitinib	no consensus	satisfactory outcomes	the intracardiac electrocardiographic records	the 1-year arrhythmia event rate	Recent publications	a cost	panuveitis	microenvironment	a pragmatic trial	a small dose	current dosage	occur	NRG-1-treated mice	the newborn	no type	the Vicious Cycle	MTX-induced toxicities	the end	evaluation [	Another approach	distant failures	The daily cost	demonstrable way	dendritic cell vaccine	intravenous immunoglobulins	general experience	stable phase	autologous iPSCs	comply	renal cell cancer	multiple antiepileptic drugs	vestibular disorders	formulation	physiology-based diagnosis	the approved indication	tumour progression	intravenous bisphosphonates	cancer development	agonist therapy	breast cancer imaging	hepatocellular carcinoma	clinical improvement	'Music therapy	nonsteroidal anti-inflammatory drug	vestibular diagnostic tests	pembrolizumab	decreased suppressive function	insulin-glucose infusion	the escalation	the comparative risks	the episodic	median duration	malignancy	invasive markers	normobaric oxygen	No benefit	targeted therapies	urinary stones	treatment effectiveness	teratoma formation	neuroimmunological disorders	profound changes	the postoperative wound management	high dose insulin euglycemia	pediatric osteosarcoma patients	retrospective analysis	the only treatment modality	effective treatments	forgotten treatment	an elderly patient.6	arterial hypertension	Conclusion	recurrent hospitalizations	content	lengths	fenofibrate	reduced exacerbation frequency	some debate	Antithrombotic therapy	intensive human-resource allocation	serum transaminase levels	a potential target	nucleosomes	tumour burden	statin patients	the short-term use	lymphoma induces lesion regression	the utility	either tiotropium	The goal	these areas	multiple fractures	inhaled corticosteroids	potential targets	enalapril	close endoscopic surveillance	uncertainties	the microenvironment pathogenesis	combined imaging	human prostate cancer	emergence	inefficacy	no remission	the long-term follow-up	the disease activity	follow-up	heal	Natriuretic peptide concentrations	enoxaparin	any medication	advanced cervical carcinoma	benefits	extensive use	eicosapentaenoic acid	theory	a daily teriparatide dose	psychological types	clopidogrel	fecal incontinence	a Double Approach	Irradiation	management difficulties	immunodepression	collaborative	different type	myocarditis	lymphocyte	first line	acute pulmonary thromboembolism	an understanding	anti-inflammatory properties	standard bisphosphonate	this subtype benefit	continuous veno-venous renal replacement	Long-term oxygen therapy	Oxygen saturation	predictive marker	bone loss	retinal hemorrhages	viral infections	bone metastases	prior renal transplant	a simulated trial	the mainstays	a pilot study	paroxysmal atrial fibrillation	these types	etiology treatments	Orthopedics	–2591	use	polarization	the fraction	botulinum toxin	cycles	a means	the adult respiratory	the client	etanercept	recent line	sudden cardiac death	any clinical sign	long-term efficacy	the termination	The addition	risk factor modifications	protein reduction	implantable cardioverter-defibrillator	platelet-low vWD	Cure	aetiology diagnosis management	month	an endotracheal tube	mm versus	institution preference	substances	culture negative	the cardiovascular safety profile	neurophysiological deficits	bone material properties	synthetic estrogen	cardiac disease diagnosis	p-value* Pressure	continued poor seizure control	quantitative assessments	the same period	clinical trial	patient demographics	cardiovascular toxicity	ST-segment elevation	these limitations	the latter group	myelodysplas- tic syndrome	the oncologist	the stop	hypoxemic patients	attention	transient focal cerebral ischemia	thiamine	partial thrombin time	bronchodilators	values	intensive monitoring	immunological follow-up	severe heart failure	mental practice	special techniques	No other complication	azoles	mitogen-induced activation	gain	mCRC patients	toxins	immediate effects	a 15-min episode	echocardiographic measures	disabling	appropriate pre-clinical validation	biofeedback	mucosal healing	the statistical significance	the only significant predictor	the following	conservative options	defined treatments	predict clinical outcome	gene mutation	rapid on-site evaluation offers	a historical cohort	clinical application	reflex sympathetic dystrophy syndrome	switch cohort	an N-methyl derivative	an initial drop	old patients	Stratification factors	adequacy	The overall goals	β-blocking agents	only trastuzumab	an open-label 24-month randomized clinical trial	multiple tumour types	prolonged benefit	assignment	all-cause mortality	an independent consultant	subarachnoid bleeding	The only methods	variance analysis	the extraction	oral hypoglycemic agents	attempts	blood transfusions	an anti-TNF agent	a combination therapy	any benefit	pathological tissue	the average cost	report	preventive measures	year post-therapy	various integrins	the cord	:1795	The side effects	human congenital leptin deficiency	diverse modifications	traumatic orbital hematoma	malignant progression	the optimal antibiotic regimen	median time	this diverse patient population	sore throat episodes	acute myeloid leukemia	mechanims	titration	the potential high benefit	two-week intervals	The seizure frequency	toilet training	GOLD	Physiological consequences	psychosocial	the second day	granulocyte macrophage-colony stimulating factor	echocardiography findings	month course	non-toxic therapy	clearance	initia- tion	the initial modality	High-intensity rehabilitation	rivastigmine	immunotherapy	some early clinical trials	a bacteriological evaluation	both supplemental oxygen	secondary hypertension	asystole	niacin	the past trials	radioactive iodine	anticoagulation Patients	noncompliance	Others	tri-london.ac.uk13	a fourth category	a proven ineffective form	submicromolar concentrations	:292	survivin correlates	recent retrospective studies.21	flux	human cancers	chronic cough patients	autologous tumor-infiltrating lymphocytes	overall response rates	2-4 month	this setting	venous hematoma	the human airways	this hypothesis	cannula	refractory multifocal bladder tumors	the hyponatremia	the initial costs	staff	joint symptoms	.61	prescriptions	The electroencephalographic objective	both screening	irrespective	entry	continuous positive airways pressure	E-mail	pulmonary involvement	the patient underwent	total sleep time	Oral anticoagulation	no definitive clinical benefits	the possible association	increased adverse events	pirate	goal	ventricular couplets	The potential benefit	omalizumab	vivo immunodiagnosis	past	arthropathy	all ventilatory activity	a renin angiotensin system inhibitor	erythropoietin-stimulating agents	.40 Expectations	cardiac therapy	a relevant agent	a disease-modifying effect	centuryA.D	upstream therapies	×	metastatic melanoma	a therapeutic target	cytoreductive treatments	prompt initiation	The response	parenteral medications	fecal incontinence mechanism	a daily subcutaneous injection	The further longitudinal research	the vacuum	an angiotensin receptor blocker	infective exacerbations	aggressive tumor	The clinical efficacy	patient outcome	a relapse	cardiovascular development	inhaled corticosteroid	diuretics	the total leukocyte count	training	immunolocalisation	Variable procedures	hydrochlorothiazide combination therapy	single course	policy issues	all items	oral prednisone therapy	novel line	Efficacy	a focused update	diversity	a combination	The present study	bladder tumors	active components	log reduction method	integral component	some men	this body	sinogenic focus	psychological rehabilitation	robot-mediated movement	the thousands	thalidomide	Impairment-oriented training	budesonide	inhibitors/angiotensin	any prior line	ventricular interaction Annals	non-compliance	zebrafish survivin genes	oxygenation –	chamber quantification	platinum-	salsalates	Positive expiratory pressure	cyclosporine administration	intravenous abciximab	the perspectives	checkpoint blockade therapy	late initiation	anti-interferon antibodies	cancer progression	thrombophilia	interferon	versus warfarin	prisms	endoluminal airway stents	feasibility study	both modes	external direct current cardioversion	methotrexate	hormone-refractory disease	intratympanic injection	HZO	facilities	the benefit	own set	any effort	prevent complications	favorable changes	:302-8	Partial upper airway obstruction	this course	enzyme enhancement therapy	The optimal duration	The overall response rate	frequent maximal arm movements	a next-step class	cancer risk	overall understanding	subclass disorders	titres	anti-CD25 results	the diseases activity	concomitant injury	indocyanine	a nonpharmacological therapeu- tic intervention	cell apoptosis	the large majority	experimental strategies	vasodilators	Male	idarubicin	imatinib mesylate	sarcomeric cardiomyopathies	device replacement	availability	“ correct ”	Correspondence	acute dyspnoea	mechanical de-obstruction	monthly Urinary markers	the periodontitis group	antibiotic therapy	an early age	electroporation	an appendix	longitudinal studies	insulin-like growth factor	simultaneous regulation	milder	full dose	the pulmonary test	the minimum 12-month subsequent period	dendritic cells	sex-matched healthy controls	cancer cells	towels	advanced hepatocellular carcinoma	a route towards	the androgen-receptor gene	functional iCMs	the preemptive use	the neurological improvement	little clinical consequence	include combination strategies	ICDs	previous major bleeding	the lymphocyte stimulation test	melanoma	edrecolomab versus observation	psychosocial scores	potassium supplements	critical issues	low genotoxic risk	nasal trauma	time.59	homogeneity	bisphosphonate	the clinical syndrome	l fluid hydration	β-blocker therapy	the appropriateness	a drug	cardiovascular co-morbidities	mineralocorticoid receptor antagonist	physiopathogen- esis	mg/M2	multisystemic disorders	The beneficial effects	The duration	the last line	a monoclonal anti-CCR4 antibody	in-hospital survival	radiomethabolic therapy	good candidates	menopause	chronic noninfectious uveitis	vasospasm	screen	the affinity constants	the interventions	previous heart failure	human B-type natriuretic peptide	p=0.46	an alternative form	Prostatectomy	the exact amount	the first course	respiratory secretions	stable outpatients	the addition	ultrasound-guided transbronchial needle aspiration	both repertoires	several months	PC	sustained clinical improvement	escalation	microbiological results	variable duration	simplex virus	the goals	the mRNA expression	The first line	No other types	daytime blood pressures	patient outcome regardless	no observed toxicity	cyclophosphamide/doxorubicin/vincristine/prednisone	bold lines	the net effect	the main modifications	superimposed relapses	exception	peripheral nervous system	the first month	current guidelines	mandatory part	transfusions	palliation	maladaptive mindsets	the maintenance	sufficient magnitude	the structural effects	the low rates	a rare disease	primary spontaneous pneumothoraces	Clinical presentation	well-known problems	new aspects	lesion location	et al11387360	sarcoid alveolitis48'9 release	daily routine	long-term administration	psoriasis induces	asymptomatic adult patients	both conditions	interstitial microwaves	the daily dietary supplementation group	osteocyte apoptosis	well-powered studies	same explanations	official journal	plastics	−5.65	patient intolerance	the antimalarial drug hydroxychloroquine	doctor	meningoencephaloceles	any additional immune suppression	a mode	severe form	no significant benefit	nonacog alfa	Good efficacy	mg/die	metastasis diagnosis	other immunosuppressant therapy	a trial	combined oral antifungal	subtle mechanisms	oral deferiprone	well-documented [	nebivolol	a simple coexistence	prompt changes	event classification	omalizumab improves	moxifloxacin	current insights	gastric cancer patients.Fig	”	an autologous immunotherapy	chronic thromboembolic pulmonary hypertension	intervals	A major aspect	cerebrovascular events	permanent complete atrio-ventricular blocks	INR record book	properties	neurological evaluation	a major problem	:785–795	a section	the intracellular pH	statin use	Timing	wall thickening	a high score	long-term adherence	acute inflammation	lifestyle interactions	neuro-genetic disorders	new anticancer drugs	great attention	reassess	metastatic breast cancer patients	the targeting	signal transduction	lung prognostics	beta-	an effective treatment	the instructed therapists	disease severity classification	high success rate	standard dual antiplatelet therapy	both imaging	the primary cancer	a cornerstone	anti-vascular endothelial growth factor	drug therapy	hyper-reflective choroidal lines	IJU	moderate immunophenotypic changes	a week	the dental curriculum	2-dimensional echocardiography	the necessity	stable disease	serious side effects	great relevance	lesion‐symptom mapping	dalteparin	seizure freedom	cumulative dose	The existence	the responders	relative risk	nature sights	benefit	neurological conditions specialty	prognostic tool	the combined determination	morphologic type	advanced breast cancer	surgical planning	the evils	heart diseases	contraindications	the vertebrobasilar system	routine invasive management	the subxiphoidal view	The endonasal access	the anti-CD20 monoclonal antibody rituximab.16	oral anticoagulation	−0.97	re-colonization	the overall changes	percutaneous interventional techniques	the initial period	the expertise	the fibroblastic process	long‐term disability	No sustained arrhythmic events	initial mode	other medication trials	Shim- kim et al	early sodium bicarbonate	evaluations	non-immunologic hydrops fetalis	accurate disease monitoring	misdiagnosis	glutamate-mediated neurotoxicity	mismatch	time	a significant parenchymal relapse	refractory graft versus host disease	trial	the advanced age	vaccination studies	bone turnover marker levels	echocardiograms	fac- tors	the long-term persistence	noninferiority	prompt institution	histologic type	surgical repair	upmost relevance	cyclic neutropenia	concurrent endometrial cancer	these therapies	The main goal	increased intensity	the great majority	the chronotropic incompetence	sequential 1-β -D-arabinofuranosylcytosine	complete transurethral resection	definitive management	% compliant	essential components	drugs	several trials	gestational toxicosis	another diagnosis	negative physical exam	inter- leukin-2	novel therapeutic targets	eosinophil	the Mediators	these lines	a serum potassium level	[ 12-14 ]	those problems	The search	p=0.030	miglustat	biochemical investigations	iron supplements	hematologic relapse	urinary cytologies	transgenic-knockout sickle mice	prior line	methotrexate naïve patients	improved survival	PPR-OT group	the long-term maintenance	the chemoprevention	the inner ear	tissue iron levels	mitoxantrone	an absolute contraindication	the ex vivo selection	fibers	elastic lung recoil pressure	retrobulbar	the significant advantages	conventional therapies	.80,82	arrhythmic patterns	gait disturbance	concrete health improvements	deferiprone	fatal side effect	actionable therapeutic targets	cost-effective lifetime	studies	the diversity	nitrates	The nanometre-scale physiology	eye patch	press	The spectrum	a lack	significant reductions	prolongation	the total duration	patient compliance	a regimen	the later stage	autologous bone marrow	activated prothrombin	combined pirfenidone	p21	a male patient	the mode	a combined approach	reentrant atrial arrhythmias	carvedilol	possible influence	antacids	shockwave lithotripsy	late enhancement technique	other neurodegenerative diseases	elamipretide	cyclosporine A	frozen prior	white matter hyperintensities	high bleeding risk	high-concentration oxygen	possible value	the observed failure	epoetin alfa	the potential carry-over benefits	logic	an additional course	the sixth day	cholesterol-lowering drugs	Seminars	high-grade gliomas	motor performance	any definitive advantage	any improvement	a single course	Standardization	pressure monitoring	immunomodulator agents	the discontinuation	akinesia	schedule	the first line	T2-lesions	sensitivity	cto00008110.3205/cto000081Doc08urn	first evaluation	microbial flora	myeloproliferative disorders	placebo and/or	trilliumtherapeutics.com	trial Archives	This result	tumor-induced osteomalacia	a significant effect	this scheduling	aid evaluation	the device model	the underlying disease	persistence	passive drainage	mainly gastrointestinal	lipid formulation	needs high suspicion	an abrupt cessation	rate ratio	The average percentage adherence	any systemic therapy	other risk factors	amphotericin	:2761 –8	glucocorticosteroid	cardiac transplantation	the positive benefits	no control trials	disease severity	chromic phosphate	time postcompletion	the potential benefits	colitis disease	a line	This form	the relative risk	cancer patients	Non-pharmacologic Up-front initiation	The new imaging-based classification	other chronic diseases	low proliferative activity	ovarian cancer	the diagnostics	ppb	nsAI treatment fails	prevention	ruxolitinib	adherence patterns	a pulmonary rehabilitation program	prior experience	1476-9255-9-382303981810.1186/1476-9255-9-38ResearchDifferential expression	this mode	guidelines	these independent trials	OS	an excretory form	therapist	autologous stem cell transplantation	regular transfusion	the seventh cycle	low mortality	residual reading ability	azathioprine	these measurements	Further simplification	the observed restoration	therefore initiation	documented favorable prognosis	this risk	Chinese patients	differential diagnosis	care	risk factor modification	hr sessions	time points	clinical outcome	bladder cancer	central midfacial fractures	combination formoterol/beclometasone	an opportune intervention	certain anti-cancer drugs	systemic antimicrobial and/or	indomethacin versus placebo	external beam radiation therapy1	idiopathic arthritis Annals	events	the cardinal	a cessation	selective β3AR	antiresorptive therapy	component	a trend	molecular imaging	a report	a result	advanced oxidation protein products	oxidase	the clinical efficacy	evidence-based dentistry	special clinical interest	dosage	≥3 months	% decrease	some chemotherapies	no myocardial iron	album	each patient	lung parenchyma	a rapid virological response	chronic lymphocytic leukemia	the practice	a recent scientific statement	comorbidity score	sodium balance	the anti-Her-2/neu antibody	virulence	growth factor receptor	the atorvastatin component	scalable manufacturing strategies	the advancement	horse	countries	surgical debulking delays recurrence	non-steroidal drugs	a component	perioperative evaluation	active inflammation	any acute effects	intravenous immune	persists	several side effects	‘ conventional ’	experimental stroke	a certain extent	hypnic headache	endpoint	a strict advice	anticoagulation ”	innovative antithrombotic agents	suppression	an antibiotic	disease progression	The cornerstones	the date	previous anthracyclines	the initial months	post-relapse survival	The success	pain medicine	atenolol versus	hormonal dependence	blood pressure medication	general observations	the major challenges	sinus rhythm	the cytokines present	cognitive deficit	a blood pressure differences	mental consequences	shortening	cardiotoxic regimen	The multivariable logistic regression model	accurate pretreatment imaging	autotoxicity	future perspectives	sinonasal diseases	balanced electrolyte solutions	The patient	breast cancer prevention	long-term effects	adherence	prior studies	the spontaneous recovery	end-of-life care	the sequencing	available histology	omission	the risks/benefits	this condition	Medication	ligand-targeted toxin conjugate	address	minute walk distance	3-month intervals	a recombinant adenovirus	shock-only implantable cardiac defibrillator	massive-dose prednisolone	This second phase	papillary muscle infarct scores	the clinical advantages	Selective internal radiation therapy	a documented history	postoperative complications.7,9,40	venous thromboembolism	polysomnographic manifestations Pediatrics	the first several weeks	the therapeutic range	systolic blood pressure	a renin angiotensin aldosterone system inhibitor	relapse risk	an important goal	a related family member	non-susceptibility	surgical tumor	different pathological processes	conventional measures	a new anti-allergic agent	physical health	hypoglycemia	otorhinolaryngological surgery	economical standpoint	cardiovascular disease diagnosis	the terms	patient samples	cellular mechanisms	no relapse	prior exposure	the guideline	durable complete remission	normalizing	adequate diagnosis	vinca alkaloids	bleeding risk	picotamide	a good prognosis	this time point	] Experiences	the long-term success	duration	the main life-threatening complication	the superiority	therapy.78	cancer-related fatigue	breast cancer brain metastases	useful marker	underlying mechanisms	a cardiovascular event	cancer screening	preservation	dry system	low disease activity	subgroup	high-sensitivity immunonephelometry assay	A decrease	surgery –	clinical benefit	the clinical progress	The type	biochemical parameters	patient number	consecutive months	the predominance	giant aneurysms	The acceptance rate	a substantial benefit	pre-hospital initiation	superficial bladder cancer	the systemic involvement	experimental single-armed trials	long-acting muscarinic antagonist	suppressive levothyroxine	non-diabetic patients	coexistent	same organism	the selection	patient perceptions	transfusional iron intake	future patients	sodium valproate16	recurrent high-risk non-muscle invasive bladder cancer	acute toxicities	the exclusion	pulmonary function test	wet cupping	resumption	amyloidosis	ordinal lines	aloud	experimental allergic asthma	this disease	glutathione antioxidant system	the hypodense lesion	gastrointestinal arteriovenous malformations	An interdisciplinary strategy	the hypomethylating agent	the quantity	any significant clinical improvement	optimal agents	pulmonary vasculitis	propanolol	deferipone	valid biomarker	present subtypes	vaginal estrogen therapy	pyridinium	antegrade flow	intermittent parathyroid hormone	left ventricular reverse remodeling	other approved immunomodulatory agents	diagnosed cancer	calculi	that proportion	increased risk	All-cause mortality	angiotensin receptor blocker	a score	a meaningful benefit	obesity hypoventilation syndrome	the airflow obstruction	the neuroleptic therapy	the optimal total duration	angiotensin-converting enzyme inhibitors	prostanoids	a key grant	further escalation	medical condition	proper cell lineages	a hand	SF3B1-mutated cases	sur	trachea Annals	the indications	the secondary cause	vaccination	††Hypertension	future management	lifestyle changes	further study	the proven benefit	three-quarters	appropriate use	5-year event rate	this cohort study	refractory primary chronic headache subjects	malignant pleural effusions	high-dose chemotherapy-induced cardiotoxicity	The feasibility	Heunks	regular intervals	hs-CRP	oral calcitriol	epoetin alpha	the tumor microenvironment	year	lercanidipine	a grant	these considerations	Many studies	adrenal suppression	the 6-month period	supplemental oxygen	serial measurements	the treatment goal	Survival benefits	caspase-3 inhibitor	the primary goal	5-year final follow-up	tumour metastases	possible treatment consequences	postoperative undesired reactions	high risk patients	stroke injury predicts gains	the poor compliance	exercise training	lateral synechiae	respiratory isolation	meant	androgens	serum transferrin receptor	target	monitoring therapy	individualized immunization	anticoagulation treatment	the debridement operation	subaortic septal ischaemia	bone metabolism	maintenance	further consideration	the cornerstone	tailored strategies	negative conversion	unfavourable outcome	the nasal entrance	repetitive transcranial magnetic stimulation	prognostic category	copy numbers	adoptive tumor-infiltrating lymphocyte	the follow-up cases	monkeys	normalization	clinical trial assessments	access	a stone-free status	pleomorph sarcoma	appropriate antimicrobial agents	internal radiation	any kind	first choice	cancer cell biology	mucoactive medications	a senior pediatric cardiologist	massive pulmonary embolism	parental reporting	home sessions	additional cycles	all chromophobe samples	rapid improvement	carbolithium	the fracture risk	an effective antiinflammatory treatment	cerebral angiography	analogues	osteoarthritic equine carpi	cancer vaccines	compensate	budesonide/formoterol maintenance	exon-9 mutant	The second question	careful timing	–84	each asthma death	therapeutic benefit	hour post initiation	bone marker levels	the anti-tumor efficacy	the first choice	promising avenue	oncolytic viral	device function	the anti-IL-6 receptor	[ 6-10 ]	reappearance	the synergistic effect	pediatric trauma	self-administered massage	Society	no clopidogrel	neoplasms	probucol	identical annual relapse rate	experimental trials	lung fluid	negative emotional states	red-fluorescent SKW-RFP cells	the appropriate method	:2134	cardiotoxicity	the duration	renin-angiotensin system blockers	the existence	proteasome inhibitors	human parathyroid hormone	consecutive days	placement	an antiplatelet drug	c5462	selective pressures	percutaneous lead	the next line	a decreased incidence	vemurafenib	structural heart interventions	naltrexone	renin-angiotensin system inhibitors	a bladder-preserving alternative	segment duration	inflammatory bone loss	the titration period	clinical efficacy	anabolic effects	recombinant human erithropoietin	the mouth opening	long-term survival	acute myocarditis	behavioral/cognitive therapy	an ectopic bone formation model	intratympanic dexamethasone+high-dose prednisone taper	fragment	a key determinant	the antioxidant enzymes	adult stem cell	non-invasive positive pressure ventilation	undergone surgical consultation	treatment failure	drug testing	endexpiratory positive airway pressure support	an interdisciplinary consensus	biventricular pacemaker	the definitive form	no requirement	“ non-dippers	absorption	salvage management	a visual acuity	each course	the focus	a retractor device	no reported randomized clinical trials	early intervention	dose combination	radiation techniques	trials combination therapy	respiratory support	siRNA	releganve	an attractive prospect	Continuous positive airway pressure	everolimus	vestibular ganglionitis	the presumed beneficial effect	intellectual content	regulator	hemodynamic instability	No treatment	a 7-year-old boy	nilotinib prolongs survival	initiation	this process	vacuum-assisted closure	man Archives	the favorable outcome	the tinnitus	many other patients	the surgical approach	continuous positive airway pressure	these fibers	hepatic arterial infusion	an acceptable safety profile	gastroesophageal	derive great benefit	antibody transport	options	current treatments	significant graft dysfunction	vascular diseases	haemoglobin levels	an additional level	alone settings	nivolumab	mg/Kg/day	autoimmune encephalomyelitis	'Sometimes	the other confounders	valuable past experience	the other half	start	A concern	cognitive therapy	the combined regimen	mutations,4 patients	19554195copd-4-203ReviewExacerbation rate	metastatic breast cancer	hepatic veno-occlusive disease	an adverse prognostic factor	the angiotensin	cardiovascular dysfunction	the conclusion	beta-interferon	stratification	taper	rapid implementation	the steroid tapering	the online version	hazard ratio	mass	intensive glucose control strategies	this strategy	complex activities	the era	another treatment	subjective ailments	radical resection	The main goals	little physical activity	The overall results	the unprecedented progress	obstructive sleep apnea	mechanistic insights	future directions	metastatic spread	the underlying cause	third-line chemotherapy	a treatment	% breast cancers	the rational combination	systemic corticosteroids	the options	b blocker	the major drawback	urinary pH	this complication	metastatic renal cell carcinoma	additional support	the patient	pretreatment planning	a 2-week medroxyprogesterone acetate	% failure rate	back-titration	prostaglandins	vedolizumab	repeat	chronic idiopathic purpura	iguratimod	Side effects	the indolent clinical courses	the minimum total duration	Patterns	metastatic progression	The meta-analysis	arrhythmia	Both cognitive behavioral therapy	limited survival benefit	rate	antithrombotic therapy	chronic tension headache	a 6‐week course	nursing students	low-dose methotrexate	increased awareness	n/a*	anticoagulant	phosphate	a mainstay	next line	other words	a TLR-dependent manner	high tibia osteotomy	⩾2 cycles	week	Report	monitoring response	a prolonged taper	a do	management options	mexiletine reduces	an evidence-based mainstay	The causative organisms	biological agents	a simple face mask	several samples	the checkpoint blockade inhibitors treatment	primary tumor burden	anemia	preoperative levels	safe analgetic effects	e257	acute leukemia	prospects	several choices	metastatic prostate cancer	internal carotid artery lesions	cyclical hPTH	regular maintenance	t-APL	life diagnosis	individual cases	the initiation	general measures	= −0.17	regimens	prior nephrectomy	the success	autologous stem-cell transplantation	Discontinuation	genetic characteristics	heart failure treatment	restrictive fluid regimens	the first few days	the treatment outcome	infliximab	graft-versus-host disease biology	Negligible side effects	fortunate conditions	the autoPAP device	the concern	genetic polymorphisms	data sequence	favourable overall prognosis	fluticasone bid	the educational work	all medication doses	trial basis	the acute phase reaction	potential biomarkers	the grouped data	toxic effects	underdiagnosed till	social support	manufacturing processesKaiser	advanced-stage follicular lymphoma	the first week	the single collaborative group	the current widespread use	glycopyrronium bromide	disease activity	timely initiation	high arrhythmic risk	gradual improvement	al.21 report	interleukin-6 receptor	clinical speech‐language pathologists	surgical treatment	pressure settings	continuation	the commencement	either chronic myeloid leukemia	the consolidation	Current smoker	pathology	baseline disability	additional functions	reversible types	potential therapeutic role	cardiovascular drugs	the study results	the antioxidant agent	Moderate-intensity rehabilitation	low percentage	the cholinergic	electrolyte levels	psoriasis guttata	primary mode	alternative types	fosters uncertainty	the gold-standard	prior lines	different data sets	favourable prognosis	a proper diagnosis	Ozone	wk	locoregional administration	long extreme subatretic aortic coarctations	the bypassing agent	intermittent abdominal paracentesis	dexamethasone	transarterial radioembolisation	A natural way	known risk factors	the possible pathogenic role	aerosolized ribavirin	traditional antibiotics	frataxin gene expression measures	lymphomas	weeks	decitabine	the first cycle	male sex	average	the optimal duration	compliance	a short trial	the last century	marrow stromal cell	vitro fertilized embryos	a hospital stay	an oesophageal perforation	the apparent benefits	the ischemic penumbra	anticytokine therapies	:278 –287	neuritis	relaxation	various malignant tumors	scientific bases	the strategies	myelodysplastic syndromes	systemic therapy	an inflammatory connective tissue disease	important long-term outcomes	acute infections	deferasirox	other genes	circuit	equal efficacy	progressive fibrosis	thrombocytopaenia	various protocols	the hepatic arterial circulation	later sections	frontal sinus osteoma	continuous days	an anti-inflammatory effect	a neurodestructive treatment	preserved ejection fraction findings	iPSC	anti-PD-1 leads	Rehabilitation periods	conventional treatment	the intensification	vascular function	widespread use	rosiglitazone	subsequent graft-versus-host disease	advice	severely ill patients	potency	antiepileptic drug	logs	anti-fungal therapy.19	a large majority	hematopoietic stem cells	combination	experimental methods	childhood cancer survivors	the means	subsequent stability overtime	differentialdiagnostical aspects	differential therapy	amantadine	The bone	prognostic indicator	The choice	angiotensin receptor blockers	the malignancy	psoralen	d-penicillamine enhanced therapeutic advantage	the knowledge	venous thrombosis	skin pigmentation	hypercapnic patients.64	anti-TNF therapy	tocilizumab	the metabolic acidosis	cardioprotection	fetal arrhythmias	The categories	liver fibrogenesis	ng/l	esophageal squamous cell carcinoma	the pH	the clinical benefits	Adverse reactions	initial stroke severity	the allergy	the mentioned methods	improved patient prognosis	different antihypertensive classes	Diagnostics	toxin type	appropriate implantable cardioverter defibrillator	the first days	chronic metabolic	Adherence	premature discontinuation	either nebivolol	months	long-term oral corticosteroids	guided imagery	compounds	secondary injury	classification	till institution	neglect rehabilitation	treatment line	diagnostic techniques	a protective effect	antagonist treatment	physical therapy	Early antiviral therapy	defibrillator	inhaled	any context	BCG-unresponsive disease	high mortality	the effectiveness	der auditorischen	gold standard	clinical confirmation	risk stratification strategies	clinical cancer research	Another patient	fibrinolytic therapy	concomitant medication	captopril	diagnostics	0.649-1.422	Adaptive servo-ventilation	high mortality rates	sebaceous hyperplasia	rapid diagnosis	[ 16-21 ]	anticholinergic bronchodilator	completion	the tolerability profile	a good prognosticator	possible effects	early thoracic	optic nerve damage	unforeseeable aspects	an operative mortality	metastatic colorectal cancer	further studies	efforts	acute ischemic stroke	an objective response rate	therapy trials	need	corticosteroid	hyperemic complications	the cortical bone toughness	receptor antagonist gene	These data	Intravenous immunoglobulin	the induction period	the potential clinical benefits	both patient groups	performance status	glucocorticoid	significant histological changes	single areas	likely targets	favor	The lack	beginning	pulmonary arterial aneurysms	No patient	antiplatelet drug	the landscape	patient cohorts	focus	further courses	–30	no uniform answer	The original trial	steroid	spontaneous adverse event	inhaled budesonide	alpha-1-antitrypsin deficiency	each cycle	previous lines	cytotoxic drugs	gonadotropin-releasing hor- mone agonist	α1-Protease inhibitor	selective occlusal adjustment	underwent vacuum-assisted closure	belimumab	a factual combination therapy	foundationmedicine.com02	hs-TropT	sirolimus monotherapy	various times	interdisciplinary consultation	compositean animal model	these risk factors	no serious adverse events	these forms	subsequent drug resistance	endothelin receptors	each subsequent line	primary sarcomas	no new epileptic focus	ongoing symptomatic benefit	the second cycle	angiosarcoma	the lack	α1-Protease inhibitor deficiency	cardiac structure	ovarian borderline tumors	lncRNA-based cancer diagnostics	sotalol	other standards	active disease	osteoporotic patients	angiogenesis	the mortality rates	biological plausibility	ventilatory support	the first year	technique	These patients	the only way	late recurrences	Prompt initiation	angiotensin-converting-enzyme inhibitor	immune rejection	tumor response assessment	a total	intensification	a ventricular arrhythmia	pluripotency	outside	low-flow velocities	the delivery	long-term outcome assessments	restarting	anti-TTx	little peer-reviewed data	a relative	nodular opacity	familiarity	feasibility	stable condition	patient-specific parameters	cell-wall skeletons	potential avenue	the long course	inhibitor veliparib	some variable differences	papillary tumors	the standard mode	spatial‐motor	% oxygen	young age	conditioning	other interventions	the completion	cervical cancer diagnosis	some cases	n=1	this time period	the hopes	anthracycline-based chemotherapy	this recommendation	nasal high-flow gas therapy	The following drugs	silent carriers	the preferred mode	initial prednisolone	the recommended mode	technical use	complete control	the optimal choice	enterocolitis	radical cystectomy	long term compliance	sponta- stimulation	future clinical trials	inhaler technique	a marked difference	Modification	endstage heart failure	the relationship	the cytokines	the possible value	autoimmune inflammation	checkpoint blockade	the neuromodulatory systems	the promise	the short duration	early cessation	many tumour types	progressive iron loading	Korean patients	coded diagnosis	induced histamine release	commencement	the same tests	systematic analysis	nucleosome levels	albumin	the future	seminal mutli-center studies	the initial assessment	physical examination	the pooled conclusion	analgesic effects	:527 –30	μg bid	the endpoints	recommencement	Tapering	primary percutaneous coronary intervention	practitioners	multi-contrast late enhancement	pneumocephalus	an analysis	endothelial repair	NT-proBNP levels	the cornerstones	triptans Triptans	the effect	the monthly cost	the diagnosis	Radiofrequency surgery	clinical examination	specify completion	the efficacious methods	professionals	lesion	high-dose beta-adrenoceptor antagonist treatment	Relaxation	account	a significant number	Additional forms	prescribed cardioprotective agents	immunosuppressant therapy	ischemia-related pathological processes	an outpatient setup	similar velocity	amoxicillin-clavulanic acid	oral antifungal prescriptions	immunoscintigraphy	prior procedures	vancomycin	humoral immunity	the median duration	The hematology laboratory	debilitating	checkpoint inhibitor	the toxicity	Other concomitant drug	intravenous A1-PI products	the positive effects	Intravenous thrombolysis	a maximal delay	treatment modification	ischemia times	thrombolytic therapy	vitamin supplementation	clinical evaluation	direction	fulvestrant	muscle alignment techniques	the clinical management	combination valsartan/HCTZ	first day	fibrotic disease	the utilization	acceptance	eds	immunodeficiency	lenalidomide/dexamethasone	IL-6	current swallow status	therapies.6,7	aminomethane	other pulmonary disorders	guidebooks	Guidelines	histological studies	acute lung	the potential financial impact	blood-derived macrophages	borderline statistical significance regardless	tract infection	additional therapy	apoptotic peripheral blood cells	emphysema	articles	hyperbaric oxygen	The main drawback	study populations	details	decreased pulmonary vascular pressures	omalizumab decreases	therapy response	concomitant	clinical success	initiation till discontinuation	the sham group	A polymorphism	Current prognostic factors	a systematic literature review	a full course	hrs/night	non-castrate metastatic prostate cancer	intratympanic dexamethasone	residual sequelae	traditional approaches	additional external access	management choices	symptomatic patients	epithelial ovarian cancer	low concentration	the contrast	optimal pressure settings	various efforts	an inhibitor titer	The increased prevalence	Odds	the risks	surgical correction	other immune suppressive agents	standard diet therapy	an acoustic retraining therapy	stem cell transplantation	effective use	orthostatic reactions	stem cell research	platinum-based chemotherapy	human transmissible spongiform encephalopathies	als	a well-known complication	arterial location	a second cohort	a bisphosphonate	winfocus.org1	survival estimates	A variants	the long-term acceptance rate	these courses	complete adherence	–2350	recalcitrant ulcers	No correlation	series	±3.75	thrombocytopenia	the additional effect	the bronchodilator effect	Total duration	chronic inflammatory disorders	gemtuzumab ozogamicin	important component	bromocriptine therapy	The predominant aim	erythroid differentiation	and/or failure	Urinary markers	cataract surgery	oxygen supply	6-month intervals	the belief	a specific form	The objective	edge	genetic counseling	low fibrinogen levels	Edwards	tPA location	no difference	platelet inhibitors	exercises	tumor-infiltrating lymphocytes	these agents	declined consent	ticagrelor	neutrophil gelatinase-	simple advice	partial response	kck0502	multiple tracts	majority	the prognostic capability	agents	conventional modes	the 4-year data	low-molecular-weight-heparin	vascular endothelial growth factor	man	psychological [	chronic aphasia	a positive outcome	chemo	first date	tract infections	the study period	targets	enhance recovery	the nadir value	likelihood	logistic assistance	initial efficacy	long-acting bronchodilator	epilepsy patients	interferon beta	modalities	disease	The length	The future	orthostatic responses	a significant net decrease	tiotropium	weight	b	later index dates	biomarker analysis	the overall sum	immunogenicity	multiple sclerosis pathology	a proton pump inhibitor	a life-threatening disease	clinical practice	inpatient	stereotactic biopsy	atrial pacing	“ biomarker-guided monitoring	anti-programmed death ligand	infarct heterogeneity	each vestibular receptor	a superior clinical cure rate	chronic steroids	biochemistry tests	acute lymphoblastic leukemia	traumatic optic nerve damage	vinblastine	non-OSA patients	rHIL-2	the left basal ganglia	a great deal	sudden cardiac arrest	hemoglobinopathies	prognosis	suboptimal use	document adherence	little guidance	event rates	signal size	a skeletal imbalance	heart-failure events	a small retrospective epidemiological study	a further improvement	a comparable reduction	intravenous immunoglobulin	response criteria	third-generation	abandonment	chemotherapeutic agents	aortic isthmus	the maintenance phase	/paclitaxel	first line treatment	basic principle	surgery radiation	a molecular diagnostic	the primary mode	Primary prevention trials	A Meta-Analysis	advanced diseases	that therapy	recent experiments	fracture rates	effective forms	an optional treatment	cold irrigation systems	cure rates	prior combination chemotherapy	no specific	exercise tests	interval development	symptomatic arrhythmia	the second week	the mdx mouse	roswellpark.org	some other form	a decrease	the new antiviral drugs	Chemotherapy	functional benefits	appropriate clinical applications	the viral load	sarcoma family	disease-free rates	:3173	recombinant human growth hormone	The combination	Change	patient adherence	the gold standard	both diagnosis	The positive effects	last day	the survival	an adverse event	a small sample size	multiple stem cell markers	a long-acting calcium channel blocker	lung metastases	fixed-dose amlodipine besylate/benazepril	targeted prevention	long-term deferiprone	long-term effectiveness	the barriers	The mainstay	The disappearance	Pathogenesis	this vicious circle	Treatment options	foreign body infections	the third year	effective treatment	pulmonary complications	an update	Vaccines	additional metabolic syndrome components	Expectation	pretreatment level	all phases	whereas anabolic treatment	metastases	flow signal	a case report	discussed topics	timesteps	granulomatous iritis	good reproducibility	immunosuppressives	a macrolide	baseline investigations	conventional therapy	chelation	chronic heart failure	The prompt initiation	symptomatic stable ischemic heart disease	stages	the correct choice	individual types	the affecting factors	malignant gliomas	Comparison	severe anaphylactic reactions	olmesartan medoxomil	psycho-social support	rifampicin	congenital heart disease patients	a pneumocephalus	a colon adenocarcinoma	cardiac arrhythmia issues	a good response	the typical side effects	anti-CD22 immunotherapeutics.1	the choice	prostate cryoablation	cognitive-behavioral treatment	lung diseases	a stopping rule	All laboratory protocols	the preconditions	confounding factors	the perioperative setting	receptor antagonists	that day	tissue plasminogen activator	COPD-related hospitalizations	lymph depletion	a recommendation	antioxidant vitamins	broad-band noise generator therapy	this cohort	uterine serous cancer diagnosis	new therapeutic targets	moderate anterior uveitis	sputum rheology	an expert consensus document	Local anesthesia	continuous treatment monitoring	poor tolerance	breast cancer stem cells	prodrugs	Early diagnosis	the eighth session	chronic myeloproliferative disorders	cost-effective approach	disease-modifying activity.10	The primary goal	taxanes	chronic obstructive pulmonary diseases	the desired response	a randomized trial	anti-NMDAR encephalitis	several ways	prerequisite	abatacept	neurogenic dysphagia	clones	skin eruptions	clinical characteristics	deferoxamine	a new class	the biological properties	weeks post-therapy	negative gastrointestinal side effects	safe next step	other factors	a second washout phase	anti-tachycardia pacing	% b	interferon [	nasal continuous positive airways pressure	treatment day	The aim	eventual cure	delay	biological forms	oral candidiasis	Fredens	platinum sensitivity	the maximal time	column	individualization	nifedipine monotherapy	large vessel ischaemic stroke	anti-TB therapy	this single cycle	continued benefit	maldescended testes	several oral agents	ophthalmoparesis	lung mechanics	Adjuvant forms	an isolate ’	drug therapy options	mainstays	anti-EGFR monoclonal antibodies	severe rheumatoid arthritis	Response	Xue	vWF concentrate	chronic wounds	daily antiepileptic drug	a favourable prognosis	usual care	5-years	many clinicians	the right choice	hours	metallopeptidase expression	drug holiday	the above agents	//www.goldcopd.com	atypical fractures	obese patients	any long-acting medication	the long-term effectiveness	
digital clubbing	complexity	no clubbing	restrictive atrial septum	no edema	cyanotic congenital heart disease	a toddler	respiratory disorder	acidosis	a six-year-old boy	diastolic dysfunction	cyanotic spells	positional worsening	severe right ventricular hypertrophy	spells	Forty-two patients	a mosaic ring	no peripheral clubbing	acute onset respiratory distress	distal	cool extremities	insufficient intraoperative cardioprotection	advanced heart failure	finger clubbing	clonic phases	reoperation	ventricular dysfunction.58	finger	cold extremities	limb jerks	permanent muscular activity	peripheral edema	heart failure symptoms	chronic hypoxemia	life-threatening paroxysms	florid heart failure	a large pulmonary arteriovenous malformation	recurrent supraventricular tachycardia	% mortality	eye deviation	diffuse wheezing	an absence	skin	unusual presentation	long duration	the respective condition	hypertonia	poor ventricular function	nasal congestion	significant systemic arterial desaturation	a flow murmur	clubbing	adulthood	hypercyanotic spells	Secondary findings	apnea	no tremor	paradoxical chest wall movements	blue lips	estimations	the progressive clubbing	organ damage	prolonged period	a massive dyspnoea	pedal oedema	cardiology section	p=0.007	mild exertion	the arterial oxygen	a recurrent	acute respiratory failure	Two-day-old male baby	icterus	poor exercise tolerance	oliguria	oedema	definitive interventions	tachycardia	limb edema	Treatment	cor triatriatum dexter	capillary refill time	percent	the worsening	eg	bradycardia	right heart failure	odynophagia	acute apnea	respiratory collapse	15-year-old female	new signs	Eisenmenger-type physiology	life-threatening event	A 3-year-old girl	pulmonary arteriovenous malformation	a 14-year old Egyptian girl	insignificant flow obstruction	the overall degree	emergency procedure	A rare cause	potential role	atrial myxoma	no pallor	
the third place	mugwort	birch	paradisiaca	
equol	
pseudobulbar palsy	emotional incontinence	speaking	wall	The hypofunctional form	
pulmonary function tests	

peripheral pyogenic granulomas	fibromyxoid chondroma	the nasal cavity	chondroblastomas	joints	a distinctive benign tumor	rhabdomyoma	lipoma	the ethmoid sinus	epulis fissuratum	cardiac hemangioma	plasma cell	vol	myxoma	apical hypertrophic cardiomyopathy	odontogenic tumor	the nasal bone	paranasal sinuses	sarcoma	a rare benign	the frontal sinus	the parietal bone	chondromyxoid fibroma	the petrous-sphenoid junction	fibrous defects	and/or mesothelioma	the tumors	xanthoma	aggressive benign	false tendons	
tertiary care facilities	
atrophy	abnormal fatigability	chronic urinary tract infection	both symptomatic patients	spontaneous movement	sleep disturbances	hypertrophic cardiomyopathy	reflex deficit	desminopathies	forelimb flexion	suspicious history	Drug-induced myopathies	progressive bone pain	reduced peak expiratory	wasting	complained	fatigability	cranial nerves	frailty	storage diseases	muscle cramps	episodic attacks	musculoskeletal pain	fat free mass depletion	reduced pulmonary function Patients	diplopia	The uneven distribution	nervous system damage	proximal	early onset	cardiomegaly	distal involvement	the flow volume loop	medial nerve involvement	symptomatic	proximal joint contractures	early signs	skeletal deformities	upper trunk involvement	unaffected limbs	temporal relationship	defecatory obstructions	respiratory involvement	suit	falls	external ophthalmoplegia	Early onset	muscle wasting	extensor plantar reflex	obesity	cardiovascular fitness	impingement	These drugs	restlessness	sensory abnormalities	an autosomal dominant disorder	muscle mass loss	chronic diseases	reduced tendon reflexes	a main cause	posture	nursing care	ulnar nerve involvement	interosseous nerve involvement	Muscular symptoms	muscle dysfunction	neuromuscular disorders	common symptoms	postural tremor	variable degrees	reduced survival	the trunk	a pattern	right-sided heart failure	abnormal craniofacial features	disabled patients	an infraclavicular plexus involvement	one-week history	the diaphragm	abnormal gait	Immunosuppressive treatment	tiredness	hypokalemia	sensory motor deficits	cerebellar features	nerve injury.3 Osteophytes	any pregnant patient complaining	neuromuscular transmission impairment	a wide spectrum	marked tremor	the bone pains	contractile protein	a synergistic effect	movement disorders	The clinical manifestations	tremor	hypoactive deep tendon reflexes	marked hypotonia	cachexia	the independent mobility	cardiomyopathy	hyperparathyroidism	other non-systemic causes	the additional effects	myasthenia gravis	the arms	the cortical proprioceptive tract	an intermediate form	characteristic patterns	reduced strength	distribution	impaired balance	bilateral peroneal nerve palsies	experience temporary attacks	the symptomatic limbs	X-linked hypophosphatemic rickets	rhabdomyolysis	muscle fasciculation	tremulousness	antecedent illness	impaired performance	first complaints	myoglobinuria	minor degrees	wastage	a long history	painless	paraparesis	limbs	X-linked hypophosphatemia	chronic hypophosphatemia	reduced exercise capacity	sensory disturbances	the writing hand	the patterns	severe hypotonia	normal pattern	a few weeks	next patient	musculoskeletal system	hypotension	hypalgesia	spasticity	metabolic causes	hepatic failure	hyperpnea	a key driver	areflexia	postural hypotension	increased serum creatinine kinase	cerebrovascular events.3,4	increased fracture risk	hyporeflexia	the respective region	functional performance	facial weakness	subsequent deconditioning	immobility	Pulmonary rehabilitation increases strength	unsteadiness	
the metabolism	mucus	galactomannan	melanocytes	pathological forms	pointers	spindled epithelioid cells	tryptophan	epinephrine	a unifying concept	core-aspect	the pro-oxidative form	biasing biochemical assessment	green/blue coloration	color	melatonin	amelanotic tumors	The cells	the protective effect	the paramagnetic effects	protective effect	precipitate	

obstetricians	potential impact	these anomalies	short-term outcomes	hypoplastic left heart syndrome	

apathy	disinhibition	excitement	hallucinogenic effects	positive feelings	stereotypical movements	other psychiatric disturbances	compulsive behaviors	locomotor activity	These symptoms	arousal	Contraindications	
progressive microcephaly	nystagmus	
an aggressive management	

trunk palpation	pain tolerance	reference values	pm	All motor	a sensory abnormality	
landmark navigation	The selective impairment	The human perirhinal cortex	an aesthetic emotional response	sensory features	links	pre-activating memory circuits	storage disorder	access disorders	memory regions	language	mnemonic processing	embodied simulation	the functional architecture	disorder	mental status correlates	procedural memory	early hippocampal pathology	memory impairment	s inaccurate claim	the drawing	circumscribed cerebral atrophy	a task	the cards	15-items short-form	the impairments	executive functioning	quick regain	memory—might	temporal lobe atrophy	
hyper-responsiveness differ	a worldwide common disease	absent	itchy-watery eyes	asthma exacerbation	upper respiratory tract infections	the upper respiratory system	psychiatric disorders	μg/mg	anti-inflammatory treatment	no associations	a significant correlation	sIgE	excessive posterior rhinorrhea	This under-diagnosis	a suitable model	'perennial non-allergic rhinitis	characterised patients	an operational definition	the general burden	early childhood	both allergic asthma	tobacco dependence	medullary infarction	self-reported hay fever	compensatory hypertrophy	a sore	focal luminal dilatation	headache	Tuberculosis	sensitization	pollution-related episodes	Work-related rhinitis symptoms	intrinsic asthma	occupational rhinitis needs	the controls	The definition	certain manifestations	nasal secretions	allergic respiratory diseases	laryngitis	concurrent	post-infectious cough	an early manifestation	the main physiologic features	No significant difference	rhinosinusitis	a common global disorder	asthma169	the frequent co-existence	doi:10.1016/S0034-5687	asthma share	no other atopic comorbidity	healthy people	pro-asthmatic inflammation	acute decrements	sinus headache	the characteristic features	Endotoxins	initial complaints	No symptoms	laryngopharyngeal reflux	The broad spectrum	Anxiety†	both asthma	hyperractive disorders	work-related symptoms	allergic asthma	the above methods	specific criteria—high total	short-term mortality	the usual course	asthma comorbidity	the general population asthma	a sore throat	vivo animal models	:37 –41	the upper respiratory tract	mild asthma	occupational asthma	other confounding diagnoses	biweekly surveys	epidemiological studies	rhinitis treatment	the mouth	atopic dermatitis	sphenopalatine ganglion block	allergic	hypersecretory forms	tuberculosis	allergic asthmatics	nasal reactivity	blood eosinophil count	Bronchiectasis	states	virus infection	physiological indices	non-asthmatic controls	Ever	induces symptoms	allergic history	pharyngeal irritation	considerable clinical evidence	asthma patients	work-relatedness	Concordance	Both bronchiolitis	Notes	turn	experienced loss	bradykinin induces symptoms	secretory otitis media	workup	dermatitis	a sufficient number	an early diagnosis	detailed methodology	a strong adjuvant effect	all asthmatics	conjunctivitis	the work environment	manganese sulfate	the interaction	allergic illnesses	influenza-like symptoms	general practitioners	laboratory animal allergens	rr801173792910.1186/rr80CommentaryImpact	differential diagnoses	frequent sneezing	occupational rhinitis	the criteria	Other relevant conditions	rhinosinusistis symptoms	other airway disorders	The Swedish part	sinusitis	thunderstorm-related epidemics	socio-economic impact	persistent symptoms	adrenoceptor β2	nitric oxide.49,51	various pharmacological treatments	
deep hypothermic circulatory arrest	
ankle	
angioedema	

other dopaminergic medication	disease effect	notable exceptions	The majority	influences time	quetiapin	the intermittent use	toxin	pergolide	current treatment	zolpidem	benzodiazepines	standard therapy	posttreatment	trihexyphenidyl	carbidopa	anticholinergics	:1484	tetrabenazine	Long-lasting effect	this treatment	dopamine agonists	persistent asymmetry	Dopamine agonists	subthalamic nucleus stimulation	tablet	morning levodopa equivalent dose	fluency	guanfacine	ropinirole	connectivity patterns	axial motor scores	pramipexole	significant rigidity	:850	


hypovolemic symptoms	potassium correction	polydipsia	dehydration	the persistence	hyperglycemia	body weights	dry mouth	a high tumor burden	persistent polydipsia	hand tremors	polyphagia	insipidus	water diuresis	breakthrough	Early morning urine	mouth dryness	thirst	an arbitrary definition	dysuria	a transient	
oil vapors	others	



the sedated infant	reopening	the tracheal airway	right atrium	episodic dyspnea	ratio	the vertebrae	mechanical load	interbronchial collateral channels	a large element	tibial component	the upper airway	intensive care	neurologic deficit	recurrent infection	collapsed alveoli	retropulsion	the airways	graft failure	a sensitive echocardiographic sign	the interval	increased upper airway resistance	grow	the affected regions	the right internal jugular vein	forebrain axons	reduced hyperinflation	associated vertebral body destruction	cartilagineous framework	marathon runners	gas trapping	the inferior vena cava diameter	consolidation	the tibial component	affected joints	interactions	the therapeutic effect	lung consolidation	the mircrocirculation	further enhance	cardiopulmonary bypass	bone	elderly patients	decreased drainage	the distal true lumen	airway remodeling	increase	These physiological changes	These lesions	interval	matrices	the vertebral slip	impaired postural tone	cava size	Reasons	osteophyte formation	areas	% reduction	mechanical support	jugularis interna	adult degenerative scoliosis.9	the pharyngeal walls	collateral ventilation	consolidation substances	right leg pain	the oscillator	ablation	the control curve	the right lung	the increased thickness	first patient	laryngotracheal chondritis	unfavorable neurologic outcomes	attempted pericardial drain withdrawal	primary endoleak	vertebral displacement	the right atrium	Slit2-Mediated chemorepulsion	the microcirculation	the life	decreased volume	the opening phase	arrow head	tricuspid annular plane	intermittent narrowing	the repair	peripheral airways	% body	chronic thrombus	Instability	real intraluminal narrowing	dorsal lung segments	immediate bystander	inspiration	bony destruction	translation	a sniff	all cardiac chambers	infiltration	a large circumferential pericardial effusion	preloads	reducibility	these airways	legs	alveolar spaces	sudden death	immature bronchi	plasma proteins	the cartilaginous external auditory canal	posture ’	the pharyngeal airway	radial traction	the microvascular lumen	an inward movement	severe dyspnea	spondylodiscitis	pt	each breath	upper lobes	the inferior vena cava	Lack	the neck vessel	spontaneous union	alveolar instability	deep inspiration	blockage	cell walls	vertebrae	forces	


peyote crowns	paste	
aciduria type1	

the reconstructive ear surgeon	challenging procedures	aural atresia	craniofacial anomalies	Congenital atresia	a pre-surgical baseline	the acoustic meatus	aural atresia.5-7	an 11-year-old boy	ear malformations	bilateral moderate-severe conductive hearing loss	various grades	non-microtia children	
right pleural	Physical examination	serum lactates	
the subclavian vessels	skull	cavernous sinus thrombosis	MRI-Brain	

copper	cobalt ions	serum concentration	lithium	high concentrations	quinines	the median serum cobalt	Other transition metals	cobalt serum levels	asbestos	iron	Both cobalt	paramagnetic depending	speciation	diesel fumes	both physical forms	transplatin	the release	tars	cobalt	:2946	boron	iron-loading conditions	the principal elements	molybdenum	
the males	eugonadal mice	total body	race	

potential cause	
phosphorylethanolamine	the endogenous haloamines	mg/kg b.wt./day	chloride-dependent transport	a low concentration	both antagonists	preventive effect	rat brain	These protective mechanisms	tocopherol	a post-transcriptional modification	current studies	positive influence	the bench	dietary intake	the possible beneficial protective effects	a defective mt tRNALue	mg/kg rat body weight	The protective effects	sup- plementation	mg/kg b.wt	present state	myo-inositol	glutamine	the precise mechanism	the biphasic effect	The therapeutic role	glia	the consequential release	phytic acid	2,3-butanedione monoxime	antioxidant activity	L-glutamic acid	window	small molecule	neuronal damage	neuroprotective function	a strong antioxidant agent	the mammalian actions	meat	No adverse effect	Suitable administration way	Similar effect	The potential usefulness	the functions	accu- mulation	both sexes	the sum	tris base	biochemical pathways	production	taurine derivatives	Haloamines	the mitochondrion	Composition	Extra-cardiac tissues	the human trials	antioxidant effects	the transcription	inhibitory	The neuroprotective mechanisms	taurine transporters	human mitochondrial diseases	the neuroprotective effect	the protective mechanism	this dose	neuroprotective mechanisms	striatal extracellular dopamine	functions	chloramine	the rate-limiting enzyme	The important role	glutamate-induced endoplasmic reticulum stress pathways	the protective role	taurine accumulation	ppm	the ischemic-induced release	serine	the neuroprotective mechanisms	efficiacy	The antioxidant action	phosphocreatine	2-aminoethanesulfonic acid	vitro study	thromboxane receptor stimulation	phosphocholine	succinate	brain insult	endogenous glutamate	substantiating evidence	osmoregulatory	time predictions	teratogenic effects	glycerylphosphorylcholine	threonine	muscimol blocks	neurons	osteoclastogenesis.7677	generation reproduction	intravenous treatment	The neuroprotective effect	a dose-dependent biphasic response	a pathological brain condition	a sulfur amino acid	scyllo‐inositol	certain doses	The protective effect	Other functions	biosynthesis	record	neural cell damage	cell-damaging conditions	disodium	roles	total choline	a high concentration	neurotoxin monosodium glutamates	
granulomas	caries	psychiatric disorder	downstream	
a glycosylated form	diaminobenzidine	the block elements	early loss	ODN	metal particles	a new generation	an attractive option	capillary array	device visualization	ceramic-polymer surface	hydrophobic coil wires	the Greek word	the enzymatic produced	a research group	Subcutaneous implantation	a biodegradable polylactic acid	incubation	molecules	The antibody	polyimide tubing	a high molecular-weight form	Non-conductive materials	lipids augment	a blend	ethylene glycol	albumin elimination	v3.2	stent strut coverage	hydroxyapatite	chronic inflammation	The ability	ready	metal	salicylic acid	cellulose acetate succinate	impart unsatisfactory mechanical properties	cell composites	the relative change	Each type	bioresorbability	hydrogel	coral-containing scaffolds	ligand	peroxidase labelling	–38.9068793	strut thickness	
occasions	conventional ascending aorta	the aneurysm	a standard general anesthesia protocol	


endovascular treatment	
right atrial pressure	pulmonary blood flow	transmural stress	systolic wall stress	°C	central venous pressure	intractable pulmonary edema	the subcostal view	increased pulmonary capillary wedge pressure	the mitral valve opens	cardiac production	the entire procedure	a pulmonary capillary wedge pressure	trans-mitral pressure gradient	this loss	left ventricular pressure	transesophageal	the aortic pressure	pressure-volume loops	cardiac catheterization	invasive monitoring	-both	pulmonary venous systolic flow	postoperative ventricular stunning	right ventricular end-diastolic pressure	transmitral gradients	the systolic filling fraction	hemodynamic measurements	hypovolemia	atria	ventricular end-diastolic pressure	pulmonary capillary pressure	ventricular filling	ventricular end	This definition	
multi-planar reconstruction	non-motor symptoms scale	plasma homocyst	fractional shortening	epidemiologic studies	nerve conduction studies	human prefrontal cortex activation	central nervous system	the initial lesion	complement	cumbersome assessment	anatomical connectivity	paraplegia	duplex ultrasound	lung cancer deaths	connective tissue diseases	left ventricular hypertrophy	marmosets	many disorders	left atrium side	a neurovascular conflict	tomographic scanning	cardiac catheterisation	ultrasound-fine needle aspiration biopsy	a subsequent examination	venous blood samples	diffusion tensor	no abnormalities	magnetoencephalography	tomographic angiography	advanced surgical techniques	anti-sN-methyl-D-aspartate antibody	transcranial magnetic stimulation	paediatric traumatic brain injury	Resolution	lumbar puncture	sensory	sonomicrometry	the right knee	transanal/rectal ultrasound	phase contrast	unilateral hypoglossal nerve palsy	invasive angiography	fetal cardiac evaluation	the preferred imaging modalities	tomography scans	scanner	asymmetric sensorineural hearing loss	in-phase	similar pathological hypointense changes	any structural abnormalities	micro-positron emission tomography	bilateral mild hyperintense signal alterations	Seventeen patients	preliminary data	:393 –401	right ventricular angiography	newborn piglets	dimensional echocardiography	the imaging findings	long-term evaluation	abnormal leptomeningeal enhancement	cervical spine	the rat cortex	routine genetic tests	high speed drills	apparent diffusion coefficient	neuropsychological testing	A retrospective study	chronic dysarthric speech	adrenal vein	Wada tests	cardiac pacemaker safety	the high levels	a comparison	the kidneys	T2-hyperintense lesions	Good results	headache-like pain	maximum spinal cord compression	transrectal ultrasound	atrial clots	sleep electroencephalogram	the primary somatosensory cortex	mild hyperintense signal alterations	verbal learning	surgical findings	this ability	eventual diseases	high-resolution contrast	scanning	fistula tests	cortex white matter	skeletal scintigraphy	a population-based retrospective case series	tomodensitometry	invasive catheter hemodynamics	the respondents	cineventriculography	another method	concentric hypertrophy	this therapy	verbal fluency	the last decade	nerve conduction study	conventional angiography	computerised tomography	laboratory	no lesions	whole-body positron emission tomography-CT	Endovenous acyclovir treatment	initial examination	coronal volumetric fluid-attenuated inversion recovery images	multiple sclerosis	techniques	an abscess	a uniform protocol	a high resolution	the upper airway structures	crude behavioural assessments	a retrospective analysis	transesophageal echocardiography	total hip arthroplasty	axial tomography	angiography neither	accurate method	an alternative technique—on-resonance CE-sensitive spin-lock	scintimammography	additional value	a cerebral computerized axial tomography	innovative tools	no positive scans	parasomnias.2	some hyperintense lesions	gadolinium-enhancing	symptomatic breast lesions	Chromosomal microarray	electroencephalo- gram	the assumption	rat brain oxygenation modulation	a pacemaker-dependent patient	nonperimesencephalic subarachnoid hemorrhage	easy availability	anatomical details	acute vascular cell adhesion	hyperosmolality	science	human embryonic stem	brain function	segment elevation	duplex sonography	electroencephalogram recording	inflammatory changes	Initial tumor size	cerebellar signs	sodium fluoride	Khatcheressian et al	The spinal cord	Differential longitudinal changes	the imaging studies	temporal resolutions	equal success	An international report	the unique ability	videotapes	routine radiography	tomography angiography	monthly doses	adenosine test	intrathecal immunoglobulin synthesis	The first factor	an important modality	infarcts	clinical grounds	arrowheads	trigeminal neuralgia	fetal cardiac magnetic resonance imaging	radiography	vascular ultrasound	three-dimensional surface modeling	the liver lesions.Fig	the routine use	Both ventriculography	serum binding antibody	high field strength scanners	hyperintensity	substance use	echo	ventricular ischemic dysfunction	right ventricular wall thickness	Non-enhanced computed tomography	whole body bone scintigraphy	young woman	the suggested difficulties	MRI-based hepatic iron concentration	Characterization	echoes	neuropathological examination	clinical-physiological considerations	detects	the preoperative diagnosis	magnetic resonance angiography	ventriculography	the geometric accuracy	a solid neoformation	gas agents	barrier permeability	the neurodegenerative lysosomal storage diseases	These tests	the visual cortex	cerebellar atrophy	intracardiac ultrasound	inter-observer agreement	cortical grey matter lesions	idiopathic arthritis	positron emission tomography imaging	multiple hyperintensities	spinal canal stenosis	imaging protocol	positron-emission tomography	obstructive hydrocephalus	X-rays	an evaluation study	the assessment	speed	plain radiographs	:347 –357	the bullet	ataxia	microvascular obstruction	brain ultrasound	magnetic resonance	the craniovertebral junction	no regional wall motion abnormalities	ventricular volumes	neck	venous magnet resonance angiography	conventional autopsy	reconstructs	The nonionizing nature	high-resolution anatomic images	complex human movements	18F-fluoro-2-deoxyglucose positron emission tomography	Right breast ultrasound	a few months	field	XLAG	electrocardiogram	cardiovascular magnetic resonance Circulation	absolute myocardial blood flow	The interviewers	biopsy evaluations	Evaluation	’ s	breast ultrasound	the clinical setting	hydrocephalus	desmoplastic fibroma	the myelin g‐ratio	onset time	the multicenter multivendor	blood oxygen level-dependent	increased sensivity	the individual sizes	electrophysiological location	animal care	aminobutyric acid	aid diagnosis	unifocal disease.26	the combinatory procedures	dysostosis multiplex	allow characterization	Morphologic analysis	:132-137	an occluded artery	A hybrid approach	Devices	both cohorts	recent years	microelectrode recordings	ventricular premature	emission tomography	auditory canal	the central nervous system	the exact position	computed tomography scans	sequences	aortic stenosis	diffusion tensor imaging	maximum intensity pixel projection	neuro- logical examination	total cavopulmonary connection	probabilistic tractography	neurological expertise	squamous cell carcinoma antigen	regional functional improvement	Note	brain ]	the nosology	the real-time integration	no ultrasound	catheter angiography	pacemaker-dependent patients	biochemical analysis	multifocal hyperintense	coronary vessel wall enhancement	tongue	Typical transient lesions	the head	distinct signs	hepatic steatosis	the periventricular	Neurological evaluation	the adolescent brain	dual-energy X-ray absorptiometry	institutional review board	aphasic patients	the corresponding infarcts	e842 e843	Tumour volume	74-76 ]	solid lines	pilocytic astrocytoma	involuntary non-epileptic dystonic movements	possible anatomic anomalies	transoesophageal echocardiography	the diagnostic performance	thrombotic occlusion	neuropathological findings	collagen	advanced imaging	a powerful bouquet	acute infarct	brain biopsy findings	the female breast	area-length method	motion-registered spatiotemporal phase	complex anatomy	pediatric brain development	electroen- cephalography	optic coherent tomography	immuno- logical screening	hippocampal [	venogram	electroencephalogram	the affected area	all extremities	electroanatomic mapping	high resolution research tomograph	initial European experience	some point	the sleep course	the myocardium	a special physiological phenomenon	cellularity	pelvic radiography	polymeaerase chain reaction	velocity mapping	major structural changes	nerve conduction studies findings	The capacity	isolated syndrome	electrophysiological testing	bilateral intracranial subdural hematoma	mass effect	examination	supratentorial infarcts	biological factors	a minority	visceral fat mass	stenosis	cervical myelopathy	tumor origin	T2-weighted imaging	-scan	equipment	brain scans	the affected limb	amplitude	tau inversion recovery	multiple sclerosis aPatients	evacuated mass lesion	abnormal meningeal proliferations	these vascular territories	adjacent segment pathology	antibody status	complementary studies	macromolecular distribution	post-traumatic amnesia	disease onset	post-traumatic headacheintracranial hypotensionsyringomyeliacerebral spinal fluid leak	old woman	postural headache	milliliters	balloon	The eligibility criteria	white matter fiber systems	late venous return phase	out-patient blood tests	technical reasons	heart appearance	liver injury	a tumor	Functional brain mapping	intraoperative findings	hip radiographs	TAVI-associated cerebral microembolism	acute brain inflammation	these patients.34	spinal instability	dynamic computerized tomography	type-1 malformation	disability progression	cervical spondylotic myelopathy	humans meningiomas	brains	a left atrial appendage thrombus	utility	the neurological complication	single fiber electromyography	synesthesia	nuclear medicine	vascular lesions	a prospective trial	adjuvants	sagittal	implanted radio-opaque markers	a focal seizure	relevant information	Postoperative imaging studies	the value	intravascular ultrasound,17,21,24,25,27,32,33,37,38	interventional x-ray	radionuclide ventriculography	prolonged hypoglycemia	angiography	the fetal brain	dental evaluation	laser speckle imaging	normal myocardial segments	tomography-computed tomography	a sum	these procedures	contrast image	echocardiographic methods	the mdx mouse model	no artifacts	the new millennium	e44	benign	cardiac defibrillator interactions	dataset	atezolizumab	bone edema	serum sodium level	head scans	axial view	mental state examination	standardized coordinates	positron emission tomography brain imaging	brain structure	dimensional ultrasonography	the investigations	vascular risk factors	ultrasonography	nuclear cardiology studies	mediastinal invasion	accurate measurement	reduced pulmonary compliance	subtyping	an upfront simplified ‘ all-in-one ’	The value	a rudimentary spleen	the diagnostic evaluation	the fourth ventricle	the liver	A detailed clinical evaluation	other technologies	anterior descending	select high-risk women	free precession sequences	cardiac cauterization	the delayed enhancement technique	reliable methods	cardiology	different strengths	detailed evaluation	whole body	the lumbar spine	important clues	cardiomyopathy process	cerebral white matter hyperintensities	a single session	both genders	retrospective cardiac synchronization	no funding	annual screening mammography	Application	interventional radiology	.Fig	an underlying cause	dynamic arterial spin labeling	AID-ANA21 >	eosinophilic endomyocardial disease	useful information	variations	deep white matter leukoencephalopathy	invasive imaging	sufficient sensivity	cerebrospinal-fluid analysis	international normalized ratio/prothrombin time	anesthesia	Neurological examination	white matter changes	gray‐matter volume	focal brain injuries	a novel 3-dimensional real-time video acquisition system	relationships	transcutaneous electrical nerve stimulation	congenital cardiac anomalies	senior spinal surgeon	a fluorine-18 fluorodeoxyglucose positron emission tomography/CT scan	This syndrome	and/or angiography	pathologic conditions	suffering	111-monoclonal antimyosin antibody	human breast lesions	an alternative imaging modality	T2-weighted magnetic resonance images	other necessary examinations	eye	examinations	–297	nonspecific changes	the ischemic lesion	Clinical Implications	an alternative	cervical spine radiographs	this same cohort	tomography myelography	a clinical evaluation	leptin levels.31	diffusion-weighted imaging	inversion recovery	successful imaging modality	multislice	stereotactic localization system	superior accuracy	additional tissues	neuromyelitis optica	electromyography	endmyocardial biopsy	compatibility	new neurological symptoms	a mass	multicentre study	the particles	underwent batteries	spinal meningioma	potentials	The underlying lenticulostriate vasculopathy	typical	iron concentration	anthropometry	human brain development	tracking	asymptomatic volunteers	the diagnostic stage	radioisotopic techniques	neurosyphilis	human brain activity	diagnostic purposes	thorax	positive cerebrospinal fluid	the cut-offs	abnormal findings	small lesions	an inappropriate tool	arterial spin labeling	further investigation.Fig	dMRI	a un meningiome	a severe heat	each case	accurate staging modality	the major finding	characteristic pattern	gastro-intestinal tract	histopathology	monoxide brain toxicity	stenotic mitral valve area	motor outcomes	carotid plaque hemorrhage	right ventricular function	left ventricular endocardial fibroelastosis	episcopic fluorescence image capture	signal hyperintensity	another contraindication	chel	bicuspid aortic valves	:3814	early response	viral upper respiratory tract infections	a cerebellar expansive lesion	enzyme replacement therapy	age group	positron emission	upper extremity	single photon emission	pulse sequence	the cytologic differential diagnosis	the atherosclerotic burden	reorganization	superior vermian atrophy	conventional computed tomography	gadolinium-enhanced magnetic resonance imaging technique	the radiographs	near-infrared spectroscopy	intracranial magnetic resonance angiography	mbhattacharyya	The known c.638C	several transient zones	the optimal imaging modality	technical help	the form	magnetic res- onance angiography	a computed tomography	18-Fluoro-deoxyglucose positron emission tomography	quantitative iron concentration	the mouse heart	29610.1186/s12968-016-0296-4ResearchImproved high-resolution	the same time	the bony	robust body composition measures	cortical reorganisation	no abnormality	bony structures	these groups	invasive oximetry	A prospective study	an extra-intracranial magnetic resonance angiography	research protocols	laboratory monitoring	AID-ANA9 >	further diagnostic assessment	computer tomography	white matter cData	an cerebrovascular event	underwent total hip replacement	aquaporin-4 expression	late gadolinium enhancement	The neuropathology	CSC-treated patients	tissue properties	myocardium	Profile views	an incomplete picture	other rapid dementias	learning-impaired children Archives	safe mr practices	Monitoring	electrocardiographs	other modalities	non-invasive imaging	inaccurate	superior spatial resolution	bone scans	paroxysmal nocturnal hemoglobinuria	mean diffusivity	dyspnea score	a sensitive tool	either high-resolution	comparative diagnostic performance	gross pneumocephalus	correct placement	lymphocytosis	a high failure rate	the early diagnosis	triple-phase bone scintigraphy	normal inner ear structure	diffuse hypointensities	asymptomatic patients	a bone	breast ultrasonography	right occipital haemorrhages	precise injection positioning	the ablation procedure	accurate	peripheral macrophages	high resolution trans	cerebrospinal fluid analysis	a possible diagnosis	high-risk endometrial carcinoma	Video-EEG monitoring	computer-tomography	coronary blood flow velocity	a pseudomeningocele	A possible mode	scanners	imaging exams	positron emission tomography	tonic–clonic seizure	bioelectric impedence analysis	mammography	bolus injection	endosonography	cerebral white matter development	ultrasond	anatomical information	hemodynamic information	tomogram	space-occupying lesion	thoracic outlet syndrome	the details	Wallerian degeneration	signal variation	the advent	thalamic volumes	full analysis	a diagnostic lumbar puncture	radionuclide lung perfusion	fucosidosis	2,5-11 ]	modality	the 6-month long intervention	suspected multiple sclerosis	diseased heart	the brain	gadolinium-enhancing lesions	arteriography	spin echo	neuropsychological performance	microarchitectural measures	dimensional speckle	moderate disability	human carotid	tomography scan	hearing‐impaired children	the first generation	Multivariable linear regression	bloc spondylectomy	cranial computer tomography	safe performance	metabolic assay	a preoperative temporal bone	–28	the current use	a dual energy	electron beam tomography	The clinical clustering	line	the involved lesions	superior performance	significant atheroma	non-traumatic origin	human brain activation	promising techniques	tagging	scintigraphy	atherosclerotic lesions	an accurate	cardiac gating	autopsy	liver consequences	Challenges	cerebral edema	:1048 –60	Usefulness	multiple strokes	red blood cells	strain rate imaging	an important imaging modality	thin-slab three-dimensional surface rendering	ileal inflammation	these restrictions	dual X-ray absorptiometry	computer-assisted tomographic scanning	scan findings	the present manuscript	human stroke	histological examination	dual energy	the brains	cerebral atrophy	thigh muscle mass	brain imaging	urine pregnancy test	endometrial cancer	T2-weighted images	fluid attenuation inversion recovery	a fracture classification	unilateral mesial temporal sclerosis	human visual cortex	endomyocardial injections	strain echocardiography	this aim	The contribution	unrecognized myocardial infarction	frontotemporal dementia	aortic valve implantation	a comparison study	speckle imaging	magnetic resonance data sets	late stages	a high pre-contrast signal	similar findings	Epub	molecular techniques	MRI-conditional dual chamber pacemakers	no previous exposure	craniocervical junction	depressed ejection fraction	donovani	progressive outer	neuropsychologic evaluation	joint arthritis	magnetic resonance spectroscopy	other imaging technique	electroencephalography	brain–immune interactions	conditional devices	the periprosthetic soft-tissues	the coronary sinus	upper-normal limit	a double-blind placebo	tomogra- phy	fMRI	gold standard ’	a diagnostic tool	new foci	corpus callosum size	coronary thrombosis	monoamines	The prenatal diagnosis	digital subtraction angiogram	This case	saggital	ventroanterior nucleus	middle cerebral artery occlusion	liver biopsies	A 60-year-old male	pseudoaneurysms	detailed clinical neurological examinations	arthroscopy	venography	sonography	the trial	new techniques	fluid-attenuated inversion recovery	plain radiography	Quantitative pathology	size criteria	spine	an osteoid osteoma	radial motion	a significant impact	lesion activity	atrophy measurements	sever- ity	leptomeningitis	a complete evaluation	early diagnosis	new treatments	bone scanning	myocardial contrast uptake	ventricular tachycardia	extensive ischemic microvascular disease	cognitive testing	prospective clinical study	internal auditory canal	intracerebral lesions	the slip angles	tractography	leptomeningeal enhancement	nuclear imaging	revision surgery	the cranial bone	a useful technique	the cochlear nerves	the diagnoses	symmetrical lesions	composite	acute myocardial damage	out-of-phase	The term	investigations	cMRI	emission	the follow-up electroencephalography	the thoraco-lumbar spine	the hip2	hospital day	lumbar spine	tomography radionuclide imaging	single–photon emission	dwMRI	perfusion measurements	stereotactic body radiotherapy	comparative analysis	[ 10-12 ]	inner speech	antibody	spectroscopy	computerized tomography	Eligible patients	cardiovascular implantable electronic devices	] water	computational fluid dynamics	multiple masses	psycho	tissue model	multiplanar reconstruction	a detailed neurological evaluation	bone scintigraphy	genetic testing	reward prediction	

the closed state.37	aromatic amino acids	vasopressin	arginase	interacts	advanced lung cancer	Enteral nutrition	20-30 μM	a medium	8.5-fold increase	amino acid substitution	neuroendocrine alterations	asparagine	synthase substrate	other alkyl esters	the oxidation	and/or omega-3 fatty acids	the voltage sensor	valine	selective elimination	aspartate	an amino acid	amino acids	an arginase-mediated metabolite	the substrate	amino acid	codon	taurine	a substitution	proline metabolism	mM	the first intracellular loop	μM solution	a replacement	this pathway.13	multiple basic amino acids	silicon	early enteral nutrition	reference base	substitution	omega-3 fatty acid	negative relationships	undergo monomethylation	the enzymatic conversion	the substitution	the only different amino acid	nitric oxide synthase	the extracellular levels	glycerophospholipids	any genetic association	vasopressor	proline	large quantities	the positive charge	an oxidized form	lysine	osteogenesis	acylcarnitines	deimination	bacterial channel	a proline	aminoguanidine	the p53 gene	the insertion	histidine	glycolysis	the cGMP phosphodiesterase inhibitor	potential mechanism	omega-3 fatty acids	creatine-i.e	acid substitution	Replacement	the human phospholamban gene	an apparent contradiction	glucosamine	the competition	an additional amino acid	cultured	alanine	

wort	no additional sensitivity	systemic dapsone	FP	resistance	Systemic trimethoprim–sulfamethoxazole	ethambutol	isoniazid	active pulmonary TB	the triple chemotherapy	isoniazid resistances	pyrazinamide	isoniazid Antiplatelets	imipenem	first-line oral anti-TB drugs	a 12-month course	carbamazepine	anti-tuberculosis medication	inducers	mg/day	effective anti-TB drugs	katG	the fetus	mg/kg/day	nafcillin	trimethoprim–sulfamethoxazole	
caffeine treatment	


hemiplegia	limb involvement	triplegia	
active duty	non-amputee patients	
mass lesions	fistulas	blood	lateral medullary syndrome	congenital cysts	lump	tuberculoma	granulomatous lesion	recurrent cancer	No space-occupying lesion	fistula	a stiff neck	blood cultures	a pseudoaneurysm	pseudocysts	size	myelitis	septicemia	infarction	transfusion	complicated presentation	bowel obstruction	no vegetation	aorta-left ventricular fistula	atrium	cholangitis	meningism	bacterial meningitis	minimal periosteal reaction suggestive	the orbit	chronic lung infections	superficial thrombophlebitis	anorectal fistula	microbiologic aspects	infarct	a septal hematoma	infectious mononucleosis	tuberculomas	0.97-2.5	septal hematoma	no exudation	the bowel	central sequestrum	empyema	new dehiscence	normal transabdominal ultrasound	device exteriorization	collapse	the front	subdiaphragmatic abnormalities	purulent meningitis	bleeding	granulomata	macroglobulinemia	surgical wounds	neurologic structures	a recent series	:341 –347	leg	casseous material	osteomyelitis	bowel	*all free flap case	±standard deviation	pseudotumor recurrence	post-operative complications	endomyocardialfibrosis	pediatric orbital cellulitis	General information	a definable pus retention	0.6-3.0	vegetation	Septal hematoma	urinoma	the nasal septum	:5177	clinical neurology	psychosis	inflammatory disorders	phlegmon	neurologic impairment	

electrons	the solubility	dihydroxyadenine	XO	XO reacts	atazanavir	hypoxanthine	uric acid	


al9	transseptal access	large vessel	14-Fr catheter	cerebrospinal fluid	sublavian/axillary venous puncture	organ dysfunction	cecum ligation	Randomisation	cannulation	serological tests	a sham procedure	oligoclonal bands	the interatrial wall	the tip	the common femoral artery	preprocedure	the whole animal	transseptal approach	manometry	a first febrile convulsion	cecal-ligation	routine examinations	post-dural puncture headaches	murine cecal ligation	the subsequent procedure	a femoral vein	cecal ligation	relevant mechanisms	disturbances	the transseptal sheath	nasal sinus	blood patching	pleura effusions	the femoral vein	partial ommentectomy	the interatrial septum	Cardiac function	the location	percutaneous drainage	the epigastric artery	precipitates	Cecal ligation	the cecal ligation	superiosteal abscess	an essential medical procedure	guide-wire insertion	arm	short sheath	the jugular	the fossa ovalis	these investigators	lingual frenotomy	the length	ligation	

phenyl	phenylacetate	hydrolysis	

gastrointestinal stromal tumor	gastro-intestinal stromal tumor	pheochromocytoma	focal lipomatous hyperplasia	
Any signs	axillare	the identification	
refractory	a Hispanic male	the peripheral blood smear	relapse	a suboptimal response	haemolyticuraemic syndrome	thrombotic microangiopathy	hypernatremia	the impression	plasma protein product transfusion	a preclinical baboon model	indications	10.2147/JBM.S46458jbm-5-015ReviewManagement	Experience	spetial reference	delivery	exchange transfusions	acute renal failure	other thrombotic microangiopathies	the hemolytic-uremic syndrome	a high volume procedure	hemolytic uremic syndrome	repeats	polyarteritis nodosa	agranulocytosis	multicenter survey	glomerulopathy	a life-threatening disorder	plasma exchange improve suppressor cell function	acute refractory	first-line rituximab	
vitrectomy	the C-terminal ends	the ciliary membrane	ciliary body traction membranes	

the correct diagnosis	the same conference disagreed	aortic valve disease	heart muscle disease	hemorrhagic stroke	altered mechanics	insertable cardiac monitor	Sex differences	altered myocardial metabolism	congestive	Causes	diabesity ’	The progression	flutter	familiar hypertrophic cardiomyopathy	mild heart failure	cardiomyopathies	fibroblasts Advances	this information	dilated cardiomyopathy	the clinical assessment	systemic hypertension	common aetiology	socio-demographic aspects	organ fibrotic changes	ischemic cardiomyopathy	rheumatic heart disease	magnetic resonance measurement	the differentiation	An autopsy study	3-5 ]	early coronary	pericardial disease	ventricular compacta thickness	stable coronary artery disease	myocardial ischaemia	age-standardised separation rates	important cardiovascular disorders	genetic association	

family member	disulfide	nucleotide polymorphisms	statin-based drugs reduces caveolin levels	hypoxic conditions	synthase-1	the enzyme	the homeostasis	coagulation factor	hydrogen peroxide	ventilator-induced lung injury	important advantages	an efficient cholesterol-lowering medication	an important enzyme	cystathionine beta-synthase	appreciable amounts	μl	p45-related factor	the mammalian heme degradation pathway	a selective inhibitor	Atorvastatin	pilot studies	oxygenase domains	prothrombin	3-hydroxy-3-methyl-glutaryl co-enzyme	xanthine oxidase	cholesterol 7α-hydroxylase	Search terms	3-hydroxy-3-methyl-glutaryl-CoA reductase	enzymatic systems	case control	The system	ROS generation	the active site	drug target	myeloperoxidade	rs1801133	the activity	nM cytochrome c	deficiency	+1.6	plasminogen activator	The competitive inhibition	the activities	competitive inhibitor	homocysteine metabolism	nondiabetic renal disease	prenylation	reduced folate carrier	biliverdin reductase	
a major complication	rare case	disseminated intravascular coagulation	nocturia	
an unusual manifestation	unusual language problems	the thought	musicogenic epilepsy	


excessive use	
harmonics	sinusoidal waveforms	primary	active scalp	The normal response	square wave	“ carrier	

a nonselective β-blocker	propranolol	placebo-controlled crossover trial	isoprenaline	non-dihydropyridine calcium channel blocker	acetbutolol	alpha-1-blockade	
The difference	storage symptoms	Any cause	possible detrusor dysfunction	constitutional symptoms suggestive	external sphincter	
nitrate-enhanced technetium	platinum compounds	gallium	the intracellular uptake	Myocardial uptake	the reinjection	a control solution	technetium-labeled agents	technetium tracers	half-life	intact mitochondria	bismuth	a novel hierarchy	ECG-gated acquisition	pulmonary uptake	influx	exercise test	contact	myocardial viability	membrane integrity	technetium	
upper respiratory infections	congenital rubella syndrome	mumps	whooping cough	toxoplasmosis	the herpesviridae	measles viruses	measles	varicella	Both anterior uveitis	cytomegalovirus	evaluated pregnancies	maternal hyperphenylalaninemia	fetal teratogens	cervical pain	low cross-reactivity	
the regeneration	synovium	the subchondral bone	articular cartilage	primary antibody	
understood therapy	percent sodium cromoglycate	symptomatic relief	the symptomatic treatment	other allergens	beclomethasone dipropionate	dose-response	the topical treatment	nonrhinitic subjects	coughs	pseudoephedrine	allergen-challenged individuals	neuropeptide release	sterile women	placebo-controlled clinical trial	a model	nasal insufflation	school children	maximal response	pollen rhinitis symptoms	carbon dioxide-oxygen mixtures	free eosinophil granules	
the therapeutical options	basic visual spatial ability	ST-elevation	follow-up evaluation	the surgeon	action selection	drug addiction	judgment	surgical technique	endeavor	essential processes	clinical values	this systematic comparison	emotions	healthcare	the surgical strategy	tensor imaging	semantic processing	accurate response selection	priorities	The go/no-go task	patient preference	language processing	the consistency	advanced assessment	care provider attitudes	annulus	the immediate	-61	this particular subtype	the subsequent therapies	symptom recognition	patient selection	advise patients	cortex	alternative models	a continuum	An integrative model	mitral valve complex	the orbitofrontal cortex	self-care	an individual analysis	categorization	policy decisions	critical limitation	social norms	This population	individual judgment	satisfaction	cognitive characteristics	insula	other acute headache medication	lots	management practice	reinforcement learning	selection	policy impact	learning	post-operative patient counselling	communication skills	decision regret	the ethics	phenotyping	The main effects	computational models	self-regulation behavior	diseasecostsepidemiologyinfluenzainfluenza‐like illnessLatin	health policy	problem solving	reading	Broad-thinkers	modes	executive function	preactivation	the motor preparation	effective decision	risk perception	probabilistic biased-competition models	plan manipulation	lung cancer screening	the decrease	left ventricular assist device implantation	navigating team dynamics	

hemifacial spasm	partial continuous epilepsy	habitual spasm	

the risk	Clinical signs	prognostic value	nitric monoxide treatment	00670-G	the technical ability	Perioperative management	severe pulmonary arterial hypertension	emergency reinstitution	resultant pulmonary hypertension	tricuspid regurgitation	pulmonary hypertension	ventricular dilatation	ouabain	transthoracic echocardiogram	suspicion	vascular collapse	an atrial septostomy	an interatrial shunt	Predictive factors	cellular bioenergetics	hemodynamic collapse	shock	a major concern	atrial septal communication	vivo mitochondrial oxygenation	cor pulmonale	
an arterial side branch	a crescent	these anatomic landmarks	the posterior vessel wall	profound	profound femoral artery	judgement	
optic aphasia	inattention	/	sensory symptoms	auditory spatial deficits	
idiopathic pulmonary neuroendocrine cell hyperplasia	cell hyperplasia	carcinoids	the designation	
hree cases	phantosmia	the topic	

-L-ornithine amide	Morphological features	ovarian carcinoma	anti-angiogenic therapy	pegylated arginine deiminase	
facial pain	clinical findings	no association	rhonchi	pyrexia	exercise intolerance/poor performance	the horse	otitis media	coughing.1	horses	an owner complaint	sneeze	characteristic biopsy findings	nasal obstruction/blockage/congestion	sleep disturbance	nasal obstruction	a positive titer	variable coughing	pharyngitis	recurrent sneezing	postnasal dis- charge	variable fever	chilliness	nasal blockage	purulent	oral ulcers	anterior/posterior/nasal drip	facial pressure	rhinorrhea/nasal obstruction	throat sore	blowing	
familial Synonym	thyroid nodulation	arrhenoblastoma	nodules	
Area-under-the-curve	brain	X-ray	CK-MB fraction range	creatine kinase isoenzyme	mg/dL	hemoglobin level	decreased efficiency	the normal value	alanine aminotransferase	cardiac enzyme	elevated levels	serum.2,9	human heart	Myocardial function	cytochrome c oxidase	an isoenzyme	lactate dehydogenase	bone morphogen	the brain isoenzyme	an elevation	hyperkeratosis follicularis	myoglobin9	mg mL−1	specific monoclonal antibody	kinase-associated reactions16,47	hepatic enzyme elevations	Other laboratory tests	experimental data	The cellular transmembrane potential	hearts.Figure	cardiac troponin	troponin levels	laboratory values	inorganic pyrophosphatase	isoforms	serological parameters	dehydrogenase	chromogranin	thyroid function tests	cardiac troponin-I	CK-myocardial band	creatine kinase-myocardial band isoenzyme fraction	total peripheral resistance	tartrate-resistant acid phosphatase	pro-brain natriuretic peptide	evaluation shows leucocytosis	physiological stress	g/dl	troponin	bulbar weakness	increased transaminase values	microparticle enzyme	aspartate transaminase	myoglobin	left ventricular ejection fraction	mm/h	∗∗	myocardial injury	other oxidative enzymes	The initial chest x-ray	the forced swim test	low specificity	Efegatran	non-muscle	cTnT	cardiac enzymes	preoperative time	isoenzyme	autoimmune profiles	lactate dehydrogenase	the dosage	troponins	cardiac troponins	serum troponin	energy reserve	isoform	troponin-T	B-CK shows	the electrocardiogram	lactate dehydrogenase activities	gamma-glutamyl transferase	blood spot	normal range	plasma glucose	cell-specific distribution	mM creatine phosphate disodium salt	this enzyme	reversible phosphate exchange networks	tissue activity	isoenzyme creatine kinase-myocardial band	blood gas analysis	
dorsal flexion	numbness	plantar flexion	lateral walls	curved arrow	pronation	the morphogenetic phenomena	the labial salivary glands	the cladistians	some groups	lateral pallium	the telencephalic walls varies	inversion	a marked thickening	the various actinopterygian groups	the pallial parts	dorsiflexion	a distinct lateral olfactory tract	dorsiflexion strength	an outward bending	
a comparative trial	replacement therapy	beta	continuous human cell line	


old patient	a young patient	

a series size	swellings	thrombin injections therapy	a large amount	abdomen	partial flap loss	a wound	abscess [ Figure	pseudoaneurysm	patient analysis	intradermal backup options	visible tissue damages	the lesion	formation	Subdural fluid collectionDural metastasisMucusExtravasationMalignant neoplasmsissue-copyright-statement©	The mass effect	pulmonary artery rupture	non-access-site bleeding	intraventricular mass	impaired breathing	complete extirpation	low attenuation consistent	vascular surgical repair	tumor	direct evacuation	surgical evacuation	Traditional teaching dictates	the clearance	the drainage-bag	The second model	arterial vessel wall	liver failure	density	the major complications	sub-acute periods	Subarachnoid hemorrhage	occasional ruptured vessels	acute subdural hematoma	dural metastasis—case report	evacuation	subarachnoid	the eyelid	puncture point	hypoperfusion	lesion-tailored approach	the nasal flank	small hematomas	the mouth floor	renal artery injury	skin laceration	foreign body	The overall incidence	vessels	midline shift	herniation	a ruptured aneurysm	pleurocutaneous fistula	small changes	the nerve	major bleeding complications	easy haemostasia	localized pain	such cases	large contusions	active bleeding	effective removal	groin	aggressive external compression and/or	the width	the pericardium	the right treatment	arterial puncture	contusions	metastatic neoplasms	dural metastatic tumor	the anastomosis	signal changes	the relevant rates	a benign lesion	Time	ctofundamentals.org	the muscle tissue	neuroma	brain edema	peri-procedural seizures	atherosclerotic ulcer	arrowhead	abscess formation	canal fractures	subarachnoid hematoma	Contusion	metastatic malignant disease	minimal evacuation	bone graft	the side	intracranial hemorrhage	ulcer	intemal flap	bleedings	Epstein-Barr virus infection	transient vasospasm	blood thicken	the center	the frontal area	cystic-appearing zone	microglia/macrophages activation	ulcers	diameters	impaired healing	present edema	consequent local trauma	arteriovenous fistula	needle-like hematoma disintegrator	hemorrhagica	center	the above approach	international normalized ratio	retractors	a septum abscess	false membrane	the midface	required revision	severe pocket hematoma	subdural fluid collection	The density	the areas	complete skin overgrowth	excitotoxicity	any additional component	the surgery	width	periprocedural hemorrhage	intravascular coagulopathy	limb lengthening	enlargement	postoperative inflammation	subdural accumulation	

proneness	quantitative classification	r=−0.32	Another limitation	The disability	communication difficulties	Neurological impairment	benefit analysis	no significant difference	patient management	the lived experience	r2=0.19	:645 -51	sentences	r2=0.11	all listening options	r=−0.37	some form	r2=0.15	person-reported hearing disability	Self-reported disability	r=−0.36	r=−0.38	r2=0.12	an elderly population	Occupation	long-term stroke disability	hearing disability	pure tone thresholds	hearing measurements	r2=0.07	mean hearing loss	r=0.68	r=0.25	a minor proportion	s life	neurological disability	experienced hearing disability	each category	a new outcome measure	the response shift	
laryngospasm	papilledema	Neuromuscular symptoms	muscle twitching	motor dysfunction	
IL-1β production	the microglial inflammatory responses	a significant place	enema	The leptomeningeal cells	the efficient attenuation	honey	mouse macrophages	microglial activation	leptomeningeal cells	various concentrations	
proliferative actions	% polyacrylamide gel	membrane	strontium	phenylmethylsulfonyl fluoride	gels	a good example	membranes	secondary antibodies	strontium ranelate	high reactivity	
another calcium channel blocker	

protein transport inhibitor	μg/ml	


fusion status	pepsinogen	mesenchymal progenitors controls	oestrogen levels	androgen ablation serum	stromal response	androgen-independent prostate cancer	combined inactivation	the cooperative effects	type cultures	OVCAR-3	inhibin levels	The endogenous expression	epithelial stem cells	Quantitative analysis	caused regression	The synthetic analogue	distinct effects	Epithelial basal cell expression	hippocampus-derived estrogen	prostate cancer cells	oestrogen influence	The cooperation	the androgen-dependent nuclear import	cyclicity	Hereditary prostate cancer gene	androgen dependent	estrogen receptors	reduced levels	vascular endothelial cell growth factor receptors	other transcription factors	estrogen	progesterone concentrations	different concentrations	androgen dependet	a large number	androgen receptor	oestrogen	
fowlpox	a lethal challenge	dissociation inhibitor	the simian adenovirus	peptide	rMVA-	viral particles	viral vectors	
disc space heights	sagittal plane rotation	
the tropics	spectrum	a rare form	poor prognosis	
natalizumab	glatiramer acetate	gamma	antibody-mediated decreased bioactivity	mg/week	a specific effect	serum binding antibodies	influenza virus	interferon gamma	the cost effectiveness	antibodies	the experiments	interferon alpha	archival tissues	indicated concentrations	
valproic acid	the intracranial/spinal mass	external ventricular drainage	cerebrospinal fluid fistula	cystic encephalomalacia	myelomeningocele	
hypercholesterolemia	both tidal volume	a respiratory therapist,53	funds	menstruation-related factors	acute bouts	cortical bone compartments	the potential therapeutic effects	non-pharmacologic interventions	carbon dioxide inhalation	the potential health benefits	myocardial biopsy	pharmacological stress echo	symptomatic athlete	alteration	airway clearance	physiologic indices	the recumbent	cerebral blood flow velocity	normative values	an address	the effort level	echocardiography parameters	cessation counselling	the pulmonary microcirculation	healthy eating participation	a recent physiotherapy-	oral contraceptive usage	the final analysis	minute	both mPAP	fluid intake	nutrition countermeasures	tract obstruction	work status	exercise intraventricular dyssynchrony	the athletes	wait‐list observational control groups	hypoxia Circulation	further examination	This paper	food intake	diet	axial compression	the general health benefits	balance exercise	energy restriction	the well-established benefits	high-fat diet animals	Pain	the parameters	the essential role	anaerobic metabolism	Elevation	low-salt diet	The beneficial effect	a workload-matched session	the water content	no differences	a home-based exercise programme	the morning	eccentric actions	stimuli	n =40	symptomatic responses	previous phases	value	mild-moderate hypoxemia	sulfonylurea	repetitive episodes	the exact intensity	heart-type fatty acid-binding protein	cytokine levels	an antiinflammatory cytokine	reliance	s	few reported adverse events	this level	pairwise differences	the promising influence	gastric pressure	the expiratory reserve volume	the diffuse nature	a clinical context	the exercise sessions	sports science position statement	aerobic training types	various experiences	bush foods	intra-ventricular gradients	cross-over trial	cellular protein levels	twist	dry air	other techniques	addition	diastolic filling pressure	valsalva	the present experimental model	study capsule	the acute effects	beclin-1 protein levels	molecular indicators	the cerebral cortex	synergistic effects	the appropriate dose/intensity	combination exercise	cerebral blood flow	an echocardiographic examination	exercise-induced adult	possible mechanisms	high intensity	dobutamine stress	meta-regression analysis	[ 42-45 ]	this contributes	digital video display	both improve behavioural profile	coronary arterial stenosis	ventilatory demand	left	cardiac catheterisation findings	increased levels	invasive measurement	neurogenesis	a percentage	cardiovascular medications	an on-kinetics analysis	both previous experiences	stress perfusion imaging	dyspnea index	pain modulation	effective means	baroreceptor mechanisms	voluntary isocapnic hyperpnea	the human hippocampus	voluntary hyperventilation	driving	central nervous system apoptosis	specific modalities	access programs	several possible mechanisms	type headache	the performance	Tian et al	peak levels	expiratory volumes	catabolic effects	a single bout	The breathing pattern	ventricular dysfunction	each 2-minute interval	sclerostin	rest values	regulation	pounds	no significant ischemia	sport	precision	uncover new areas	b.p.m	possible predictive value	the ventilatory limit	diastolic dysfunction grading	management options—trigger avoidance	head-to-head comparison	a healthy diet	the different effects	Impact	the histological observations	beating- versus	dipyridamole stress pts	the searching	the ST-segment depression/heart rate analysis	segmental wall abnormalities	the sinus rate increases	mental stress	the opening	moderate intensity	vivo conditions	a nutritional countermeasure	contractile reserve	leisure time	human intelligence	a 12-month randomized clinical trial	non-nutritive blood flow	every minute	group	high mechanical loading	dobutamine-atropine	the efficiency	augmented rate	noted benefits	hypertonic airway challenge	the follow section	intra-class correlation coefficients	cardiac function	preferred voluntary rate	attention parameters	daily life	catecholamine-liberating conditions	insulin action	a finding	these changes	al5	the aldosterone	an underlying vascular predisposition	the estrogen deprivation effects	medication compliance	the same mechanisms	an exaggerated blood pressure response	bromide	a strong motivation	morphine	cognitive function	a few minutes	nonhyperinflators	the muscle	Both types	electrical stimulation	yoga	an improper systolic volume	an acute increase	self-reported behaviours	A few months	the required dose	the cardiovascular changes	a modifiable risk factor	other contractile activity	bottom panel	the therapeutic potential	The paradox	immune function	the rat	the human circadian system	alterations	activity capacity	.7,12,46,50,52–58	ischemia reperfusion ”	] patients	respiratory muscle fatigue	ventricular filling pressure	caloric management	pharmacological test	pharmacological stress test	physical well-being	low-attenuation area	capillary density	the prognostic power	normal daily life	a 2-week period	present situation	case-managed program	myocardial ischemia53	Physical activity	the blood pressure response	the long-term effect	correlate	the total time	major abdominal surgery	inspiratory muscle training	appropriate nutrition	sham group	survivorship study	pharmacologic	stent revascularization	ventricular torsion	the imbalance	the brain-enhancing effects	the major qualitative dimensions	regular physical activity	a good valvular reserve	a potential trigger	arch curvature	biomechanical correlates	ozone	reference	control subjects	this sort	Cardiovascular benefits	insulin sensitivity	droplet spread	total exercise duration	non-pharmaceutical therapeutic approach	neurobiology mechanisms	exertional sports	heart failure patients	physical exercise	direct proof	this methodology	cycle	health-related research	bariatric surgery increases	cigarette smoke cessation	depressed patients	+1.1	oxygen	health professionals	cardiovascular complications	perfusion reserve	femur bone	SF-36 subscales	induce	behavioral stimulation	fruits/vegetable intake	the multiple health benefits	bronchoprovocation tests	challenges	respiratory rate increases	cold air	the exercise hypertension	a standardized exercise test	sedentary diabetic	physiologic stress	a large muscle mass	scores	achy-breaky heart	nutrition	satisfactory lung function	significant benefits	n=85	a non-invasive diagnostic test	p=0.18	the anomalous vessel	no significant effect	adolescence	the clinical characteristics	resting images	the participant	mineral densityBTM	eucapnic voluntary hyperventilation challenge	the limited sample size	an important component	consequent modification	The cardioprotective benefits	an additional benefit	Two-dimensional paraesternal view	reversibility	pharmacologic agents	an imaging modality	unknown factors	this type	treadmill speed	aerobic performance	a ΔmPAP/ΔCO ratio	increased cardiovascular risk	new ischemic uptake	the direct effect	upright posture	exercise-induced hypoxia.10	functional neuroimaging scans	mobilization	beta-adrenoceptor blockade	resistive	both developmental alcohol exposure	orthostatic position	appetite	pathophysiology	“ exertional headache ”	“ cough headache ”	the cardiac reserve	preconditioning-mimetic action	the rat hippocampus	healthy young adults	the initial phase	these periods	long-term oxygen therapy	health care services	vascular resistances	vegetable intake	non-ischemic conditions	ml min-1	% exercise capacity	the acidosis	serotonergic neurons	physical activity counselling	significant improvements	an optimal pace	this response.14	the adoption phase	daily weight	rodents	early breast cancer	Breathlessness descriptors	mild airflow obstruction	diet regimens	short vs	the rehabilitation process	alprazolam	operational lung volumes	the plastic benefits	aerobic training	sleep desaturation	catalase	The anti-inflammatory effect	the adipose tissue inflammation	many cardiovascular health benefits	co-workers	the middle	HDL-directed pharmacological intervention	artificial loading	profound alterations	ambulatory monitoring	cardiac events	The effectiveness	multi-layer short-stretch bandaging	lifestyle factors	index18	no beneficial effects	The long-term effect	The protective mechanism	mitral regurgitation	a potential linkage	high-resolution	diet changes	irisin	ventricular arrhythmias	same day	gravity	the adverse effects	the recovery period	the increased inspiratory effort/displacement ratio	power	disability scores	peripheral chemoreceptor stimulation	particular interest	interdisciplinary patient education	mitral gradients	the non-invasive estimate	severe respiratory failure	patient position	the inflamed rheumatoid joint	hyper-inflation	the physiotherapist	this increase	high intracellular pH values	The required duration	the lifetime prevalence	seventh column	all groups	no overall effect	miRs	unstable angina	dipyridamole-atropine stress echocardiography	an “ RC-type ”	probable vessel diameter change	right ventricular extracellular volume	a significant dose-response related benefit	the reduced coronary flow reserve	cardiovascular arousal	a brief period	pulmonary vascular resistance	hunger	various provocative maneuvers	ischemic test	metabolic mechanisms	reduced muscle	both wheel	a 4-year absence	normal dimensions	ventilatory volume	standard exercise protocols	disease-modifying treatment	care receptive	respiratory impedance	hypertrophic cardiomyopathy patients	neurohormonal activation	BSA-matched subjects	intermediate stages	self-administered questionnaires	comprehensive strength training	Modes	defecation	overall health	any contraindications	plasma beta endorphin levels	skeletal responses	dobutamine stress echocardiography	existential thoughts	the later stages	manufactured foods	elevated mean pulmonary artery pressure	the institution	diabetes	histamine	hyperpnoea	stress echocardiography tests	risk factor management	autonomic regulation	physiotherapy sessions	a beta-blocker	complete lack	a prolonged period	a pharmacological challenge	total heart volume variation	severe emphysema	late adverse effects	the systemic changes	the load-based effects	adrenergic stimulation	Intention-to-treat analysis	a specific modality	activities	open circles	no adverse clinical events	mL min−1 kg−1	usual activities	exercise prescriptions	Beta-blockers	these findings	Use	systolic dysfunction	the immune system	the human myocardium	four-point bending	ST-segment shifts	scales	low frequency fatigue	exercise intensity	barotraumas	passive smoker groups	a central exercise limitation	a particular nature	t	travel	the inspiratory	breath	cardiac rehabilitation programs	evidence	metabolic rate	genetic factors	chemoprevention interventions	glycemic control	low body mass index	daytime sleepiness	Movement	remitted major depression	const	maximum exercise capacity	chronic effects	all day	stress management	normal life migraine characteristics	motivations	specific irritants	the cardiovascular system	sleep medications	discomfort	preventative lifestyles	the participants	epinephrine infusion	regular meditation	forearm blood flow	work load	abdominal muscle contractility	different intensities	chronic airflow limitation	the impaired oxygen transport	oral laxatives	healthy controls.22,44	countermeasure	the increases	artificial loading experiments	The formation	Clinical effects	serum hormones	dyspnea arises	the mechanical output	co-investigators	lifting	oxygen uptake	myocardial perfusion scintigraphy	a decreased sensation	brief sessions	precise control	filling capacity	cost	the present findings	each indicator	the quadriceps muscles	fractionization	rapid left ventricular	either hypoxia	the baseline values	respiratory rates	metabolic demand	Subjects	alcohol drinking	exercise testing	an example	hormonal therapy promote muscle anabolism	summer	an effective form	deal	oxygen cylinders	cardiac resynchronization therapy	the combination therapy	6-min walk tests	Spirometry	a large sample twin study	the postnatal guinea pig	non-insulin dependent diabetic subjects	drug adherence	another methacholine chloride	a later phase	aged mice sufficient	environments	The anti-inflammatory effects	advanced stages	the final score	mechanistic insight	the optimal intensity	influenza vaccination status	a portable digital glucometer	no statistical interaction	Participant demographics	muscle group	the monoamine systems	skeletal muscle tissue adapts	repetitions	right ventricular ejection fraction	reduced adiposity	the onset phase	sclerostin antibody	profound limitation	heat stress	the healthy brain	Dec	intervention techniques	dopamine neurons	previous experiences	small volume	v	virtual reality	the handedness	physical fitness	a significant overall effect	The antidepressive effects	peak stress	recovery phases	fat adaptation	aging	all-cause death	decreased breathlessness	brain plasticity	immediate postexercise imaging	elderly people	sum	Both baseline	segment depression	area changes	asthma diagnosis	hyperosmolar challenges	a goat	the minimum intensity	blood sugars	adjacent muscles	an exercise training program	a level	counselling	reduction	aged mice	trabecular volumetric	cardiac rehabilitation	exCMR	statement	sustainability	the cardiovascular	anatomical correlates	pulmonary pressures	school	normal morphology	no disclosures	harms	left arm	the height	the air	the volume	sodium intake	certain matrix mutations	hangover	sub-maximal exercise	hemodynamics	the process somehow	an acute exercise paradigm	an index	low intensity	resting	low-intensity	al25	a valid method	physical interventions	endogenous antioxidants	normal life attacks	mitral deformation	psychological factors	postmenopausal	left ventricular torsion	non-HDL cholesterol	energy drinks	animal species	systemic vascular resistance	the dentate gyrus	the benefits	n=6	group b	sham	gradients	gradient measurement	coronary revascularisation	rate-pressure products	these results	adequate left	improved exercise tolerance	study71	neuroanatomy	aerobic exercise	function imaging	brain activity	ventricular mechanics	each power output	Younes	the metabolic load	various levels	the different muscular groups	The ratio	neural responses	different previous experience	torsion increment	the recovery phase	inotropic	nuclear perfusion	conditions	frequent hospital admissions,31	biglycan-deficiency	neuroanatomical measures	cortical activity	ejection fraction	factor	The chronic effect	the resting	lactate	a bout	relative success	oxitropium	cellular proliferation	orthopaedic disorders	a protective phenotype	the right ventricle	extreme fatigue	the trials	mouse studies	maximum voluntary ventilation	the dependent variables	the great news	the probable pathologic significance	healthy participants	that morphological variables	the pain-relieving effects	this abnormality	'no room	caloric restriction	relaxation practice	rarely/never	proof-of-concept rituximab trial	the skeletal benefits	burns	a significant additive effect	‘ indirect tests	evaluation costs	this apoptosis	myokines	coronary angiographic findings	antioxidant supplementation	an adaptive response	certain activities	ibuprofen versus placebo	sensitive marker	the mortality	Other beneficial effects	physical activity exposure	an intensive program	everyone	manual treatment emphasis	no particular type	hemispheric brain infarction	bronchodilator treatment	clinical relevance	interaction	the individual	protracted period	osteoporosis treatments	a statement	pressure work	challenge tests	education sessions	nonaerobic forms	metabolic functions	stress pts	inadequate glycemic control	manipulative therapy	the cold air test	peak overload	treatments	stress echocardiography	increased neurogenesis	objective fevers	a decreased amount	prandial	a single daily dose	The resting	this factor	arrhythmogenic right ventricular dysplasia	both rest	human studies	habitual smoking	different forms	the Spring	the possible role	The average volume	the anabolic effects	Sports	fitness	significant dynamic hyperinflation	emotional stress	a central moving average filter	ventilation become	adaptations	The twist velocity change	post-exercise blood pressure	any adverse events	TV	impaired children Seizure	lymphedema trial	The old view	any clinical adverse event	a direct association	a non-immunological stimulus	amount	a 12-week program	ArticlePhysiotherapy-supervised mobilization	ibuprofen effects	An effect	chronic patellar tendinitis	The advantageous effects	general considerations	other situations	a constant intensity	prolonged periods	both baseline	the postulated benefits	the powerful therapeutic advantage	The intervention	Mean arterial pressure	normal myocardial relaxation	so-called exercise-induced asthma	mild pain	medical clearance	cardio respiratory	recorded volume	induced stress	risk stratification	the vessel wall	pacing	:451	significant positive effect	Fear	standard visual criteria	a significant ischemic load	severe exercise-induced asthma	oral intake	functional near-infrared spectroscopy	the programme	methylphenidate ameliorate symptoms	the typical aura	an issue	carbohydrate-rich meals	caffeine	reproducible modality	permanent atrial fibrillation	ERS	the sole use	nonmechanical roles	case-control study	The combination therapy	life domain	possible interventions	upper-limb exercises	impression	short term	administration	systemic inflammatory process	early mobilization	stress perfusion	exercise periods	an international advisory panel	extended periods	the intra-class correlation	a jumping protocol	a fall	Physical training	The long-term prognostic value	lung transplant recipients	ibuprofen use	other environmental factors	validity	fainting	the aforementioned biomarkers	systemic effects	the effects	respiratory training	h time point	the upper limit	increased expression coincides	gene insertion/deletion polymorphism	a potent inhibitor	pharmacological stimuli	beat	a significant fall	“	foods	atrial fibrillation patients	seconds	respiratory tract infections	The early initiation	swimming	other physical stress	an important stimulus	placebo therapy	metabolic support	the idea	household	p	ba-PWV	splanchnic blood redistribution	neuroinflammation	eat	dietary components	early dobutamine stress echocardiography	cognitive recovery	dyspnea	a continence physiotherapist	metabolic demands	the immediate benefit	the small independent predictive value	chronic sertraline	tract	the individualized prescription	exercise dose	signals	the cardiovascular response	incomplete recovery	preload decreases	Regular physical activity	the optimal dose	a rate	chest tightness	issues	whereas obesity	rate control	sexual activity	pulsating	–53	the potential benefit	the stress test	genetic abnormalities	acute	improvements	stressors	scale	the long-term impact	the only predictor	normotensive subjects	the physiologic benefits	a twelve-lead electrocardiogram	expiratory flow	balance	compensatory parasympathetic hyperactivity	inhalation therapy	advanced disease	downregulation	basic research	cardiac adaptation	heart transplant	important clinical outcomes	methacholine	The coefficient	the saturations	a therapeutic regimen	extreme types	no previous experience	clinical guideline	the cardioprotective effect	the central drive	a training	the long-term prognostic value	the anti-inflammatory effects	thermal bio feedback	the augmentation	collaborators	the poor control rates	the second 18F-FDG imaging	mismatch increases	a mean peak workload	a combined analysis	exercise-induced bronchospasm	betamethasone	volume,19	cardiorespiratory	either rest	cardiac resuscitation	post-treatment reconstructive surgeries	a detailed history	pharmacologic stress 99mTc-tetrofosmin gated-SPECT	behavioral impairments	peak	NO production	the initial stages	motor training	An EOAi	the entire warm-up	cessation therapy	certain foods	opportunities	oxyhemoglobin desaturation.13	such outcome	inspiratory capacity	sedentary	urinary excretion	fibrinogen concentrations	the molecular markers	low calorie consumption	dobutamine infusion	Something	total duration	a significant decline	a favorable outcome	an independent predictive factor	mild cognitive impairment	underlying genetic factors	secretion clearance	acute exposure	a normal maximum tidal volume	exercise-induced metabolic acidosis	left ventricular filling pressure	the endogenous activity	a standardized version	ibuprofen supplementation	the same extent	Both meditation	consistent evidence	the protective properties	Thent	dietary changes	moderate physical activity	The benefits	formoterol	these tests	low level	feasible intervention	the training	//www.archivosdemedicina.com	the mechanism	significant difference	arterial blood gas samples	morphologies	drinking	provocation test	a slight increase	intervention group	no change	initial experience	potent dilator effect	myocardial functional recovery	heating	fundamental activity	the real practice	this parameter	chronotropic response	workload	rate-control	some plausible mechanisms	inhale salbutamol	diet modification	cardiovascular etiologies	impair	circulatory responses	resistive loads	a protective metabolic phenotype	potential additive effects	nutritional support	acute administration	the anxiolytic effects	systolic myocardial performance.1	No change	self-reported overall health status	a bath	hormone replacement therapy	flail leaflet	safe methodology	protocols	physiological parameters	lipids	short burst	health care systems	Exercise-induced asthma	resistance exercise	Spanish schoolchildren	no additional effect	neural regulation	alters activity	these candidate genes	Seven adolescents	mild traumatic brain injury	the entire cohort	fR increases	a pulmonary	early osteoarthritis	15-23 ]	a reduction	low-calorie diets	an elevated gradient	clinical applicability	different modes	low air temperature	previous experience	an international survey	the variables	risk factor modification programs	worsening abnormalities	the vasodilatory effects	exercise heart rates	maximal expiratory efforts	The transient release	likely contribute	exacerbation frequency.4	den	a stiff sponge	18F-FDG imaging	the chronic antihypertensive mechanisms	breast cancer diagnosis	anabolic triggers	air temperature	notable differences	and/or oral	an acceptable maximum heart rate	optimized prescription	warm	The importance	the increased activity	overweight men	central cholinergic	drying	geometric measures	PScl-Ab	chemoprevention	the gradient	bouts	a final diagnosis	exercise echocardiography results	beneficial effects	self-management education	sports cardiology	bone strength	weight reduction	treadmill exercise	dipyridamole stress test	The net change	eucapnic dry air hyperventilation	central command.8	study capsules	arrhythmogenic right ventricular	an effective method	the anxiolytic role	alendronate	a cardioprotective effect	humans	induced expiratory-flow limitation	The subacute effects	postoperative physiotherapy-supervised mobilization	opioid blockade	dietary modification	the favourable effect	the difficulties	pronounced effect	single bout	excessive motion	the narrowed valve	a healthy elderly subject	many metabolic substrates	Desaturation	postural change	the observed duration	flu illness	pharmaceutical stressors	durations	fasting	a heart rate	the excellent prognostic accuracy	glycogen metabolism	early stage disease	the diabetic condition	long term mortality	unilateral electrical muscle stimulation	peak exercise	the cardiomyocytes	low-fat diet	emotional well-being	first line recommendations	cardiac output reserve	the ability	min duration	conservation systems	losartan	sequential days	different outcomes	eucapnic hyperventilation	a spirometer	pharmacologic protocols	histamine challenge	the further steps	artificial gravity	merges	The onset	various behaviors	apical perfusion defect	salt reduction	static hyperinflation	anxious non-exercising patients	bed rest	untrained subjects	vascular-related risk factors	zoledronic acid	age.Fig	mitochondrial myopathies	sildenafil-triggered vasodilatation	pulmonary function	regional wall motion abnormalities	potential factors	affects	ie	ergometer	a population-wide	gentle terminal stretch	wks	chronic heart failure patients	the insulin antagonist	cardiovascular health	worsening	favorable cardiorespiratory responses.45	depression scores	Meditation	exercise asthma	intense physical activity	common forms	dopamine	progression ]	muscle soreness	coronary flow	any possibility	anesthetized dogs	meditation groups	this relationship	exercise endurance time	exercise test markers	sleep	a fraction	dobutamine acts	upright evaluation	diaphragmatic function	the capability	an impaired reduction	ventricular apical ballooning	dobutamine atropine stress echocardiography	the case	cardiac imaging	compensatory changes	the start	tolerable limit	an acute mismatch	mediates effects	delayed-onset muscle soreness	consequences	similar degree	summer-active ground squirrels	the diagnostic accuracy	cycling	ST-segment changes	primary factors	The clinical significance	the high-affinity	high intensity levels	rhythmic exercise	few patients	postural changes	aerobic exercise/or exp exercise/or exp exercise test/	an interaction effect	dead space ventilation	Variables	continuous positive airway pressure application	reduced risk	This fear	the intraventricular gradient	the cardiovascular benefit	a 16-segment model	cancer treatment	recovery period	an unexpected finding	the meaning	m stalls	pulse oxymetry monitoring	estrogen receptor alpha genotype	the anti-inflammatory IL-1β antagonist	promoter polymorphisms	a non-exercising comparison group	the submaximal isotime	end-tidal partial pressure	the dystonic muscles	protocol	dyspnoea	the heart rate response	protein levels	cardiac inotropy	The inhibitory effect	maximum aortic velocity	post-menopausal breast cancer	lung volume reduction surgery	abnormal baseline	These haemodynamic consequences	al.Meditation	the context	intensity	heart failure decompensation	the current findings	a similar incidence	no treatment-related differences	a functional capacity	fall prevention	developmental alcohol exposure	achievement	the structure	mannitol	heliox breathing	hemodynamic improvement	electrical activity	the safety	physical activity	Physiological response	nurses	self-report enjoyment	elevated pulmonary hypertension	light	peak reservoir pressure	the prevention	the echocardiogram	short-term effects	the physiological effects	the upregulation	no other serious events	the application	eucapnic voluntary hyperpnea	significant positive remodeling	exercise duration	intervention Participants	pets	lifestyle	all age groups	gaming elements	quit	severe airflow obstruction	the groups	active play	lifestyle interventions	% saline	oxygen consumption	Exercise training	enhanced cognitive memory impairments	the beneficial effects	night	that ventilation	any additional effect	ml/kg/min	geometrical measurements	open area	goal-setting	the peak	any relationship	exercise adherence	undergoing concurrent cancer treatment	no details	cooperation	A dynamic duo	alternans	Furthermore	radionuclide rest	subclinical atherosclerosis	the robust beneficial effect	the acute effect	that amount	pooled summary test performance statistics	capillaries/mm2	1532-429X-12-412062429410.1186/1532-429X-12-41ResearchReal-time cine	the optimal dosage	expectations	the experience	the last minutes	the final phase	outcome expectations	solid circles	chronic stress	the therapeutic effects	dietary salt reduction	symptomatic women	the fear	the physical fitness parameters	depressive symptoms	bodyweight	the cardiac cycle length	an active relaxation process	the tiotropium	measurement	da	the progressive deterioration	a first session	the promising use	a focus	multiplex immunoassays	the guidelines	the aortic wall	training effects	the intermediate stages	a left ventricular wall thickness	The potential anti-inflammatory effect	function	the long-term effects	the first time	physical activity efforts	an examination	Eves	The known cardioprotective effect	This reduction	these promising results	circulatory power	peak oxygen consumption	SCT-based behaviour change approaches	the hyperpnea	the summed difference score	recovery periods	a programme	nonischemic cardiomyopathy	the initial adoption	paramyotonia	physiotherapy	the patient grouping	·····	cessation	a predominant glycolytic metabolism	data support	humoral agents	ed	stress levels	monoamine levels	every stage	many health gains	facilitators	maximal heart rate	prior experiences	high rate-pressure product	:239	persistent leaflet	upright position	an intensity	sustained programs	Environmental factors	the break-point	a hot environment.9	the impact	cell	This type	jogging	the additional motor activity	maximal exercise	a scientific statement	no alcohol intake	lipid profiles	short bursts	false-positive rate	progressive increase	polycystic kidney disease	early termination	The acute effects	corticosteroid injection	pleasure	The randomization	bronchial reactivity	subtle systolic dysfunction	the regulations	athletes	musculoskeletal management	a bicycle	the methodological quality	vigorous exercise	No side-effects	smooth muscle hypertrophy	and/or	the potential role	the significant decreases	arterial hypoxemia	stress reduction	chemical ventilatory stimuli	end-expiratory lung volume	procedures	dietary advice	the various levels	dyspnea intensity	mental health	the potential cardiovascular benefit	different beverage energy substrates	Disorders	moderate exercise	geriatric assessment	each day	these acute increases	X-irradiation	bronchial drainage	chamber view	cessation programs	ambiguous results	nonpharmacological treatment	avoidance	exercise stress echocardiography	sports	continuous exercise	ex	numerous studies	any condition	a rich variation	men	significant heat loss	dynamic obstruction	heterogeneity	long-term prognostic value	expensive [ 4-7 ]	a social life	physiotherapy-supervised mobilization	nitric oxide uptake	exercise echocardiography	muscle function	the dynamic hyperinflation	triplets	past experiences	undergo apoptosis	The cortical control	Head-to-head comparison	hospitalization benefits	see	the phenomenon	significant abnormalities	young animals	times	neural insults	hypercapnia	other regular physical activities	each set	non-exercise control	animal model	coffee drinking	submaximal levels	education	resistance training versus flexibility training	manual therapy	resistive loading	motor benefits	no further rise	quiet rest conditions	diastolic pressures	laboratory session	barriers	exercise intervention	environmental complexity	the same subjects	abstinence	severity estimates	delayed after-depolarizations	the end-diastolic volume	afferent feedback	the short term	a prudent weight-reducing diet	stamina	cardiovascular systems	further training components	emotion	alcohol ingestion	restenosis	healthy subjects	every day	the potential relationships	chronic respiratory load	above	the execution	dipyridamole test	low glucose availability	dietary preparation	the on-transient	any type	available software	systolic pulmonary artery pressure	rest	the osteocyte network	a few trials	cell survival	n =61	a large decrease	autologous-conditioned plasma injections	the subacute effect	recreation	a dynamic condition	this benefit	significant musculoskeletal	balance interventions	Non-pharmacologic treatments	a potential protective effect	obesity etc	volume challenge	The intensity level	a central hemodynamic exercise limitation	the metabolic syndrome	long-term physical training	hyperinflation	significant levels	an effort test	normal activity-induced increases	↑	interleukin-10 levels	hyperventilation challenges	r	Marital status	a regular high dose	movement	the consequences	coronary artery bypass operation	the cardioprotective benefits	pulmonary congestion	anxiolytic behavioral effects	a dual treatment	the long-term benefits	the possible causative role	the regulation	monitoring equipment	pranayama	different ischemic stressors	moments	eucapnic voluntary hyperpnoea	mucus overproduction	the orthostatic stress test	self-management interventions	the exact volume	both variables	caloric deficit	braked cycle ergometer	massage	such sequences	bisphosphonates	antioxidants	ab	The cardiovascular benefit	pulmonary artery stiffness	monitoring	no cognitive benefit	the potential beneficial effects	patent	the demands	kilocalories	diastolic abnormalities	the trained organism	The hindlimb	Both mPAP	central fatigue	exercise self-efficacy	the exercise	control session	minutes	myocardial function	tolerance	fragmentation	the exercise protocol	quantified home-based exercise	light sports	exRML	mindfulness training	the powerful influence	related disorders	the aged rats	appropriate exercise programming	games	:4S –42S	the impaired effects	the influence	% fall	pharmacologic stress	limb blood flow	the cessation	some other high risk-heart failure patient categories	hypotheses	the method	goal setting	a subsequent drop	substance-use disorders	minimal physical limitation	bone mass	This volume	startle	elbow manipulation	hard work	myocardial energy deficiency	a high amount	index cases	a good predictor	each minute	a normal end-diastolic volume	avoid physical activity	regard	coworkers	rhythms	recurrence.80	pressures	any tests	other minority communities	other conditions	training heart rates	mobilisation	that type	reserve	–898	pain sensitivity	inspiratory flow-resistive loading	respiration	the expiratory flow limitation arise	molecular pathways	meaningful benefits	salbutamol	limit activities	Article	medullary output	treadmill exercise echocardiography	a proportionally increase	the parasympathetic activity	remobilization	skin care	cognitive processes	The positive effect	submaximal isotime	some studies	the various phases	sit	imagined movement	the notion	the exercise diary	fluticasone propionate/salmeterol	light physical activity	isoproterenol test	oxygen therapy	The rate	mPAP	strenuous sports	distinct	heavy levels	lifestyle counselling	the dead space	the individual intensities	evaluation	end-of-care issues	the tracer	myocardial perfusion imaging	suspension	sclerostin antibody treatment	resistance training	exercise-related changes	The benefit	Ejection	those modalities	the cardiovascular benefits	right ventricle dilatation	this modality	the final period	other pulmonary conditions	exercise incapacity	such modulation	atropine	no significant differences	The poor predictive ability	both enriched environments	low cholesterol	the level	the exact contribution	successful non-pharmacological approaches	the final part	any association	myocardial stress	heart rate recovery	provocation	The optimal dose	The 6-keto-prostaglandin-F1a levels	respiratory muscle training	anti-diabetic treatment	survival time.16	termination	the post	confidence interval	pain-relieving effects	multi-nuclear spectroscopy	cardioprotective effects	full weight bearing	exercising	adequate interpretation	Vital signs	genotype	quiet rest	false-positive results	maximal oxygen consumption	either methacholine	body mass index	endurance training	vs home	a stationary home trainer	induced expiratory flow limitation ion	meditation	active lifestyles	consequent improvement	
protein homologue	any independent biological activity	
tenofovir	emtricitabine	potential cardiovascular risk	long-term results	
symptomatic unilateral ureteral calculi	expulsion rates	tamsulosin	safe treatment option	stone expulsion rates	a control	analgesic requirement	inactive controls	organ specificity	controlled trials	naftopidil	
wide local excision	histo-pathological examination	stain	the mass	a low recall rate	Sacral laminectomy	


Respondents	typical character- istics	other headache syndromes	the reason	the migrainous headache	oral contraceptive	The general impact gradient	non-migraineurs	idiopathic stabbing headaches	default mode network	anxiety disorder	Trochleitis	migraine,12	The genetics	A positron emission tomography study	a wide variability	:307	double-blind	the high burden	other sociodemographic factors	counter parts	migraine natural evolution	cluster headache attacks	the prophylactic therapy	year prevalence	sensitization theory	the mimics group	headache days.1	the mixed-headache group	crossover study	sister	lifetime history	frequent manifestation	consecutive persons	cohort Characteristics Patients	The prevention	the relative frequency	sleep duration predict headache severity	a personal history	any migraine	subsample	Mitochondrial dysfunction	this limit- ed series	many physicians	serotonin receptor agonist	a central diagnostic symptom	the same centre	a different frequency	an important impact	the cardiovascular comorbidity	migraine prophylaxis	other health factors	prevalent disorders	venous blood	gender-standardised prevalence	clinical trial ]	Psychiatric outpatients	cross-over study	Localisation	aura cod	an angiotensin	paroxysmal dyskinesia	interictal burden	other type	a population-based door-to-door survey	a deficient thalamo-cortical drive	bad headaches	the psychological component	morning migraine	no false-positive cases	Concurrence	familial burden	amelioration	Copenhagen	An appropriate recognition	TTH patients	related headache	periorbital pain	:331-333	the vascular mechanism	dissimilar proportions	body mass index exists	the possible causal association	Previous diagnosis	control study	a two-year period	healthcare resources	other recurrent headache	the 4-year persisting remission	mean attack duration	vascular head pain	non-obese subjects	16-20 years	The correct treatment	The preva- lence	outcome variables	brain lesion	cognitive assessment	representative	BMI-matched controls	an overlap	co-morbid symptoms	a typical attack	% power	current use	prodromal features	the co-morbidity	The trigemino‐vascular system	somatic disease	professional agreement	c-fos expression	few consistent correlations	the reappearance	hard physical exertion	The 1-year prevalences	intracortical inhibition	the sleep pressure	ch- ronic paroxysmal hemicrania	familial history	the attacks	a mediator	wine-	a his- tory	neurologist	strict familiar environment	gustatory stimuli	tolfenamic acid	The crude 1-year prevalence	both direct	monoamine oxidase activity	independent groups	synthase inhibitors	vestibular symptoms	sim- ilar efficacy	the prevalences	epileptic children	the non-increased risk	all female migraineurs	questionnaire-misdiagnosis	the main trigger	beta version	secular trends	double‐blind	a causal relationship	sleepiness scale score	opposition	calendar	few controls	the acute oral treatment	the characteristic	The headache phase	pain conditions	cluster headache	common triggers	monocular visual symptoms	clinical associations	polypeptide	p=0.0015	a reliability	the following pregnancies	a pre- vious history	oral contraceptive-induced menstrual migraine	no partner/child	a majority	avenues	a woman	behavioural effects	posttraumatic headache	an item pool	central dysnociception	The size	transcatheter	migraine management Pain	a short history	a primary headache disorder	anxi- ety disorders	paired magnetic stimuli	receptor genes	the interview	chronic headache disorder	a vascular component	common medical conditions	this age range	The co-occurrence	initial surveys	septal defect closure	Table [	The median frequency	glutamatergic transmission	acute confusional episodes	therapeutical aspects	control women	suggestive progressive dementia	a random sample	an epileptic focus	Characteristics	the same database	the reported increase	a practical standpoint	source image	menstrual cycles	the premonitory stage	both obesity	characteris- tics	urinary serotonin	day life discomfort	daytime performance	an inflammatory	the positive findings	ketogenesis reduces	tension- type headache patients	objectives	e7	the verisimilitude	pure	societal burden	true migraine	mitochondria	risk populations	other menopause symptoms	particular problems	many other headache disorders	Pathophysiological studies	Further investigations	An evaluation	phenotypic analysis	clinical migraine =	cortical hyper- reactivity	metabolic disorders	episodic ataxia type	several primary headache disorders	a clear picture	unaffected siblings	physical programme	tension type headache sufferers	the prodromic phase	coordination impairment	normal weight subjects	ictal epileptic signs/ symptoms	children/adolescents	trainers	an episodic pattern	considerations	pharmacological review	cellular levels	e1	hygiene	the different clinical features	i-TBS neuromodulation	cranial autonomic symptoms	the sensitivities	no patients	new daily persistent headache	no headache	the second version	hyperactivity/inattention	pre-clinical data	other medical conditions	pericranial	seemly	The vascular theory	a major attack	cortical potentials	community	aura [ mean	the good tolerability	s state population	inappropriate vasoactive	migraine therapy	the trigemino-vascular hypothesis	The one-year prevalence	Sensitization	med- ication	a headache	the complex relationship	cell degranulation	cervical nerves	a secondary manifestation	all migraine patients	term decline	that particular group	generator	some pathogenic mechanisms	many methodological shortcomings	The genetic basis	common biochemical pathways	such abnormalities	prophylactic treat- ment	that dysfunction	:812	Different theories	associa- tion	the univariable analyses	hematologic	overlaps	cranial vessels	headache days	nonmigraine headache	a Danish population study	specific migraine drugs	receptor gene haplotype	Migraine patients	this age group	a predominant left-to-right shunt	effective approach	some disorders	self-assessment	this phenomenon	bilateral presentation	high severity	aura + tension-type headache	anticardi- olipin antibodies	that obesity	brainstem	ages	Circles	phenomen	gene-related peptide	migraine-related disability	aura subtypes	additional risk factors	genetic forms	This rare type	Courses	multidisciplinary management	the treat- ment	A randomized trial	an aggravating factor	possible link	other headache disorders	The 1-year prevalence	the co- morbidities	enhanced arterial stiffness	frequent headaches	primary analysis	Deficiency	premonitory symptoms	Several other vascular risk factors	a migraine-like headache	patent foramen	frequency-specific alterations	caveats	any headache disorder	each symptom	a negative impact	neurogenic mechanisms	sleep bruxism	acute migraine attacks	a focus group	Author	reflect dysfunctions	independent prevalence studies	neck tenderness score	the g-i symptoms	no data	the trigeminovascular pathway	sleep breathing disorders	the methyaltion pattern	environmental triggers	The impact	cities	misdiagnoses	the cognitive representations	habituation characterizes	a stable dose	the meta-analysis	high-frequency ranges	postischemic neuronal damage	dose-ranging study vs	multiple linear regression analyses	neurovegetative symptoms	:8–152	emesis	−4 days	lifestyle and/or environmental factors	exogenous estrogen-withdrawal	several hours	reflexes	three-fold relative risk	an unavoidable course	low medical needs	clinical transformation	provinces	magnetic stimulation	sexual function	migraine—a double-blind placebo-controlled study	cognitive measures	onabotulinumtoxinA	other severe headache	the additional risk factors	optimal treatment	the early treatment	episodic tension-type headache regardless	lives	no measure	Psychophysical precedents	abort cluster headache	this lack	some features	Sub-acute angle-closure glaucoma	The rise	peripheral vascular endothelial function	preventive	habituation lack	This conflict	a potential cause	right-handed healthy controls	a novel syndrome	a cross- sectional study	the sphenopalatine ganglion	tension-type headache [	puncturea	the pathophysiology mechanism	definitive previous history	the visit	the common causes	central processing	Steady-state visual-evoked potentials	The nitric oxide hypothesis	quarters	the s allele	the end point diagnosis	primary headache	a comorbidity	some common mechanism	documented associations	various diseases	] treatments	several cerebrovascular disorders	intracranial aneurysm	accompany	a recent case-control study	12-15 yr	a general gradient	nociceptive pain	common mechanisms	the debate	work ability	cluster headache pain processing	tension headache patients	:1081-1085	consecutive children/adolescents	a partner/spouse	abstract	headache burden	the endothelial system	a clinical interview	severe sleep disturbances	another functional neuromodulator	iron deficiency anemia	efficacy side	mg.anastasio	human leuko- cyte antigens	non-migraine headache controls	cerebral ischemia	cardiac diseases	clear decrease	l'anoes- thesie	The female preponder- ance	sophisticated studies	other psychiatric comorbidities	definite	tonic-clonic seizures	the features	oceans	vascular theory	goiter	both anxiety	the multifactorial genesis	central trigeminal neurons	peripheral arterial function	any personal history	the psychologi- cal component	the mean prevalence	the cat model	disordersMigraineTension-type headacheEpidemiologyBurden	pCM	tDCS	dull headache	income [	aggregation	ache	the clinical course	a primary care	sensitivities	many cigarettes	aura criteria	a physiological point	other primary headache types	tension type headache	therapeutic drugs	Se- min	the trigeminal reflex circuits	haplotype	the headache phase	EVIDENCE	lifetime attacks	the aggregate effects	Spierings	Patho- genesis	sleep issues	a monthly frequency	tension type patients	adenosine accumulation	The classification	occasion	the population-based studies	understood interaction	thalamo-cortical cholinergic drives	both chronic daily headache	other types	intermittent torticollis	the temporal scalp	the well-established prevalence figures	the high rates	that migraine manifes- tation	the causative relation	a similar nationwide study	proteases	the rapid modulation	no smoking history	tension-type headache—evidence-based treatment recommendations	parallel group	the direct result	certain prothrombotic polymorphisms	The variance	short-term primary motor cortex	13-year-old children	hyperactivity-impulsivity symptoms	researches	both disorders	Japanese workers	the ICHD-II diagnosis	chronification	country	less-senior staff	Diamond	a difficulty	no further occurrence	hyposerotonergic status	different psychopathological disorders	the natural temporal pattern	university students	diag- nosis	the neurovascular pathophysiology	diabetic pain	the headache aspect	the shift	cerebral infarct patients	productive time	catecholamine production	a clinical popula- tion	the one- digit level	a transformation	” age	periodicity	additional headaches	general psychometric properties	A psychological profile	13-16 ]	an additional negative effect	the cumulative lifetime risk	cortical excitability	48-year-old woman	Coexistence	a brain stem cavernoma	meta-analyses	multiple headache symptom measures	a challenge	The best-studied contraceptives	A CLUE	small number	another type	chronic tension- type headache	the vestibulo-collic reflex	other paroxysmal disorders	the sexual dimorphism	significant correlates	migraine relative	childhood headache	a high index	daily practice	a mild-to-moderate headache	a specific self	the complex pathogenetic mechanisms	gout	Sleep disorders	social impairments	normal weight women	a property	latency	mood disorders	the crucial role	social discomfort	headache duration	Past history	educational level	many complex traits	all associated features	balanced gender distribution	% overlap	chronic headache patients	dis- tinguish	the grey hypothalamus	a crude odds ratio	the different pathophysiological basis	questionnaire diagnoses	age-matched Italian smokers	social impact	sporadic hemiplegic migraine	interictal phase	a true trigger	both feeding	the healthy subjects	Some clinical aspects	serious somatic disease	cannabinoid receptor activation	Misdiagnosis	headache studies	neuropsychological correlates	ultra- soundimagingandbiologicalmarkers	incident cases	similar quality	the co-mor- bidity	the substantial contributors	rural areas	a cold stimulus headache	the comorbidity	chronic tension type headache	the impairment	aura cases	therapeutic problem	platelet aggregates	the primary mechanisms	no hypothalamic activation	a borderline/abnormal score	platelet serotonin content	The children	all required criteria	negative predictive values	headache prevalence	The menstrual cycle	mystery	prevalence estimates	post-dromal symptoms	overall advances	primary chronic daily headaches	an environmental factor	the hypotheses	inactive migraine	co morbidities	frequent tension-type headache	meningeal blood flow	:792-797	the complex mechanism	experimental animal models	memory deficit	conceptualization	cardiovas- cular disease	interparoxysmal headache	future analyses	an average migraine fre- quency	assistant professor	chronic head pain	point prevalences	clinical aspects	whereas gender	occipital neuralgia overlap	the selective 5-HT1F receptor agonist	ren	adolescent populations	sleep duration	the month ”	receptor field size	logistic regression analyses	a small part	single aneurysms	bisoprolol	the financial impact	aura symptoms	“ muscle contraction headache	a common functional disorder	visual disturbance	the Korean population	comorbidities share	plasma serotonin	facial pain disorder	active migraine	ten- sion headache	psychiatric comorbidity	platelet aggregation	pillar	severe intensity	spontaneous headache	genetic polymorphism studies	the actual prevalence rate	the polymorphism	temporal pulsations	The odds ratios	compari- son	recurrent headache	a characteristic sign	the pathogen- esis	chronic daily headache management	axis disfunction	The mean years	intra-oral orthoses	pulmonary right-to-left shunts	impact.24	common type	the migraine	Attacks	arteriovenous malformations	the prophy- lactic treatment	progressive supranuclear palsy	an experimental animal model	aura subjects	household partner	theoretic implications	seizure generation	post-traumatic headaches	the 'pathogenesis	sero- tonin re-uptake inhibitors	different vascular	endo- thelin type	no prior history	gustatory hallucinations	mental disorders	extracranial vasodilation	a pathophysiological pathway	non-depressed patients	pharmaceutical treatment	different subtypes	other headache types	A cross-sectional evaluation	nociception	these disorders	non-headache symptom	face-to-face structured interviews	The primary headaches	balanced words	sexual intercourse	combination analgesics	certain subsets	female stu- dents	functional gastrointestinal disorders	the triggers	mean hs-CRP levels	pain medications	the father	appearance	the human peripheral microcirculation	epilepy	e37903	The same association	early prophylactic therapy	the diagnostic question	structural brain lesions	the intracranial portion dilates	the mild-pain phase	non-genetic forms	many children	these estimates	all headache sufferers	potential underlying mechanisms	re-uptake inhibitors	mean ±SD	trigeminal autonomic cephalalgias	mixed headache	risk regardless	severe pain intensity	childhood risk factors	consequence	the patient suffers	a simple headache	pASDC	the thalamus	labor force	vertebral arteries	hazardous alcohol consumption	ivabradine	the medical students	mg nasal spray	1-year prevalences	consistent relief	neurocysticercosis	dwelling	a previous examination	nau- sea	com- mon symptoms	differ- entiation	transient focal neurological symptoms	the path- ophysiology	the ice cream	tension type	zolmitriptan	The trigemino-vascular system	postsurgical nummular headache	individual loss	multiple-dose tolerability	transient ischemic attacks	hemicrania con- tinua	other pro- inflammatory cytokines	the com- mon pathogenic mechanism	the first line treatment	hs-CRP level	anxiety disorder patients	aura	small vessel damage	a natural preventive treatment	a 22-year-old man	serotonin	e23	menstrual migraine	alcohol flushing	cerebral amyloid	a nation-wide population-based interview survey	a progressive brain disease	cortical demyelination	an unadjusted population-based analysis	5-hydroxytryptamine accumulation	One-fourth	sumatriptan	neuromagnetic signals	serotonin 5-HT1B/1D agonists	HIT-6 scores	some commonality	metabolic syndrome Mediators	other unilateral headache	the peak frequency	Cephalalgia	the probabilities	multiple brain hemorrhage	the hypocretin system	inconsistent results	the neurovascular nature	different primary headache types	aura attacks	the scotomas	a population-based epidemiological study	tension-type vascular headache	a well-known animal model	recurrent attacks	few different ways	an international web‐based survey	normal performance	vascular origin	the typical response	a potential modulator	Postictal headaches	common features	other interval headaches	the enigma	a possible cause	scientific adviser	alexithymic features	the ratio	complete relief	key characteristics	permanent visual loss	common headache disorder	prolonged symptoms	a nonevident seizure	opposite directions	tension-type head- ache	aura.and	migraine index	com- monly precursors	dyspepsic symptoms	well-characterized individuals	Impairment	a dramatic clinical picture	della	treat- ments	a systematic assessment	mol/L	:1304-1312	the episodic forms	frequent episodic tension-type headache	living	the recent symptomatic treatment	the headache frequency	Premonitory symptoms	s allele	the actual prevalence	Secondary headaches	normal controls	combined anxiety-depression	high blood pressures	prophylactic non- pharmacologic management	a daily diary study	the transformation process form	near-daily headache	chronic ten- sion type headache	psychopathology	chronic sensitization	a worldwide prevalence	mean stress	few side effects	family histories	severe impact	complex regional pain	positive familiar history	a variant	the treatment plan	autonomic dysfunction	neu- rovegetative symptoms	dietary sodium	the specific factors	long-latency auditory	the acute treatment	All other factors	the populations	this sample	symptoms item	metabolic syndrome Neurologist	surprising finding	beta criteria	Cerebrovascular disease	the prophylactic treatment	episodic vertigo	the essential diagnostic criteria	cysticercosis	Slow-wave sleep	insight	tension type headache attacks treatment	either ten- sion-type headaches	tran- sient	common headache types	common diseases	clinical interview	a close relationship	The classic type	visual aura patients	central sensitization	the clinical observation	chronicity	current concepts	a common factor	the subtypes	a wide range	endothelin type	headache centres	acute hypertension	the patho- physiology	cuta- neous allodynia	joining	The overall use	the vasodilator responses	a past trial	potent inhibitors	A past history	pharmacodynamic variability	a systematic analysis	regulatory endpoints	-CI [ 69.56-83.17 ]	the pain phase	casein kinase	occipital epilepsy	the visual disturbance pattern	chronic tension-type headache patients	an ongoing pilot study	aura status	the clinical presentations	no previous diagnosis	Positive change	headache-attributed lost productive time	dietary sodium intake patterns	door-to- door survey	the duration criteria	specific abnormalities	the preferential occurrence	unaware	Microembolic theories	randomized comparative efficacy	miscellaneous headache	non-hypertensive subjects	many people	no validated tools	previous migraine treatments	both symptoms	a seizure	’	Canadian adolescents	lactating patients	present	disability scales	auditory hallucinations	cutaneous allodynia	cutaneous pain thresholds	The medical costs	significant personal impact	health disorders	the migraine onset	the same habituation deficit	specific comorbidity	excellent academic performance	a substantial clinical improvement	epi- lepsy	low arterial oxygen saturation	The observed 1-year prevalence	jolts	a matter	These cases	Cessation	primary headache cases	migraine [ 2-11 ]	a spontaneous clinical course	key factors	miscellaneous headaches	The clinical prevalence	somatic diseases	The individual impact	the fifth chapter	the common forms	function- al	chronic animal model	daily headaches	total difficulties	the headache	Population-based study	:1693-1696	anxiety suffer	medication overuse headache aPatients	Comorbidity	selective approach	a num- ber	the significant burden	The neurogenic basis	all areas	the impressive characteristics	the observed prevalence	:3-5	The endocannabinoid system	both subjects	many adult-onset cases	a persistent increase	Red ear syndrome	Paediatrics	this period	a 36-year history	a web‐based panel	consecu- tive children	some pathophysiology	:314–322	the total cost	an occasional mild headache	occipital neuralgia	hereditary haemorrhagic telangiectasia	migraine subjects	the temporal pattern	misdiagnosed patients	all primary headaches	Excessive daytime sleepiness	insomnia symptoms	central theory	occipital epilepsies	predominant symptoms	renal colic	the gender differences	All diagnoses	Conclusions	acti- vation	a general population—a prevalence	the typical characteristics	a general population–a prevalence study	place	the gender-related differences	similarities	debut	:289-292	A detailed history	eNeura	headache syndrome	the total difficulties score	slow cortical potentials	reversible cerebral vasoconstriction syndrome	neuropathic pain	simultaneous prevention	underlying high levels	The trigeminovascular system	occipital pain location	searches	working days	cluster headache,15–18	the non-pharmacologic treatment	familial headache recurrence correlates	family impact	prevalence increases	years history	study Pharmacoeconomics	millisecond-level resolution	the tension-type headache mechanisms	> .05	CGRP levels	self-reported relationship	worsens	chronic daily headaches	a satisfactory treatment outcome	cognitive dysfunctions	channels	44810.1007/s10194-012-0448-3OriginalSerum levels	The stability	a high specificity	high headache frequency	familiar form	ivabradine treatment	cigarette consumption	neuro- genic	:403-410	the headaches	efficient recognition	extracranial vascular theory	normal functioning	ten- disorders	The comorbidity	migraine treatment	:1053	any whole animal model	fre- quency	migraine pain intensity	the different study groups	inadequate diagnostic information	young men	hopelessness	cortical spreading depression	the first survey	peritonitis lie	One-year prevalence	the clinical judgment-IHS	a further elucidation	metabolomics	reductase gene variant	a substande-P antagonist	allele frequency	no reported correlation	strong trigger	primary exercise headache	no significant changes	high intelli- gence	intranasal hydroxocobalamin	a negative predictor	the common final mechanisms	the pathophysiological equivalent	the ictal state	unipolar psychiatric comorbidities	the syndrome	univariable logistic regression analyses	both types	anxiety comorbidities	splanchnic	potential therapeutic targets	headache intensity	cluster headache prophylaxis	treatment design	The subtypes	short interstimulus	the ICHD-II diagnoses	son- nambulism	compli- cations	abdominal obesity	a trigger	serotonin uptake	the proband	the following visits	pain limb	paroxysmal neurological symptoms	these vasomotor features	de	a monogenic disorder distinct	numerous scientific evidences	an increased occurrence	premenstrual headache	sinusitis symptoms	cardiovascular diseases	a case control study	.38	headache frequencies	each psychiatric disorder	congenital deafness	interesting results	a desire	anger	complementary examinations	Distribution	trochlear pain	pharmacological treatment	headache disorder specialists	this correlation	a worldwide problem	the analogies	college	a genome-wide significant p-value	those students	both depression	aura attack	head- aches	a strong diagnosis	usual headache	the face-to-face interview	gastrointestinal disorders	Co-occurrence	a main pathophysiologic mechanism	headache clinic	the individual headache disorders	manual therapies	The dysfunction	dihydroergotamine mesilate	eNeura Therapeutics	a portable apparatus	The correctness	The platelet	different headaches	The estimated 1-year prevalence	headache genetics	migraine characteristics triggers	primary headache disorders	The negative impact	concurrent headache	0.75-3.12	different ethnicity	dietary sodium intake levels	the alterations	aura sub- jects	vascular theory ”	the negative impact	much evidence	genderandethnicity.TheG684Avariantwasalsofound	the main neuromagnetic activity	intracellular mag- nesium	Mechanism	an impact	the serotonin transporter gene	the chronic forms	these pulsations	brainstem nuclei	study versus	significant relief	research ed	exclusive diagnoses	reveal new genes	visit	configurations	an inferior performance	a fast-disintegrating/ rapid-release formulation	the neurological symptoms	screening instrument	topiramate possesses	chronic tension-type headache	epilep- sy	this animal model	preventive non-pharmacological treatments	muscle tenderness	the visible responses	a single day	Migrainous features	the specific cases	neuroinfections	decreased risk	a life-time history	the trends	activa- tion	psychiatric comorbidities	motion sickness	few clinical evidence	mean age	other severe headaches	oral prophylactic treatments	normal-weight girls	the effect estimates	excellent school performance	headache misdiagnoses	:698-705	this polymorphism	calcitonin gene-related peptide receptors	The possible association	whereas college education	psychogenic headaches	The platelet theory	the corresponding symptoms	noxious inhibitory controls	the clinical presentation	reversible enhancementof intraparenchymalabducens	secondary-school students	the main purpose	tension-type headache patients	These observations	Consulters	comorbidy	autonomic symptoms	video-case demonstrations	all survey participants	Stimulation	urban dwelling	identifiable triggers	a complication	pain symptoms	the following age-distributed prevalence	High prevalence	common primary headaches	the mega biodiversity centers	underlying endophenotypes	all other features	several guidelines report indications	rs73532286	tread	childhood bronchitis	several patients	fibromyalgia comorbidity	the meningeal arteries	The overall preva- lence	menstrual attacks	the specific prevalence	1-year prevalence	selective activation	ophthalmoplegia	cluster headache pathogenesis	this distribution	sub- jects	:321-334	the persons	pure oxygen	:2746	migraine attack	headache sufferers	the index	the smokers	comorbidity Individuals	excitability	electroencephalographic study	human regional cerebral blood flow	The percentage	the full spectrum	some researchers	twenty-one healthy subjects	separation anxiety symptoms	sex-biased methylation	rare attacks	vascular pathophysiology	gastroesophageal disorder	tension-type headache patients versus controls	the ionic constituents	This association	pre-EVT history	medication overuse headache	painful dissection	individual clinical features	migraine ]	angiotensin	any neurologic disease	a Canadian population survey	the resulting delay	paediatric patients	1471-2377-4-41500581010.1186/1471-2377-4-4DebateAcute treatment	benign reversible cerebral angiopathy	oral magnesium	different acute headache drugs	work impact	:4-5	a neurovascular disorder	certain sufferers	unrelated migraine	some previous studies	a prophylactic treatment	non migrainous headaches	des maladies	stress [	a subject	no suspicion	a vascular disorder	the aura phase	interatrial shunts	unilateral cranial autonomic symptoms	an acute attack	other countries	a migraine	the community	migrainous features	a family-history	vascular risks	clinical characterstics	headache type	any headache	an epileptic seizure	a mechanism	the temporal course	70-90 %	vs controls	the Chinese adult population	anxiety symptoms	a nationwide population-based headache survey	partner	del	predictor variables	a rare monogenic form	All headache	special attention	such reflexes	the rat model	arterial function	substantial burden	primary headaches	the mean scores	adrenergic sensitivity	frequent headache	the financial burden	these headaches	syndrome exists	pharmacological prophylaxis	The perceptions	Finnish schoolchildren	neck pain	medicinal therapy	other headache-associated disorders	bilateral headache	population-	a 10-year-old child	reproductive age women	common cold	:205-216	chronic tension-type headache subtypes	consecutive first-visit patients	some migraine attacks	tension-type	the underlying mechanism	Frequent attacks	suffer	both pain syndromes	= patients	atopic disorders-the contribution	biochem- istry	strate	a polygenic multifactorial form	brainstem activity	the future studies	some related factors	the pre- vention	a population‐based survey	large samples	all euthyroid	partners/spouses	certain subtypes	pathophysiological change	cor- onary angioplasty	u.6	oculomotor	bType	some others	doi:10.1002/14651858.CD010610	chronic forms	race/ethnicity	body mass index categories	atrial septal defects	the neuropathology	migraine characteristics	additional attacks	precur- sors	Italian study	a significant association	interictal period	some headaches	research implications	receptor gene	exertional headache	epileptic foci	5-HTT gene polymorphisms	a hormonal impact modeling	chronic headache	A 22-year-old female	strong family history	meta-analysis [	Similar effects	population-based study	the first study	the primary headache group	some association	adrenoreceptor function	association study	the menstrual period	aneurysms Factors Patients	paresis	respective global estimates	migraine aura	antibody levels	fifth	that glaucoma	global amnesia	a tertiary headache	Premonitory	12-23 13-23 12-23 Duration	the mean time	psychiatric conditions	second edition criteria	:195-197	% incidence rate	The different temporal patterns	:232-237	numer- ous patients	communication barriers	the trigeminal autonomic cephalgias	Neurobiology	occidental countries	treatment outcomes	the first population-based study	elaboration	episodic	secondary headaches	univariate regression analyses	sleep quality parameters	the others	the analgesic use	indirect evidence	pharmacotherapy	the sequence alignment	a specific systemic vascular vulnerability	trigeminal neuralgic types	new daily-persistent headache	his- tory	primary-like headaches	serotonin metabolism	headache severity	:245-250	arterial vasodilation theory	topira- mate	‐Migraine34	Evers	an enantiomer specificity	nasal symptoms…cluster headache	The impacts	Need	ten patients	this supplement	jugular vein valve insufficiency	the outpatient-neurology clinic	post-traumatic headache	slight neurological signs	ys	pain research	a rare variant	an aggravation	e-mail	ller-Ho cker	aura caution	a neuropsychiatric disorder	the provocation	School	The last ten years	the migraine aura	p13	paroxysmal vertigo	mood disorder	individual environmental and/or genetic factors	migraine forms	Continuous variables	regional structural differences	pre-obesity	comorbid anxiety	neuralgias	thrombectomy	lifetime occurrence	pre-obese subjects	a population study	chronicization	:291	Aggravations	the main molecule	The soldier	PedMIDAS	A case-control study	a population-based diary study	The pressor	overall cancer	charateristics	:561-	paroxysmal hemicranias	The lifetime prevalence	total population	probable diagnostic entities	the likely burden	differentia- tion	emotional states	neurovascular mechanisms	functional serotonin transporter gene polymorphism	the later analysis	migraine symptoms	tension-type headaches	particular similar premonitory symptoms	spontaneous attacks	tension headache form	the visible components	Independent factors	population-based studies	dis- ease evolves	chronic course	reduced days	educational needs	The first physician	the autonomic hypofunction	clinical transfor- mation	variable localization	notable gender differences	discontinuous treatment	a bidirectional relationship	lab- oratory evaluation	carisbamate	therapeutic management	the comorbid conditions	the algorithm	platelet serotonin	A condi- tion	different modalities	The placebo response	pain location	habituation	vestibulopathies	the medical files	The aura	all other provinces	a headache duration	the indirect costs	associated symptom	disability worldwide	migraneous headache	a new finding	a pre-EVT history	:17	new-onset migraineurs	other primary headache disorders	paraclinical investigation	trigeminal neuralgia patients	recent surveys	the menstrual cycle	radiological characteristic thunderclap	phenomena	sensory deafferentation	critical excessive daily sleepiness	migraine pain	Prevalences	the WHO-QOL domains	—clinical lessons	other neurological types	a subtype	animal studies	stringent primary outcome measures	continua	an independent type	the cerebral cortex excitability	citalopram	Sleep habits/patterns	self-medication	well-documented cases	Intra-group contrasts	% prevalence	a promising avenue	pathogenetic mechanisms	the stimulus presentation	other vas- cular headaches	the first attack occur	confirmed diagnosis	A dipole model	the excitability	both control subjects	the confusional migraine	migraine features	study men	lifetime prevalence	otalgia	no clear evidence	self-efficacy	Conclusion Patients	spouse/domestic partner	neurologic syndromes	An epidemiologic survey	female gender	several neurologic disorders	possible new cases	the nausea symptom	[ 1-3 ]	all headache diagnoses	trinitrate induces attacks	cumulative effects	Placebo-Controlled Phases	pain relief	a preliminary open study	cod	the distortions	the chronification process	a total difficulties	large right-to-left shunts	a rare autosomal dominant subtype	the prophylac- tic therapy	associated features	The trigeminocervical complex	other epilepsies	the whole painting	hyperactive-impulsive behavior	autosomal dominant vascular retinopathy	the author	secondary headache disorders	the tumor necrosis	aura »	the common headache disorders	lateralization doubtful	an exacerbating factor	A clinical study	versus placebo	a monogenic disorder	an association study	acute treatment	good evidence	dizygotic twin pairs	outpatient neurology clinics	disease duration	good prophylaxis	the jugular venous blood	patient interpretation	the chronification	elderly patiens	the prodrome phase	small case–control studies	migraine frequency	pharmacoepidemiological survey	adequate numbers	self-diagnoses	numeric rating scale	pathophysiologi- cal mechanisms	degree relatives	ICHD-2 criteria-location exclu-	phenomenon	both dietary intake	the complex serotonergic biochemistry	episodic form	life effects	The gender-adjusted prevalence	The electrophysiology	rs1487275	attributable risk	A form	tension headache	prophylactic management	onabotulinum- toxinA	the improvement rates	aversion	corticosensitivity	migraineurs	the person	major depressive episode	anything	preventive migraine treatment	ICHD-2 criteria- location	previous users	different authors	Rees	:313 –317	ser- vices	a release	a unilateral headache	Episodic syndromes	The worsening	non-migraine headache	several clinical features	the premonitory phase	amitripty- line	a mild prevalence	:408-416	sharing	characteristic criteria	different formulations	adolescent patients	other clinical parameters	present estimates	a potential association	A nationwide survey	:7-44	these values	an increased risk	The reported prevalence	middle-income countries	positive-123/339	all headache	the temporal lobe	somatic disorders	the cat	co-existing	days/month patient	coffee consumption	tension-type headache differs	neurophysiologic marker	a large-scale epidemiological study	the week	a systemic disorder	intensity dependence	the distinct characteristics	the human potassium channel gene	chronic fatigue syndrome	a histo- ry	intraoral orthoses	some important concepts	The pain	post-ictal headache	The occipital cortex	several medical conditions	aura [ 1-7 ]	tension-type headache groups	any diagnostic groups	father	a separate clinical entity	preventive drugs	alexithymia	tension -type headache	low income	other head pain	initial frequency	adult data	comorbid conditions	records	various vascular disorders	a pivotal role	enzyme	definite association	hangover headache differs	neuronal hyperexcitability	:1187-1189	the past [	possible links	migraine-related metabolic risk	tension-type headache	nonmigrainous headaches	neural theory	instruments	nasal spray	the various primary headaches	many nonspecific causes	migraine status	main groups	overall headache	headache days/month	the actual pathogenesis	any family member	frequent history	concomitant asthma	percentage body	migraine headache	teristics	next migraine attack	other headaches	Post-epileptic headache	The logic	children differs	nocturnal polysomnography	daily migraine	the headache characteristics	peripheral leukocyte	Hypothesis	the serotonin	questionnaire-based diagnoses	a poor clinical prognosis	turnout	clear epileptiform features	appetite behaviours	the interictal impairments	solid line	the gender-specific influences	a fast-disintegrating/rapid-release formulation	either tension-type headache	clear prevalence	the careful methodology	double- blind	transmitting parents	migraine patients	probable migraine criteria	an important role	ion channel gene	non menstrual type	sleep difficulties	severe risk	cerebral mitochondrial injury	repeated meningeal nociception	the cardiovascular risk	personal level	seasonal headache	A migraine history	behavioral treatment	the past history	chronic headache sufferers	hemi-cranial headache	indi- viduals	systemic connective tissue abnormalities	the family impact	Brazilian women	other vascular headaches	The diagnoses	cardiac autonomic function study	the overdiagnosis rate	the aura	altitude	the adult form	subscale	upcoming classifications	S1-S150 control group	childhood migraine	improved clinical course	a small minority	this context	tension-type patients	a cross‐sectional module	:725-732	dys- peptic-migraine patients	associated comorbidities—clinical considerations	several explanatory hypotheses	psychi- atric comorbidity	key molecule	a central biochemical dysnociception	the functional anatomy	The courses	the common types	the clinical traits	bothersome headache	:55-58	a possibility	physiopathology	the seventh disabler	genetic susceptibility	the association specific	young women	Positive family history	The father	Indian patients	i/d polymorphism	lifestyle/psychosocial covariates	pituitary tumors	genuine migraine attacks	The headache disorders	Thirty-eight percent	Worthing	a new locus	headache treatments	other pain disorders	a door-to-door survey	sleep disorder exhibit	central nerve terminals	manage- ment	somatoform disorder	a primary headache	primary thunderclap headache	the pathomechanisms	the red nucleus	anxious depression	peripheral blood DNA	Literature	individual items	proper treatment	the spectrum conceptualization	use reduces	individual level	edition	prevalences	dizziness dates	a combined diagnosis	par- oxysmal hemicrania	sighted subjects	global disability	Suggestive evidence	myogenous facial pain	an additional diagnosis	a peculiar symptom	symptom history descriptions	medicine development	ovale/atrial septal defect closure	behaviours	sonnambulism	a peripheral reflexion	other common headaches	accompanied trigeminal autonomic symptom	afflicted individuals	any serious systemic diseases	the participation rate	consanguineous suffering	separate entities	co-prevalent conditions	some types	female predominance	cephalic pulse amplitude	functional dyspepsia	a demonstrated substrate	tension type headache attacks	subclinical vascular injury	the spinal trigeminal nucleus	Sances	an important marker	tension-type headache sufferers	economic burdens	The course	the first common variant	other primary headaches	a weighted average	a healthcare professional	Circadian rhythms	low prevalence	aggravations	Poverty	the usual indications	Prophylactic drug treatment	nonheadache groups	Neuro-otological manifestations	several characteristics	vertigo rank	pneumoniae infection	exceptional cases	unnecessary interventions	mixed features	fair	affective disorders	short-term prophylaxis	cervical arterial dissection	the concordant changes	successful short-term prophylactic treatment	Japanese male workers	the hypothalamus	foramen ovale	a population-based case-control study	intracranial origin	laser-evoked responses	a no-longer episodic form	these same parameters	the endothelial function	resistant migraine	modulators	intima media thickness	rolandic epilepsy	public-health terms	achievement motivation	the visual disturbances	these reasons	the rela- tion	bipolar disorders4	cluster headaches	recent prevalence estimates	many pain-associated conditions	the 5-HTTLPR polymorphism	cross-sectional population-based survey	the transformation	self-considered migraine	physical maltreatment	phobic disorders	neurologic mechanisms	matriptan	intracranial neuroendovascular procedures	rat dura mater	default	2.3- fold	auraArterial stiffnessEndothelial functionFlow	initial analysis	:131	abstracts	common primary headache	iv administration	hay fever	any pharmaceutical company	pediatrics	the preva- lence	A consequence	neuroticism	personality disorder	rural dwelling	some attacks	normal incidence	The weighted prevalence	epileptic causes	sexual abuse	normal individuals	the spontaneous evolution	suspected diagnosis	post partum	nocicep- tive pathways	trigeminal afferents	such children	clinical similarity	the facets	Trigeminal autonomic cephalalgias	impacts	psychological co-morbidities	mitochondrial disorders	income countries..	a longitudinal web‐based panel study	new diagnostic criteria	smoking worsens migraine	long-lasting changes	[ 1-year history	date	the reported common trigger factors	these children	healthy control subjects	Inhibition	a clinical sample	estudio	the long term	non migraine headache	placebo comparison study	Anecdotal reports describe episodes	post-ictal headache symptoms	sociodemographic factors	the different age groups	A control group	functioning	subtype	other episodic headaches	headache features	pain management	a difference	the aspects	non-migraine subjects	another cause	rebound headache	classification classifies	the chronicization	migraine seizures	intravenous models	certain clinical characteristics	≥8 days/month	medication- overuse headache	A trend	the diag- nosis	minor associations	lay trainers	*Simultaneous multiple brain haemorrhages	REM sleep	First case	lifetime anxiety disorders	a homogeneous group	the 1-year prevalence	A new syn- drome	The readers	inherited charac- ter	5-hydroxyindolacetic acid	the final cohort	a validated animal model	the investigators	recep- tors agonists	5-HT1F receptors	pressure pain	Alleviation	cluster headache patients	migraine preventive effect	cluster etc	forehead dot syndrome	the high symptom burden	pre-existing gastroesophageal conditions	co-morbid psychiatric disorders	a potential consequent relief	past-year prevalence	nervous headache ”	healthy persons	neurogenic inflammation	an alternative treatment strategy	the significant neurogenic cortical changes	the prophylaxis treatment	tension	a close family member	single nucleotide polymorphisms	juvenile primary headaches	the fundamental mech- anisms	some triggers	the physiopathology	negative predictive value	0.5-2 Legend	previous epidemiological studies	An updated review	a chemical	rhinogenic headache	a gender difference	negative variation	chronic/recurrent headache	tension‐type headache	whiplash-associated headache	malignant stroke	the biochemistry	41-43 ]	a recent increase	The peculiar diagnostic approach	an expression	`abdominal epilepsy	dose-ranging study versus	adequate management	probable history	precise correlation	motor cortex	a closed structural analogue	A patient	an important assistance load	personality traits	associated diseases	the original theory	female ratio	second study	short sleep duration	the sole diagnosis	probable medication-overuse headache	early detection	Hargreaves	detailed clinical information	age-standardised prevalence	an epidemiological study	The estimated prevalence	the func- tional role	substantial family impact	a key symptom	former history	other idio- pathic forms	a strong history	evaluated subjects	The average duration	age groups	depressive disorders	Waters	no delayed headache	a total group	future treatment	a positive association	neuroveg- etative aspects	trigeminal antidromic activation	migraine pathogenesis	The prophylactic treatment	multiple attacks	an overall mean prevalence	a university hospital	Neurovascular headaches	heterogeneous autosomal dominant subtype	an increased frequency	that disorder	this topic	all people	the present data	no firm conclusions	a severe subtype	episodic tension type headache	many sub- jects	:1255-1257	bladder meridian	% report	the accumulated burden	white matter abnormalities	professional areas	satellite glia	sumatriptan tablets	symptomatic headache	platelet serotonin secretion	many uncertainties	great effect	severe depression	the neuronal effects	sex-specific incidence rates	high fre- quency	The high frequency rate	the single attack	ben- efits	issue	compulsive disorder	a univariable analysis	a False-negative cases	non-migrainous headache–head-HUNT	the index disorder	the dependent	anterior localization	important distinctions	The background data	pMOH	status migraine	diag- nosis criteria	a familial component	other primary headache syndrome	frovatriptan	an early life expression	treatment.Some headaches	ictal headache	public-health importance	cortical hyperexcitability	perma- nent headache	economic costs	first attacks	episodic migraine	days/month	door-to-door survey	the psychiatric symptoms	The same treatment	COMETE	patients progress	The striking association	neurological disorder	the ventral posteromedial nucleus	dietary sodium intake	the white matter	aura group	all routes	fast	intractable seizures	a primary underlying headache	con- trast	the acute phase	mixed headache disorders	Population-based door-to-door survey	old infant	The family impact	v.s	transcranial direct current stimulation	caseness	a MS-Q diagnosis	improved diagnosis	the cerebral hemodynamic change	tension headache.Headache	any particular association	blood flow velocities	thalamic microstructure	The precise etiopatogenesis	a tertiary referral hospital	chronic daily headache	mg vs	hemicrania	specific phobias	these disturbances	antidepressants	A decreased risk	activation specific	18-23 ]	the external jugular vein	paroxysmal hemicrania	primary headache diagnosis	a predominant symptom	a clinical model	aim	gender samples	a first degree con-	1H-magnetic resonance spectroscopy	The factors	families 1-13	subsequent migraine	oral prophylaxis	an intermediate	complains	the female	a population‐based case‐control study	recurrent	muscle contraction headache	anatomical peculiarities	suicide risk	] orientation detection	clear prodromal symptom	central trigeminovascular neurons	all combinations	careful case-ascertainment	allo- dynia	a gap-junction modulator	vestibulopathy	prefrontal cortical areas	an eight-year interval	extensive gastrointestinal work-up	the dura mater	the Canadian population costs	all headaches	the aurae	meningeal involvement	ten	early-onset dementia	these unsolved questions	considerable interest	–5 .10.1016/S0140-6736	specific headache types	vestibular dysfunction	pairwise concordance rates	matches migraine aura	≥15 days/month	vascular associations	a peripheral cause	The clinical picture	a multicenter follow-up study	deep compartment	Early recognition	pivotal role	a [ 1-year history	biannual follow-up	acute control	headache disorders	oral contraception	migraine subtypes	influence prevalence	cervical manipulation	whereas patients	neurologists clinics	point prevalence	any other neurological disease	gender-adjusted 1-year prevalence	these illnesses	clear epilepti- form	tension headaches	a common comorbidity	cluster headache mechanisms	young subjects	The reported frequency	non-spe- cific	the impacts	major depressive disorder	disease modification	a low income	total headache	The fre- quency	reduced sleep duration	“ perceptions	Primary headaches	bullying	legs syndrome	acute attacks	nonlinear brain responses	score predominance	disabling form	the study participants	hyperlipidemia	high amplitudes	Non-alimentary trigger factors	frequent differential diagnosis	3-question headache screen	% frequency	test differentiates	the economic effect	pain intensity	occasional aura symptoms	the familial history	The immunologic studies	a biological-based classification system	the non-participants	study aims	the supports	nutritional intervention	The mixed headache syndrome	temporomandibular disease	activated attacks	headache patients	psychiatric	a migraine-like headache syndrome	nervous system function	mild mental retardation	non-invasive magnetic resonance angiography	the vestibular system	a 1-year history	an initial genotyping phase	mag- netic resonance	classical cardiovascular	Agreement	a diagnostic categoryc	Differentiation	premenopausal women	Comorbid conditions	vertical bar	Canadian dollars	the acute treat- ment	secondary headache	evidences	enhanced platelet aggregation	Edmeads	all kinds	Attention difficulties	pupils	recurrent seizure	vascular morphogenesis	+49-9131-8534457 Fax	the neural mechanisms	aura events	related entities	ot ]	A concept	treat- ment	possible associations	pressure headache	tension type headaches	the increased functional connectivity	% children	nocturnal enuresis	endovascular closure	the prophylactic management	The term chronic	a transition	nervous system disorders	this atypical neural network	radiological correlates	Treatment Effects	the headache clinic	burden/impact	the overall prevalence	severe episodes	1-3 attacks	non-classifiable headache	tension- type headache	menses	hormonal changes	the inhibition	common causes	:534 ‐539	ongoing tension-type headache	thera- peutic implications	Other headachesb	’ pain	structural lesion	nortriptyline	historical information	a good can- didate	particular chronic headaches	headache frequency	incomes	An epidemiologic review	headache research	these resemble tension-type headache	an initial diagnosis	A cross-sectional study	the focal intravascular manipulation	’ subsample	certain trigger factors	clinic-based studies	patho- physiology	flushers women	The high concordance rate	parent	a DWI-visible lesion	A case	Recent advances	p trend	headache treatment	genetic features	the preventive	socio-economic factors	all headache disorders	heartburn symptoms	the other primary headaches	the gender-specific influence	the ages	psy- chiatric disorders	a rare disorder	common pathogenetic mechanisms	the physiopathogenesis	visual perception	the predominant group	endothelial injury	diagnostic groups	nationwide population-based study	prophylactic treatments	oral treatment	General practitioners	aura Frontiers	any headaches	the preventive treatment	phonophobia	estrogen withdrawal	poor diet	the diagnose	the reported case	outpatient headaches	attack frequency	the prophylaxis	brain infarcts	the rs1835740	a headache center	no abnormal physical signs	focal symptoms suggestive	drug efficacy	menstrually-related migraine	Adjusted prevalence	the small group	the preceding headache	the menopause	employment status	magnetic resonance imaging characteristics	first manifestation	:256-259	Features	serotonin re-uptake inhibitors	stimulation therapy	Obsessive-compulsive disorder	the neural network impairment	gen- der	poor sleep quality	the migraine group	the phenotypes	the lifestyle factors	Triptan/ergot-overusers	minimal	effect size	sufferers	individual burden	aura [	a conservative downrating	tension-type =	All employed groups	migraine headaches	typical aura	The epilepsy	Average hours	occipi- totemporal lobe epilepsy	some authors	the altered neuronal excitability threshold	The prognosis	sleep problems	nummular headache	cerebellar infarct-like lesions	an accurate power calculation	triptan overuse	Clinical features	pattern glare	the first manifestation	behavioral correlates	ten- sion-type headache	adrenomedullin	leisure activities	migrainous characteristics	the self-medication	prophylactic medical treatment	amino acid levels	active manifestation	other pain	dizziness experience	an endophenotypic marker	a simple association	cephalalgiaphobia	occipital epileptic discharges	the trigeminal the- ory	other chronic headaches	no previous history	//www.who.int/mental_health/management/who_atlas_headache_disorders.pdf	Past-year prevalence	other pain conditions	single diagnoses	An accurate diagnosis	recommenda- tions	other headache	migraines	brainstem aura	the early pain phase	paroxysmal positional vertigo	a migraine headache	migraine attacks	prophylactic treatment	wide improvement rate	nitroglycerin infusion	severe coarse	a dysfunction	no statistical significant changes	malocclusion	the last attack	potential sur- gical treatments	The interrelations	comorbid depression	aura n	hyper- lipidemia	intercalate seizures	a multifactorial disease	sig- nificant reduction	credited.Background Patients	autosomal subtype	Associations	headache spectrum	delicate nerves	likely suffering	other triptans	a poor country	headache location	:1-48	polymorphism	the pharmacotherapy	a functional polymorphism rs3813929	% slept	the rural village	The place	significant burden	common types	limited information	the last year	sub- arachnoid hemorrhage	energy intake	28:877-886. doi:10.1111/j.1468-2982	these respondents	organic distinctions	The discovery	positive family history	clustering	increased comorbidity	Platelets	a reciprocal association	a cost-estimate	episodic tension-type headache	persistent visual aura	the total costs	migraine-like attacks	all measures	sumatriptan nasal powder	intracranial disorder	capsaicin-induced increase	postictal states	some mild treated hypertension	a pediatric sample	a module	Rains	Migraine	minor modifications	infarct-like lesions	36:471-475. doi:10.1046/j.1526-4610.1996	prevalent headache type	cephalic vasodilation	nonmigraine primary headache	main types	The responders	electroencephalographic findings	drug overuse	Females	improve- ment	depressive severity	treatment options	a metropolitan city	healthy volunteer	headache-free controls	whereas increases	vice versa	Acknowledgements	refrac- tory	Clinical course	concordance	The coex- istence	headache diagnosis	dural meningeal vessels	one-sided headaches	onset age	jugular vein	mistreatment	a reliable animal model	medication overuse	either direction	cluster headache pathophysiology	any other type	episodic headache	cervicogenic headache shows	headache suffering	prevalent diseases	other models	The human μ-opioid receptor gene polymorphism	Menstrual migraine	18-60 years	predictive animal models	medication-overuse headache	all other regions	specific brainstem structures	4-30	a first attack	s examination	epilepsy	:400-405	tsklinikum	prev- alence	% female	a genetic animal model	a Danish epidemiologic follow-up study	a select group	Antidepressants	psychiatric disorders–a national population-based study	the occipital region	Within-patient early versus	any other regular medications	a great impact	the major primary headache disorders	Major depression	no recent change	Males	the dizziness	A debate	associated digestive problems	5-HT transporter polymorphisms	vascular nociception	trigger factors	every year	the fre- quency	the multifactorial etiology	self-reported high burden	understood entities	% prevalence rate	usage patterns	somatic symptoms	classic migraine	some extent	A 70-year-old woman	The variables	a brief intervention	the peripheral trigeminal system	celiac disease	a pain phenotype	gene polymorphism	probable migraine	both headache burden	no past history	:413-419	scarce data	large number patients	deficits	A 40-year follow-up	oral delivery	a strong relationship	head pain	online supplementary files	headache characteristics	cardiovascular risk	thirds	the interictal phase	hemiplegic	vasospastic disorders	the primary event	some psychological features	the search	the attack	any ” activation	Previous epidemiologic study	:506-510	the well-known risk factor	a population-based survey	the typical visual aura	worldwide disability.1	the ibuprofen-containing medicines	migraine predisposition	co-occurrence	peripheral form	other primary headaches disorders	devel- opment	neurological origin	a prescription	both poor productivity	the university	gest education	societal impact	severe headaches	Co-morbidity	the original study	the disability weight	recognised.Cyclical vomiting	the underlying pathomechanism	the drug treatment	restless legs syndrome	ergotamines	increased illness	migraine participants	related disability	treatment outcome	an important comorbidity	feature	co-morbid psychiatric diagnoses	male respondents	pulmonary arteriovenous malformations	secondary ones	headache types	thunderclap headache	chil- dren	coinheritance	the emotional component	coloured shapes	the other previous reports	a psychogenic context	several attacks	particular support	the neurology	the publication	cluster headache share	substantial proportions	absolute terms	search arguments	A cutting-point indicating suspicion	prevent	both focal seizures	many suscepti- bility genes	the diagnostic criteria	favour	chronic diagnoses	short-term prevention	a tertiary pediatric headache clinic	a hormonal factor	the progressive nature	irregular sleep	accurate [	cervicogenic headache	complicated form	health-related risk factors	another primary headache disorder	vascular headache	magnesium	neurologic disease	andclinical characteristics	the abortive treatment	chronic daily headache ”	complete picture	socioe- conomic status	The phenotype	motor weakness	neurophysiological abnormalities	various pathophysiological mechanisms	high-dose riboflavin	coeliac disease	neurological condition	a different syndrome	:396-402	fre- quent episodes	possible answers	painkiller headache	Changes	neuronal hyper-excitation	distinct disorders	a school population	sensory phenomena	life time drug use	comprehensive system	challenging migraine variants	methysergide	± standard deviation	consultation	toxic abuse	Test information curves	headache phenomena	the resolution	that subjects	a reliable experimental model	the questions	salivary magnesium levels	acute migraine	previous thrombotic disease	oblique angles	the unknown pathophysiology	strokelike episode	the representa- tions	seizure disorders	post-operative epilepsy	some common symptoms	The functional repercussions	no doubt	the other headache subtypes	stomach aches	the multifactorial pathophysiology	a child-adapted prospective daily headache diary	common comorbid condition	many fea- tures	menstruation	inconsistency	daily persistent headache	the improvement rate	only subjects	parental headache	other vascular	Study	No gender difference	vascular hypothesis	global prevalences	primary care study	complete cessation	saschakra	:488-491	cerebrovascular accident	other head- aches	clin- ical diagnosis	smoking cigarettes	the anticonvulsants	young adult patients	related vascu- lar headaches	coexistent headache	lepsy	headache attacks	further history	the “ cause ”	a separate nosological entity	the neuromodulation	The acute treatment	chronic/16 episodic	significant impacts	a first-degree relative	any detectable medical conditions	other headache diagnoses	the age group	a close match	Societal impact	erythrocyte magnesium concentrations	a lifetime history	probable forms	The co-morbidities	The multi-factorial pathophysiology	p=0.0042	Preliminary observations	attenuated headache intensity	Polymorphism	intensityxduration	diagnosis cases	the main feature—gradual increase	the reported frequency	intractable attack	psychological profile	cohort Characteristics	white matter lesion load	non-migrainous headache	a slight shift	No family history	oral contraceptives	any other one	twenty-four patients	Many people	prior history	visual aura	a nationwide survey	the first sign	organization	specific gene polymorphism	pharmacological management tend	nationwide survey	significant impact	The clinical features	every month	neurologists	genetic indicators	a community-based study	a real mental disorder	S3 –8	the identifica- tion	an intimate relationship	the analyses	menstruel attacks	False-negative cases	a right-to-left shunt	current health behavior	nimodipine	calcitonin gene-related peptide	government health surveillance studies	Sand	uncontrolled vasodilation	remission rates	miss subtle changes	ten- sion-type	common mimics	the neural theory	ipsilateral activation	a single diagnosis	clinical profile	no disease	marker	p values	public health perspectives	the predictors	new clinical neuroimaging modality	large shifts	a mean disability	both occipital epilepsies	severities	intracellular magnesium	15-17 ]	persistent central sensitization	frequent episodic tension type headache	various forms	The observed influence	high incidence	familial transmission	the overall management	the age-standardised 1-year prevalence	Benefits	pathogenetic theory	warrants	reduced frequency	neurotransmitters	personal history	similar proportions	non-migraine status	common migraine	significant results	tension-type hea- dache	a migraine-pro- voking agent	associations	the separate impacts	the cerebral mechanisms	cerebral endothelial dysfunction	auditory processing	sterile inflammation	bruxism	[ tiab ]	several moderate-severe migraine attacks	contraction headache	an unrestricted fund	psychiatric illness	the disorder	an English district	cranial autonomic symptoms/signs	other somatic dysfunctions	several psychiatric conditions	common feature	the trigeminal gan- glion	A third sister	respons- es	The classified headaches	il	the mean global prevalence	the other associated features	a clear normalization	societal burdens	a few studies	migraine days	normal weight controls	photosensitive epilepsy	adoles- cence	a similar mechanism	any other headache	the primary visual hallucinations	the common form	peptic ulcer	demographic characteristics	serotonergic disposition	CD patients	//www.lecrat.org	REVIEW	equal sex ratio	small minority	the nociceptive system	The overall prevalence	vivo models	angiographie changes	TTH	agonists	a small proportion	the confirmed diagnosis	related headaches	familial forms	the main symptom	:21-32	health conditions	ten- sion type headache	This observation	pediatric age	the hypocretin receptor	any other disorder	the analyzed polymorphisms	well-known features	a popula- tion-based survey	total scores	cranial autonomic features	a total difficulty score	definite migraine Patients	extended families	a dignosis	a pattern adaptation	financial impact	The topic	other headache characteristics	a population	diagnosis ’	a rational under- standing	an analgesic adjuvant	general medical conditions	physician diagnosed conditions	the 1-year prevalence rates	many studies	recurrent coma	the one-year prevalence	a broad range	a normal weight	estab- lished diagnosis	the chronic form	cular headaches	s100b	episodic syndromes	a sequela	celiac patients	The same rank order	Today	socioeconomic impact	general population	a questionable specific effect	% males	similar- ities	intravenous valproic	excess change	the interictal period	the interest	neuro-otological symptoms	self-reported borderline/abnormal score	other trigeminal-mediated headaches	focal symptoms	several pain disorders	All primary headache sufferers	a muscular component	headache disorder	an epigastric impedance method	a recognizable limitation	classification criteria	a 5-year history	Transformation	menarche	an urban population	other primary headache	posterior localization	the second headache type	seniority	5-hydroxyindolyl acetic acid	sexual headache	low correlation	dopamine agonist treatment	a headache centre	western countries	occipitotemporal lobe epilepsy	other prima- ry headaches	the vast majority	the occipital lobe	:1533	the available studies	brain tumor development	some clinical characteristics	a firm conclusion	the pathological mechanism	The typical localization	cost-benefit ratio	a tendency towards	the particular conditions	Unfortunately sufferers	126:241-247. doi:10.1093/brain/awg009	a serious lack	no familial history	high cost	cognitive change	emotional regulation	somnabulism	presumed pathophysiology	Habituation	a 4.5-fold increased risk	tension -type headaches	120:157-171. doi:10.1016/j.pharmthera.2008.08.003	probable headache forms	chronic migraine	the underdiagnosis	a drastic level	non-migraine headaches	the primary headache disorders	medical doctor diagnosis	Sixty-two patients	the underlying reason	no differ- ence	the validity	the vascular theory	a prophylactic drug	migraine prevalence	photophobia	The science	medical students	occipital pain	twenty-nine Chinese patients	acute management	:1259	acute therapy	A study	co- morbidity	Western countries	the general correlation	subclinical brain lesions	nitric oxide stress	articlePatients	:98-104	the elderly group	isolated psy- chopathological features	relative	lipton criteria	pri- mary exertional headache	familial aggregation	aura drove patients	biological validity	fair agreement	the periph- eral origin	migrainous subjects	demographic variables	trigeminal autonomic symptoms	An increased risk	practical usefulness	tension-type headache ”	the treatment strategies	commonly precursors	Provocation	main subtypes	a migrainous syndrome ”	outpatient care	ovarian hormones	frequent dissociation	A case control study	migraine illness	the headache disorders	a local community	a poor evolution	consistent triggers	Localization	facial allodynia	periaqueductal grey matter involvement	post-treatment	aura patients	The headache burden	prevalence estimate	the indication	minimal pharmacologic treatment	genetics	psy- chological evaluation	healthy children	Tension-type headache	moderate agreement	a potential behavioural correlate	prolonged aura	possible brainstem origin	:218-222	bidirectional influence	auraw22	psychiatric outpatients	migraine prevention	the sole ictal epileptic manifestation	prospective dietary studies	both levels	a familial history	a distinguishing feature	episodic migraineurs	the circle	spontaneous episodes	the age distribution	:1851-1861	a common diuretic	20-25 % switch	episodic syndrome	non-migraine primary headache	new appendix criteria	the chi-square test	the linear regression analysis	a verisimilitude	
dialysis access surgery	


osteoporotic bone remodelling	local angiotensin	stent recoil	Side-specific endothelial-dependent regulation	//guidance.nice.org.uk/CG95	a reversible inflammatory process	early aortic valve disease	valvular inflammation	that inhibition	calcific deposits	serotonin levels	trial Circulation	mitral annulus calcification	chronic renal disease	obstructive coronary artery disease	coronary artery calcium	apoE-null mice	coronary artery calcium severity	tricuspid regurgitations	mitral annular calcification	neovascularization	plasma osteopontin levels	
a standard dose	transient dizziness	the possible neuroprotective effect	The findings	the same concentration dependence	this agent	the treatment group	μmol/L	flufenamic acid	glibenclamide	study completion	transient nausea	experimental allergic encephalitis	consecutive tests	mention	placebo subjects	
The monoterpene	the metabolites	orange peel	a major metabolite	
The mean levels	pseudouridine	the physiological deamination	a wide inter-patient variability	These nucleosides	essential molecules	citicoline	The excretion	
:24	gene mutations	Mutant mice	
the first post-operative day	coronary artery bypass graft surgery	beta-blocker	ordinary beta-blockers	rubidium-82	spironolactone	ibutilide	blockers	quinidine	verapamil	the German registry	pindolol	magnesium prevents	b-blockers	the proarrhythmic effects	cardiac surgery [	underwent open heart surgery	abolish reentry	sertraline	little experience	disopyramide	a propensity-matched analysis	terfenadine	Intravenous magnesium sulphate	nadolol	the typical rate control drugs	flecainide	this purpose	a randomised open trial	Prophylaxis	dofetilide	significant adverse reaction	similar attention	beta blockers	potassium efflux antagonism	atenolol	coronary artery bypass operations	propafenone	a meta-analysis Annals	dronedarone	amiodarone	neuroleptics	
-153	painful bone metastases	radium	

fine-needle aspiration	marrow aspiration	cHR	bone marrow aspirate	significant hormone status discordance	haematopoietic cells	the posterior iliac crest	crest bone marrow aspirate	endoscopic examination	cytogenetics	bone marrow aspirates	marrow aspirate	
transmissions	tabes dorsalis	hepatitis	primary intraocular lymphoma	sarcoid	fungal	antiphospholipid antibodies	burgdorferi	pallidum hemagglutination	drug screening tests	severe anemia	leprosy [	blood-transmitted infectious agents	the high incidence	histoplasmosis	other transfusion-transmitted diseases	chronic sequelae	uveitis	borreliosis	brucellosis	active immigration	coinfection	laboratory haematology	donors	The pathogenesis	other infections	Infectious arteritis	a 2-year period	neoplastic diseases	rapid plasma reagin	virus	Danish men	the spread	the optic nerve	other systemic investigations	similar prevalence rates	Peripheral blood counts	posterior scleritis	heterosexual men	schistosomiasis	febrile gastroenteritis	rickettsioses	the option	gonorrhea	anal cancer	Megaloblastic anaemia	chronic hepatitis	transmissible diseases	other patients	segment manifestations	allogeneic hematopoietic stem cell transplantation	The prevalence rates	previous observations	takayasu arteritis	hepatitis-B	aortic dissection	prevalence rate	normal values	streptococcus	lues venerea	recent infection—logistic regression models	inflammatory disorder	infectious disease	screening tests	employ preventive measures	neoplastic disorders	heavy metals	toxoplasma	blood products	
Secondary hyperparathyroidism	breast cancer tumor growth	
cerebral malaria	myeloid-derived suppressor cell	lethal infection	knockout	a highlight	

reactive pupils	punctate keratitis	numerous dental caries	inoculum	graph	anterior uveitis	skin fragility	
retinal detachment	proliferative vitreoretinopathy	cellular adhesion molecules	macular hole	doi	hyperglycemia causes	adhesion molecules	retinal pigment	abnormal neovascularization	
no findings	initial mastication	doses	Clinical picture	sounds	Recent studies	flushing	
a retro-spective study	facial paralysis	severe redness	the left ear	bulging	no other otologicsymptoms	cranial nerve	ear fullness	temporomandibular joint disease	recent symptom aggravation	otorrhea	dizziness	erythematous vesicular rash	facial nerve palsy	the foramen	mandibular joint pain	tinnitus	aural fullness	intermittent otorrhea	mucosal lesion	photofobia	no other complaints	
influence outcomes	surgical margin	recurrence rate	cause	intraoperative parameter	tumor extension	


an impaired desaturation	comprising	
forest	the bank	




reversible neurologic deficiencies	eyelid	ocular motor disturbances	the orbital contents	blindness	hearing	behavioral abnormalities	rapid paraparesis	speech disorder	intracranial pressure	
TH2-mediated disorders	corticosteroid therapy	This table	the same criteria	gastro-intestinal symptoms	the anti-histaminic properties	eventual chronic nature	hyper-responsiveness	the correlation	the future development	the subsequent pattern	The origins	a history	bronchial inflammation	general perspective	a decreased likelihood	2595833321510.1186/s12931-015-0215-5ResearchSleep-disordered breathing	receptor antagonist	reversible airflow limitation	high dose	numerous conditions	the decline	host characteristics	The direct costs	personal observations	several years	accurate medical diagnosis	n=536	steroid hormones	hyperresponsiveness	obstructive airway diseases	accordance	clinicians	Japanese children	tralokinumab	Xuan	the second study	the natural history	populations	10.2147/COPD.S82179copd-10-739ReviewPatient preferences	bronchitis	causation	The cumulative prevalence	a neuromuscular disease	the database	anti-interleukin-5 treatment suppresses	understanding	“ cough	excessive production	twin study	Risk	’ disease	the pathogenesis	smooth muscle remodeling	The therapeutic activity	percentiles	chronic obstructive lung disease	diabetic nephropathy	person-years	a blood eosinophil count	classification system	dental pain	unscheduled asthma care	gene expression	Barnes	quantitative study	early stage	pulmonary emphysema	chronic obstructive pulmonary disorder	clinical symptoms	the following years	atopic sensitization	neurodermatitis	institutional prevalence rate	growth factor	early determinants	disturbed resistance	consistent decline	that adequate workup	persons	functional profiles	patient education monitoring	similar figures	epidemiologic assessment	no adverse effects	inclusion criteria	the large geographic area	the systemic impact	the health care costs	allergies	many chronic inflammatory lung disorders	−0.29	birth weight	the overweight	mild	the inflammatory changes	anaphylactic shock	childhood pneumonia	decline	special emphasis	probands	syncytial virus infection	The results	national asthma education	yrs	rhinitis symptoms	se	relation	economic burden	airway responsiveness	experimental models	allergic rhinoconjunctivitis/hay fever	the following groups	esophageal pH monitoring	sleep disorders	the self-management	a genetic predisposition	considerable uncertainty	hayfever	mild forms	p=0.08	transient bronchoconstriction	The safety	no history	this point	adipokines	those studies	small airways	this subgroup	Epidemiology	twin studies	sputum eosinophil counts	An undetected burden	% accuracy	the theme	Activity	A mouse model	bystander	1465-9921-6-951610517010.1186/1465-9921-6-95ResearchIncidence	casts	persistent airflow limitation	drug studies	residences	These classifications	general symptoms	absolute count	new member	consistent relationship	allergic conditions	all relevant patients	self-report	onset-age	exercise-induced bronchoconstriction	supplemental oxygen vs room air	the chronic inflammatory disease	allergic rhinitis	the diagnostic coding	early-onset wheeze	percent gas-trapping	a working diagnosis	these studies	physician diagnosis	the nature	the organisational silos	other significant comorbidities	the whole school community	area-level measures	similar thickness	All experts	This issue	a 12-year-old boy	the respiratory morbidity	respiratory	hallmark features	randomized trial	air pollution	functional parameters	unconfirmed reports	care guidelines	a juvenile mouse model	severe obesity	the administration	pronounced symptoms	all individuals	any underlying condition	adverse effects	asthma Patients	chart review	new diagnoses	term respiratory consequences	the protocols	nonasthma group	family history	smoking status	the variable airflow obstruction mechanism	A small study	doubt	a link	medical conditions	childhood	secondary care	important pragmatic domains	other respiratory morbidity	a molecular docking simulation	active tuberculosis	the seasonal patterns	cigarette smoking	lung volumes	female subjects	the genetic role	correlation analysis	education levels	emphasis	the treatment quality	diagnostic criteria	responses	RV-induced exacerbations	induction	diminished sweat secretion rates	antireflux treatment	any pulmonary disease	Average annual incidence	the smooth muscle layer	Twenty-five children	many features	the sample	a definition	maternal antibiotic use	important predictors	hospital outpatient clinics	the disease pathogenesis	health services utilization	the fundamental cause	low quality	houses influence symptoms	asthma study	Strategy	the strong association	possible cases	the pathophysiology	the example	seasonal symptoms	lung function growth	the presence	the paediatric population	] domains	reductions	any acute cardiorespiratory disease	the percent	obese people	ii64	–699	these drug evolutions	the epidemic increase	the economic cost	An outbreak	various severities	a population-based study	timely diagnosis	severe exacerbations	bronchopneumonia	upregulation	pulmonary immunity	the authors	outdoor environmental factors	severe forms	the specific inflammatory phenotype	−0.03	The overall impact	Parameters	the primary objective	questionnaires	no causal relationship	successive patients	allergy	the average age	eosin	nightmares	Several registry-based twin studies	lung fibroblasts	leukotrienes	probiotics	positive clusters	Clinical trials	markers	recurrent wheezing	related allergic diseases	achievements	a prominent feature	der	prevalent chronic respiratory disorders	rs4950928	incomplete reversibility	several intermediate phenotypes	year history	respiratory infections	the evidence	groups	cerebrovascular disease	receptor usage	the adult-onset	endothelial dysfunction	the main goals	both pneumonia	parallel-group safety study	wheezing symptoms	univariate associations	separate diseases	presentations	hilary.pinnock	“ real life	different risks	The differentiation	an impulse oscillation system	pulmonary diseases	pulmonary emboli	Many airway diseases	thyroid dysfunction	eosinophil trafficking	‘	dianosides	complete remission	a large case-control study	contributions	allergic airway responses	all children	the exclusion criteria	a common physiological component	airway reversibility	inflammatory bowel disease	allergic athletes	concomitant respiratory infection	suitable ascertainment	a chronic respiratory disease	long-acting β-agonists	the population	cystic fibrosis.3	rhino conjunctivitis	interest	peripheral obesity	a different risk	pharmacological therapies	Epidemiological studies	lifetime risk	a reduced risk	fold change difference	Control	these different indicators	appropriate treatment	other obstructive diseases	current therapeutics	rheumatoid arthritis	correct classification	respiratory stenoses	laryngomalacia	allergen	white adults	nocturnal gastro-oesophageal reflux	both congenital heart disease	host susceptibility	the pollution-induced exacerbation	doctor diagnosis	atopic history	acyloxyacyl hydroxylase	normal control subjects	the salient features	management seeks	dyspepsia	normal-weight children	healthy controls	concerns	follow-up appointments	the misdiagnosis	well-controlled ’	hypnotic medications	severe airway inflammation	the children	reflux triggers	anyone	aspirin intolerance	a sample	rests	obese individuals	Prevalence	well-controlled ”	potential confounders	other chronic inflammatory conditions	pediatric subjects117	the clinical radar screen	the case series	monoxide	the clinical severity	neuromuscular disease	conclusion	mild joint stiffness	a new presentation	a medical diagnosis	a first diagnosis	the screening	the researcher	postbronchodilator	the suppressive activity	long term effects	bronchial smooth muscle cells	heritability estimates	sources	public schoolchildren	a protective	6-7 %	a marker	subsequent resection	cystic fibrosis	early life infection	gender	Limitations	international study	ten pharyngitis	the outcomes	an age-	a potential misclassification bias474849	smoking	healthy volunteers	serious clinical presentations	practice	asthma ’	another pulmonary chronic inflammatory disease	atopic	the clinical importance	chronic obstructive airway disease	respiratory syncytial virus bronchiolitis	the general practitioner	anatomic variants	antinociceptive effects	immunomodulatory effects	:25 –31	such long-term effects	later life	standard general practice	central obesity	asymptomatic individuals	low birth weight	longitudinal population-based cohort study	receptor polymorphisms	asthmatic patients	mildness	previous diagnosis	a large population	the adult study	the cellular composition	insulin resistance	the emergency room	the obligate	other chronic medical conditions	functional changes	the disease characteristics	certain features	a Link	The terms	expiratory reactance	asthma occurrence	a Th2-driven mouse model	a boy	participants	concurrent hay fever	homepage	economic development	sedentary non-obese asthma patients	the prevalence rate	the patients	pulmonary embolism	women—23 people	severe clinical presentations	reviews	other allergic conditions	the analysis	chronic obstructive pulmonary disease exacerbations	a previous diagnosis	chronic lung disorders	the classic atopic/immunological model	mouse model	the subsequent onset	other respiratory conditions.6	healthy non-athletes	other airway diseases	ranges	no hospitalization	drug-induced pneumonitis	the response	routine reversibility	early infant lung function	total	presence	the small airways	Reconcilable Differences	the nocturnal symptoms	important characteristics	ed.ac.uk	the irreversible form	the acceptable subject curves	body	irritable bowel disease	mortality rate	leptin concentrations	congestive heart disease	high ozone levels	chemokines	different types	the likely candidates	dietary supplements	bronchial symptoms	common comorbidities	particulate air pollution	rhinitis patients	seasons	the underlying risks	rs20541	treatment plan	an early episode	existence	nonallergic rhinosinusitis	nonexposed peers	μg/m3	therapeutic implications	foundation	the Th2-related eosinophilic inflammation	forms	the population suffer	trimellitic anhydride	viral persistence	symptoms	any time	The occurrence	cytokine expression	the clinical expression	nocturnal exacerbation	the progression	multiple respiratory disorders	an epidemiological survey	systemic steroids	an integrated model	asthma-like symptoms	a high prevalence	clinical study patients	severe disease exacerbations	ozone-induced pulmonary inflammation	obese increases	the main baseline characteristics	Side effects People	a range	the long term management	aclidinium bromide	other comorbid conditions	a family history	the high heritability	experimental approaches	a long-standing history	the co-occurrence	These markers	cross-sectional measures	deaths	animal models	much variance	the subgroups	reduced lung function	one-fifth	consecutive thunderstorm	a complex relationship	potential confounding factors	the genetic basis	new cases	obstructive sleep apnoea-hypopnoea syndrome	trends	the median overall mAQLQ	related common complex diseases	several cancers	management planning	several observations	a common pathophysiology	the relative underdiagnosis	twins	birth	c-reactive protein	asthma models	a unique opportunity	asthma–COPD overlap syndrome	episodic flare-ups	inflammation	the systemic effect	immunological triggers	The criteria	different genotypes	The incidence	the major primary cause	a weak correlation	the diagnosed prevalence	recent population-based twin studies	:359–63	reported history	the biomarkers	statistical tests	an average absence	a strong family history	chronic respiratory disorders	air pollutants	long-acting beta agonists	urban school environments	primary-care spirometry	blockade	other atopic conditions	concentrations	Internet-based monitoring	parent-reported questionnaires	The control	lung comorbidity	lung fluid balance	these consequences	the exacerbation	the direction	the first half	bronchial hyper-responsiveness	a population-based cohort study	an infiltration	occupational origin	episode	all ages	co-morbidity	additional questions	a common murine model	chronic obstructive pulmonary disease exhibit	asthmatic mouse model	obese subjects	a current diagnosis	the problems	both exposure	young people	scientists	inappropriate management	chiefly pneumonia	the airway hyperresponsiveness	sepsis syndrome	unemployment/premature retirement	self-management	guideline.13	a term	pregnancy	wheezing	the same level	:116 –123	prior knowledge	healthcare experiences	diseases.3	acute lung injury	a condition	African-American patients	decomposition	severe asthmatics	respirable antisense oligonucleotides	that treatment	hospital emergency visits	residential proximity	association	the manifestations	other respiratory disorder	the recent evidence-based guidelines	pediatric allergy	An overview	few prophylactic interventions	disodium cromoglycate	acute pancreatitis	treatment-resistant cases	a fixed threshold	5-Lipoxygenase inhibitors	mixed emphysema/bronchitis	a dozen potential biomarkers	immune-mediated diseases	The application	parent-reported asthma	the complex biology	study subjects	the cause-effect relationship	descriptive study	conventional psychiatric treatment	dupilumab	observed apnea	Asthmatics	new data	asthmatic bronchitis	the general population	eosinophilic bronchitis	recent data suggest	sjukhuset	the natural evolution	pathological states	asthma susceptibility	causality	distinct phenotypes	further up-regulation	y	the reference category	hypereosinophilia	risk factors	The Dutch hypothesis	primary clinical diagnosis	different definitions	uncontrolled asthma	team	other non-COPD respiratory disorder	several lung diseases	the near future	a different physiological meaning	pre-clinical models	the advanced disease stage	Studies	processes	initial response rate	certainty	±34.3	contraindication	these diseases	other inflammatory pulmonary diseases	asthmatics	the long-term management	the exacerbating role	age adults	future twin studies	The relationships	schizophrenia	a primary diagnosis	a distinct disease	an inverse relationship	chronic bronchitis	a dose-dependent risk	GOLD-defined chronic obstructive pulmonary disease	outcome data	trials	the importance	review	related allergic disorders	wheeze	cited.The prevalence	positive response	The high prevalence	ng/mL	The differences	the same population	relative humidity	Spirometries	the functional abnormalities	the discovery	rhinitic patients	gastro-oesophageal reflux disease	severe exacerbation	illness	facial edema	a short-term priming model	traffic exposure	inpatients	cell signature	The pathophysiology	an important severity	moderate-to-severe chronic obstructive pulmonary disease	atopy	stiffening	a respiratory cycle	diffuse panbronchiolitis	leptin levels	respiratory airways	delayed diagnosis	a linear increase	extensive pleural effusions	occupational exposures	the number	prevents	various pathological pulmonary conditions	a large population-based study	respiratory allergy	interleukin-13 blockade	a physician diagnosis	respiratory complications	growth retardation	physician-diagnosed asthma	the elite athlete	great interest	exhaust	the similar disease	the potential effects	Relation	policy mismatch	a self-reported diagnosis	the market	the occupational environment	a large degree	nonasthmatic individuals	mouse models	classical atopic asthma	severe outcome	biological clustering	normal aging	–1171	the major histocompatibility complex	referral	atopic asthma	edema	communication	pylori	corticosteroid resistant	Medical treatment	other immune dysfunctions	bronchial hyperresponsiveness	a feature	tracheal stenosis	preoperative diagnosis	quiz	both children	effectiveness	irreversible airflow obstruction	eosinophil numbers	eosinophilic airway inflammation	overweight	a mismatch	severe aortic stenosis	childhood asthma risk	relevance	health history	ovalbumin model	hypersensitivity	multimorbidity	the 6–40-year age band	a self-management model	chronic rhinitis	information	dry powder inhalers	nasal polyposis	filaggrin counterparts	granulomatous angiitis	treatment response	flow-volume curve	heritability	Danish adolescent twins	treatment suggestive	clinical control	paracetamol use	the probability	nocturnal reflux	families	mucin	The genetic correlation	atopic subjects	rhinovirus	Population-based studies	no previous studies	refractory asthma	oseltamivir	the negative effect	readmission Pediatrics	the overlap	the exacerbations	the origins	high prevalence	cellular thiols	et al	systemic inflammatory diseases	specific cause-effect relationship	a child	proinflammatory diseases	the independent association	self-management Self-management	a determinant	sensitized patients	the poor control	allergic airways inflammation	the recommendation	some factors	the severe form	typical clinical features	that clinical improvement	An underestimation	recognition	gender differences	clinical deterioration	no family history	other respiratory illness	bronchitis symptoms	sensitisation	R	the total number	Importance	exacerbation	certain types	the early detection	the immunopathogenesis	severe treatment-insensitive inflammatory diseases	airway rewarming	these cytokines	environmental exposures	s28 s38	the positive association	the national guideline	syndrome	recurrent chest infections	low-osmolar contrast medium	chronic care management	knockout mouse models	different models	COPD	the anesthesiologic course	smooth muscle	Other potential diagnoses	nasal hyperreactivity	cell disease	recommendation	% improvement	additional conditions.1	the diagnostic process	sputum cytokine profiling	the prevalence rates	a detailed examination	Each patient	viral respiratory infections	chlamydial infection	the significant overlap	the defect	a different etiology	significant predictor	a cross-sectional analysis	both respiratory allergy	skin-prick tests	developmental delay	meticulous attention	additional analysis	sleep apnea	bronchodilation	any role	those subjects	weight loss interventions	parental rhinitis	a dangerous mix	pathogenesis	//thorax.bmj.com/content/63/Suppl_4/iv1.full.pdf	a useful phenotype	viruses	probandwise concordance rates	aeroallergen sensitization	a four-fold increase	particular matter	The etiology	the acute exacerbation	ambient levels	strategy	airways	an experimental model	–307	respiratory stridor	the phenotypic assessment	these programs	prominent eosinophilia	developed countries	No incident dates	occurs	Simons	respiratory syncytial virus infection diminishes development	this project	the acute respiratory distress syndrome	the long-term fluctuation	Restrictive ventilation disorders	additional conditions.3	some experimen- tal models	concept	many types	the third decade	tobacco treatment	experimental asthma	The potential impact	diagnostic shift	The economic impact	long-term prevention	author	interstitial pneumonia	asthma control	tests	this study	,12	prevalence	hypertension	Inuits	point scale	The worldwide incidence	similar diagnostic methods	wall thickness	nocturnal dyspnoea	allergic diseases	​​​​	:599 –605	aspirin-sensitive respiratory tract disease	other diseases	significant changes	sd	national guidelines	variants	the susceptibility	demographic factors	acid-suppressive therapy	heart diseasec	a proband	the contribution	the long-term risk	airway function	the risk factors	proof	a cause-effect relationship	a significant difference	many cases	These studies	the state	β1-receptor blockers	such differences	cough episodes	beta-adrenergic agonist sensitive	Ratios	the possibility	mild-to-moderate airflow limitations	symptomatic prostatic hypertrophy	the immune dysregulation	optimization	the fact	normal groups	a prevalence	survey data	beta2-agonists	the severe asthma phenotype	chronic cough.7	society	moderate forms	a positive ‘	no recent birth cohort study	the isolated impact	persistent inflammatory stimuli	healthy intermittent smokers	other general medical conditions	The division	effective therapies	innate immune genes	no clinical features	the hypothesis	von	the recurrence risk	human medicine	the pulmonary inflammation	study cohort	infancy	development	resistence	atopic wheeze	wildfires	association studies	chronic obstructive pulmonary disease	Canadian adults	post-BD spirometry.4	genetic makeup	cytokine interferon	interview	epidemiological survey	consequences.60,61	corticosteroid-insensitivity	the subsequent development	the finding	the heritability	large number	Associated factors	primary health care	differ	Many mediators	the different components	genetic correlation=0.20	a tendency	Additional files	objective measures	β-defensin-1 level	the appearance	a rat model	leptin	many human respiratory diseases	characteristic phenotypes	previous use	second-hand smoking	a rare opportunity	the overlap diagnosis	an IFN-γ -dependent mechanism	The patients	ml	the dual-diagnosis	atypical infections	included hay fever	other common therapies	Substantial differences	attack	some modification	house dust mites	classical antimicrobial activation	a period	collaboration	asthma probands	the recurrence	nitrative stress	verified allergy	nomenclature task force	this cause	a fixed pattern	bronchorrhea	serologic	pairwise comparisons	Early childhood overweight	cancer [	antagonists	control children	share	current psychological symptoms	the failure	carbon monoxide	autoimmune diseases	Quality	male gender	epigenetic studies	inflammatory lung diseases	The management	histories	the cohort study design	A comparative evaluation	n =	longstanding allergic rhinitis	numbers	further attention	The basis	The associations	the airway wall	a possible link	eosinophilia	a modest benefit	aspirin sensitivity	an acute exacerbation	various health disorders	cutaneous reactivity	chronic pain	The aims	obstructive pulmonary disease	natural history	multiple breath biomarkers	driven innate immune responses	a potential biomarker	this dual-diagnosis	van	prevalent viruses	considerable side effects	asthmaticus	pathophysiological features	these conditions	close-proximity air pollution	satisfactory control	the tumor necrosis factor gene cluster	the triad	delayed consultation	the detrimental effects	pulmonary fibrosis	“ asthma	recurrence risks	pandemic cohort	related traits	a respiratory virus	mothers	a single sputum sample	Previous studies	significant adverse effects	seasonal allergic rhinitis	antibiotic treatment	negative emotions	improved lung function	No specific cause-effect relationship	randomized clinical study	maternal smoking	the acute bronchodilator response	current diagnosis	the study population	asthma-related phenotypes	other inflammatory diseases	an OVA-induced murine model	obstructive respiratory disease	chronic inflammatory disorder	these asthmatics	many chronic diseases	17-associated cytokines	the warm season	an allergen-induced acute exacerbation	the peripheral nervous system	e.g	both.27	A previous study	each year	an inspection	atopic allergy	inhaled corticosteroids decrease goblet cell hyperplasia.78	vitro	the spirometric examination	nonsurgical weight loss	other cancers	environment	Several large studies	expensive clinical manifestation	progress	the eosinophil	hairdressers	pollens	An OVA-induced allergic airway disease model	ischaemic heart disease	prior lobectomy	allergen presence	an attack	long-term prospective microbiological	the expression	vehicle air pollution	primary prevention	an overall decreased risk	other underlying conditions	an index condition	a portable stadiometer	a physician-diagnosis	conventional guideline-based anti-inflammatory treatments	other aspects	Meyers	a limited number	the aetiology	some degree	systematic review	long-term conditions	mixed bronchitis/emphysema	jtamaoki	severe asthma	7-year-olds	the remodeling changes	corticosteroid responsiveness	respiratory issues	pre-existing respiratory diseases	asthma triggers	responsiveness	oral corticosteroids	different phenotypes	a subgroup	other known causes	mild-to-moderate obesity	a person	other potential risk factors	a large group	a particular symptomatology	childhood asthma	Obesity	a formaldehyde-induced model	–1026	consistent history	separate cases	a clear diagnosis	current history	O	the occurrence	nonobese adults	a nonselective phosphodiesterase inhibitor	regards	inhaled steroids	specific subtypes	genetic heterogeneity	poor asthma control	an episodic form	an important mediator	venous obstruction	immunizations	pulmonary rehabilitation	important features	Death	the study populations	self management	colonization	ibuprofen	increased prevalence	controller	control animals	recent onset	a murine model	The allergic mouse model	healthy adults	Histories	Early treatment	Secondary outcomes	decision support	inhaled corticotherapy	induces goblet cell hyperplasia	a study	side effects	these small studies	a nasal allergy	bronchospastic disease	the induction	the treatment guidelines	hyperreactivity	salbutamol prescriptions	yes/no	The heterogeneity	the people	mechanism	The risk	proxies	a deficient production	boys	healthy individuals	the late phase reaction	inflammatory pulmonary diseases	The burden	gastro-oesophageal reflux	increased infiltration	syncytial virus bronchiolitis	the development mechanisms	the never-smoker patients	7777120-induced amelioration	% confidence intervals	increased frequency	active females	school health departments	acceptability	other lung diseases	other lung conditions	susceptibility	certain collateral subjects	p=0.37	rodent model	chronic bronchitis.11	mobile devices	control populations	clinical asthma	the proteome	function growth	–422	a chronic inflammatory infiltrate consisting	that incidence	parity	indicators	The hallmarks	perforin production	food allergy	section	aspirin	a significant smoking history	primary care practitioners	non-atopic subjects	the expected waiting time	questionnaire	the baby	sites	a defective innate immunity	some asthma patients	follow-up studies	the care	antiresorptive therapies	agreement	professional obligations	seasonal allergies	adolescent	additive effects	severe outcomes	the epidemic aspects	several population studies	the view	CXCL5-dependent mechanisms	the pathology	prevent occurrence	a long-acting bronchodilator	pulmonary function parameters	a vast impact	pathological similarities	license.The prevalence	intensive care support	recent decades mortality	the subjects	no unifying explanation	house dust mite hypersensitivity	symptom characteristic	several potential applications	aromatic hydrocarbons	asthma attacks	burden	phenotypic classification	liver cirrhosis	mellitus	specific clinical areas	the term	the adipokine	recent medical therapy	pulmonary conditions	long-standing disease	vitro release	recent studies	pneumoniae infections	a small frontal sinus access	various etiologic diagnoses	other respiratory diseases	experimental evidence	control	long-term studies	record linkage study	morphology	concurrent diagnoses	respiratory viral infection	Current evidence	% confidence interval	metabolic alkalosis	child obesity	The adult incidence	viral bronchiolitis	radiological features	thickening	the subject	s-ECP levels	adolescent twins	the exact abnormality	irritable bowel syndrome	an underlying diagnosis	different genetic correlations	the concept	outcome measures	Recent research	Evidence	pollen allergy	—and/or	the significant improvement	knowledge	Longitudinal studies	wheezy bronchitis	a combined pool	chronic cough syndrome	the cause	the overlap syndrome group	Cardiovascular disease	genetic effects	extra-fine	severe acute exacerbation	steps	spp	dyspnea descriptors	severe cases	high numbers	asthma treatment	severity risk	a giant bulla	these associations	long-term treatment	The relation	another obstructive disease	Similar results	overweight/obesity	all severities	sex hormones	murine models	receptors	plant-based aeroallergens	:743 –8	estrogens	a bronchodilator	7-9 ]	woman	any place	certain phenotypes	whereas industrial air pollution	coexist	The chitinase	children41	this statement	this test	obstructive lung disease	regardless	this figure	different inflammatory subtypes	suspected cases	future medical costs	non-affected family members	standard treatment	altered pulmonary function	neutrophilic chemokines	sheets	few similarities	non-smokers	both health	off-season	No association	The total cost	severe polyposis	hay	a significant determinant	oxygen radicals	paracetamol exposure	maternal allergic rhinitis	community residents	the current conceptual framework	flare ups	the recent past	a clinical approach	any other significant respiratory diseases	each single pollutant	The socio-economic burden	the spring	treatable influenza-induced exacerbations	future asthma deaths	stimulate	prognosis differs	early warning signs	phase	perennial allergy	a significant burden	angina pectoris	longitudinal follow-up	phenotype	atopic symptoms	major chronic obstructive airway	a similar picture	steroid-treated severe exacerbations	previous studies	pathologic phenotype	inner-city children	Many “ triggers	positive associations	perennial allergic rhinitis	lung function consistent	The pathogeneses	model	The point prevalence	the phenotypic expression	bacterial infections	respiratory viruses	an important feature	nitric oxide measurements	The other atopic diseases	asthma-COPD overlap.2	the child	noninfectious self	a significant trigger	Primary non-asthma diagnoses	second-hand smoke	gastric ulceration	immune response mechanism	homozygous parents	obstructive sleep apnea syndrome	history	computed tomography-assessed emphysema phenotypes	rhinitis.78	Churg-Strauss syndrome	other airways disease	asthma-COPD overlap	remodeling	other common inflammatory diseases	co-exist	This hallmark feature	centrilobular	cytokines	a unique clinical phenotype	instance	first attack	oral prednisone	many diseases	Cases	pesistence	Danish children	pollution	Flood-Page et	former smokers	a useful tool	lipopolysacharide	other respiratory	low sensitivity	other chronic lung diseases	the Dutch hypothesis	aggravate symptoms	promising	new immunological mechanisms	the airway	the day	the pathobiology	sleep apnea syndrome	particular adult onset asthma	atopic disorders	viral infection	common environmental pollution diseases	those children	potent bronchoconstrictive	asthma exacerbations	wide-spread use	respiratory allergies	illnesses	inflammatory airway diseases	a genetic linkage	underlying health conditions	active smoking	different disease mechanisms	particular	asthma symptoms	pulmonary resection	allergic sensitisation	difficult-to-treat patients	emphysematous destruction	alternative activation	The current management	infectious diseases	prenatal tobacco smoke exposure	high blood pressure	these mouse models	lung function impairment	rhinoconjunctivitis	Cumulative incidence	severe bronchiolitis	the associations	a key role	an atopia	a positive exercise test	a true cause-effect relationship	gene promoter	programming	respiratory diseases	the different sputum inflammatory profile	other mechanisms	an aetiological association	rhinitis comorbidity	the link	clinical allergy	respiratory comorbidity	comorbidities	a differential diagnosis	the challenge	albeit	the pattern	overlap phenotypes	obese adults	some evidence exists	only patients	strong positive epithelial cells	schoolchildren	The natural history	the initial management	the childhood risks	the average annual incidence	the past year	//dx.doi.org/10.1016/j.anl.2006.05.002	Sick building-associated diseases	neutrophil numbers	Asian ancestry	patients Patients	migration	occupational status	daily use	hospital admissions	chemotactic chemokines	pulmonary eosinophilia	psoriasis [	The production	other respiratory disease	post-bronchodilator pulmonary function	Vickers	inc.	reflux symptoms	inhalable pollutant exposure	the variable nature	criteria	the obstructive airway physiology characteristic	allergic disease	the numbers	endothelin	Pharmacological treatment	aspirin hypersensitivity	a systematic review	The clinical manifestation	a distinctive feature	work-exacerbated asthma	overlap syndrome groups	ex-smokers	sGAW	pathologic feature	classical respiratory symptoms suggestive	major outbreak	%	a role	clinical implications	confirmation	concomitant chronic obstructive pulmonary disease	a 13-year-old girl	the Foxp3-dependent developmental program	Classical twin model	upper gastrointestinal bleeding	the mechanistic underpinnings	The clinical differentiation	chronic obstructive airways disease	Differences	the anti-inflammatory effect	specific test	single doses	eligible patients	differentiation	bariatric surgery	seroatopy	an influence	female population	diseases.6–8	β-defensin-1 protein	nasal polyps	a new dyspnea measure	activation	maternal history	complex diseases	A diagnosis	the further differentiation	the global rise	non-respiratory hospitalized patients	these data	dairy farmers	Years	all-causes mortality	oral clefts	other innovative therapeutic concepts	distinct approaches	the excess risk	the toxic induction	neutrophils	a personalized therapy	The hypertonic saline	inhaled air	incipient asthma	A distinction	related airway disorders	virus-induced wheezing	the complete set	an asthma-related comorbidity	accelerated lung function decline	The cohort effect	each child	the individuals	industrialised world	overlap syndrome	outdoor air pollution	the clinical manifestations	that inflammation	hyper responsiveness	traffic-related air pollutants	influenza‐infected children	components	neutrophil elastase	major vascular procedures	an alternative path	acute hypercapnia	epithelial cells	a retrospective cohort study	nasal polypectomy	other traits	comorbid	child	the awareness	the national population	transient ischemic attack	a deficiency	Bronchodilators	no new patients	validation	atopic eczema	tobacco	Other forms	epidemics	small bronchiolar-alveolar airways	increases	the possible subsequent development	the respiratory response	≥2 oral corticosteroid	adult-onset asthma	eels	ethnic origin	the null results	the relevance	arthritis	The treatment	an observed reduced risk	a similar disease	the following criteria	high school	This research	treadmill	resides	empirical considerations	mutations	the inflammatory processes	s diagnosis	pulmonary function testing	sulfonamides	nonasthmatics	diagnosis	increased production	triggers	eosinophils	models	Previous experience	Family-based association analysis	nonpneumococcal infections	chronic non respiratory conditions	diet reduces risk	the human disease	commentaries	chronic pulmonary diseases	theophylline withdrawal	disparities	chronic suppurative respiratory infection	airway epithelium.13 Patients	status asthmaticus	a new drug target	co-twin	chronic respiratory conditions	an eosinophil count	radiologic features	medicine notwithstanding	general population sample	familial hyperlipidemia	the differential diagnosis	such treatment	great importance	lung cancer risk	asthma–COPD overlap	asthma.10	negative health consequences	socioeconomic status	acute respiratory inflammation	other pulmonary diseases	the other atopic diseases	the national average incidence	a formal diagnosis	in-hospital systemic corticosteroid use	polymorphisms	van der	a specific disease	these biomarkers	reduced post-bronchodilator	a reasonable definition	nocturnal symptoms	genome-wide linkage studies	a positive bronchodilator	general practice	allergen-specific immunotherapy	joint task force	the known heterogeneity	outbreaks	allergic rhinoconjunctivitis	a possible mechanism	impact	sensory responses	many years	active drugs	These immunological differences	disease immunopathophysiology	the increased prevalence	leukocyte recruitment	multiple cells	A lengthy history	limited quantitative evidence	a continued increase worldwide7	p40	inflammatory pathways	a previous history	the humid air	‘ new-onset ’ asthma	obstructive airways diseases	any official definition	mannitol challenge	the point prevalence	influenza infection	previous history	All respiratory diseases	subsequent recurrent wheezing	specific treatments	prospective epidemiologic studies	These hallmarks	Swyer-James syndrome	disease development	nitric oxide	extensive nationwide questionnaire surveys	the control	health impairments	clinical features	thirty-seven patients	action plans	chest physicians/american college	house dust mite	a significant predictor	an accurate diagnosis	the inhibitory effects	ultrafine particles	other chronic respiratory symptoms	underdiagnosis	all cases	steroid-naïve asthma	Women	Individuals	LLN-defined cohorts	the opportunity	the genetic variation	aureusHaemophilus influenzaeAsthma Patients	preclinical animal models	chronic lung inflammatory states	variable severity	E181-190	rhinitis	The relationship	guidelines,17	breath condensate	subsequent asthma	a prospective-retrospective hypothesis-driven analysis	acts	a misclassification rate	reunification	preventive medication	this model	employment	other hypersensitivity disorders	immune compromise	a long-term increased susceptibility	a clinical diagnosis	therapeutic issues	significant bronchiectasis	inflamatory mediators	a modified e-Dephi consensus study	other noncommunicable diseases	adult	–2196	:1189 –95	asthma action plan	an inducer	environmental factors	asthma severity	no relationship	the north	several risk factors	any obvious record	increased risks	delayed phase	the status	mite sensitivity	the disproportionate spread	virus-induced asthma exacerbation	severe clinical outcomes	hallmarks	stabilisation	hypothesis ”	chi-square P-values	airway hyperresponsiveness	the first attack	steroid-dependent asthmatic patients	the environment	other respiratory illnesses	pulmonologist	genetic diseases	The childhood origins	the epigenetic aspects	airway diseases	the overall symptomatic severity	persistent asthma symptoms	the expression pattern	eosinophilic phenotype	the trachea	physiological testing techniques	healthy airway microbiota	prompt appropriate treatment	determinants	this child	health education activities	routine practice	a neutrophilic phenotype	overdiagnosis	outpatient	the major sequelae	feG	aHR	hypothesis	the study physician	substantial number	over-expression	humid climates	long observation period	EBC analysis	both main effects	the promotor	the absence	respiratory problems	argue	mother	arrest	The assessment	improved clinical relevance	the trait	–202	antigen-induced eosinophilia	similar symptoms	myocardial infarct	chronic proinflammatory diseases	antigen-induced airway inflammation	the observed association	poor control	some patients	the epidemiology	early adulthood [	physiology characteristic	The work impact	the connective tissue alterations	psychiatric disorders.7,15	necrosis factor	different results	misclassification	ventilation maldistribution	the identified susceptibility loci	the subgroup	http	The global burden	nonatopic subjects	self-reported diagnosis	asthma-COPD overlap syndrome	specific serum	lung functions	age group.70 Patients	the illnesses	children2526	inhaler	high specificity	linear regression	other atopic diseases	easy-spreading viral infections	students	heavy exercise	notions	oxidative stress genes	coexistent atopic dermatitis	clinical phenotyping	the hospitalisation/emergency room visit	long-term daily high-doses	an airway disorder	the similarity	both duration	pneumonia and/or influenza	diagnoses	the history	insufficient data	thunderstorms	the modern disease	severe impairment	macrolide therapy	intermittent asthma	reflux	obliterative bronchiolitis	baseline	the systemic inflammatory effects	the high expression levels	the normal range	ambient air pollution	the airway reactivity	These qualities	the inclusion	pool attendance	childhood overweight	indoor environmental risk factors	therapeutic purposes	Subcommittee	additional inflammatory cells	guidelines,12	congenital heart disease	smokers	ovalbumin-induced murine model	myocardial infarction	individuals	the controllability	symptomatic sample	The pathology	awareness	Bergqvist	parents	intermediate asthma phenotypes	a potential risk	obstructive lesions	inflammatory bowel disease.74,101	sample frame	infectious exacerbations	rhino sinusitis	the type	the physiologic response	The international study	atopic diseases	evidence-based asthma interventions	certain outcomes	the early pathogenesis	’ wider views	nocturnal gastroesophageal reflux associates	the consequent research implications	the natural course	precipitants	the various infections	these subjects	estimates	the coexistence	bronchial epithelial damage	A recent study	recognise symptoms	allergic airway inflammation	asthma-COPD overlap syndrome21	practices	These analyses	overlap	obstructive diseases	biological considerations	The pharmacological treatment	radiologists	affect occurrence	emergency healthcare use	the theory	urticaria	allergic rhinitis report symptoms	inflammatory lung disease	undergoing treatment	pneumoniae	a predominance	both percentages	tissue samples	common factors	the great arteries	increased inflammation	the costs	remission	a multidimensional perspective	patient-specific feedback	asthma-related symptoms	epithelial cell genes	cigarette smoke exposure	fumigatus induces	inflammatory pathway	a possible association	category	subjects	lymphocytes	the common international asthma treatment guidelines	several polymorphisms	discordance	the other hand	μg/m3 increase	the lung microbiome	adults	allergic rhinitis patients	clinical severity	:1013 –19	respiratory diagnoses	chronic conditions	an increased sensitivity	repeated measurements	overall mortality	allergic rhinitis.40	variability	features	real life	any history	load	twin pairs	maximal effects	analgesic intolerance	early childhood development	the initial onset	climatologic	important issues	the common problems	asthma control status	night awakenings	exaacerbations	odds ratios	acute pulmonary inflammation	the high rate	regression analysis	therapies	renal cancer	disease controls	half	chronic pulmonary	the single nucleotide polymorphism	The coexistence	//www.maths-in-medicine.org/uk/2011/asthma/report.pdf http	post-bronchiolitis wheezing	papers	Athens	a vagal reflex	plots	an elevated level	the burden	asthma versus patients	The extracellular water movement	chronic sinusitis	the hospitalization rate	industrialized countries	normal polyposis	The observation	a childhood diagnosis	metabolic diseases	therapy—novel treatments	modulation	future studies	service use	a palliative treatment	odds ratio	the cardinal features	the observed associations	alert	the total incremental cost	high body mass index	traditional markers	urban adolescents	aOR	humidity	fungal sensitization	.52–54	disease management	The underdiagnosis	emergency departments	murine model	nonatopic forms	the characteristics	other obstructive airway	unrecognized impact	sinonasal inflammation	reflux disease	rightful use	an overlap phenotype	inflammatory features	prolonged steroid treatment	-γ	comorbid condition	an influx	immunopathology	an association	the pathophysiological features	a diagnosis	the immunological features	airway inflammation	a direct cause	a Feasible Tool	histopathologic outcome	non-shared environmental effects	Anticholinergic agents	no diagnosis	allergic sensitization	smooth muscle cells	the major causative agent	functional abnormalities	baseline control	swimming pool attendance	clinical course	acute effects	asthmatic symptoms	the aim	undertreatment	other significant respiratory conditions	cardiac ischemia	previous study	heart disease	this distinction	a rash	pneumonia aspiration	the global burden	respiratory disorders	a small number	diagnose	clinically-relevant characteristics	The swimming issue	demographics	The overlap syndrome	the responses	the complexities	non-Hispanic white subjects	some pathological characteristics	the chronic nature	cross-sectional surveys	structural changes	hospital use	an animal model	the overall results	the steroid dosage	a risk factor	the ninth leading cause	contrast serum	allergic disorders	particular severe asthma	al27	no familiar history	the difficulty	a strong predictor	an inflammatory biomarker	an exacerbation	cytokine profiles	the sponsor	gastroesophageal reflux	History	Caucasian children	variation	postnasal drip syndrome	cross-sectional population studies	brain tumor	% –61 %	explanatory variables	The clinical hallmark	lung cancer	Hypertension	other chronic inflammatory diseases	alcohol use	both components	inappropriate treatment	major subphenotypes	the complexity	A two-week trial	committee	neutrophilic inflammation	recurrent wheeze	adjustment	these cells	increased severity	a typical history	cancer	Exacerbations	obstructive sleep apnoea	the different subtypes	the throat	the physician-based diagnosis	a maternal history	human immunodeficiency syndrome	aggressive management	analysis	the same degree	0-62y	An improved murine model	Danish adult twins	the hallmark	several features	comorbidity	research questions	the deterioration	reliever therapy	Obese individuals	mass population movement	The estimated total cost	The sensitization	neurological disorders	chronic respiratory indications	airway narrowing	vasculitis	the various diagnostic tests	the multiple logistic regression modela	short-term exposure	new-onset allergy	the picture	diving	climate change	ear infections	immunological phenotypes	basic definition	allergy susceptibility	seasonal factors	the underlying mechanisms	acute bronchitis	a primary cause	a respirator	breathlessness	post-extubation respiratory failure	vascularization	adult onset	peripheral blood eosinophilia	similar problems	a genetic correlation	subsequent death	Cardiovascular diseaseb	note	adenosine	cough receptors	bronchoconstriction	the incidence rate	a confirmed diagnosis	upper airways diseases	obese children	Allergen-specific immunotherapy Patients	a random population	current cigarette smoking	eczema	during/after	The prevalence rate	modifications	the languages	infl ammation	release	initial diagnosis	coronavirus	https	a clinical follow-up study	allied diseases	uncontrolled asthma display	clinical management	a clinical history	the acute management	cited.Gastroesophageal reflux disease	codes	well-characterised Danish patients	habitual snoring	An early report	years	common conditions	the following diseases	upper respiratory disease	these inflammatory mechanisms	a proper management	a certain bronchodilator	acute inflammatory lung injury	irreversible asthma	several studies	some individuals	the respiratory comorbidities	adult asthma patients	obstructive lung diseases	further analysis	The neutrophilic inflammatory phenotype	a new dry-powder inhaler device	thunderstorm	the requirement	the economic costs	experimental observations	the pathological roles	positivity	out-patients	another strong predictor	probable occupational rhinoconjunctivitis	ine	the pathophysiological nature	no therapeutic approaches	etiologies	the adenosine	a classification	unnecessary therapy	spouses	health care costs	versus	normal subjects	the precipitation	this issue	fact	this possibility	health	mild persistent	distinct entities	neurological abnormalities	a network meta-analysis	many patients	Adenoviruses	certain chronic illnesses	the same patient	practice characteristics	both complex cyanotic congenital heart disease	suitable tool	census tract poverty level	Diagnosis	usual pharmacotherapy	inflammatory phenotypes	a group	ovalbumin	upper respiratory symptoms	lung disease	different pathophysiological derangements	major putative targets	disorders	childhood wheezy bronchitis	difficult control	epidemiology	gene	inflammatory diseases	All participants	attention deficit disorder	characteristics	female	the exception	chronic airway diseases	the different groups	prevalence rates	Semi-structured literature review	several drugs	researchers	other atopy-related conditions	-4	glucocorticoids	the heterogeneity	a past history	different doctors	co-morbidities	eventual pathogenesis	% risk	acute exacerbations	vegetable intakes	a cross-sectional nation-wide study	*	red triangles	the lung	phenotypes	a thunderstorm	relevant structural nasal abnormalities	subsequent development	the innate	a risk	the airway inflammation	the primary manifestations	upper airway obstruction	cardiovascular disease	a specificity	intravenous administration	al.,45	this form	objective evidence	high-performance athletes	a loss	a prior diagnosis	rye grass pollen	s study	diseases	a selection factor	range	the above data	myocardial disorders	permission	disparate strategies	bronchodilator responsiveness	an OVA-induced Th2-driven mouse model	The microbiome	pulmonary inflammation	that study	later development	life-threatening pneumonia	the chronic treatment	immunosuppression	
0101-restricted immunodominant	wedge biopsy samples	subsequent axonopathy	cross hyporesponsiveness	deceased donors	chronic hepatitis,44,45	liver tissue	’ hyperthyroidism	neonatal lupus	chemotactic protein-1	antimicrobial choice	biliary atresia	anti-dsDNA antibodies	progressive systemic sclerosis	concurrent disorders	cirrhosis	transforming growth factor-β	beta-glucuronidase activity	α1 antitrypsine deficiency	autoimmune diseases/autoimmune hepatitis	autoimmune hepatitis	alcoholic liver	liver-toxicity	systemic sclerosis	interlobular bile ducts	
clonazepam	diphenylhydantoin	this rare side effect	encephalomalacia	a new antiseizure medication	cortical dysplasia	elaborate investigations	neurology recommendations	vigabatrin	
inhibitor	selective non-steroidal anti-inflammatory drugs	selective COX-2 inhibitors	meloxicam	central sensitisation	heat-evoked hyperalgesia	
onion	a day	the adult rodent brain	high consumption	alcohol intake	coffee	the avoidance	haloperidol	any effects	stimulant effects	a known vasodilator	the highlighted recommendation	black tea	sham animals	antiemetics	the therapeutic benefits	nonsteroidal anti-inflammatory drugs	glutamate receptor-5 antagonists	antacid	analgesic intake	flu- narizine	a short-acting barbiturate	propyphenazone	calcium channel blockers	the monotherapies	an adenosine receptor antagonist	exercise less.137,138	undisclosed drinking	physiological levels	cortical neurons	phenazone	Actions	theobromine	respiratory drive	a consumption	varied caffeine dosage	the stimulating effects	precocious pepsinogen synthesis	olfactory hallucinations	fetal bovine serum	adenosine antagonist	contracture-associated enzyme release	any beneficial effects	curcumin	continuous outcomes Biometrics	A benefit-risk assessment	any alcohol	sterile saline	the primary metabolites	cola	Smokers	Strenuous exercise	low-sodium diet	robust evidence	caffeine metabolites	mg/ kg	cortical cell cultures	other agents	ventricular balloon	phenacetin	many abortive headache treatments	physiological correlates	a different sensitivity	the neuroprotective role	The analgesic effects	the possible neuroprotective role	all single substances	sham saline	other therapeutic agents	sham vehicle	continued use	theo- phylline	oral sumatriptan	methacin	no stimulatory effects	The elimination	alcohol abstinence	bedtime doses	NSM patients	reply	dextroamphetamine	other xanthine derivatives	combination therapies	beetroot	The pharmacology	procaine	the ingestion	almotriptan	multiple injections	cycloheximide	the double combination	the prolonged vasoconstrictor effect	the tests	that prochlorperazine	the above remarks	a low intake	the disposition	a therapeutic role	mg tablets	butalbital	the pharmacokinetics	progesterone	rapid removal	rat pups	theophylline	flunarizine	the medulla	the triple combination	a non-specific adenosine receptor antagonist	magnesium lithospermate	alcohol	dihydroergotamine	fluid-intake	The combination drugs	pro- chlorperazine	anoxia	tartrate	saturable carrier-mediated transport mechanism	energetic beverages	atomoxetine	40-60 mg tablet	Protective effects	the therapeutic benefit	butalbital combination	the apoptogenicity	revert hyperalgesia	an overnight fast	alcohol-containing beverages	depress respiration	deleterious effects	appropriate liquid	pelvic floor exercises	the specific stim- ulatory effects	ergots	A lumbar blood patch	phenazon	prochlorperazine	ergotamine	xanthines	antagonism	Cells	other substances	smoking cigarette	The neuroprotective effects	the neonatal brain	the acetic acid injection	Temporal abstinence	a low-to-moderate amount	sham [	past history	the calcium paradox	sham comparison	a previous spinal surgery	the intake	the neuroprotective effects	Combination analgesics	azilsartan	combina- tion	overhydration	knock-out mice	the last case verapamil	
nocturnal cough	jugular venous pressure	pedal edema	peripheral embolism	leg edema	flow limitation	paroxysmal dyspnea	abdominal volume enlargement	paroxistic nocturnal dyspnea	pulmonary rales	abdominal volume	progressive dyspnoea	bilateral phrenic nerve involvement	effort dyspnea	contusion	Paroxysmal nocturnal dyspnea	multivariable analysis	acute pulmonary edema	minimum exertion	a 5-day history	paroxysmal nocturnal dyspnea	the injury score	acute onset dyspnea	intermittent occipital headache	
memory	the chance	mild dysarthria	obvious clinical signs	reversion	mild dementia subjects	The neuropathological profile	vascular	the amnestic variant	neuropsychiatric symptoms	PiB-positive healthy controls	amyloid-positive healthy controls	Incidence	normal cognition	s disease	accuracy	Evolution	blood–brain barrier	ribosomes	An epidemiologic study	subjective cognitive impairment	amyloid-positive subjects	a simple algorithm	mild CD	PiB-positive patients	a resting-state fMRI study	exercise-induced response	thinking	an intermediate stage	substrate	disease Neuroimage	Regions	clinical subtypes	The study	soluble intercellular adhesion molecule	preclinical stages	a transition state	top-down attentional control	basic protein	mild dementia	cohort study	doi:10.1159/000112509	:321–8	early dementia	Extracted measures	non-demented elderly subjects	A diffusion tensor	interleukin	disease brain	a controversial diagnostic category	cognitive deficits	neuroimaging correlates	Further caution	neurodegenerative disease	other predementia syndromes	amyloid-positive patients	Telephone-based identification	cognitive impairment	the posterior cingulate cortex/precuneus	A new instrument	The concept	emotional problems	subgroups	gustatory	dos	subjective memory complaint	vascular cognitive impairment harmonization standards	vascular dementia	cognitive impairment Neuroimage	tensor tractography reveals	sec	posttraumatic stress disorder	a particular disease	elderly individuals	disease dementia patients	a dice coefficient	entorhinal cortex	healthy elderly controls	the pathologic origins	a proinflammatory cytokine	clients	common cognitive deficit	battery	” suggestive	a high-risk population	that group	s disease patients	early AD	tensor‐based morphometry	intracranial stenosis	subtypes	PiB-positive subjects	medical researchers	normal aged patients	healthy at-risk people	age-matched controls	executive dysfunction	Tel	blood micronutrient risk profiles	posterior cingulate cortex/precuneus regions	amnesic patients	event-related power spectrum	clinical utility	nicotinic receptor	epsilon4 carriers	high standard deviation	Conversion	vascular disease	repetition	post-traumatic disorder	the sampling	cyclooxygenase	the primary diagnoses	a longitudinal study	inclusion	white matter volume changes	the standard deviations	data points	twenty-two consecutive patients	brain pathology	comparisons	subjective sleep markers	PiB-negative healthy controls	standardized neuropsychological indices	tumor necrosis factor	measurable deficit	matrix metalloproteinase-9	receiver operating	the hope	dementia	an evidence-based review	pathologies	
the lesions	partial obliteration	diabetic kidney disease	glomerulonephritis	membranous nephropathy [	cited.Chronic glomerulonephritis	–48	focal glomerulosclerosis	proliferative forms	histological pattern	striatal cholinergic interneurons	electron micrographs	proteinuria	
the inflammatory markers	All information	hospitalized children	implication	bronchiolitis	viral bronchitis	Non-neutropenic infection	pneumococcal pneumonia	mixed bacterial infection	interleukin-6	several weeks	emergency room visits	atypical bacterial	cyanosis	acute bronchiolitis	neutropenia	a Neutropenic infection	classical bacterial	

inspired oxygen concentration	the methodology	severe bilateral bronchial stenosis	long-term prognosis	the odds	cardiopulmonary arrest	respiratory effects	noninvasive mechanical ventilation	acute exacerbation	urethral trauma	acute pulmonary congestion	common form	the treatment	treatment	ReportSuccessful management	longer-term support	a patient	moisture exchangers	other forms	survival	exacerbations	hypoxemic respiratory failure	HIV-negative patients	the total face mask	ill subjects	the humidification device	multi-lobar pneumonia	hypocalcemia	gastroenteritis	people	The evidence	endotracheal intubation	admission	pulmonary disease	intensive care unit patients	the same benefits	histiocytic hemophagocytosis	acute coronary infarction	interstitial lung disease	The adjusted odds	the roles	mechanical ventilation	neuromuscular origin	p interaction=0.07	immediate survival	diffuse lung infiltration	90-day mortality	the development	other pulmonary insufficiency	presentation	Influence	online supplementary table	definition	oxygen delivery	impaired consciousness	home	a ventilatory support system	the definition	odds	heart failure	hypoxic	acute coronary syndromes	severe cardiogenic pulmonary edema	n=381	mortality	the main components	severe sepsis	the role	renal failure	≤10 ng/mL	the mortality rate	the effect size	fatal arrhythmias	inflenaza	these preterm lambs	jirovesi	multivariate analysis	the complications	a high dose	Agency	mask	vitamin	sistress syndrome	adjusted odds	the standard	Primary outcome Preadmission	alveolar haemorrhage	unstable patients	a rule	the heart	.1	influenza	complications	a literature review	cohort patients	no other specific cause	recovery	home care	natriuretic peptides levels	multiple diseases	acute congestive heart failure	randomized	the management	Type	an ovine model	failure	a prognostic tool	German patients	severe hypoxemia	the aHR	smoking habits	univariate analysis	a national survey	granulomatosis	persistent disease	different diseases	all causes	Transfusion	a fatal case	ventilated hematologic patients	a new full face mask	cent	p=0.011	specific protocols	ventilated patients	jmasip	the respiratory	severe acute exacerbations	outcome	nasal necrosis	≥30	count	pulmonary infiltrates	major causes	no report	other causes	significant predictors	a young adult	Insights	initial treatment	The epidemiology	Admission	bilateral bronchial stenosis	physiological track-and-trigger warning systems	the age	significant interaction term	respiratory conditions	different populations	leading causes	p=0.009	right-sided heart function	non-invasive ventilation	covariates	Yes	the main modalities	critical care patients	adaptive pressure control	**	efficacy	dr_gabrielmoreno	The utility	positive pressure ventilation	parallel-group study	the admission	various causes	all forms	anasarca	mechanical ventilator support	another study	intensive care unit	dengue shock syndrome	critical care outcomes	randomization	noninvasive ventilation	anoxic encephalopathy	kyphoscoliosis patients	complication	diffuse lung infiltrates	risks	positive-pressure ventilation	severe chronic obstructive lung disease	Non-invasive ventilation	the measured incidence	progressive complications	systematic prone positioning	Management	a complete resolution	The odds	alternative mechanisms	noninvasive positive pressure ventilation	the limitation	acute renal	muscular dystrophy	transbronchial application	the medical management	an assessment	a serious change	endothelial nitric oxide synthase	

halazepam	nitrazepam	diazepam	


the stones	particulate matter	zinc	the trace metal	airborne nickel	altered buccal cell	selenium	% solution	stones	nickel	titanium	55010.1186/s12931-017-0550-9ResearchShort-term exposure	the current study	
some preexisting hallucinations	hys- teria	psy- chasthenia	hysteria	an individual ’ s	promise	psychotic depression	masculinity-femininity	delusion	
interim removable partial denture	informent consent	social histories	

muscle pain	nails	xerosis	frequent urination	lichenification	dry hair	paresthesias	URL	pruritic excoriations	sclerodactyly	treatment-related rash	acneiform	foot	lips	brittle hair	the drug	fragile	hyperkeratosis	callus	a Herculean look	afferent pupillary defect	
mg/ml stock solution	leukemia cell lines	the inhibitory effect	intracortical administration	neointimal proliferation	the plausible candidates	mechanistic target	bevasiranib	both inhibitors	the phosphatidylinositide 3-kinase/AKT/mammalian target	the leukemia cells	VEGF-suppressive effects	brain-derived neurotrophic factor-induced mammalian target	The molecular target	Mammalian target	IGF-1R inhibitors	a kinase upstream	dimethyl sulphoxide	catalytic-α	–428	/AKT/mammalian target	cell culture	renal benefit	serine/threonine kinase	absolute ethanol	mTOR inhibitor	a SH2 domain-containing phospatase-2/phosphatidylinositol 3-kinase/mammalian target	new macrolides	this relocalization	a specific kinase inhibitor	heart-transplant recipients	mice injection	the phosphoinositide 3-kinase-Akt-mammalian target	non-small cell lung cancer	mTOR1mechanistic target	The mammalian target	mammalian target	mg/kg/da	cyclosporine	vascular/metabolic neuroimaging	whereas mTORC2	combination treatment	skin cancer	intravesical treatment	mTOR inhibitors	nM	whereas treatment	a novel oral derivative	cascade inhibitor	the animal	viral oncogene/mammalian target	metabolic deficits	immunosuppressants	poor survival	catalytic subunit alpha	the fungus	metformin	mTORC1	subependymal giant cell astrocytoma	/mammalian target	either wortmannin	cure	the time points	macrolides	hypoxia-inducible factor-1alpha	kinase/mammalian target	the target	phosphorylated mammalian target	neurometabolic functions	oxidoreductase chain	early events	mTOR	mofetil	SP-A mRNA levels	the animals	cell development	autophagy	= mammalian target	docetaxel	particular starvation	reduced calcineurin inhibitor dose	starvation	B-ALL leukemogenesis	nutrient depletion	protein tyrosine kinase	wortmannin	lymphangiogenesis	the mammalian target	tacrolimus	an anti–IGF-1R mAb	leukocyte infdtration	an immunosuppressant agent	humans.40–42	a mammalian target	treatment group	kinase activation	the immunosuppressant	analogs	a new immunosuppressive drug	preventive administration	an inhibitor	preventive group	rapalogues	pathways	μM	the mechanistic target	mTORC2	mTOR inhibition	an mTOR inhibitor	feedback activation	
internal iliac	external iliac	the external iliac	
low specific humidity	high flow	exothermic peak	periods	the protective effects	layer	Combinations	

cardiac	childbirth	oncology/haematology	similar procedures	professor	psychiatry	major noncardiac vascular	general medicine	vascular surgery	gynecological outpatient departments	the clinics	the internal medicine	major non-cardiac vascular	aortocoronary vein grafts	
metabolic factors	nutritional status/dietary habits	mansoni	Helminthic infestations	parasitic infections	protection	
new onset diplopia	
sertindole	risperidone	thioridazine	dimethylsulfoxide	mirtazapine	some evidence	phenothiazines	
a form	the intrapulmonary spread	human leukocyte interferon	importance	malignant transformation	primer set	respiratory papillomatosis	response	papillomatous growth	Respiratory papillomatosis	a review	manifestation	

the frequent use	humeral head	fork	
Usual level	bed	that chondrolabral damage	a peri-prosthetic mass	-0.02	transport	dynamic mechanical causes	femoro-acetabular impingement	stiffness	postural education	exertional dyspnea	back	the mechanical causes	degenerative arthritis	symptomatic labral tears	low-back	associated deformities	recurrent labral tears	
serum calcium levels	increased medical costs	reality	ventilator-free days	The possible causes	the superior management approach	Chemokines	dementia becomes	bowel/bladder incontinence	sedation	gastrointestinal hyper-excitability	the central features	Environmental manipulation	Benzodiazepines	open cardiac surgery	reduced attention	multiple adverse outcomes	common subtype	cognitive tasks	adult cases	psychiatric complications	opinions	the early identification	cardinal features	various etiologies	Clinical subtypes	subsyndromal delirium	bed shortage	definitive treatment	delusional disorders	intensive care units	cognitive impairment cause	the long-term consequences	Typical symptoms	persecution	the hyperactive form	another clinical feature	persistent hallucinations	vigilance	a single factor	the time interval	a possible relation	thought	Any delay	the underlying vulnerability	inattention occurs	related respiratory weaning	Prognosis	other clinical features	agitation	the first indicator	severe dementia	hip fractures	short-term consequences	a medical term	visual hallucinations	Revision	the high prevalence	hospital stay	pre-existing dementia	The symptoms	the above	benzodiazepine withdrawal	the cholinergic system	prolonged duration	confussion	previous admissions	p=0.01	the following diagnostic investigations	functional decline	psychiatric side effects	nosocomial infection	motoric subtype	und	a close clinical follow-up	this criticism	–346	an episode	these alterations fluctuate	–56	i.v	adequate analgesics	the disturbance	both required hospitalization	susceptible individuals	The causes	the hypoactive form	amnesia	absolute thrombocytopenia	medical inpatients	massive air embolism	several times	pre-existing frailty	analgesia	causative factors	a recent systematic review	Depression	Theneuroinflammatoryhypothesis	cerebral microembolic load	shorten hospital length	Clinical characteristics	this controversy	sleep deprivation	profound neuropsychosis	The withdrawal syndrome	–316	high-grade fever	dementia:175	The prognostic significance	subtle neurological effects	–349	postoperative pain	healthy 53-year-old male patient	prolonged mechanical ventilation	the fluctuating nature	a registered nurse	non-pharmacological interventions	A review	increased morbidity	the present time	multiple neurological findings	Factors	the under-recognition	oral mycosis	“ acute confusional state	severe depressive disorders	the intensive care unit	–948	’ recognition	Delirium	neurological complications	toxic-metabolic encephalopathy ”	the second comprises	routine	mania	Relationship	the poor prognosis	The misdiagnosis	reliable evaluation methods	certain clinical situations	the effective management	this classification	ventilator-associated pneumonia	the primary care level	these authors	blurred vision	specific diagnostic tests	sedation scales	another central feature	no specific evidence	pathophysiological mechanisms	strict criteria	Non-detection	drug toxicity	correctable contributing factors	A combination	p=0.03	optimal management	motor activity	spatial disorientation	disruptive behavior	adverse outcomes	Saunders	acute onset	acute kidney failure	aggressive behaviour	poor compliance	bipolar disorders	Consequences	itching	detection	the profound sense	postoperative neurological outcome	–303	neurological patients	dementia attention	independent risk factors	contact precautions	current evidence	motor neuron disease	concomitant neuropsychiatric disturbance	the whole syndrome	neuroscience patients	cognitive dysfunction	mental illness	hallucinations	all medications	increased rates	hypoactive subtypes	possible causes	hypoactive symptoms	severe hallucinations	advanced age	Phenomenological subtypes	neurocognitive decline	the hypothalamic-pituitary-adrenal axis	a true understanding	neurocognitive functions	behavioral problems	memory loss	speaking overlap	optic atrophy	Subsyndromal delirium	conservative treatment	the working diagnosis	sleep disorder	
the myofibers	scalp soreness	The mechanosensitivity	muscle swelling	wrist muscle	a feeling	full strength	the median nerve-territory	a moderate pressure	nerve trunks	crawling	
a humanized anti-human interleukin-5 antibody	old female	
left face	erythema	subjective obstruction	tramadol pain	sinus infection	various neurological symptoms	immediate onset	diminished sensation	warmth	the elbows	paraesthesias	intermittent claudication	sudden weakness	hands	video-endoscopy	transient neurological deficits	a new weakness	paresthesia	hyperalgesia	trapezius atrophy	the palmar aspect	vision	thigh	dizzy	radicular leg pain	a hemiparesis	ankle dorsiflexion	left thigh	left hipthigh	visual impairment	face pain	feet	difficulty ambulating	vision loss	triptan use	tingling	both distal extremities	muscle tension	tightness exercise	the weakness	the face	allodynia	extremity	the palate	bilateral leg muscle weakness	the shaking extremity	the left hand	coldness	lateral leg	imbalance	the infusion	sensations	neurological deficits	skin reaction	both leg weakness	visual distur- bances	abnormal sensations	extremities	a one-hour episode	sensory loss	visual disturbances	left half	some dysesthesiae	right side	posterior nasal packing	both hands	Temporary buccal swellings	hypoaesthesia	A sensation	heaviness	burning	trauma-induced upper extremity pain	neurosurgical department	pain radiating	transient dysphasia and/or dysarthria	
preoperative radiotherapy	the local recurrence rate	a clear circumferential radial margin	
a previous obstetric history	para	the birth canal	ectopic pregnancy	prenatal diagnosis	
active compounds	icariin	
gastric bypass	gastrointestinal adverse effects	
cortical blindness	immunosuppressive drugs	reversible encephalopathy syndrome	Reversible cerebral arteriopathy	nitrate measurement	hypertensive encephalopathy	postpartum angiopathy	Etiologies	the dysregulation	oral therapy	pre-eclampsia	severe headache	low platelet count	preeclampsia	post-partum	renal dysfunction	cerebral venous sinus thrombosis	placental growth factors	all generalized seizures	an ICHD-II diagnosis	renal disease	The hypertension	placental abruption	sickle cell disease	nonpregnant hypertensive encephalopathy	gestation	uncontrolled hypertension	the subacute	outcome assessment	cvt	fluid retention	severe refractory hypertension	autoimmune disease	pres	
kneading	acetabular component	the elements	the modular junction	flexion	chemical inertness	a low coefficient	metabolic reactions respiration	catheter navigation	tortuous vessels	The nerve	lubrication	wear	petrissage	energy losses	


confusion	8-14 days	the proximal colon	encephalopathy	that malignant hypertension	life-threatening ketoacidosis	tremors	gastrointestinal manifestations	ankle oedema	endocrine dysfunction	diarrhoea	coma	pica	severe arterial hypertension	global neurological dysfunction	decreased locomotor activity	concentration	A 3-week history	severe weight loss	cardiac tamponade	metabolic acidosis	8-12 hr	stupor	hyperactivity	blunt affect	peripheral ankle oedema	convulsions	Clinical examination	insomnia	consciousness	1-week history	eye exudates	these clinical features	disorientation	somnolence	difficult feeding	irritability	bilateral inguinal lymphadenopathy	severe drooling	mental changes	inability	TLR9-D mice	a viral illness	mild confusion	sneezing	the inappropriate speech	visual field defects	incontinence	any treatment group	a 10-month-old boy	decreased appendicular sensory loss	experienced significant side effects	excessive weakness	the emergency department	severe hypertension	sub-diaphragmatic vagotomy	mental function	progressive dyspnea	hyperglycinemia	cerebral dysfunction.1,2	drowsiness	poor feeding	mental status change	diarrhea	acute change	constipation	sweats	stereotypes	high fever	brain stem	nasal	frenzy	sluggishness	green sputum	fatigue	Recurrent vomiting	vomiting	a hypertensive emergency	shortness	fluid overload	
internal medicine	some visited departments	teachers	specialists	Annals	many specialties	orthopaedic surgery	
intrinsic muscle paresis	upper arm level	
fistulae	

congenital anomaly	abnormali- ties	] infections	extraluminal spread	potential risk	curvature	pyloric antrum	iPSCs	both infection	plasma cells	specific myelodysplasia-related cytogenetic abnormalities	cardia	the suspicion	particular category	transitional cell	postoperative change	A search	fundus	active infection	and/or spread	embolism	:470	accidents	granuloma	active peptic ulcer disease	a focal vascular lesion	adult life	hernia	*C16.0	rheumatological disease.2	cerebral vascular accident	parenchymal diseases	all fields	inflammatory conditions	pylorus	pancreatitis	inflammatory processes	a misdiagnosis	exogenous hor- mone-induced headache	‘ cancer	adult-onset temporal lobe epilepsy	a high frequency	active demyelination	an organoid	expansive growth	Exogenous hormone-induced headache	leukemia/lymphoma	blastic natural killer cell leukemia/lymphoma	pancreatic panniculitis	stomach	the aorta	the urinary bladder	these patients	iatrogenic	T-lymphoblastic lymphoma	anaemia	
the perfusion	pulmonary arterial pressure	bronchodilator	inspiratory time	excellent inspiratory flow	milliseconds	esophageal pressure	Tidal volume	peak inspiratory pressure	Measurement	transmission	the equation	clinical improvement correlates	breathing	hemodynamic parameters	settings	the advantages	use application	pulmonary dynamic compliance	transpulmonary pressure	recruitment	both frequency	high pressure	the anomalous arch	elevated transpulmonary pressure	the mean inspiratory pressure	pressure	pressure transducers	this difference	


The hormone	thiazides	restoration	mean arterial pressure	dual phase protocols	central venous pressures	inversion therapy	a concomitant improvement	This effect	aquaresis	urinary citrate excretion	facilitation	vasoconstriction	hematocrit	the anion gap	vasodilation	normalizing blood pressure	specific membrane-bound receptors	uricosuria	this inhibitory effect	the neurohormone	limited inversion	volume contraction	vasodilatation	natriuresis	preserve	stone expulsion	the passage	poor oral intake	the possible use	a history suggestive	organ perfusion	diuretic therapy	different stages	forced hydration	hydration	ceftazidime	additional benefits	Circulation	adaptation	ml/kg/h	crystallization	renal function	renal perfusion	antibiotics	mechanical percussion	crystals	clinical experience	a nondiagnostic bronchoscopy	anti-inflammatory agents	renal electrolyte loss	rapid dyspnea relief	the urinary excretion	the adequacy	antagonist	potassium replacement calcitonin	inotropic therapy	percussion	intravascular volume status	rehydration	supplementary oxygen	

low cardiac output syndrome	pre-operative hs-cTnT concentrations	the sECC group	intraoperative desaturation	blood loss	The first post-operative day patients	


the studies	alcohol overlap	intramuscular injections	the compartment	subcutaneous injections	the antinociceptive action	cyclobenzaprine	halothane	average physiological variables	rCBF effects	paracetamol	rCBF changes	addictive drugs	Comparative opiate receptor affinities	the 25-μg fentanyl	piritramid	continuous infusion	im	the right hippocampus	both situations	withdrawal	hydromorphone	normal man	m.	a positive effect	a consistent increase	promethazine	any effect	remifentanil	tat	the additive effect	drastic side effects	synergistic antihyperalgesic effects	the combination	similar opiate drugs	drug consumption	potential clinical significance Pharmacogenetics	pharmacological postconditioning	morphine-6-glucuronide [	benzodiazepine	analgesic activity	clonidine	the plasma levels	ropivacaine	non-opioid analgesics	the beneficial effect	the plasma concentration	blood-brain barrier function	beneficial effect	alcohol effects	sufficient systemic doses	mg/kg s.c.	pharmacovigilance study	control rats	withdrawal programs	systemic administration	the antinocicep- tion	alcohol treatments	the appropriate use	the peak effects	a metabolite	placebo-controlled study	fentanyl	oxycodone	transfusion rate	dissociable effects	acetylmethadol	Regional effects	stable chronic obstructive pulmonary disease	a 20-mg dose	h. Animals	i.p	infusion	different effects	depends	mg	apomorphine	remifentanyl	sincere thanks	no effect	carbachol	strenuous exercises	opioid	MS-related neuropathic pain	well-described behavioral effects	thaliporphine	other strong opioids	an effect	oral morphine	mg/kg/twice	local co-administration	intracerebral application	injections	A single study	spinal opioid receptor activation	anandamide	a long-acting synthetic opiate	stable serum levels	Morphine	a regular dose	a mu	a morphine syringe	palliative external beam radiation	a beneficial effect	the locomotor effects	Effective myocardial tissue concentration	mean improvements	The plasma levels	The effects	plasma level	a glass box	a benefit	the ideal dose	an apoptogenic dose	active metabolite morphine	the standard drug	alcohol treatment	chronic cocaine	A single injection	overlapping effects	a correlated physiological factor	the opiate	A beneficial effect	methadone	acol	nmol/L	sustained-release morphine	Oral solution	robust [	neonatal rats	g/ml	diamorphine equivalent	Many drugs	daily nicotine	an exogenous opioid agent	morphine pellets	a standardized dosage	
central compartment pathology	a posterior translational force	sciatic nerves	a large hypertrophic posttonsillectomy scar	movements	retroflexion	immobilisation	white dimple	neurovascular structures	lb	minimising risks	corti- cal veins	anteriorly	nerve roots	the vehicle	the bio mechanics	the annuloplasty ring suture	the ciliary processes	cyclitic membrane formation	the body	external fixation	partial tears	angulation	fusion	the operative field	irritation	stretch injury	Complications	integrin activation	halovest management	rectal diseases	easiness	hyperextension	adherent fibrotic tissue	peribronchial cuffing	subsequent casting	little loss	either positioning	distension	manual traction	halo	cranial nerve palsies	the initial mechanical trauma	the treatment outcomes	compression forces	a well-distended joint	lbs	ours	sensitive structures	tear	neural compression	excess flexion	the tumor capsula	The lateral force vector	the tissue	distal direction	external orthoses	elective surgical procedures	ruptured acetabular labrum	management techniques	the traction theory	the venous sinuses	the pterygoid	basilar invagination	Numerous alternative etiologies	the masseter muscle	a different angle	instrumentation	dural sinuses	acute brachial neuritis	distortion	a lot	reflexol- ogy	mm vs	the ciliary body	a direct blow	Traction lengthens	irri- tation	
domperidone	clebopride	
likely effect	the nonselective endothelin receptor antagonist	sildenafil	endothelin antagonists	endothelin- receptor antagonist	an endothelin receptor antagonist	a single dose	good symptomatic improvement	ambrisentan [	improving	Post-operative sildenafil therapy	the medium-term effect	normal ventricular function	sildenafil therapy	reduced attachment	controlled trial	the negative results	sea-level baseline	a single oral dose	other pulmonary vasodilators	a randomized placebo-controlled trial	stem cell therapy	echocardiography	+15 mm	category X	the present case	bosentan therapy	macitentan	inhibitors	iloprost	endothelin receptor antagonists	oral sildenafil	Operation	active antiretroviral therapy	symptomatic improvement	the comprehensive pharmacological profile	manipulation	this double-blind multicenter	the nonselective endothelin antagonist	
oral factor	rivaroxaban	some differential safety effects	erythromycin	and/or thrombolytics	a different anticoagulant	thromboprophylaxis agents	significant drug interactions	dRVVT reagents	alfa	ml/min	h post-surgery	either rivaroxaban	the enzymes	dose adjustment	mass balance	a single 60-mg dose	direct factor	the anticoagulant effect	An oral transition	aPTT prolongation	fondaparinux	concomitant use	The conversion	a P-gp inducer	dose-adjusted warfarin	the systemic exposure	open-label trial	intracranial bleeding events	this patient group	betrixaban	primary safety outcome	Both doses	re-anticoagulation	apixaban	The non-inferiority	pharmacokinetic interactions	Bristol-Myers	both high-	a concentration-dependent manner	emergent adverse events	an oral factor	total knee arthroplasty	vitro metabolism	The anticoagulant effect	
a low dose	topotecan prolongs survival	No vascular occlusion	oral administration	antihypertensives	supplementation	the infused liquid	] dilation	cell doses	isoproterenol	another murine model	This resorption effect	coli	the vasopressin actions	baboons	cause splenomegaly	continuous subcutaneous infusion	tPA	vehicle	systemic equivalent dose	peak dosage	a nitric oxide donor	filling	protein resistant	glass pipettes	serotonin agonists	g/100 ml	rFVIIa	autologous blood	immune cells	additional doses	hemodynamic baseline changes	procedure	end-stage renal failure	vitamin K-dependent clotting factors	the bladder capacity	blood lactate levels4	heart rate variability	large volume	the maximal response	an unspecific T-wave inversion	lidocaine	transplant recipients	respective cages	lung injury	minutes postinfusion	different rates	increased myocardial eNOS activity	sodium dichloroacetate	lg/kg/min	excretion	donor–evidence	μg/min	an inflammatory response	echo contrast	aortic clamping	the retained responses	coagulation factors	down-regulation	hepatic artery chemoembolization	both renal function	exaggerated accumulation	The reduction	inotrope support	a peripheral venous line	gr	nano-particle bound rEPO	blood sample collection	channel-dependent mechanisms.73	backflow	sequential recombinant factor	loop diuretics	the slow infusion	equal hemodynamic responses	arvanil	low doses	colloid	cold	the first 2-5 days	the human peripheral blood mononuclear cell fraction	mild flush-like sensations	intermittent cold blood cardioplegic solution	mild hypothermia	the right heart	j	>	a new B-natriuretic peptide	many other vasodilator substances	rFIX	receptor antagonism	expanded cells	peak plasma concentration	guide cannulas	Co-infusion	interleukin-1 receptor antagonist	core	neurologic changes	embolization	posterior reversible encephalopathy syndrome	pups	the solution	vehicle infusion	a contaminated hub	subendocardial perfusion defects	a normalization	the infusion phase	synthase-1 increases sensitivity	a critical role	intermittent positive pressure ventilation	final product	receptor expression	α-lipoic acid	gut	concentrates	trial-averaged current source density	clevidipine	cystic fibrosis patients	the tested agonists	pentobarbital/ketamine	16,25-29 ]	courses	normal saline	variable platelet factors	possible adverse effects	rod	those patients	increased cardiac output	bypass replacement therapy	mcg/kg/minute	supra-nigral lipopolysaccharide	μg/min h-αCGRP	briakinumab	AQP4-IgG depletion	day course	mg day-1 naproxen	The height	an initial increase	Initial dose	lg/	purified immunoglobulins	proliferative responses	sterile saline solution	the Gram-positive bacteria	intestinal contents	some hours	the venous capacitance bed	pregnant rats	hypothermia relevant	gradual starting	fasudil	∼30	several days	a monoclonal antibody	Total	a daily dose	The decision	anesthetic induction	a dose-dependent increase	the coagulopathy faster	excessive manipulations	min recovery period	20-30 min	neonatal rodent models	the monoclonal antibody	calcineurin inhibitors	catheter placement	180-200 sec	a novel pressor agent	human trials	hypertensive patients	significant effects	blood pressure records	g/min	an approach	propofol	general safety	pdFIX	oral syrup	dipyridamole/adenosine	fluorescent motor nerve terminals	dams	renal toxicity	atropine coadministration	cells/min	both cardioprotection	increased cost	oxygen solution	solution	inflammatory soup	ketamine	4-5 minutes	cardiac heart failure	a subsequent prophylactic regimen	inotropes	an upregulation	μg/d	the speed	smoke exposure	the same principle	other second line chemotherapy	mg/kg	adrenergic	μg/kg	the adipose tissue biopsy	early renal failure	venous access sites	the third minute	acetylcholine	hypertonic sodium chloride	the urethra	a platelet count ≥20K/μL	cell activity	tauroursodeoxycholic acid	a repeated bolus	hypotensive action	the abciximab bolus	1-13C leucine	pool ”	a common paradigm	μg/kg/h	delayed	Magnesium sulfate bolus	emptying	epoprostenol	frequent monitoring	the feasibility	no delayed migraine-	fifth day	on-demand factor	total rFVIIa dose	the patient awakens	initial assessment	mononuclear cells	the wire	1-deamino-8-D-arginine vasopressin	arterial dilatation	the guinea pigs	an intra-aortic balloon pump	baseline imaging	key components	anticoagulant-excluded tubes	mystacial pad stimulation	other previous reports	ischemia/reperfusion	long-term repetitive intralymphatic	both treatment protocol	short course	injection	lame horses	methylprednisolone	shunts	steady states	vivo model results	lessened bilateral symptoms	the operation	ex vivo	fifth days	zoledronate	a maximum	plasma concentrations	surgical patients	endothelial progenitor cells	amotosalen	skin temperature difference	various time points	receptor agonist	thiopental infusion	mm-spaced bipolar stimulator	high levels	glyceryl trinitrate	platelet inhibitor	vasodilatory shock	the reconsideration	an alpha-1 adrenergic agonist	Beneficial effects	esterase inhibitor	cytostatics	trinitrate	μg/kg/min	Endplates	a free-radical donor	sPLA2 substrate-like compounds reduces	The regional cerebral blood flow	increased blood pressure9	the studied variables	mg/kg/hr	an EGFR-targeted toxin	baseline images	stimulates	mRNAs	The retroperitoneal space	the main component	µg fentanyl	the first disease-modifying therapy	myocyte size	lipid-encapsulated oxygen-gas microspheres	chronic angiotensin	cryopreservation	therapy-associated toxicity	the methylation status	The OPG-Fc pretreatment protocol	the scheduled surgery	This contrast	no additional protection	:18-24	adequate premedication	different stimuli	state-of-the-art dipyridamole protocols	cells/kg	litres	physiological saline	overnight fasting	minor procedures	no intubation	glucose concentration	fluids	delayed headaches	sumatriptan administration	% mannitol	5-10 x	fluid boluses	mesenchymal-like progenitors	inhibited accumulation	dilute solution	the 7th day	each dose	subcutaneous sumatriptan	the adenosine stress	another case	the intravenous contrast medium gadolinium	atrial slices	Infections	platelets	middle column	furosemide	diabetic animal model	viral encephalitis	the last dose	a great intra atrial volume	no inhibition	h-αCGRP	tetrodotoxin inactivation	macrophage-targeted human placental glucocerebrosidase	factor concentrates	anakinra	reestablishment	Any interruption	another mouse model	adenosine stress	the fluorescein isothiocyanate dextran	μl/min	infection∗	neuronal firing	whereas naproxen	acute intervention	rebound hypertension	orbital inflammatory disease	mg/kg/h	donor	desmopressin	adoptive immunotherapy	confocal microscopic image	systemic angiotensin	the diffusion	temperature	aortic banding Circulation	2-3 minutes	a very-low dose	death rate	a valid surrogate	the medical team	transgenic hypertensive rats	sRANKL	the neurotensin receptor agonist	treat-to-target protocol	units/min	both preparation	naloxone reduces degeneration	whereas rats	% paraformaldehyde	the interstitial space	cyclophophamide	microbiota	heart rate monitoring	an inhaled formulation	placebo-controlled crossover study	agitation sedation scale	purified factor	dihydrocapsaicin	ml/kg	oxytocin	an automatic inflatable arm cuff	the joint cavity	concentrate	patient cells	thymoglobulin	the hypotensive effect	hyperkalemia	rat complement	argatroban	conceptual implications	the third day	primary aldosteronism	The background intensity	the subjective assessment	dialysis fluid	maintenance fluids	a preliminary report	anti-CD62L antibody	tariquidar plasma concentrations	the infants	fibroblast growth factor	midazolam infusion	the second hour	high volume	monoclonal antibody	Each cycle	patient admission	olvanil	low grade	the heat pain score	the first clinical studies	reflex facilitation	initial attempt	irradiation	gene array data	dose vasopressin	right mystacial pad stimulation	mg/h	standard bolus	replacement factor	the above studies	original identification	a migraine attack	inj	the contrast medium	subtherapeutic dosages	good agreement	short-term treatment	a hydrogen	placebo day	plasma concentration	background levels	the respective doses	fresh frozen plasma	hypertonic mannitol	multiple intravenous inotropic agents	endogenous substances	vascular endothelial growth factor.10	the hypercalcemia	cerebrospinal fluid pH3	the embolic response	nitroprusside	a central venous catheter	inhalation	prostacyclin	this cytokine	systemic mesenchymal stem cell	
coenzyme	thioredoxin reductase	tube coagulase tests	the stigmasterol-treated animals	glutation peroxidase	secretes	superoxide dismutases	antioxidative systems	High amounts	superoxide dismutase provide protection	mmol min-1 ml-1	modified proteins	radical scavengers	mRNA expression	the respiratory chain	the proteasome	Other differences	kidneys	the wound site	reductase	free radical scavengers	The activities	lipoic acid	gluthatione-peroxidase	a subsequent reduction	cell-mediated immune	heme oxygenase	glutathione metabolism	glutathione peroxidase	superoxide-dismutase isoenzymes	superoxide dismutase	oxidative processes	exogenous free radical scavengers	dismutase	manganese-superoxide dismutase	the control animals	glutathione-S-transferase	proteasomal activity	cat	PD-patients	endogenous molecules	healthy smokers	vitamins	enzymes	glutathione peroxidase activity	a short half-life	glucose-6-phosphate dehydrogenase	metallothionein gene expression	n.s	sod1	hydrogen oxide	the antioxidant response	kDa	brain-derived neurotrophic factor	knowledge activity	carbonic anhydrase	Luchese et al	Free radical scavengers	lipid peroxidation	both lipid peroxides	tissue levels	glutamate cysteine ligase	ascorbic acid	experimental model	methionine sulfoxide reductase	important antioxidant enzymes	flavanoids	the superoxide	glutathione peroxydase	glutathione-peroxidase	kit number	diminished expression	thiobarbituric acid reactants	enzymatic-superoxide dismutase	antioxidant enzymes	The antioxidant activity	other peroxidases	the enzymatic activities	kidney homogenate	endothelin-1	nonenzymatic pathways	glutathione peroxidases	the inflamed joint tissue	These compounds	glutathione reductase	parasite survival	glutaredoxin	
mM sodium citrate	uncoupled nitric oxide synthase	Involvement	thiobarbituric acid-reactive substances	The reaction result	the final infiltration step	The latter	reduced antioxidant properties	Nano-Pure water purifier	mimetics	radicals	peroxynitrite	founder effects	phenol	okadaic acid	↑Bim	acetaldehyde	rabbit	exhaled breath condensate	μmol/ml	superoxide anions	molecule	dangerous second messengers	reactive oxygen species	haematoxyline	platelet function	The sections	invade compact myelin	the hydroxyl	unit/mg protein	the single-electron reduction	burst firing	liposomes	polymorphonuclear leukocytes	superoxide anion	chemotherapeutic reagents	The superoxide-anion	aggressive burring	oxidase activity	the mitochondrial membrane potential	
leukemia	increased interstitial fibrosis	skull base defects	tissue	chronic osteomyelitis	frontal bone	woven bone spicules	osteoblastoma	pedicle	a tumor capsule	the mobile spine	osteoid osteoma	the right superior articular process	osteochondroma	an endosteal location	fibrous dysplasia	computed tomography-guided percutaneous radiofrequency ablation	

Accumulation	Fundamental effect	micro-computed tomography	osteoprogenitor cells	the physical environment	kidney	the tibia/femur	Preparation	crystal growth	
platelet products	monocyte origin	cryoprecipitate infusions	second-generation platelet concentrate	this sense	coagulation proteins	ethyl ester	The flow cytometry tests	white blood cell count	blood cells	white blood cell	recombinant growth factor	midbrain	vascular physiology	the mean±s.e.m	sole therapy	a high fresh frozen plasma	the first trial	coli binds	polycythemia vera	red cell apheresis	responsive platelets	cardiac allograft vasculopathy	vascular endothelial growth factor-receptors	ribonucleoprotein	leukocyte	the thrombosis defect	Contributions	epidermal growth factor	the 7th hospital day	the selective inhibitors	the proatherogenic effect	culture-expanded osteoblast-like cells	a concentration	high- er levels	The accepted model	hidden epitopes	mandibular osteoradionecrosis defect	cortisol	marrow aspiration concentrate	equation.15	picolinic acid	growth factor receptors	tumor cell cx integrins	the hematocrite	monocyte activity	lymphocyte counts	tercer milenio	reticount	progression-free survival	deposition	Biomimetic tubular nanofiber mesh	fibrin bonding	fluidity levels	low platelet counts	neutrophil	clinical evidence	role	g/L	membrane-active analogues	the habituation phenomenon	g/l	white blood cells	XI-deficient plasma	leucocyte concentrations	hematuria	leukocyte elastase	no proven side effects	medicine applications	fresh frozen plasma transfusions	increased blood thrombogenicity	gr/ dl	bone marrow cells	a nephelometric method	neutrophil migration	megakaryocytes	neutrophil sequestration	↓	microparticle activation	% blasts	donations	antithrombotic actions	hydroxyapatite scaffolds	neutrophil conjugates	thrombin-rich clots	metastatic tumor	post-antioxidant supplementation	granulocytes	percutaneous coronary intervention	postoperative bleeding	the stable fibrin	proteomic characterization	leukocyte concentrations	dynamic properties	erythrocyte arginase activity	PCs	insufficient	rich plasma	Alteration	mesenchymal stem cells	oxidized phospholipids–paraoxonase	the secondary analysis	The hemoglobin	formulations	prothrombin time	platelet activation	endothelial cell interaction	a migraine patient	the coagulation pathways	monocyte function	prasugrel Thrombolysis	growth factor-β	vascular endothelial	leukocyte release	proliferation	leukocyte aggregates	post-essential thrombocythaemia	hydroxyurea	reticulocyte count	fibrin microthrombi	the synergistic interaction	plasma components	toll-like receptors	small platelets	endothelial cell adhesion molecule	mg/l	cells/µL	The lipoprotein-associated phospholipase	endothelial function	split	thrombospondin-1	saturation	interleukin-7 alpha receptor	an effective strategy	nitrite levels	the additional mediator	g/dL	up-regulation	The molecular basis	hemoglobin	neointimal thickening	increased numbers	increased inhibition	an important step	polymorphonuclear leukocyte	thrombin	platelet activation level	recent single photon emission	monocyte/macrophage	Differential effects	Upregulation	The origin	stable results	increased platelet aggregation	blood losses	natrium	pathogen inactivation	blood typing	selectins	The role	endothelial cells	morphogenetic protein-2	pro-gastrin releasing peptide	a lipoprotein-associated phospholipase	fibrinogen	human platelets	Expandable intramedullary nailing	individual coagulation factor replacement	An embolic occlusion	Staurosporine-induced apoptosis	mitogen-activated protein	endothelial activation	:707	angiotensin-converting enzyme	prasugrel-Thrombolysis	immunoblot analysis	c-kit	Release	the subtitle mechanism	residual plasma	a parallel decrease	red blood cell	bone marrow function	potential interactions	The release	blood cell	The blood parameters	the platelets	counts	physical stage	a reduced interference	erythrocyte	leukocyte systems	flow cytometric assessment	histogram analysis	plasma 5-HT	lecithin cholesterol acyl transferase	thienopyridines	platelet-leukocyte gel	total leucocyte counts	l−1	lipid infiltration	platelet-rich plasma	
ligament	Scale Bars	hard tissue	wound	insertion sites	tendon–bone junctions	

i.e	the tumor	
catabolism	a randomized study	The antioxidant	an equipotent antioxidant	candesartan	restenosis rate	stable modification	anti-atherosclerotic effects	
p70S6 kinase	The expression levels	the quantification	subunit	cell adhesion molecules	ab6161	the filter	nNOS	the cell division machinery	primary antibodies	transcription factors	middle panel	a fold increase relative	nuclear factor	cell line	the polymerization	eNOS	the bound proteins	alanyl tRNA synthetase	an internal control	actin	microtubules	vimentin	the kinetics	anti-mouse tubulin antibody	h. Lysates	dihydroorotase	Steady state levels	tubulin mutation	hearts	secondary fluorescent conjugates	
external loop recorder	vasovagal syncope	electrophysiologic study	the 5th min	an external loop recorder	electrophysiology study	a Abbreviation	


dexfenfluramine	phentermine	
protein transport inhibitors	ionomycin	ng/mL ionomycin	a protein transport inhibitor	μg/ml calcimycin	golgistop	the last hour	IFN-γ accumulation	All cells	μL/mL	a water bath	


antihistamine plasma level	antiallergic effects	cetirizine	
oral tacrolimus	a DNA	
short arrows	anti-tumour necrosis factor	diphtheritic myocarditis	experimental autoimmune encephalomyelitis	no tumor	ischaemic ocular motor	orbital apex syndrome	Principles	labyrinthitis	Toosy	herpes	Signs	vata	retinal ganglion cell loss	cyst formation	retinal vasculitis Antibiotics	cranial neuropathy	neuralgia	maculopathy	optic disc edema	thoracic nerve involvement	recurrent myelitis	the anterior interosseous nerve	axonal degeneration	ganglionitis	retinal vascular changes	long arrow	the shoulder girdle	chikungunya virus infection	deafferentation pain	
cystic dilations	
the pCO2	the newborns	recurrent vomiting	the concentration	The depth	inspired air	ventilator	strong sedation	
participant	
urbason	intranasal drops	intraocular growth	situ clearance	a topical therapy	hyaluronic acid.10	a new group	respectively3	a post-exposure acute therapy	low affinity	The present status	thyroxine	drops	clinical medicine	the peripheral blood	adhesions	psoriatic arthritis	the consumption	systemic application	preoperative administration	hormonal effects	multiple sclerosis Neurotherapeutics	insufficient duration	a dose-dependent inhibition	pituitary adrenocorticotropic hormone	Local application	The antirheumatic effects	16α-Methyl analogs	different therapeutic options	certain other conditions	
total repair	simple defects	patent ductus arteriosus	interrupted aortic arch	muscular ventricular septal defects	atrial septal defect	a severe elevation	major aortopulmonary collateral arteries	pulmonic atresia	additional left heart obstruction	unrepaired pulmonary atresia	great arteries	aberrant subclavian artery	major aorto	an anatomic finding	acyanotic patients	non-restrictive patent ductus arteriosus	other congenital cardiac defects	Double patch closure	the aortic arch	aortic valve stenosis	valvular pulmonary atresia	single ventricle heart.11	interventricular septum	pulmonary artery atresy	cardiac malformation	fallot	coronary-pulmonary artery fistula	subpulmonic stenosis	pulmonic stenosis	complex cardiac malformations	valvular pulmonary stenosis	childhood repair	side-by-side great vessels	circumflex coronary artery	new technique	increased pulmonary vascular resistance	Tetralogy	aortic regurgitation	thick	aortic valve prolapse	patch closure	aortic arch obstruction	pulmonary venous baffle obstruction	aortopulmonary window	transposition	6-month-old girl	extreme hypoplastic pulmonary arteries	an atrial septal defect	free wall rupture	increased right heart pressures	Percutaneous transcatheter closure	Pulmonary atresia	common lesion	congenital cardiovascular malformations	underwent intracardiac repair	the left atrium	ventricular outflow tract	minimal gradients	postinfarction	tetralogy	a complete one-stage repair	double aortic arch	coarctation	coronary artery	coronary revascularization	subpulmonary stenosis	high-dose spironolactone	shelf	the preoperative assessment	percutaneous closure	bicuspid aortic valve	the previous shunt	aorta	truncus arteriosus	mVSD	extreme tetralogy	congenital anomalies	coronary anomaly	the left brachiocephalic artery	other congenital heart defects	an atrioventricular canal type	hypoplastic central pulmonary arteries	intact interventricular septum	major aortopulmonary arteries	pulmonic valve atresia	persistent truncus arteriosus	mcaste	tricuspid atresia	underwent cardiac surgery	descendent aortic stenosis	pulmonary stenosis	tubular arch hypoplasia	acute mitral regurgitation	other congenital abnormalities	the atrial septal defect	subaortic stenosis	severe pulmonary vascular obstructive disease	major aortopulmonary collaterals	common congenital cardiac malformations	surgical considerations Circulation	patch	Infants	year-old man	double-inlet	bicommissural aortic valve	a rare complication	surgical closure	favorable long term results	patches	unidirectional valved patch closure	atrioventricular septal defect	anomaly	an off-label manner	atresia	A challenge	anomalies	simple lesions	severe peripheral arborization abnormalities	biventricular non-compaction	Some types	Interventricular septal hematoma	the amplatzer	cm/s	invasive perventricular device closure	pulmonary atresia	clinical results	Two-thirds	severe tubular arch hypoplasia	pulmonary regurgitation	hypoplastic pulmonary arteries	pulmonary vascular obstructive disease	device closure	pulmonary vein stenosis	hypertrophic nonobstructive cardiomyopathy	pumonary atresia	intermediate-term complications	unifocalization	papillary muscle involvement	left atrium	other cardiac lesions	mild mitral regurgitation	double outlet	arteriosus	detachable balloons	subaortic membrane	reproducible approach	septal occluder	pulmonary valve stenosis	serious complication	Preoperative characteristics	major systemic	septal defect	outflow tract anomalies	
residual shunt	quantitative cardiac magnetic resonance	The saline injection test	severe mitral	a round mass	a large flow	echocardiographic assessment	cardiac valve disease	papillary muscle	persistent cardiopulmonary arrest	suppl	Aortic dilatation	
low-volume/high-intensity training	
an alteration	protein trafficking	rash	direct fusion	the glucose transporter	arterioles	coated vesicle	the plasma membrane	the chronic control group	ejaculatory duct cysts	crust	network	vatalanib	force transmission	low viscosity	human hemoglobin	
catalepsy	perseveration	mutism	
ordinary headache	individual difference	a situation	The delimitation	mus- cles	ethanol drinking	mediators	chronic abusers	excessive drunkenness and/or	these features	hangover headache	common ingredient	
identical look	megestrol acetate	
kits	total cholesterol	peroxidase	peroxide-producing enzymes	
any pertinent family history	included spinal cord problems	manual	special reference	statistical manual	cerebral palsy	

non-insulin-dependent diabetes	Hoejmakers	triglycerides.25,26	obese women	recent-onset type	the pre-diabetic state	sensory polyneuropathy	glucose regulation	diminished insulin sensitivity	dyslipidemic subjects	c group	an early genetic marker	acute kidney injury	min time point	macrovascular disease	pre-diabetes	normotensive men	elderly men	impaired fasting glucose	this paediatric cohort	telmisartan improves	recent onset type	

transverse aortic arch	modified parasternal long axis view	descending aorta	
the French surgeon	
adenomyoepithelioma	the salivary glands	glandular epithelial neoplasm	the breast	


open-heart surgery	complete neutralization	the post-antagonization	versus heparin	poly-THIQ	the 5-minute period	anti-factor Xa levels	an activation	polybrene	the hemoconcentration process	All blood	equivalent dose	arrival	the surgery heparin	oxygenators	stilbamidine	myocardial depression	all sheaths	an extra dose	neutralization	clamp removal	The administration	The dosage	heparin activity	subsequent adverse events	complement-fixing antiprotamine immunoglobulin	
cervical spine injuries	
a behaviour modification	
mental confusion	aspiration	retrosternal pain	motor incoordination	abdominal pain	leg weakness	lassitude	blood phosphorus	chills	joint pain	an overwhelming sense	arise	inappetence	teratogenic risk	ground-glass attenuation	hyperreflexia	nonproductive cough	memory problems	six-month progressive dyspnea	following tests	mucositis	exertion-associated dyspnea	geographic tongue	clinical history	
bitemporal hemianopia	
other dietary supplements	Local administration	decoction	] drugs	a potent suppressor	heroin-dependent patients	finer capsule	a constituent	a probiotic mixture	search_word	acute headache treatment	eighty-nine cases	
a hydrogel	poly	innate stimuli	cAMP	μg/mL	a gel formulation	intralesional interleukin-2 increase	a toll-like receptor-7 agonist	systemic agonistic anti-CD40 antibody	an immunotherapeutic toll-like receptor	electrodessication	resiquimod	local administration	each experiment	a combined adjuvant immunotherapy	topical application	Effect	
a low -molecular weight heparinoid	nmol/l	free haemoglobin	the same morning.12	Injectable anticoagulants	Low-molecular-weight heparin	normothermic conditions	hydrocortisone	frail population	related glycosaminoglycan	the total dosage	chondroitin sulphate	a combination strategy	alternative medicines	mg verapamil i.a	antithrombin	entactin	the femoral arteries	an activated clotting time	a bolus	nidogen	chondroitin sulphates	the antithrombotic effects	the arterial cannula	the possible influence	a complex	medical treatment	low-molecular weight heparin	anti-inflammatory effects	mL tubes	non-endothelial cells	% sodium bicarbonate	various lymphatic organs	additional boluses	the left common femoral artery	a course	PDGF-induced proliferation	Peripheral blood	somato-evoked potentials	the same healthy individuals	low concentrations	units	anticoagulation therapy	ardeparin sodium	the arterial catheter	phenprocumon	arin	femoral neuropathy	modified surface	statins	the polyurethane valves	fatal thromboembolism	exsanguination	circuit components	the minerals magnesium	Several other drugs	inserted cannulae	the bivalirudin	mg/100 units	The marginal ear vein	the bleeding	nerve growth factor	heparan sulfate	topical administration	simultaneous application	heparinoid drugs	underwent hemodialysis	subsequent injection	stent implantation	small amount	a cold icebox	increased warfarin doses	carbohydrates	abortive treatment	This catheter	The technical aspects	substance administration	partial thomboplastin time	The standard dose	anticoagulants	recirculation	blood levels	The group	heparinase	Persistent administration	whole blood v/v	mesilate	aluminium	The inhibitory effects	the native state	an intracoronary dose	heparan sulfate domains	these adverse effects	Low-molecular weight	low molecular weight heparins	the retention	trillium	pain control	puncture	postoperative period	preclinical models	platelet-activating factor	High doses	anti-chemotactic effects	Inhibitory effects	catheter size	thrombus aspiration	lipopolysaccharide	derivatives	peripheral blood mononuclear cells	the anticoagulants	intravenous application	confirmed	inotropic drugs	unstable coronary artery disease	collectins	the deferment	clotting time	ionotropic agents	heparan sulphate	human lung fibroblast proliferation	further antiplatelet	luxury perfusion	hirudin	improved complete response rates	clopidogrel use	heart transplantation	lifelong acetylsalicylic acid	rhFIIa	Resident macrophages	other polyanions	antithrombin-mediated regulation	bivalirudin	U	cationic protein	optional—69 %	reversal	platelet-derived growth factor	glycoprotein	a surgical cause	Baboons	some possible alternatives	heparan sulfate proteoglycan	the monitoring	related grycosaminogrycans	du	rt-PA	underwent thrombolysis	certain experimental conditions	the specimen trap	the right internal jugular vein approach	novel oral anticoagulants	beta-blockers	the anticoagulation properties	fibrinolysin	a high thromboembolic risk	A randomised clinical trial	immediate administration	material	mg/100	uptake	the dorsal	Both warfarin	adjunctive therapy	mg clopidogrel	cytotoxic	acute unstable angina	the afternoon	The total dosage	harvest	appropriate inotrope	subsequent reversal	streptokinase	% bovine serum albumin	uninterrupted warfarin	small amounts	deep vein thrombosis	similar target	steady state	u/kg	low-molecular-weight heparins	EDTA-coated tubes	an intravenous bolus	the inhibitory action	the aPTT result	the aPTT time	type	Anti-inflammatory effects	a left coronary guiding catheter	% sodium nitrate	protamine complex	The antiangiogenic effects	a long exposure/treatment	a container	a routine surgical measure	cross-linked collagen-related peptide	these medications	cross-hatched column	cannulation technique	pacemaker	therapeutic range	sterile conditions	the normal dosing schedule	the clamp	The chromogenic substrates	the pharmacodynamic	unstable pharmacokinetics	an adequate amount	acute myelogenous leukemia	a therapeutic range	proteinases	fitting	transseptal puncture	no thromboembolic treatment	a credible concept	% horse serum	the subsequent soluble fibrin formation	initial recording	bound	stellate ganglion block	bone marrow	serum reduction	a low molecular weight heparin fragment	expert consensus	a severe adverse reaction	the reaction	the acceptable range	tert-BuOOH	de-N-sulphated heparin	other glycosaminoglycans	a bacterial enzyme	platelet factor	a low mortality	electrolytes	ml/h	the spine	p=0.013	low-molecular-weight heparin	dextran sulphates	the same anionic	final concentration	cyclic nucleotide analogues	the left internal mammary artery	venous flow	a final dose	hydrochloride	study suggest	paranasal sinusitis	the anticoagulation effects	protamine sulphate	cell counting	stainless steel	Bleeding	unfractionated heparin	histamin	an ice pack cooler	reviparin	protamine	g/kg	simultaneous treatment	spontaneous reversal	anticoagulation	warfarin	vein thrombosis	myeloma growth	aspirin users	Tyrodes solution	cardiac operations	albumin infusions	anticonvulsant drugs	thrombolysis	surgical hemostasis	exercise therapy Circulation	disruption	interventional percutaneous thrombus retrieval techniques	mg/kg body weight	The alternative treatment	intravenous tirofiban	penicillin	molecule size	the international normalised ratio	related glycosaminoglycans	systemic cooling	rtPA	organ harvesting	buffer	gadoteridol	Pharmacological interactions	lepirudin	the usual measures	successful stent placement	sulodexide	Effective peri-interventional anticoagulation	any form	nitrate	the anticoagulant effects	thromboprophylaxis	bolus	cultured human neutrophils	integrin-mediated cell adhesion	a syringe	whereas serum	the same volunteer	The nozzle	a subsequent ACT	aspiration thrombectomy	electrolyte solution	nonrecirculating mode	sul- phate	the surgical group	direct cannulation	fibroblast proliferation	acid citrate dextrose	a lymphocyte	the additional doses	bypass pump	auto	pethidine hydrochloride	laboratory management	:447 –54 .10.1016/S0140-6736	phosphate-buffered saline	acenocoumarol	nmol/l antithrombin	Collins	rt-PA injection	The rabbits	a standardized coagulation test.18	other acidic mucopolysaccharides	inhibitor therapy	the dorsal midline	citrate	deoxyribonuclease	autopsy findings	systemic anticoagulation	anti–rabbit	growth factors	factor-binding protein complexes	close monitoring	antithrombot- ic agents	peri-procedural bridging	ethylenediaminetetraacetic acid	The tube	protamine sulfate	related proteogrycans	:823–33	subsequent warfarin	complexed	blood collection tubes	peripheral artery interventions	the blood spun	heart catheterization	the best-known anticoagulant	dipyridamole	prolene suture	a single intraoperative low-dose	aspirin versus aspirin	granulocyte activation	poly-2-methoxyethylacrylate	the early use	The purse-string	a dilution	potassium-sparing diuretics	the concomitant use	p2y12 inhibitors	foetal calf serum	heparin sulfates	low molecular weight heparin	hemodilution	breastfeeding	inhipitors	inactivation	the priming	the activated clotting time	s lactate	the reversal	Human astrocytes	coumarin derivatives	urine collection	the right femoral artery	separation	an acute anticoagulation	phenprocoumon	low-density lipoproteins	low dosage	dextran sulphate	gastric absorption	aortic cannula	intravenous antibiotics	different amounts	gentamycin	All cardiac suture sites	m l	transoesphgeal echocardiogram	units/ml	dose anticoagulation	dual antiplatelet therapy	anticoagulation dosage	dicumarolics	prasugrel	no clotting	cardiac glycosides	nafamostat mesilate	:1376	


these abnormalities	dietary fiber	fat/cholesterol	
melphalan	mos	mg/m2	total body irradiation	transplant procedures	include	The mean	hydroxycarbamide	4–6/6-matched cord blood donor	a non-toxic myeloablative agent	a myeloablative regimen	pulmonary toxicity	an increased rate	mercurial agents	A preparative regimen	cytarabine	myleran	chlorambucil	donor selection	myelofibrosis	radiophosphorus	bone marrow transplantation	cyclophosphomide	eNOS−/− mice	cylophosphamide	a reduced intensity regimen	alemtuzumab	fludarabine	
month period	
jobs	all other causes	advanced stage	previous year	the time length	lung function recovery	fever ≥37·5°C	decreased exercise tolerance	an uncommon clinical cause	cardiocirculatory primary origin	intermittent episodic regular palpitations	hypoxia	A 23-day-old neonate	respiratory infection	ventricular pauses	chronic cough	body-aches	limited diagnostic facilities	daily activity	Non-productive cough	whitish expectoration	power output	reduced exercise tolerance	a rare cause	persistent fever	the supine position	no subsequent studies	auscultatory thoracic symptoms	expectoration	mastery	cough attacks	degree	respiratory pattern	rating	the exposure	exertion	the percentage	Pulmonary rehabilitation	precordial pain	a disease	capillaritis	a superior bronchodilator effect	the cardinal symptoms	Symptoms	comprehensive measurement	the sensations	cryptogenic facial swelling	mass index	positional hypoxia	placebo.14–16	metabolic disturbances	main parameters	physical performance	the pink	stabilization	A 69-year-old woman	Several step-by-step exercises	X-ray findings	questions	a chosen descriptor	no signs	A 42-year-old woman	paroxysmal tachypnoea	respiratory muscles	the reduction	Spirography	dose	hyperresonant chest wall	different symptoms	exertional fatigue	unknown origin	other signs	an independent predictor	chronic colonization	polyarthralgia	rales	sputum viscosity	a cycle	Effects	attacks	slope	post-MI	baseline levels	centile	lung deflation	nocturnal oxygen therapy	life	cardiovascular de-conditioning	gradual onset	a respiratory rate	vs	nasopharyngitis	patients,1,27–28	the continuous measurement	abdominal movement	a marked elevation	recent worsening	profound weakness	the mechanisms	a significant decrease	the general medical ward	the speakers	recent data	heliox	oxygenation	deteriorated general condition	a cause	other acute causes	aspects	the classic symptoms	The language	other common causes	exercise performance	scaling	functional capacity	the potential effect	the affective dimension	pdm09	monotherapy	sudden onset chest distress	incomplete breath	equivalent initial resuscitation rates	some aspects	quality	moderate-to-severe dyspnea	respiratory rate	all patients	the score comprising age	a formal measurement	current symptoms	laryngoscope	Presence	maximal inspiratory pressure	the inappropriate response	the exercise-specific self-efficacy	right ventricular systolic pressure	an accentuation	Occurrence	the pathophysiological basis	stage	frequency	disease-specific quality	expired tidal volume	lean arm mass	any recent chest pain	increased incidence	question refers	a case	pigs	contributes	limited independence	leg exercise patients	+2.3	many other medical conditions	exercise capacity.54	medical consultation	the clinical investigators	physical exercise capacity	the clinical picture	exacerbations index	subjective measurements	1-min intervals	mild atrial enlargement	lightheadedness	purulent expectoration	muscle fatigue	general malaise	generalized edema	chest pain	//www.goldcopd.org/uploads/users/files/GOLD_Report_2011_Feb21.pdf	unpleasant symptoms	recurrent pulmonary infections	number	mood	statistical models	general practitioner	indirect effects	phlegm	respiratory symptom	Dramatic improvements	physical outcomes	the qualitative dimensions	m	expiration sounds	an increased intensity	laboratory assessments	other common symptoms	a randomized clinical trial	postural relief	the beginning	intolerance	the chronicity	farms	Improvements	present symptoms	the anaerobic threshold	exercise dyspnea	exertional chest pain	250-349 150-249 ≤	dry cough	slight improvement	overall health status	pulmonary vascular impairment.3,63,65 Patients	points	’ subjective feelings	pathophysiologic	A 27-year-old patient	exercise limitation	sudden onset	simple assessment	the inflammatory component	distance	skin rash	exercise tolerance.2–6	the respiratory muscles	recurrent bilateral pleural effusions	some clusters	mMRC	slow resolution	therapy	Careful computer-based assessment	acute asthma	whereas improvements	ventilated subjects	reduces perception	functional residual capacity	overproduction	intense bone pain	the language	both conditions.12 Palpitations	recurrent pneumonia	leg fatigue43–46 whilst	the kinds	both groups	normal life	rectorrhagia	qualitative dimensions	ΔSpO2	anorexia	upper limb muscle strength	types	pleural thickening	cough and/or sputum expectoration	acute respiratory	the procedure	auscultatory findings	exertional angina	chronic respiratory failure	a nonproductive cough	residual orthopnea	domains	overuse	easy fatigability	sex	whereas arm training program increases	upper-body activity	a pulmonary process	the frequency	each model	thrombosis/hemostasis	global health status	Progressive cough	the inferior vena cava filter	the efficacy	progressive hemoptysis	the symptoms	great relief	a gasometric improvement	correlations	abdominal distension	a significant improvement	arterial desaturation	the perception	the central perception	extent	respiratory distress	the subsequent sense	health status/HR-QOL	ability	these assessments	rapid progression	minute ventilation	indacaterol	dysphonia	experiences	the improved baseline perception	leg fatigue symptoms.166	few symptoms	left ventricular failure	a perfusion	part	full body plethysmography	the work	no unexpected adverse events	mental status	an unexplained worsening	functional classification	descriptors	extension	the minimum level	activity limitation	new bilateral ground glass	QLQ-C30 dyspnea	fatigue [	fILD	pattern	muscle power	the distress	clinical signs	progressive cough	a decreased level	a specific evaluation	a deleterious effect	weakened ventilatory muscles	demanding levels	impairment	effusion	function Patients	contribute	Model	% incidence	reduced exacerbations	patient comfort	the desired levels	loss	both postures	abnormal gas exchange	significant change	no complaints	a predominant exertional component	scale measurements	the relief	typical symptoms	functional blockage	42-44 ]	any symptoms	a chief complaint	active rectal bleeding	activity	the pain	a 4-year history	co-existence	educational achievement	facial plethora	the discharge	men:0.37	lung function	diabetic ketoacidosis	measurements	restrictive lung disease	no dyspnea	chronic sputum production	behaviour	anxiety levels	manifestations	prolonged submaximal exercise	bpm	epistaxis	the exemestane group	cough severity	an emergency room visit	health status	physiology	a chest X-ray	Respiratory muscle recruitment	health-related quality	comfortable ventilatory support	fever	the increase	obese individuals complain	the major dimensions	patients complain	lung biopsy	expiratory flow limitation	difference	sputum purulence	low functional capacity	research	bronchiectasis fatigue	the subjective sense	leg fatigue worsen	a vicious circle	the respiratory muscle efficiency	radiograph	no significant improvement	orthopnea	hemoptysis	a cycloergometer	health status scores	gas exchange	deglutition	an additional therapeutic option	A 49-year-old male patient	sense	cough frequency	chest pressure/pain	chronic dry cough	Respiratory rehabilitation	reduced ventilatory demand	long-term prognosis.28	induced pathophysiology	the results	respiratory acidosis	several causes	ischemic equivalent symptoms	mmHg,68,69	post-test periods	no group	general health status	the same symptoms	The sensation	no recurrence	labored respiration	granulation tissue	pulmonary lobes	correlates	a dose-dependent manner	numerous other factors	delirium	a competitive swimmer	institution	Patients	pulmonary ventilatory etiology	hospitalizations	shoulder pain	the medical expert	The multidimensional pathophysiology	left-sided heart failure	exercise intolerance	stimulus	congestion	a nonproductive cough present	chronic cough/expectoration	the referred reduction	impaired exercise tolerance	age	heath status	possible factors	healthy woman	usual daily activities	The severity	terminal states	restrictive dysfunction	the skills	Pathophysiological factors	physical functioning	complaints	limb	scale.22	ii	reduced symptoms	respiratory complaints	chest distress	tachypnea1	The main causes	leg effort	the complaint	white sputum	the 6-minute walking test	salmeterol	a 6-week history	vitro data	dual-energy x-ray absorptiometry scans	scale scores	the improvement	airflow ]	platelet count	grade	this case report	local intrabronchial mechanisms	The maximum tolerated degree	physiologic function	any complaint	varied causes	a litre [	Possible components	improved nadir	mechanisms	A 72-year-old woman	sustained onset	further exercise deconditioning	A 17-year-old male	the experienced degree	bilateral recurrent pleural effusions	example	exercise responses	the rationale	symptomatic treatment	throat	The physical examination	a thorough clinical evaluation	general clinical conditions	exercise endurance.187,189	ventricular failure	functional exercise capacity	Language	colleagues	the activation	marked improvement	oxygen saturation	the descriptors	exacerbation history	noisy breathing	6-minute walk distance	all domains	ulcerative colitis	recurrent episodes	complete alleviation	pulmonary thromboembolism	different intensity levels	pharmacologic treatment	increased reticular opacities	:1067	pregabalin	quadriceps strength	decreased exercise performance	personality	dependence	peripheral muscle	asthenia	hospitalization	detail.25	medical therapy	a 2-month history	6-minute walking distance	perceptions	perception	Comfort	[	abnormal mechanics	a consequence	purulence	superior health scores	c	comfort	pain share	complaining	heart rate	a modified version	airway obstruction	undefined etiology	endurance time	opportunistic infections	sputum change	pain	medication use	abdominal muscles	dysphagia	deconditioning	increased work	meperidine	radiologic findings	functional status	financial problems	gas analysis	medical attention	positive anti-CCP serology w/o synovitis	bad days	The various respiratory factors	emphysema-like syndrome	cardiac index	certain respiratory symptoms	increased respiratory muscle effort	diffuse	Sixty-eight percent	improved auscultatory findings	muscles	arm symptoms	X5x5	the hypertensive patients	no improvement	an improvement	arterial carbon dioxide tension	the control group	Relief	mMRC score ≥2	difficult-to-clear sputum	continuous rating	other respiratory signs	pulmonary thrombosis	diverse scales	emergency department	oxygen requirements	meaningful improvements	airflow obstruction	nausea	an increased sensation	prone position	–	visits	other symptoms	no published studies	forced expiratory volume	oxygen desaturation	treadmill test	impaired exercise performance	means	diaphoresis	atrial fibrillation	a patient suffers	pulse oximetry	many inputs	plasma levels	the genesis	maximal sensation	proximal coronary artery disease	a dramatic onset	excessive sputum production	sustain abstinence	the legs	physical capability	influenza undergo progressive hypoxemia	socioeconomic characteristics	airflow	several observed adverse effects	The initial relief	light-headedness	subjective feelings	that lung hyperinflation	Many patients	no reports	liver function tests	Episodes	limitations	clonic convulsion	accessory muscle use	no other significant differences	HIV-positive patients	productive cough	similar results	predictors	respiratory fatigue	the exercise capacity	choking	difficulty clearing secretions	r =	a three-factor measurement model	health status questionnaires.8–10	chronic respiratory insufficiency	roflumilast	a new episode	new onset	arm effort	congestive heart failure	nerve injury	hospital	irreversible expiratory flow limitation	palpitations	a measure	depression	low cardiac index	:775	non-resolving cough	improves	respiratory tract infection	the measured variables	arthralgia	a research	muscle activity	quick relief	a number	aggravation	acute respiratory distress syndrome	The central perception	cardiac causes	leg discomfort	the latter	onset	unspecified antibiotics	peripheral muscle weakness	increased mortality.27,28	the sense	exhaustion	non‐specific constitutional symptoms	a block	submaximal exercise capacity	relationship	heart frequency	muscle strength	uric acid levels	chest discomfort	pleuropericardial rub	neurohumoral activation	other parameters	ticagrelor treatment	isotime levels	0.41-0.66	Data	exercise	the central perceptual processing	The neural basis	no chills	common presentation	a high clinical suspicion	cough and/or sputum production	the sensation	a right middle lobe infiltrate	expiratory flows	the limited data	total score	terms	radiological assessment	the goal	Conventional methods	labor	severe metabolic acidosis	–236	effort	small increase	previous inflammation	palpitation	disability	Exacerbation	coadministration	rates	the extent	parapsilosis	acute hypoxia	progressive airflow limitation	lethargy	tachypnea	rehabilitation	findings	the potential link	overall Quality	past medical history	result	upper-lobe emphysema	Analysis	oral steroids	subjective sensation	the change	upper limb training	Severity	person	the major factors	the breathing pattern	controlled clinical trial	exact incidence	performance	exercise capacity index	the urine	A 12-year-old girl	other origin	the prognostic stratification	continuous sputum production	the triamcinolone arm	unexplained worsening	the symptom	predose evaluation	ratings	sympathetic nerve activation	non-productive cough	thoracic pain	pulmonary tumor emboli	bilateral pleural effusion	high degree	tightness	enduring cough	recurrent pneumonias	cardiac failure	other symptom scores	leg fatigue	ventilatory capacity	the expired tidal volume	epidermidis	the intensity	endurance	Attack	Respiratory muscle weakness	the transitional dyspnea index	other methods	clinical signs suggestive	atelectasis	this finding	elevated troponins	.Our case	the main respiratory symptoms	lethargy •	exercise endurance	state anxiety	moderate effort	atypical pain	no dyspnogenic effect	rest days	flulike illness	Physical performance	inspiratory effort	night sweats	respiratory mechanics	the present study	a predictor	Several phase	The cardinal manifestations	self-reported symptoms	poor oral feeding	assessment test	the degree	0.42-0.67	a complaint	The level	the severity	exercise termination	proportion	desaturation	arterial blood gases	walk distance	airflow limitation,7	pulmonary obstruction	occurrence	any pre-existing medical conditions	these situations	Subjective scores	respiratory factors	a comprehensive appraisal	excessive daytime sleepiness	slight shortness	mood state	The percent	a weight gain	rapid relief	nocturnal attacks	The qualitative perception	health outcomes	impaired quality	thresholds	respiratory failure	hemodynamic status	clinical ratings	score ≥2	an accuracy	an exercise test	effectiveness results	A major cause	the 28th week	Descriptions	multiple causes	no surgical contraindication	The measurement	different qualities	acute psychological stress	rescue medication use	the indices	an exacerbation.14–16 Exacerbations	a worsening	increase airflow	discharge	spirometric values	re-accumulation	relief	severity	the use	bronchial breathing sounds	Descriptors	A p.Arg177Gln	neutrophil counts	pneumonitis manifests	respiratory abnormalities	The presence	capacity	right hemithorax	theories	8-week treatment	poor exercise capacity	the qualitative descriptors	dyspnea scale	a friction rub	the evaluation	swelling	palliative care	weight loss	all other inputs	staging	incremental exercise	respiratory signs	paroxysmal chest pain	a productive cough	respiratory muscle dysfunction	bloody sputum	oxygen dependence	the capacity	mono-organic symptoms	rhinorrhea	specific symptoms	anxiety	dyspnea scores	clinical outcomes	initial symptoms	Anxiety	and/or cough	the mMRC score	oxidative stress	inhaled morphine	no subject	disease-related quality	severe respiratory insufficiency	psychological well-being	physiologic determinants	heparin therapy	index	arm fatigue	objective assessments	Scores	feeling	severe acidosis	reduced pulmonary function	sputum production	progressive symptoms	investigation	respiratory sensation	health status versus placebo.6	amygdala	baseline symptoms	valvulopathies	ppi	significant improvement	secretion	the disease	social factors	the relative onset	hopes	cardiac abnormalities	each parameter	single causes	exacerbation rate	improvement	operative characteristics	weakness	certain other variables	syncopes	hypoxemia	mDOSE	minor bleeding	severe preoperative symptoms	female patient	spirometry	pleuritic chest pain	episodes	stridor	update	low perception	Pre-NST	the common symptoms	Pulmonary embolism	cough	chest dyscomfort	other clinical side effects	hypersecretion	natriuretic peptide	the association	’ experiences	exertion intolerance	central apnea	s level	hospital length	the predominant cause	these conclusions	sensation	transient ventricular pauses	alleviation	patient perception	relevant improvement	assessment	the levels	respiratory insufficiency	all pups	patient feeling	Distinguishable types	the need	the etiology	exercise tolerance	discrete measurements	assist	unknown causes	bradyarrhythmia	unproductive cough	All patients	The safety profiles	esophageal abnormalities	valve disease	increased minute ventilation	sweating	±	respiratory muscle strength	the likelihood	independence–exercise capacity	siccus cough	carbon dioxide	the hospital	the cardiogenic origin	radiographic signs	the palliation	peripheral muscle strength	walk	increasing	the factors	unwarranted fatigue	rescue medications	percentage	patients results	low exercise tolerance	pruritus	the maximal incremental treadmill exercise test	reduces ventilation	chest expansion	ascites	the nonpharmacological treatment	no blood vessel	pulse therapy	the modifications	effort intolerance	pain score	heart failure complain	the patient-ventilator interaction	rescue medication	the following terms	the total sensation	Classification	The main symptoms	major symptoms	The multiple dimensions	exercise endurance capacity	a simultaneous local effect	an uncomplicated course	maximum heart rate	respiratory noises	fat free mass	yr	position-dependent cardiac murmur	persistent atrial fibrillation	Continuous rating	normal lung function	the chest	current pathophysiological concepts	pulmonary limitation	progressive asthenia	no cough	no symptoms	signs	such controversial maneuvers	infection	the rate	an outpatient clinic basis	somatic pain symptoms	a peripheral hospital	basis	increased cough	abdominal respiration	ventilation parameters	significant associations	recommendations1	the third group	Adverse effects None	likely cause	no obvious relief	the emergency unit	The clinical descriptors	central mechanisms	the first clinical descriptions	2049-6958-5-3-2162295846610.1186/2049-6958-5-3-216ReviewDescriptors	system	different sensations	A 28-year-old female	modulate exercise dyspnea	level	no limitation	scan evidence	Work-related respiratory symptoms	the increased perception	near-fatal asthma	s respiratory rate	items	occult emboli	lung hyperinflation	fR	calendar days	pallor	the clusters	a generalized inflammatory response	mainstem	cerebral emboli	any other prodromal symptoms	both subgroups	absence	mouth-breathing patients	exercise flow	advanced cancer patients	healthy male	the persistent complaint	heavy cigarette smoking	the onset	the mMRC	ventilator support	dependent edema	an adequate support system	functional independence	blood pressure	dynamic hyperinflation	an in-patient smoking cessation therapy	chief complaints	athletic runners	visual analogue scale	the incidence	deterioration	obstruction	subjective sense	inspiratory fraction	a 2-day history	physiological mechanisms	The experience	an adaptive alveolar hypoventilation	subjective amount	fatal asthma perception	30-day readmission	s condition	airway caliber	affective dimension	physical activities	week programme	the “ classical ” form	ischemic heart disease	sputum volume	hospital complaining	target-organ damage	inhalational exposure	Systolic blood pressure	Various versions	a type	physician referral	respiratory package	ventilatory function	copious secretions	medical care complaining	smoking cessation	and/or pleuritic chest pain	physical fatigue	Non-specific cough	a sudden attack	The load	breathless	Some data	mediast	a five-point scale,14	transition dyspnea index	Investigators	health volunteers	hepotysis	myalgia	exercise intolerance.5–7	improved ventilatory capacity	Presents	pulmonary infection	measures	placebo	The evaluation	conclusions	pathophysiologic mechanisms	restless sleep	skeletal muscle deconditioning	the mid-hippocampus	gas exchange abnormalities	exercise intolerance occur	a stable state	conflicting results	ischemic equivalent	work	intolerable symptoms	patient-reported outcomes	right-sided chest pain	blood gases	typical chest pain	diastolic relaxation	a 74-year-old man	score	the severe end	air	constraints	prednisone	status	experience worse	mg/day oral prednisolone	night sweat	clinic	the night	mitral valve stenosis	central breathlessness mechanisms	undetermined origin	clear non-cardiac causes	suspected sternum infection	insidious onset	chronic	non-smoking Caucasian male	harsh cough	the dose	limitation	experience	patient-related outcomes	no obvious sputum	airflow limitation	end- stage	clinical assessment	excessive sweating	cardiopulmonary stress	chest X-ray	no complaint	improved anxiety	aid-cncr2820360440 >	these interventions	exercise capacity	emotional function	the area	malaise	reduced rescue medication use	stimulation	respiratory distress syndrome	the quality	sputum color change	right jaw	lung hypertension	6-month follow-up	score <	a sensation	continued wheezing	an increased demand	©	altered mental status	nose deformity	maximal exertional testing Patients	liver toxicity	non-users	chief complaint	kg	]	research methods	various combinations	The angina	a dry cough	ABG	expansion	multidimensional staging	sore throat	the subjective perception	coughing	the perceived level	frequent awakenings	fear	respiratory effort	physiological arousal	absent fever	systemic edema	hypoxia.8	outcomes	any activity	the inspiratory muscles	subsequent sense	alternative causes	disturbance	the absolute magnitude	pulmonary capillary wedge pressure	requirement	sputum expectoration	mild exercise	recurrent exacerbations	induces cough	phencyclidine	’ reports	vital signs	Symptomatic patients	Inspiratory muscle fatigue	view	hospitalisations	wave	complain	any other reversible cardiac causes	a clinical trial	symptom	maximal exercise intensity	This pattern	the test	chlade	The intensity	strength	mechanics	The perception	the dominant descriptor	difficulty	the anxiety	reduced work	Perception	The usual symptoms	points increase	leg muscle oxygenation	active mobilization	family heart disease	the following conditions	expiratory volume	spontaneous breathing	
A provisional diagnosis	normal lactate values	
an ethanol metabolite	deprivation therapy	short-chain fatty acids	the chronology	The resulting R-values	no normal mucosa	Intra-uterine contraceptive device	standard deviation aData	the proliferation	azoxymethane	Monoexponential clearance rate	a key metabolic pathway	chronic granulomatous iridocyclitis	metabolites	the incorporation	fatty acids	an expanded disability status scale	relapsing-remitting multiple sclerosis patients	source	colorectal carcinogenic substances	choline	the predicted production	γ-aminobutyric acid	significant effect	clínica	propionate	lesion growth	propionate production	adenine	the chemoattractant receptor	oxidative metabolism	the conversion	low rates	isoflurane	oxidation	High production	p >	a δ-opioid receptor agonist	copaxone	μg·kg−1	Both patients	pyruvate	the graph plotter	mCRPC	//www.clinicaltrials.gov/	vivo canine studies	historical controls	a phosphate	commensurate accumulation	gluconate	androgen synthesis inhibitor	rat colon carcinogenesis	acetate buffer pH	carbonate	methyl ester	The headache	oenanthate	

the behavioral effects	cephalic vasodilatation	The behavioral effects	
esterification	patient specific cell sources	hair follicle cells	
both represent reasonable first-line therapies	heart rate control	nitroglycerin	inotropic effect	hypertensive children	sodium nitroprusside	The pharmacokinetics	a mixture	cardioplegia	a beta sympatholytic drug	a short-acting beta-blocking agent	blood pressure support	metoprolol	pharmacokinetics	L-type Ca2+-channels	an ultra-short-acting beta blocker	opener effect	small series	:684	

body myositis	McArdles disease	
vasodilator	intramuscular administration	cardioplegic crystalloid solution	A controlled double-blind trial	

the abdomen	subpleural patchy air space consolidation	lung function tests	the systemic veins	partial seizures	temporal bone	the thorax	
pseudoaneurysm formation	the nasal passage	secondary organ dysfunction	a need	contrast-induced nephropathy	voiding	instrument	tranexamic acid	Location	the compensatory hypertrophy	erosion	ruptures	hypothermia	air embolism	short hospitalization	necessary anticoagulation	brachial plexus injury	cellulitis	the vWF	The primary safety outcome	secure time	a bronchial artery	ulceration	green line	The falcine meningiomas	problem	incisions	renal insufficiency	the forms	bleeding-related event	impaired wound healing	no patient	convenience	fluid exudation	the first postoperative 24-hour urine volume	both criteria	thrombosis	safety profiles	the skull base defect	pneumothoraces	the problem	the multiple micro-clots	air entry	bronchoscopic suction	prospective studies	Fem-Fem support	viable platelets	69-year-old male patients	paravalvular regurgitation	right ventricular dysfunction	nosebleeds	mucosal ulceration	Both recurrence	air leak	arterial injury	romiplostim	tension-free exposure	small nasoseptal defects	regular blood tests	postoperative course	unwanted teratogenicity	major complications	tissue injury	both scores	thrombosis.27	gums	other sources	the hospital mortality	postoperative hematoma	appropriateness	re-operation	malaria	increased quality	regurgitant jets	thrombosis Essentials	aortic insufficiency	a spinal cord granuloma	recurrent cardiac tamponade	blood transfusion	the sex difference	the biopsy site	clot formation	frequent local events	interquartile range	an increased incidence	subarachnoid vessels	skin irritation	intermittent hyperanticoagulation	The source	subsequent re-exploration [	sternal wound infection	the post-operative period	a small amount	uremic effusion	poor visualization	Western therapy	independent association	consensus documents	this patient population	cardiovascular mortality	important decrease	a post hoc analysis	this claim	simple manual parenchymal compression	adequate oxygenation.4,10	a composite	urgent intervention	pregnancy complications.13	adverse cardiac events	valve-related reoperation	life-threatening bleeding	severe skin reactions	the antithrombotic therapy	between-group comparisons	gastroduodenal ulceration	the angiographic access site	fibrinogen concentration	an unknown origin	clotting time maintenance	a common cause	increased mortality rates.16,17	petechiae	rare cases	Secondary endpoint	miscarriage	foremost concern	low rate	thrombotic complications	wound infection	acute stent thrombosis	embolisation	perforation	thrombocytosis	the main postoperative complication	The estimated amount	The nasal mucosa	forceps	the scores	antiplatelet treatment regimens	transfusion volumes	malperfusion	unadjusted incidence	a two-fold risk	respiratory dysfunctions	therapeutic control	the score ’	subsequent kidney failure	the expense	esophagus	platelet count.15,16	antiarrhythmic agents	sight	the event	bruising	gastrointestinal side effects	This risk	radiation-induced myelosuppression	transfusion requirements	common first site	oozing	all candidate variables	a glomerular source	location	Each score	probable stent thrombosis	a significant amount	F.-in	soft tissues	low risk	coronary ostia	brainstem tumors	the only indicators	spine surgery	postoperative pyrexia	intramural hemorrhage	hematoma	anticoagulation presents	a small defect	potential damage	thienopyridine	bleeding-related complications	% complication rates.1,2	haemodilution	reports	days post-operation	a measurable risk	long-term anticoagulation	annular dilatation	no bleeding problems	uremic complications	the initial platelet adhesion	sufficient evidence	this procedure	mild dependent edema	thromoboembolism	treatment-refractory hypertension	no evidence	diabetics	any sign	comments	prosthesis thrombosis23	poor cardiac status	concomitant treatment	frequent forms	perioperative prophylaxis	catheter-related complications	AF-related thrombo-embolism	early outcome	paramount importance	placing	Cerebral hemorrhage	direct thrombin inhibitors	significant risk	urinary obstruction	granularity	the additional risks	the mucosal lining	biblical times	rupture	exclusive variables	any other reason	capsule examination	other reasons	a large comparison	conversions	case	recurrent several mitral regurgitation	the nose	combined events	combined event rates	the burr hole prevents air embolism	thromboembolic complications	hemorrhage	a blood transfusion	present exteriorization	postoperative stroke	massive swelling	+	this approach	rhythm disturbances	bleeders	serve	second plasmapheresis	vascular control	polycythemia	the distal anastomosis	common initial symptom	first episode	simple manipulation	serum calcium	the inhibitor titer	increments	a common presenting factor	hemolysis	the obvious hemorrhagic sequelae	All/Any bleeding	the 12-month survival	Failure	mucosal sites	patient stability	bone fracture healing.40	limb-threatening situations	resolution	organ injury	last bout	thrombotic events	the venous plexus	Preoperative chest X-ray shows	massive head injury	Clinical outcomes	The thienopyridines	pediatric findings.200	estrogen–progesterone preparations	the 3-month study period	perforations	facial palsy	unintended vascular perforation	reinfarction	The defect	thromboembolism	haematoma	orthostatic hypotension	other complications	vital sign	abnormal bleeding	prognostic implications	major bleeding	intracranial bleeding	severe hemoptysis	the signs	dilution	a bimodal distribution	Percutaneous occlusion	the top	postoperative thrombosis	no surgical source	a continuous intravenous infusion	the posterior wall	trauma	the potential negative effects	atheroembolism	the entire gastrointestinal tract	both increase	the intent	vWF	localization	audible breathing	serious device-related complications	hemostatic management	infection post	subcutaneous emphysema	jeopardize inner	chronic idiopathic thrombocytopenic purpura	wound rupture	ischemic complications	the rates	any reason	distal limb ischemia	aortic cross-clamp removal	severe complications	the positive results	a high probability	pacemaker implantation	the gingival status	unexpected hemorrhage	drug intake	stable hemodynamic parameters	partial thromboplastin time	a single measurable characteristic describe platelet quality	preoperative fibrinogen plasma concentration	sick persons	body image	dehiscence	the limited body	mucosal petechiae	the site	the incidence transfusion	a revision	spontaneous subcutaneous hematomas	every patient risk	the notable risk	periprocedure-related complications	‘ inadequate rFVIIa trial ’	rebleeding	hemorrhage volume	no hypertension	male sexual dysfunction	sequential therapy regimens	intervention	severe coagulopathy	antiplatelet	vascular volume	tendencies	hyperperfusion syndrome	Familial superficial siderosis	prothrombotic role	necessity	Persistent oozing	difficult operative conditions	clinical attachment level	No mucosal tear	further sources	several complications	some clinicians	serious upper gastrointestinal complications	tissue edema	cross-clamp time	significant scarring	severe coughing	Morbidity	platelet transfusions	paravalvular leak	injection-associated bleeding	diagnosis,5	notable aneurysm expansion	prediction	potential sources	reactivity	pseudoarthrosis	no reliable data	acute renal injury	multiple haemorrhages	conduction dysfunction	the current post-aprotinin era	independent predictors	identifiable source	postoperative atrial fibrillation incidences	loose stools	cardiovascular death	damage	bad drug compliance	dehiscence.73	no surprise	small ulceration	either renal impairment	urological referral	ischaemic stroke	no pericardial effusion	the dissected aorta	tendency	the exact cause	a reasonable option	postcardiotomy syndrome [	the grafts	this measure	disabling bleeding-related complication	clinical types	liver congestion	the technical complexity	thromboembolic neurologic events	the medical records	a reason	% rate	risk	electrical burn	the source	prevent infection	hookworm	CPB-mediated inflammatory response	brain infarction	Rates	other baseline	femoral access	The likelihood	improved visualization	the lips	staple line failure	vascular injuries	definitions.23	a possible increased risk	many kinds	conventional factor products	bile leak	thromboembolic risk	a double dose	that point	dysrhythmia	intravascular coagulation	joint damage,28 reduction	the increased risk	the lungs	deferasirox use	The usual clinical presentation	concomitant coagulopathy	Major bleeding	cardiac arrest	hemorrhoids	this preliminary institutional report	The frequency	limb ischemia	tamponade	frequent reasons	additional hemostatic agents	thromboembolic events	stent thrombosis	masking	the overall incidence	obstructive symptoms	Tumor	the complication	parainfluenza virus	hyperdensity	a balance	a rare source	Many bleeding side effects	cold saline	a large retroperitoneal hematoma	the knee	prosthetic graft materials	:1780	mo	hemophilia	other medical history	the compression	infectious complications consequent	neurological events	aneurysm expansion	the exact site	Intermediate-bleeding-risk surgical procedures	developed infection	patient safety	the amount	s risk	the nephron	hemarthrosis.17,38	serum creatinine	chronic arthropathy	ischemia time	malignancies	observational study	pulse loss	exudation	bronchospasm	thromboembolic disease	additional subclassifications	pneumothorax	massive transfusion	a fibrin sheet	This report	cognitive damage	ischaemic events	vascular complications	total length	coil embolization	haemodynamic instability	heterogeneous platelets	improved control	delayed fracture healing	paO2	‘ bleeding	specific therapeutic algorithms	Superficial ulcer	focal edema	therefore	secondary prophylaxis	fatal adverse events	a distinct source	optimal balance	Complete cessation	Other factors	an essential starting point	dryness	recurrent ischemia	platelet transfusion	some mice	no improvement ’	all modifiable risks	ischaemia–reperfusion injury	acute visceral	
cerebral infarction	head injury	a ruptured cerebral aneurysm	
low-potency antipsychotic drugs	zopiclone	
improved new compounds dasatinib	n=556	impaired glucose metabolism	spot	Both dasatinib	non-tyrosine kinase therapy	either dasatinib	cells/106cells	a 60-year-old woman	vitro resistance	chronic myeloid leukemia patients	dasatinib.36	imatinib	kinase inhibitors	an off-target effect	n=1301	the combination effect	small-molecule kinase inhibitors	prolongation.44	potential clinical activity	dasatinib	sorafenib	bosutinib	informed consent.24	previously,7 nilotinib treatment	second generation tyrosine kinase inhibitor	

chlorpyrifos	malathion	
preserved ejection fraction	a preserved ejection fraction.41 cd59a	Such patients	both midwall	
a recent large intention-to-treat analyses	atorvastatin	Inclusion	**Metformin	insulin preparations	
no skin rash	motor evaluation	hepatosplenomegaly	
the piriform cortex	neurite formation	glial membranes	axonal growth	thick primary dendrites	cell body	astrocyte	
a redox cycler	diethyl maleate	the prevalence	maneb	the adult rat midbrain	the oxidative stress inducer	pesticides	menadione	organophosphate	X-ray irradiation	

the experiment	determination	restrictive ventricular septal defect	end-diastolic internal dimensions	respiratory variation	The septal motion	square root sign	volume overload	severe pulmonary hypertension	the differential effects	horizontal curve	
positive skin prick test	asymptomatic condition	
respiratory arrest	post-cardiac arrest	possible misclassifications	sepsis	gamma-glutamyltransferase	the suicide statistics	aspiration pneumonia	license	anaphylaxis	

self-administration	high lipid solubility	other psychostimulants	sympathomimetics	cannabis	talc	Performance	isometheptine	amphetamine	data varies	gradient effects	phenylephrine	opiates	recreational cocaine use	somatodendrites	amphetamine use	the smokeable alkaloidal form	cue-induced reinstatement	The chronotropic effects	the intranasal use	habitual smokers	propylthiouracil	intravenous drug abuse	accelerated idioventricular rhythm	the aversive effects	living standards	this putative dichotomous effect	users	past alcohol	Long term effects	coca leaves	crack	cocaine-induced reinstatement	pericardial effusions	the psychostimulant effect	ventricular geometric patterns	vasoconstrictive effects	environmental cues	the deleterious effects	mortality rates	fluoxetine	acetazolamide	the psychostimulant	the pathological effects	unirhinal installation	stimulant use	Microinjection	metabolite concentrations	All rats	amphetamine users	sirolimus	antiarrhythmic agent	triptans	marijuana	a blockade	intravenous drugs	increased motor activity	recreational snorting	intravenous self-administration	abilities	sal/sal	ephed- rine	psychostimulant behavior	The encoding	other stimulants	rapid dissociation	Neurochemical effects	2-h study	The data	intracranial surgical manipu- lation	mephedrone	maternal use	glue sniffing	the acute phase effect	symptomatology	and/or tobacco	a recreational use	Flores	anabolic steroids	tricyclic antidepressive agents	heroin use	imaging	barbiturates	polydrug users	Simpsons	the disruptive effects	amphetamine-regulated transcript	tricyclic antidepressants	inappropriate use	–704	adrenalin	peripheral amphetamine	heroin	saline exposures	intravenous methylphenidate	intravenous use	high p-ANCA	classic drugs	a syndrome	evident effects	dystonic reaction	the conditioned effects	deep dermis	heroin polysubstance users	illicit drugs	a moderate ability	normals	the usage	the chronic effect	immunomodulator	the unionized fraction	rhythmic nature	The natural source	a bag	the international context	temporal synchrony patterns	1532-429X-16-262475816110.1186/1532-429X-16-26ResearchLong term effects	substance abuse	the cognitive effects	cocaine-induced behavior	amphetamines	ecstasy	receptor mediation	unexpected death	Spanish version	atherosclerotic effects	The development	the well	cathinone	circumstantial intravenous heroin	metabolite substances	reinstatement	binge intake	specific binding	urinary drug screen	mesoaccumbens dopamine	maternal exposure	the environmental cues	a solution	stimulants	substance abuser	methamphetamine	a single injection	
massive pneumoperitoneum secondary	
strong evidence	
the prognostic poten- tial	mmol/l	particular importance	human plasma samples	biomarkers	The amyloid hypothesis	the assay	cervical mucus plugs	compositional differences	urine	ul	gingival	milk	an absorbent pad	stress-free means	An added benefit	A few promising studies	the blood	serum	versus control	neonates Frontiers	an 8-parameter urine dip test strip	polymer swabs	tear formation	parenteral drug addict patients	bacterial content	The components	impaired pupillary constriction	erythrocytes	acute graft-versus-host disease	bronchial aspirate	stool	the main reasons	milliliter	a diagnostic fluid	hypothyroid	the bacterium	these salivary biomarkers	total ghrelin levels	buccal scrapings	salivary cortisol level	ng/ml	The diagnostic applications	serum biomarkers	the inhalation	intravenous puncture	blood-feeding arthropods	chronic aspiration	the larynx	infected saliva	volatile organic compounds	the oral cavity	Food	impaired sensation	pre-study experiments	young healthy subjects	cerebrospinal fluids	high danger	Methods	manufacturers	urine sialic acid levels	The total amount	The functions	food	crevicular fluid	sweat	hyperthyroid	gastric juice	serum adropin concentrations	quantitative sudomotor axon reflex sweating	viscous18	healthy human plasma	semen	total sialic acid level	gastric juice results	prognostic marker	a major quantity	saliva sample	a stenosis	common manifestations	the constitutional DNA	tumour markers	nasal lavage fluid	therapeutic assessment	further development	The multifarious components	each individual	vitro influenza	blood leukocytes	non-smoker	transdermal exudate	the insect vector	’ s milk	bronchial secretions.5	jugular venous blood	gastric reflux fluid	clinically-relevant information	a Patient	the flow	methylene blue	body fluids	tears	plugs	anthropometric measurements	No/infrequent swallowing	gastric biopsy	the terminal oligosaccharide chain	the aforementioned lesions	this ratio	serum adropin levels	periodontitis patients	the non motor symptoms	scavenger molecules	contamination	the skin barrier	plasma data	exocrine secretions	tumor lesions	intra- and/or	various amounts	Swallowing	gingival tissue	The clinical usefulness	secretions	plasma samples	faeces	drooling	danger	output	salivary cortisol	Instructions	a non-invasive diagnostic tool	tear production	breast milk	useful clinical information	this time point blood	this unique context	heads	these gene polymorphisms	
skeletal fractures	progressive deformity	pain scale	low hip	callus volume	pelvis	intact transverse ligament	angina	the bearing	postmenarcheal tennis players	a small animal model	non-union repair	the ossicular chains.5-7,19,20	chondrogenesis	anabolic treatments	the treatment arm	increased osteoclast activity	the femoral shaft	shriveling	contralateral femora	a duplicate set	a dramatic increase	prostate	long-term mortality	no focal differences	slight comminution	the basic mechanism	hypercalcemia	a fundamental understanding	physical examinations	supplemental screw	resorption	the musculoskeletal system	ultimate load	subsequent nonunion	the deformability	a Wnt/β-catenin inhibitor	spondylolisthesis	β-catenin gene deletion	disarticulation	a time point	another sign	host mice	the collum mandibulae	long term	fluoroscopy	axial	medical costs	—a phenotype	each standard deviation decrease	nerve compression	excellent biomechanical properties	control participants	osteopenia	:20	vertebral body	excessive microdamage	muscle weakness	the mechanical competence	a burst fracture	categories	prospective trial	diagrams	high-impact injuries	an indirect link	calluses	the tibia	small retroperitoneal haematoma	paternal history	histology	common injuries	an important cause	plasticity	skeletal event	metastatic spinal cord compression	the thickness	a 2.5-fold increase	the exposition	canal stenosis	patient suffering	shares	rigid immobilization	an annual measurement	a third AGES-based analysis	10-year risk	bone pain histories	the central midface	method classifies individuals	the proximal femur	the cortex	Posterolateral involvement	dislocation	the clinical fracture reduction	impedance changes	no size	a new paradigm	the pool	nonfracture subjects	probability	:1947 –61	callus bone volume	iliac crest	mechanical forces	Serious adverse events	the human mandibular condyle	the morbidity	the slope	long bones	the main trabecular scaffold	<	hypophosphatemia	the full texts	This paper details	the condition	high risk	local stress	non-fracture outcomes	periorbital hematoma	tSAH	a residual spastic quadriparesis	mechanical modulation	Tissue	the enhancement	↓ vertebral fractures	the right temporal bone	rotation	the vertex	the clinical application	fractures	Fracture	spine fracture	mechano-regulation model	The clinical consequence	bisphosphonate treatment	Enhancement	the hemorrhage	Mechanistic aspects	employees	the osteoporotic range	parents fracture	many factors	nerve	aMorphometric vertebral fracture	reliability	skeletal regeneration	bone fragility	quality-adjusted life year	microarchitecture	days post fracture	the confirmation	fixation groups	ribs	Avascular necrosis	a limb injury	malunion	Previous fractures	odontoid fracture Figure	high work	three-dimensional computed tomography	the point	the mouse tibia	trabecular bone score	a second cervical spine injury	related factors	tissue stretch	late sequel	the left ankle	osteoporotic hip fractures	the catheter	Radical prostatectomy	union	all frontal sinus injuries	eventual failure	venous catheter pinch-off	Recent developments	baseline measurements	fracture risk	fast green	common site	mechano-biology	a murine leukemia virus	clear evidence	the heterozygous deletion	OVX	The human cost	small case series	fracture-healing	osteocyte lacunar properties	bone pain	disadvantageous energetic costs	excess comminution	the neck	morphogenetic protein levels	proper anatomical position	The radiographic delay	recent bone	both wild-type mice	body fracture	common sites	an elderly female patient	The fractures	inserted central catheter	the control arm	the diamond concept	moderate level	The serious consequences	a clinical predictor	gene sets	cystic masses	replacement	an error	the ilium.52	kyphoplasty	test method	a poor indicator	patient reporting	the female group	representative image	fragility fractures	parsinterarticularis fracture	% deformation	cerebral hemorrhage	OR	an epidural hematoma	black bars	supplements	a single surgical treatment	local application	primary damage	a non-healing wound	many other parts	maximum expression	Safranin-O–stained sections	all-cause medical costs	the humerus evaluation	The patterns	the pars	a benign	different time-dependent levels	architectural parameters	subject size	bone deformity	insulin-treated animals	prediction models	controllable osteoclast activity	×200 magnification	hardware condition	Osteoporosis-related fractures	the right ear	the callus	cataract	fixed spinal kyphosis	a time	severe glenohumeral arthritis	:97	bilateral pars	the other types	haemorrhage	an infection	Combination	hormone treatment Risk	the anterior surface	a marked reduction	≤–2.5	the contralateral	an accumulation	control ’	the skull	a single entity	orthopaedic surgeries	14-year-old boy	chondral lesions	a significant risk	fragility fracture	early radical surgery	the observed relationship	early-late-stage markers	the baseline	possible dislocation	Members	elasticity	cage subsidence	subdural haemorrhage	surgical data	the reconstruction nail	an initial deformity	Expression	the right	the floor	The biology	fold-change	Gray bars	refracture	skull thickening	a second attempt	osteoblast function	10-year probability	fracture healing	any non-healing wound	implantation	fractureC2 fracturecraniovertebral junction	callus tissue	treatment-oriented classification	shaft	concepts	vivo model	low aBMD	the compliance	the fracture	histologic phenotype	a perturbation	d7	numerical simulation	severe trauma	the growth	major joint surgery	the jaw	lead migration	a 10-year probability	micro hierarchical structure	the baseline incidence rates	the elevated numbers	the human femur	procedural complications	alkaline phosphatase	these threshold measurements	a decreased risk	:1944	distal extremity	human cortical bone	cortical thickness	Cachexia	initial elevation	thinning	elastic characteristics	a significant complicating factor	reduced endochondral ossification	the tissue properties	The number	femoral fracture model	early menopause	a specimen	risk index	increased exposure	the frontal skull base	These findings	gaping	urinary disorders	fuzzy logic model	a herald	shape	traffic accident	machine	the anatomic basis	primary polyethylene wear	the clavicle	a high cervical spinal injury	mice/group	osteoporosis-related fractures	skin necrosis	spinal compression fractures	significant increase risk	tomography-based structural analysis	bone deformities	chipping	d0	the bony septum	recent fall history	inconsistent	non-fatal hip fractures	the determinants	mouse strain	multiple types	excessive comminution	overall outcome	dislocation15	deep infection	doi:10.3171/2011.11.SPINE116 .22225488	no bending	the petrous bone	acronym	molecular biology	hip fracture	pure tension	interest ✓	Top panel	osteotomy	glaucoma.10	5-year incidence	the “	This patient	vitro identification	USD dollar	local bone formation	cost savings	dietary calcium	:491	fingers	the first-cycle indentation distance	the posterior arch	the overall effect	Progenitors	f	in-plane shear	subsequent deformity	acetabulum	bony callus tissues	The key parameters	’ risk	lead function	bone microarchitecture	proximal femur	torsional stiffness	sectional	histological analysis	flu	deformability	Three-dimensional reconstruction	Quantitative µCT analyses	secondary osteoporosis	the left febula	the ring	stability	small animal model	bone mineral density	fixation	infection recurrence	computational simulation	mechanical quality	the components	the crack	characteristic type	rib fractures	the inferior articular process,2	the temporal bone	bone infection	pathologic correlations	increased expression	parental history	QALY	the time course	A mechano-regulation model	implant	bridging	no fracture	the functional role	extrinsic rigidity	biological aspects	dietary regimen	contracture	the prediction	a low lumbar spine	The rat model	neck fractureHip	the ones	a negative regulator	nonfracture groups	Acceleration	inpatient hospitalization	cumulative exposure	magnitude	morphogenetic proteins	the widespread use	representative photomicrographs	the zygomatic bone	The site	5-year risk	the additional risk	a single mode	odontoid nonunion	a fracture	coronal plane	such access	osteoporotic bone	bone formation phases	Injection	secondary damage	the axis	the left femur	total hip bone loss	the chondrogenic phase	diabetes mellitus	a direct link	gray bars	affected newborn babies	the incremental cost	femurs	osteogenic cells	absolute risk	the second cervical vertebra	both femurs	mode	paraesthesia	unclear finding	intravascular retention	dpf	:2167	nonunions	the anterolateral femoral head	the first drop	cervical cord injury	the wedge	the penetration depth	frontal fracture	any deformity	femoral neck	the oim mice	conditional knockout mice	the iliac crest	a diabetic patient	µCT analysis	a selective agonist	all other cases	the χ2 test	significant early complications	fragility	lateral mass	the reduced rate	long-term exposure.2,16	a decreased rate	the quantitative phenotype	morphological parsing	a specific type	the epidural tumor	
schwannoma	An initial diagnosis	mild scoliosis	mucoepidermoid carcinoma	leiomyoma	chondromas	neurogenic tumor	hamartoma	non-complicated abdominal wall hernia	adenoma	radiological investigations	hemangioma	meralgia paresthetica	angioma	the pulmonary parietal pleura	

carcinoma	atypical adenomatous hyperplasia	the model candidate	cancerous prostate tissues	prostatic adenocarcinoma	racial distribution	neoplastic transformation stages	prostate cancer precursor lesions	prostatic carcinoma	PC samples	benign prostatic hyperplasia	the chair	prostrate cancer	precursor	This TMPRSS2-ERG fusion	adenocarcinoma	precancerous prostate lesions	proliferative inflammatory atrophy	benign hyperplastic	the same tumour samples	prostatic adjacent tissues	the transition	
ghrelin	tumor status	end-organ dysfunction	clinical conditions	metabolic reserves	systemic inflammation Archives	transplantation	cachectic cancer	cardiac dysfunction	skeletal muscle dysfunction	gastroesophageal reflux disease	tumor progression	dyspnea fatigue	ptosis	paradox	energy expenditure	metabolic syndrome	lymphocyte proliferation	muscle	impaired renal clearance	cancer anorexia	fish oil	the complex pathophysiology	myopathy	morbid obesity	systemic inflammatory profile	kg/m2	functional similarity	skeletal muscle abnormalities	medium	pulmonary vascular disease	progressive gastrointestinal dysmotility	end-stage malignancy	constitutional symptoms	severe chronic obstructive pulmonary disease	suppress stress-related hormones	The prevalence	osteoporosis	lesions	al	muscle atrophy	respirations	endotoxic shock	the progressive weight loss	The mechanisms	arrhythmias	reduced cardiac output	a major cause	malnutrition	brick dust	fat-free mass	energy wasting	
a priori	
codeine	tramadol	
dobutamine	a pulmonary vascular dilator	intra-arterial delivery	the norwood procedure	rate pressure index	another drug	an intravenous inotrope	vasodilatory properties	intravenous furosemide	alveolar concentration	iNO	filling pressure	continuous dobutamine	positive inotropic agents	cooperative study	rolipram	inhaled nitric oxide	low-dose dopamine and/or dobutamine	the postoperative period	the hemodynamic effects	the phosphodiesterase inhibitors	the mean dose	a phenomenon	noradrenaline	term effects	select patients	a vasoactive drug	enoximone	short runs	mcg/kg/min	0.04-0.08 μg/kg/min	a 48-hour infusion	infusions	good hemodynamics	minimal inotropic support	levosimendan	enteral metoprolol therapy	required vasopressor support	an inodilator	an infusion	procainamide	Vasodilators	h infusion	regimen design	cardioplegic arrest	
early progression	prospective study	situ	invasive bladder cancer	intravesical bacillus	re-staging transurethral resection	clinical oncology	instillations	antibody inhibits tumor growth	long-term followup	previous bacille	versus immunotherapy	intravesical bacille	the chemoresection	:344	:1408	the prophylactic usefulness	00653-1	chitosan/interleukin-12	cancer immunotherapy	high-risk patients	the standard definitive treatment	bropirimine immunotherapy	photodiagnosis	:1283	bMiller	AID-IJC14 >	:1267	invasive bladder cancers	intravesical bacillus Calmette-Guérin response	transurethral resection	:1121	lymphatic spread	:808	epirubicin	routine transurethral biopsy	:787	


Some methodological flaws	involvement	neurology	
Distortions	
A 51-year old female patient	adjusted models	A history	the same associations	subsequent clinical data	
eotaxin	chemotherapeutic drugs	an invasive procedure	The cumulative use	chemical reaction	sunlight produces	prior treatment	a linear dose-response relationship	teratogenic fumes	histological type	tumor cell responses	hardware	adjuvant radiotherapy	approach	improved quality	delivery dependent	:5645	cHL	reaction	other photosensitizers	the issue	hypoesthesia	adjuvant hysterectomy	Interaction	the indicated concentrations	connective tissue disease	receipt	systemic failures	surroundings	such high ablative doses	contrast exposure	health-compromising effects	wall deformity	the advantage	possible risk factors	nonradiation factors	brachytherapy	breast-conserving surgery	occupational exposure	*Hormonal treatment	therapeutic radiation exposure	conversion	quantitative	intravascular catheterization	non-irradiated cells	an antibody	costly guidewire guidance	Exposure/characteristic n	the sun	the antitumor effects	severe chest pain	symptomatic splenomegaly	therapeutic efficiency	chemotherapies	the specific effects	stage II patients	radical doses	recurrent embolization	the radiosensitive organs	malignant plexopathy	the promotion effect	skin exposure	the mathematical calculations	no contrast agent	either additional investigations	The dose range	mastectomy	organic solvents	radioactive tracers	anthracycline	anisomycin	prostatectomy	previous breast cancer	survive standard chemotherapy	an acceptable dose	zone	multiple times	interventional procedures	preoperative irradiation	the tumor volume	a large scale	:1125	Sanders	adjuvant radiation	the double dose	u rabotnikov radiokhimicheskogo predpriiatiia	a science advisory	a few fractions	olfactory brain systems	the survival difference	normal intestinal crypt cells	curative doses	the second	such loop	diuretic refractory	a chance	procedure complexity	weekly administration	environmental pollutants	The convergence	carboplatin	thrill	supportive care	refused chemotherapy	polyaromatic hydrocarbons	the clonogenic sensitivities	the second cancer	a survival advantage	low cost	the standard therapy	anthracyclines	non-steroidal anti-inflammatory drugs	telangiectasia	the first machine	cancer therapy	estrogen hormone	either cystectomy	wound healing	spin	a low rate	surgery Laryngoscope	such risks7	radiation toxicity	The cancer epidemiology	Surgery	cervical syndrome	mechanical force	The paradoxical role	successful antioxidative treatment intervention	important skin side-effects	anti-hormonal treatment	The biological effects	lymph nodes	β-blockade	surgeon	repetitive evaluations	mast cells.89	anthracycline therapy	conduction	many structures	ultraviolet radiation	chemotherapy	standard transthoracic examination	high dose steroids	keratinocytes	a source	high cumulative doses	conventional techniques	doxorubicin-induced congestive heart failure	magnetic resonance16	ergocalciferol	The energy	either PD-1 inhibition	carcinoid	hypertensive rats	chemotherapy drug action	chiroptera	breast cancer treatment	no apparent harmful effect	a promising	gray	ipilimumab	dietary carcinogens	high spatial resolution	fusion gene inhibitor	excessive doses	reproducible alternative	procedural time	simple snoring	protection measures	constrictive pericarditis	conservative surgery	capability	this exposure	Li-Fraumeni fibroblasts	these processes	follow-up evaluations	cyclooxygenases	long scan times	latitude	modern protocol therapies	osteosarcoma cell lines	concurrent chemotherapy regimens	angiographic studies.65	aneurysm diagnosis	cytotoxic chemotherapy	accounts	topical steroids	gynae-cological oncologists	high soft tissue contrast	contrast agents	specific drugs	breast conservation	–798	intravenous contrast	new technological advances	the relevant wavelengths	early biomarkers	surgical oncologists	excess	no risk	principle	magnetic field	endovascular intervention	all asymptomatic diabetics	Intensive chemotherapy	reader expertise	dietary vitamin	admissible duration	a complete course	cost constrains	chemotherapy agents	performance.50–52	no breast compression	treatment-related complications	fluoroscopy time	P-stimulated interleukin-8 expression	Magnetic resonance sequences	adjuvant chemotherapy	included children	kidney cancer	chemotherapy releases	the antihormonals	any area	scheme	substantial doses	drug-induced lung disease	skeletal segments	select use	concern	platinum analogs	haemorrhagic radiation cystitis	the high dose	a thromboembolic event	the prescription	the inflammatory effects	cumulative effective dose	participant numbers—and	radiation treatment.24,25 Patients	a multicenter study	median	high doses	zoledronic acid.89	experimental radiation-induced heart	myelography	an inflammatory plaque phenotype	the substantial dose	The excess risk	concurrent chemotherapy	curative dosing	portal veins	infectious organisms	re-targeting	ideal	unrelated lesions	the pelvis	hematoporphyrin	A significant advantage	the human epidermis	the mentioned exposure	5040-5400 cGy	cervical surgery	a safe modality	allergic contact dermatitis	frontal	radiochemotherapy	dosing schedule	+ve control	mCi	clark.anderson	fold increase	systemic therapies	a genotoxic drug	fractionation	a costly resource	Sphenoid-occipital bone	Japanese women	surgical treatments	midsternal chest pain	any future comparisons	medical treatments	regimen	the recurrence rates	similar information	non-radiation factors	the serial scans	the main pre-clinical studies	splenectomy	the acquisition window	varnishes	genetic background	moderate dose radiation	distal ureteral calculus detection	photofrin-mediated photodynamic therapy	The large doses	few incidental findings	prognoses	the western world	cancer hemotherapy	negligible gadolinium risk	the guidance	a possible synergistic effect	The exposure	metastatic bone lesions	steroids18	moderate doses	cyclophosphamide	aarina	a possible role	nothing	drug response	left ventricular diastolic function	other adjuvant treatment	sensitive cells	the significant amount	the Effects	invasive procedures	anthracycline cardiotoxicity	a drop	high resolution	post-radiation angiopathy	pre-existing urothelial cancer	contrast use	chemotherapy treatment	oligoastrocytoma	providence.org	radiation sequence	antagonistic effects	an in- creased susceptibility	ablative doses	enucleation	Blijlevens	survival rate	serial evaluation	the applied dose	nasopharyngeal tumors	diagnostic procedures	polymer therapy	significant issues	the absorption	the narrow pattern	lymph nodes metastases	the individual patient	equivocal results	chemical	the pelvic lymph nodes	recent surgery	chemotherapy regimen	infections/inflammation	post-therapy surveillance	The individual dose	Surgical stabilization	c-Jun N-terminal kinase	individual ablative high doses	The thioredoxin antioxidant system	surgical techniques	the discomfort	adjuvant treatment	third trimesters.185	intratumoral cisplatin injection groups	unconstrained imaging planes	chemotherapeutic modalities	parallax distortion	the preferred image modality	institution multimodality therapy utilizing surgery	current treatment methods	circulatory diseases	cisplatin	this technique	previous thoracic surgery	tumor cell death	the apex	previous cancer diagnoses	online image availability	an effort	The mean dose	a direct effect	immunomodulating agents	late effects	temperature extremes	hope	surgical resection	an alternative method	hormonal treatment	regions	some combination	The thoracic rib cage	environmental implications	a chemo-radio-sensitizer	definitive therapy	mutation frequencies	another one	segmental mastectomy	lumpectomy	chemicals	aberrations	sunlight	anti-EGFR therapy	followup time	certain immune therapies	combined treatment	The cultured cells	standard chemotherapy	a 3-days long abdominal pain	Risks	recurrence	contrast media	a recent investigation	slight inhomogeneity	an amount	degradation	recurrent infections	heart surgery	chemical factors	inherent selection biases	concurrent gemcitabine	inflammatory responses	a deleterious mutation	cystectomy	The dose	Photochemotherapy	an anti-miR-141	the modality	left-sided posterior occipital pain	genome damage	short latency periods	single fractions	solid tumors	the affected eye	resources	no use	the considerable amount	lack	photosensitization	certain effects	similar survival outcomes	The effective dose	death stimuli	bisphosphonate therapy	biopsy tracts	interference	chemotherapy combination therapy	responsible use	chemotherapy and/or surgery	magnetism	Diagnostic efficacy	Several factors	conventional angiocardiography	antitumor	drug-	erythropoietin	The dose area product	chemotherapy.3	[ 23-26 ]	hormonal treatments	aromatase inhibitor	spine tumor resection	cGy	the second course	that surgery	triple treatment	distinguish extent	surgical oncology involvement	calcifications	neoplasia	pelvic volumes	the injected amount	the conditions	health effects	a breast dosage	pathologic fractures	theoretical equipoise	previous chemotherapy regimens	fibrosing sarcoidosis	% ks	surgical interventions	criticism	the energy loss	a therapeutic dose	Thirty‐five interviews	skin pigmentation ”	the late 19th century	chimera	exposition	mitochondrial superoxide dismutase	the farther	persist	the sensitivity	the movement	sclerosis	selective organ preservation	an ongoing clinical trial	a significant dose	contrast agent	calcified pericardium	mSv	Ösophagus- und	potential benefits	temozolomide	p53 knockout mice	endocrinological reasons	Constant monitoring	unresectable malignant tumors	the limited penetrability	the individual treatments	thermal damage	devoid	dual treatment	opportunistic infection	a complement	advanced non-small-cell lung cancer	value chemotherapy	knockdown	anti-hormonal therapy	nodular lymphocyte -predominant	contrast administration	some uncertainty	low effective doses	photodynamic therapy	underwent surgery	% chemotherapy	chemoradiotherapy	disaster	therapeutic cardiac imaging procedures	hazards	Ultrasounds	the hazards	heat shock	this free breathing	a median stay	drugs/che-motherapy	high amounts	immunogenic cell death	the various chemical	a product	agents.17	associated risks	radiotherapy	the potential additional cost	sarcoidosis	inflammatory plexitis	late cardiovascular effects	the right upper arm	immunogenic chemotherapies	contrast medium	astrocytoma	biological materials	total dose	h postirradiation	The quantity	radiation-sensitive populations	cumulative doxorubicin exposure	several processes	the caret Package	insulin	this experiment	fractions	p38 activation	radiation-free methods	prohibitive doses	preoperative chemotherapy	fragnents	the cytotoxic lymphokines	underwent endovascular embolization	therapeutic levels	significant hematuria	useful image	tomographic imaging	summaries	transducer exposure	hydrocarbons	iodinated contrast	great accuracy	distinct growth delays	harmful effects	medical imaging	a 2nd time	coal tar ointment	adjuvant radiation therapy	coagulopathy	therapeutic procedures	ccRCC	the cytotoxicity	large doses	computed tomography	Both tumor hypoxia	diaphragm structure	hormonal therapy	consumption	the ten animals	cell infiltration	spectral structure	the tumor tissue	
azithromycin	cefpodoxime	doxycycline	a ten-day course	
micronodular pulmonary infiltrates	erythema nodosum	neurosarcoidosis	
tomography-magnetic resonance	iron entrapment	gentamicin	

pancytopenia	that case	joint pains	
an enzyme	subunits	mL buffer	

–222.24439929	nintedanib cancer	The safety profile	cellular activity	a second generation	family blocker	dose escalation study	a 3-week-on/1-week-off schedule	nintedanib combination therapy	continuous once-daily oral treatment	previous combination studies	intermittent	every other week	sequential combination	intermittent schedules	aetiology	nintedanib	a potent anti‐cancer effect	
a cytosine	nucleic acid	hn	cytosine	Duplication	a homozygous deletion	a phosphate group	
no residual deficits	several types	visuospatial impairment	objects	unilateral rigidity	upper limb action myoclonus	drug abuse	ideational/conceptual apraxia	dysarthria	parkinsonism	gaze abnormalities	agnosia	semantic memory deficit	this time	elderly stroke survivors	dyscalculia	aphasia	'alien hand	meals	the close association	clothes	paralysis	Cortical symptoms	the right hand	transcortical sensory aphasia	severe psychiatric symptoms	left-hemisphere lesions	various types	finger agnosia	frequent abnormalities	agraphia	
brass	non-ferromagnetic stainless steel	low magnesium intake	Calcium	silver nitrate	neomycin	carbon	glyphosate	gadolinium	a centralized placement	similar mechanisms	layers	The amount	the gut barrier	gold	A custom stand	chromium	hemodialysis treatment adequacy	arsenic	supplemental dietary boron	atomic number	nitrogen dioxide	the uptake	gray level references	rare earth metals	Each unit	divalent cations	tetranitramine	hsCRP	cigarette smoke	

access services	
trisomy	The consequences	neurobehavioral problems	good success	refractory seizures	bilateral papilloedema	the question- naire	overdose	surgery	mental handicap	a new diagnosis	relevant animal studies	The social sequelae	viral antigens	school absence	language dominance	neuropathy symptoms	l7	addictive drug abuse	the clinical pattern	marriage	The crude prevalence	the basic mechanisms	depth stimulation	Objectives	occult	febrile seizure	The annual incidence	stoke	both headache	All study subjects	drug use	no structural lesions	alcoholism	geographical boundaries	migraine.the patients	a chronic underlying medical condition	psychological origin	macrosomia	serious implications	an incorrect diagnosis	socioeconomic consequences	fMRI evidence	liver disease	:31 –37	other features	drug resistant	prolonged labor	focal epilepsy	special ref- erence	The neurobiology	episodic ataxia	psychiatric disease	the normal state.12	alcohol dependence	short duration	recent infection	research assistant	the treatment gap	Scropulariopsis brevicaulis	many neurological disorders	unknown cause	etiological features	a video-EEG demonstrating	innate characteristics	mesial temporal lobe epilepsy	voire	a 14-year-old boy	no place	hereditary disorders	abuse	a useful guide	alcohol consumption	abnormal synaptic transmission	a satisfactory estimate	a loner	unknown etiology	focal slow abnormalities	muscle tone	Drugs	electroencephalographic studies	increased duration	the prevalence ratio	endocrine	elderly persons	electric source	Parents	the new drugs	antiepileptic medications	important cause	catamenial exacerbation	The mean duration	high frequency discharges	Comorbidities	epilepsy-related factors	A cause	relate	clinical factors	possible epilepsy	associated neurological diseases	other dyssomnia	discrimination	frontal origin	status epilepticus models	Self-reported characteristics	limbic encephalitis	cryptogenic cases	connectivity disruption	female patients	epileptogenesis	etiopathogenetic relationships	supplement	% epilepsy	computed cranial tomography	partial epilepsy	a positive family history	the molecular mechanism	autoimmune encephalitis presenting	newborn distress	social aspects	no role	the socioeconomic impact	a standard electroencephalogram	epilepsy syndromes	new definition	landmark	neoplasm	the affects	hour	loss-of-function	cortical malformation	genetic studies	endophenotypes	altered gene expression	general learning difficulties	some forms	chronic pain comorbidity	faciobrachial dystonic seizures	neurophysiology recording	’ type	different patterns	None	This high prevalence	skull defect	Departments	uses	skin disease	high rates	intoxication	a chance association	macromolecules	treat children	Antiepileptic medication	the reasons	brain tumors	cyclic	cytomegalo virus	cognitive impairments	Modifiable factors	excessive neuronal discharges	neurodevelopmental delay	a convulsive episode	chronic kidney disease	preliminary evidence	hemisphere atrophy	The psychosocial impact	The nature	significant others	cognitive decline	Secondary outcome	a 10-month-old girl	nursing home	this association	a chronic neurological disorder	nearest-aged siblings	cytomegalovirus infection	drug	first incidence study	second relatives	individ- uals	the main etiologic classification	all new cases	economic impact	drug treatment	operation	The unique feature	olfaction	The imaging findings	medical cost	caregivers	Sudanese children	different severity	perisylvian localization	psychobiology	stigma	a prior history	olfactory phenomena	structural/metabolic causes	Any form	Real-time polymerase chain reaction	digestive tract hemorrhage	some typical onset	benign nature	alternative medicine use	dopaminergic circuitry	behavioral comorbidities	cryptogenic epilepsy	pocket burdens	molecular features	intellectual function	electrolyte disturbance	panic attacks	motor	language disorder	The recent definition	subtle cognitive deficits	both migraine	metabolic brain injuries	the overall population	schizophrenia patients	little attention	income	neurological symptoms	% females	Identification	the survey	cerebral toxocariasis	headaches	the world	infantile onset	macrocephaly	pathophysiological relations	juvenile	other dementias	Marks	non-ADHD counterparts	transverse myelitis	neurological diseases	65-year-old woman	autism spectrum disorders	sensory-evoked neurovascular dynamics	The family history	neurophysiologic features	Edinburgh	cerebral cortical neurons	the major psychiatric disorder	reflex seizures	the optimal time	current receipt	a licensed clinical psychologist	additional pain	acute models.12	worsening course	this aspect	secondary generalized epilepsy	the time delay	mild migraine attacks	syndromes	Macroglossia	neuropsychiatric disorders.6,7	somatosensory responses	intelligence	an increased prevalence	mental-motor retardation	a 25-year-old male patient	possible diagnosis	carbon monoxide intoxication	epileptic fits	the annual cost	transient motor deficit	febrile convulsion	primary specialty neurology	a case-control study	important modifiable risk factors	Drug-responsive epilepsy	a fluctuating course	a comorbid	the cost	recurrent seizures	structural anomalies	The psychiatric comorbidity	a statistical point	the unnecessary use	tumour surgery	etiology	non-epileptic attack disorder	consecutive male patients	methodological problems	the childhood onset	The stigma scale	neuroanatomical human studies	adult-onset unprovoked seizures	treatability	pharmacology	infantile spasms	the medical treatment	global developmental delay	epileptiform discharges	consecutive children	lifetime substance abuse	involuntary laughter	focal epilepsies	genetic etiology	permanent lesions	et al14	sensory processing abnormalities	median years	p=0.8	All children	several subsets	calcium channel gene	different kinds	non-drug-resistant seizures	mis-diagnosis	occipital lobe epilepsy	anxiety disorders	excessive anticonvulsant medications	major depression disorder	chromosomal translocation	fMRI timecourses	ketogenic diet	5-40 %	productivity losses	:322	good consistent control	% male	All subjects	neurological impairments	the adult population	textbook	the main drugs	antiepileptic drugs	psychomotor retardation	the ictal recording	common cause	infarct size	the broad classification	insular lesions	] Women	dioxide	an unnecessary component	diabetes.43	form	both cerebral palsy	reversible causes	abnormal movements	amygdala stimulation	depression.19	social outcome	the epileptogenic region	the following indicators	condition	epilepsy surgery outcome	probable alternative explanation	idiopathic photosensitive occipital lobe epilepsy	vision impairment	uncontrolled cases	a confident diagnosis	:112–123	population-based epilepsy incidence	possible molecular expression	postictal	a controversial topic	cognitive effects	cerebral metabolism	electroencephalographic features	extrapyramidal disorder	a cluster	recurrent febrile	microcephaly	idiopathic epilepsy	longitudinal study	this reason	a heavy burden	other musculoskeletal abnormalities	prognostic	multiple medical comorbidities	Migraine-like symptoms	bipolar disorder	drug-resistant epilepsy	post maturity	work capacity	cognition	all respondents	sensory processing disorders	the comorbid presentation	unprovoked seizures	mitochondrial diseases	identification	coverage	seizure	middle income countries	People	:224-230	the genetics	liver	these latter sensations	depression Neurotherapeutics	seizure types	n=15	associat- ed	photosen- sitivity	consideration	the first case	frustration	other people	pilocarpine	employment consequences	spectrum disorders	the interactions	health system	Late-onset epilepsy	all pediatric patients	febrile	epileptiform	layperson	lateralization	suggestive clinical evidences	an approximate cost	cerebellar ataxia	The economic cost	focal cortical dysplasia	a manifestation	involuntary movement	medical aspects	the co occurrence	cortical inflammation	moves	an implantable loop recorder	normative controls	] neuroinfection	an anticonvulsant	complex multidimensional consequences	different etiologies	slow wave discharges	seizure frequency	One-population-based study	potassium channel gene	the final diagnosis	community-dwelling elderly cohort	chronic headaches	hippocampal discharges	recessive disorder	cardiac arrhythmias	the annual costs	intellectual disabilities	cardiovascular function	medical records	olfactory aura	strategies	initial insult ”	a prevalent study	rights Atlas	mindfulness techniques	insom- nia	cannabinoid-induced cataleptoid state	right-	An accurate assessment	the economic impact	a new observation	unprovoked seizure increases	morbidity rates	−4.0	functional organization	digestive tract	a striking example	Other experimental microarray studies	:183 –186	the search strategy `migraine	a layperson	epileptic syndromes	the presumptive diagnosis	context	the new definition	other central nervous system diseases	global expression profiling	the elderly patient	a broad assessment	all aspects	cognitive problems	e1002129	childhood absence epilepsy	cavernous malformations	verbal communication	Syncope	The understanding	choice	etiologic class	:428 –43 .10.1016/0013-4694	neurally-mediated vs. patients	new-onset unprovoked seizures	dual pathology	the recent observation	definite cases	other disorders	tropical countries	the out-patient basis	an epileptic syndrome	syncope	contagious disease	the challenges	the true impact	restless legs syn- drome	Holmes	patho- physiological interaction	epileptic seizures	the clinical parameters	autism spectrum disorder	a graduate student	epileptic seizure	magnetization transfer ratio	a high-comorbidity	treatment strategies	future development	febrile seizures	photosensitivity	a particular variety	progressive cortical dysplasia	a skull defect	neurodegeneration	temporomandibular dysfunction	tic population	peripheral neuropathy	acid decarboxylase deficiency	vertigo	auras	lorazepam	dysrhythmias	parasagittal parietooccipital polymicrogyria	post-traumatic seizures	cortical atrophy	temporal lobe resection	cHypertension	a cardiovascular cause	severe mental retardation	Roberts	other neurological disorders	occipital spike-wave complexes	atrophic kidney	Miscellaneous Disorders	The history	altered levels	congenital heart	refractory types	intangible costs	multiple drug resistance	resource-poor settings	congenital unilateral brain lesion	seizure disorder	postoperative outcome	complex clinical manifestations	neurodisabilities	several neurological disorders	parental stress	a full control	little information	intellectual disability	side	relaxation therapies	rational management	functional brain	many causes	botulinum toxin clinics	The final etiology	the judicious interpretation	motivate	X-linked mental retardation	cerebellar degeneration	advances	a record	remote areas	troublesome headaches	known patients	intractable epilepsy	stro kes	:285-300	this bill	'duration	drug ingestion	movement disorder	general practices	dysthymic-like disorder	logistic regression analysis	an acute stroke	anti-epileptics treatment	carotid endarterectomy	+64-3-4797245 Fax	predictor	a consensus	other neurological impairments	complex partial seizures	postural control	caesarean section	obstetric care	mesial temporal lobe sclerosis	fanconi anemia	status epilepticus	hemicrania epileptica	active non-drug epilepsy	a proximate well-known provoking cause	rare causes	a kainate model	–214	explanation	mind	a possible modifying effect	a stroke	an epidemiologic study	hypo- thalamic	unstable depressive syndrome	distinctive aspects	a defined adverse event profile	obsessive-compulsive disorder	psychosocial correlates	distress	other injuries	monoparesis	action myoclonus	incidence studies	drug-resistant patients	basilar migraine	genetic etiology.14	autism	the illness	common etiology	only brainstem features	The total costs	the direct costs	the defined course	no studies	The pilocarpine model	this group	pharmacoresistant epilepsy	the main focus	human patients	substudy	financial constraint	breakdown	secondary forms	unprovoked seizure	the high frequency	a serious diagnostic challenge	metabolic abnormalities	A family history	cardiac pacemakers	reduced seizure control	direct cost	absence epilepsy	ragged-red fibers	neurological problems	the recognition	musculoskeletal problems	Direct costs	% respondents	some epileptic syndromes	amyotrophic lateral sclerosis	outpatient epilepsy clinic	nonepilepsy populations	pain syndromes	drug/alcohol dependence	various cardiovascular diseases	few studies	presurgical evaluation	alcohol abuse	unpredictable episodes	a starting point	speech defects	the associated therapy	cardiac arrhythmias.1–5	The cause	appointment	modifiable risk factor	the poor school performance	The economic burden	second year	major psychiatric conditions	an unknown psychiatric illness	correspondence	similar techniques	epilepsy syndrome	histological similarities	negative attitudes	viz	:621-630	the introduction	prognostic significance	potential side effects	someone	The borderland	brain injury	leigh-like syndrome	mental sickness	chronic anticonvulsant therapy	health care	the report	primary mental retardation	2- positive family history	the specific connectivity	chronic liver disease	unexplained syncope	photosensitive occip- ital lobe epilepsy	editor	the outpatient clinic	Methodology	convulsive syncope	prevalent	possible ”	Sudanese patients	clinical suspicion	breakthrough seizures	estimation	4-family history	febrile convulsions	generalized seizures	other organs	Epilepsy	utility measures	focal idiopathic epilepsy	neurodegenerative diseases	Frequency	intractable cases	haemangiomas	first seizure	Mutations	neuroradiologic evaluation	space	treatment practices	the various ion channels	Cost	the acute stages	psychotic symptoms	neuropsychiatric problems	a mixed group	clinical study	seizure type	seizure history	developmental malformations	frequent seizures	a single case	wide phenotypic variability	pregnant women	migraine	scope	vitro model	little investigation	a high risk	a substantial proportion	clear diagnosis	acute symptomatic seizures	predisposing	asthma comparison	head trauma	monogenic recessive disorders	The exact prevalence	regular drug intake	these issues	suicide versus mortality	Age-specific incidence	a functional model	unknown/genetic etiology	lobe epilepsy	neuro-developmental disorders	the consultation	significant association	high frequency	childhood febrile seizures	the clinical patterns	particular attention	magnetic source imaging	a brain tumor	'intelligence	the anti-migraine anti- epileptic agent	education study	dyslexia	long-term heavy alcohol users	a disruption	memory span	each subgroup	intracranial neoplasm	neurological outcomes	subspecialties	sustained seizure freedom	the risk epilepsy	ethnicity	coexistence	:308-313	the different types	new onset seizure	These databases	mean ~7.5	the annual mean incidence	precise lesion method	observational epilepsy study protocol	tumour	other chronic conditions	resonance imaging	prior occurrence	mental retardation	medial temporal lobe ischemia	mean duration	impact seizures	Circadian influences	frontal lobe epilepsy	:313	behavioural problems	true misdiagnosis	la	Nigerian children	bladder incontinence	social effects	congenital nystagmus	haemolytic anaemia	the types	an initial misdiagnosis	seizure outcome	chronic pain syndromes	population-based incidence	cortical dysgenesis	the Late Stages	outcome study	sodium valproate	calcified neurocysticercosis brain lesions	cross-talk	cardinal symptoms	manganese concentrations	a delay	fundamental understanding	thyroid disease	no seizure	various disease states	first unprovoked seizure	anticonvulsants	the natural clinical course	nonepileptic seizures	depressive illness	a well-known precipitant	other central nervous system	clinical correlates	occipitaltemporal lobe epilepsy	glutamic-acid-decarboxylase autoantibodies	the terms migraine	a direct outcome	an urban epilepsy clinic	the early stages	the pathophysiological mechanisms	a median age	secondary-care management	nerve stimulation	other neurodisability disorders	primary documentation	The cost	genetic aspects	the incidence rates	glaucoma	cardiac examination	important neurological conditions	The immunohistochemistry	Magnetic resonance scanning	defined populations	temporal lobe epilepsies	autonomous entities	systemic complications	prospective observational study	drug-resistant seizures	the primary features	mesial temporal sclerosis	fetal alcohol syndrome	the economic burden	The high comorbid prevalence	Another group	life-threatening complication	neurological impairment doubt	epidemiological indices	prior seizure control	a maternal aunt	The blood-brain barrier	occipital focal idiopathic	veterans	brain atrophy	seizure-associated disorders	Veterans	//www.ncbi.nlm.nih.gov/pubmed/15582847	headache/migraine	normal control	The border-land	genetic models	organic brain dysfunctions	al study	coupling	hypothalamic hamartomas	the same category	year.2,3	Some proportion	psychometric analysis	The subjects	deep brain stimulation	the seizures	seizure control	all types	quadriparesis	Europace	uncommon causes	the international bureau	long QT-2 syndrome	no acute brain process	sodium diphenyl	immune-mediated mechanisms	indirect costs	histological preparations	the bidirectional relationship	specific factors	neurotox- icity	treat people	leprosy	intractable partial epilepsy	consecutive cases	These differences	a preventive effect	juvenile subjects	ammonia toxicity	serum electrolytes	atypical presentation	intractability	the top common conditions	some people	a progressive increase	particular reference	Seizures	cleft palate	perspective	a critical review	benzodiazepin intoxication	frontal lobe	clinical pediatric neurology	gabapentin	a phenotype	the countries	assessments	sessions	an autosomal dominant neurocutaneous disease	patient populations	The costs	gastric ulcer	These subjects	The pathophysiological mechanisms	indirect sensitivity	1- normal development	The etiologic classification	this review	financial pressures	attention deficit hyperactivity disorder	The clinical course	
cells	precursors	the dipeptide	collagen type	homocysteine	total glutathione	nucleotides	pyridoximine	a free-radical scavenger	sulfatases	the calcium oxalate accounts	Medical Aspects	intravenous forms	abundant water-soluble organosulfur compound	favorable pharmacokinetic properties	reduced-glutation	Substitution	matrix metalloproteinases	nutrients	thiol groups	glutamic acid	S-nitrosylation	cysteine precursors	a tumor suppressor gene	arylesterase activities	glutathione oxidation	prophylaxis	plasma total homocysteine	this discussion	metallo-	total plasma glutathione	2-Cys peroxiredoxin	methionine	sodium bicarbonate infusion	the denitrosation	glutathione levels	A total	struvite	a thiol- containing antioxidant	The effect	arginine residues	an amino acid change	paraoxonase-1 activity	cysteic acid	arginine	carbamidomethylation	transient	protein acidic	cystathionine	Cost-effectiveness analysis	plasma methionine	serine proteinases	sulfenic acid	glycine	leucine-rich repeat protein	glutathione	the desulfhydration	reactive species stress	distinct roles	aspartic proteases	binding	additional modifications	reactions	the β-chain	cystine	replenishment	the p50 subunit	the relative contributions	Clinical pharmacology	immunosuppressive agents	motif	the formation	each family	lung resection surgery	glutamate	human plasma	serine proteases	a relaxant effect	a carboxyl group	cysteine/glutathione deficiency	the catalytic activity	aspartic proteinases	tissue-type plasminogen activator	taurine-	a mutation	cellular survival	animal source	mM and/or ethanol	The color	
the adolescent knee	the autologous cartilage	third generation	The first autologous chondrocyte transplantation	cartilage defect	chondroplasty consists	technical note	equine articular defects	:71S	competitive athletes	/mosaicplasty	autologous chondrocyte transplantation	encouraging results	,5	microfracture	Mean size	combined autologous bone grafting	
the neurobiology	socio-demographic status	food consumption	erectile function	exocrine gland secretion	brainstem expression	the detailed questionnaire	antidepressant effects	sexual debut	previous medical history	other domains	previous diseases	

anticancer chemotherapy	anticancer drugs	the distant recurrence	
squalene	important mitochondrial function factors	other mitochondrial metabolism intermediates	mtDNA maintenance	carnitine	garlic extract	multicomposite	alpha-tocopherol	a large dose	aminoacid	the antioxidant activity	creatine	a migraine preventive	a well-defined role	The plasmatic levels	The potential use	the study groups	applications	a double bind	hypotaurine	an energy source	banaba	folate	artichoke	streptozotocin-diabetes	vit	cardiac disease	nmol/g protein	marked lipophilicity	mitochondrial cocktails	riboflavin	a pharmacogenomic study	the participation	a similar trend-to-depletion	
the nurse specialists	interests	Cardiogenic shock	The entity	
polyethylene glycol	polymyxin	Volume fractions	kDa fluorescein isothiocyanate	surfactant	transepithelial electrical resistance	natural hydrophilic polysaccharides pullulan	available exogenous surfactant preparations	immunization	mg/ml	processing	meconium	epidural infusion	the endothelial cell	sugars	the molecular weight	lactose	the intravenous injection	the injection	carrageenan	egg	h.	the carrageenan-induced neutrophil migration	nHA	further addition	Ineffec- tive doses	amounts	other oligosaccharides	gelatin	the resistance	All Curosurf-meconium preparations	balanced salt solution	sulfate	ml/paw	fibrin glue injection	An injection	hydroxyethyl starch	high osmolality	the complex anticoagulation regimens	nonionic mannitol	starch	
mg/mL	weekly doses	
the mitochondrial transmembrane potential	the energy production	

mandibular deficiency	
potential	platinum alloys	cobalt alloys	poly-epsilon-caprolactone biocomposites	
Lineage marker	
poloxamers	benzyl alcohol	dibenzoate	



paroxysmal nocturnal haemoglobinuria	cDNA	eculizumab	overlooked condition	the erythrocytes	transcripts	discolored urine	decay-accelerating factor	abdominal complications	the granulocytes	lysis	Phosphatidylinositol-linked proteins	paroxysmal nocturnal haemoglobinuria-associated thrombosis	
Only patients	alternatives	nephrology	various aspects	gynecology	medicine	urologic oncology	reconstructive surgery	other surgical specialties	the evidence-based clinical practice	major domains	urinary tract diagnostics	the department	robotic radical prostatectomy	upper urinary tract cancer treatments	nascent	an integral part	several international societies	intestinal surgery	nerve repair	The significance	the departments	uro–oncological surgery	neurogenic urinary tract dysfunction	public health epidemiology	oncology	common solid neoplasm	postoperative complications	recto-vaginal fistula	this field	the scope	medical oncology	other specialties	the full potential	the evidence-based practice	specific alpha-1A/1D blocker	tandem	

epidemiologico e clinico	gene variation	dihydroergotamine [	rizatriptan	naproxen sodium reduces recurrence	
A third agent	antifactor	the same indication	subsequent weeks	edoxaban [	regulatory approval	dabigatran initiation	practice use	edoxoban	edoxaban	major bleeds	The rates	risk [	a large clinical trial	dabigatran	heparin	information ]	a selective fXa inhibitor	double-blind comparison	a direct factor	an advantage	the anticoagulation effect	

the long arm	transcript structure	spi1 genes	human chromosome	

angiotensin-converting inhibitors	flow time	high sensitivity	
a mAb specific	
thrombocytopenic purpura	structure-function relationships	immunoglobulin	systemic lupus	primary immune thrombocytopenia	alpha-2b	Cines	classes	adults patients	lymphadenitis	immune thrombocytopenia	cutaneous mastocytosis	systemic lupus erythematosus	A 36-year-old lady	understanding platelet production	progressive pancytopenia	intestinal ischemia reperfusion injury	the soluble tumor necrosis factor receptor	A 70-year-old man	hydroxychloroquine	proliferative lupus nephritis	Japanese patients	American group	graft-versus-host disease	
hereditary diseases	benign familial infantile seizures	sporadic cases	deafness	hemiplegic migraine	familial hemiplegic migraine	some overlap	identical disorders	
optic disc pallor	chiasmal syndrome	cerebral venous thrombosis	optic disc pallor.2,44–50	papillitis	an ischemic mechanism	subclinical temporal artery involvement	neuroretinitis	the nutrient vessels	An altitudinal visual field defect	subclinical temporal artery infection	rickettsia conorii infection	altitudinal hemianopia	
pronator quadratus	
the bispectral index	rSO2	bilateral monitoring	cerebral oximeter	
exclusion criteria	promoter sequence	detail	unitary pseudogenes	coronary stenting	pretreatment	cognitive complaint	other research groups	lung involvement	the interna- tional classification	hMDMs	a block/section assessment	This work	endoscopic sinus surgery	the period	mL.kg-1.min-1	theta	reagents	flumazenil kinetics	homocysteine concentrations	high-risk families	gene variants	the large inversions	first-line treatment	periareolar fine-needle aspiration	procedural reasons	hospital level	tumor necrosis factor-α	collagen cross-links	Experiments	the central laboratory	intergenic spacer	X-linkedicthyosis	all-trans retinoic acid	long-term reconstitution	a batch analysis	murine tumor cell lines	a concern	IL-2 binding assay	any other clinicopathological feature	plot	a sensor	a ductal lavage specimen	seasonal distribution	the bilateral posterior medial	image processing	a universal newborn hearing	Quantitative reverse transcription	conjunction	rearranged immunoglobulin/T-cell receptor genes	clinical usefulness	disease cohort	unadjusted 1-year survival probability	biological specimens	aberrant expression	each pre	the phenotype	common upregulated genes	homemakers	knee arthroplasty	fundamental importance	binary variables	the middle aged	neuropathological data	base resolution	the individual relationship	multiple genomic signatures	c-Myb protein levels	fine particulate matter	an iliac bone metastasis	patient/caregiver self-report	arcsine units	broad categories	An Approach	chimes	tumor-draining lymph nodes	theta power	human endogenous retrovirus-W env	a 10-year experience	inter-observer variation	epirubicin-treated women	metaphases	respiratory leukocytes	site relationships	human atrial fibrillation	deletions/duplications	multiple mRNA markers	hereditary prostate cancer linkage	stratified subgroups	antigen expression	derivatization	weak associations	normal lung	muscle biopsy	intracellular markers	a different result	metastatic colorectal cancer cells	cine	gene ontology	eventual systemic availability	a worldwide database	genetic alterations	experimental design	the simultaneous generation	Notation	cysteine	water maze training	experimental groups	laboratory risk factors	the blood oxygen level dependent	technical problem	cell homogenates	The top panel displays results	secondary tumors	cellulose acetate hemoglobin electrophoresis	peri	splice variants	implementation	supernatant	bone biopsies	the internal microstructure	the injection minutes	the excellent predictive power	therapeutic decisions	immune markers	the potential importance	commercial conflicts	steroid naïve patients	tooth extraction	brain membranes	vi	the tyrosine phosphatome	a urine specimen	myocardial protein expression	therapy-driven clonal evolution	extracellular microparticles	a moderate overall reproducibility	time-of-flight mass spectrometry	words	beneficial lowering	oral cavity	the specificity	thoracotomy	heart rate indicates	organ procurement	the international society	sudden deaths	the values	stage group	post-hemorrhagic shock mesenteric lymph	miRNA-21/125b/181a/193b/223/363	peak spectrum	per-protocol	both acquisition	Statistics	co	additional immunohistochemical stains	the same imatinib-combined chemotherapy	facial morphology	A 73-year-old man	the final date	prostate-infiltrating lymphocytes reveals	functional outcomes	changes	the seed region	group-wise differences	capture hybridization	variance techniques	mAb	human white matter architecture	Literature searches	the incremental diagnostic sensitivity	the initial association signal	Training	event	work loads	27+/-4 months	orexin	refractory cases	software	the final manuscript	the garlic group	quantitative trait loci	a restriction enzyme	specific immunoreactivity	A test power	The information	description	miRNA extraction	Determinants	relevant level	The predictive value	The inability	sequence variations	Such integration	data identification	autosomal dominant hereditary ataxias	rats	pulmonary function data	two-dimensional echocardiography	writing	Student	the side-to-side differences	dissociated proteins	Biological sample	nucleotide sequencing	the multiple linear regression	nephelometry.16	the prognostic factors	Time periods	the sudden cardiac death	A false discovery rate	the follow-up	separateness	kb cosmid	group differences	repairs	frequent exacerbations	harmonic phase	left internal mammary artery	leukotriene	hemocytometer	a normal concentration	erythroid cells	bone turnover markers	Immunreactive proteins	etiology.38,40–42	the subjective question	expressed sequence tags	the preclinical detectable phase	early- versus late-stage	graphs	whole cell lysates	intra-observer variability	different exons	the mean	technicians	the difference	covariance	patient survival	creation	each level	myeloid leukemia	diastrophic dysplasia sulfate transporter	the strain variables	connexin expression	κ-deleting recombination excision circles,20	prediction regions	histologic grade	some exploration	cholesterol	the biceps muscle	patient recruitment	underwent electroencephalography	failures	rearrangement	Secondary analysis	dopamine receptor binding	the nuclear androgen receptor	the curve	left ventricular wall motion	cytoplasmic staining	the mature brain	topoisomerase	rules	overall morbidity	the coracoacromial arch	a large unselected registry cohort	visualization	kb	these transgenic mouse lines	critical revision	laboratory reagents	patients Annals	Assembly	recommendations	cardiovascular disease mortality	the bone tissue	bradycardic reflex responses	diverse proteins	the time evolvement	quercifolia	performances	biomarker	noninvasive strategies	cancer families	bone marrow sample	mutation	actual patient survival	direct comparison	all coding regions	bone chips	the kids	technegas	muscular dystrophy region	statistics	the experimental immunohistochemistry work	the supervision	bone marrow cultures	nationwide database	the reference tissue	duplicate readings	calibration	similarity index	the waveforms	myc	transcript levels	the precision	the specific problems	microsatellite stability	the involvement	host immune	follow-up data	the general linear model	probes	collect clinical samples	trifluoroacetic acid	experimental autoimmune uveoretinitis	calculation	neural tracts	the incremental tendency	oligodendrocyte proteins	intergenic [	gastric cancer	The null hypothesis	cytogenetic abnormalities	pericardial thickness	acid precipitation	a median follow-up time	washout curves	either intraperitoneal injection	the histopathological analysis	the visualization	gene microarray	numerical solvers	the associated datasets	endoscopic endonasal	other molecular profiles Bioinformatics	miRNA expression	the mineral	the organization	iCycler	serum tumor markers	clarity	statistical interpretation	large impact	spikes	tiotropium versus ipratropium	pCREB protein	molecular marker	univariate	independent prognostic indicators	sodium residuals	the insulin-resistance syndrome	any antiplatelet	blood components	The manuscript	a breast clinic	specificities	the primary efficacy endpoint	disease data	these parameters	further molecular typing	E-stained sections	affinity beads	different biochemical processes	several key features	nagnetic resonance imaging	examined cases	normal gastric mucosa	body weight	transgenic mice	all available electroencephalograms	human respiratory tract tissues	deficiency family members	a primary focus	Qian et al	allele	households	large differences	the next horizons	catheterization	all subjects	the predictor madSD	growth plates	multiple experimental pain modalities	the patient ’	the forebrain expression	bone metastasis	macaque monkey	the trigeminal level	quantitative variable association	the pulmonary innate immune response	fresh bone marrow	the virus burden	bit scale	nucleic acids—the	a data base	mass spectra	paraffin-embedded biopsies	adsorbent tubes	study data	bone micro-architecture	the reference	the data management	a micro–computed tomographic	cardiovascular variabilities	compensation	the transmission electron microscopy	the functional connectivity data	trace	practice guidelines	This loss	the nucleus	Notch-related molecules	min periods	group overall	complex	pre-BMT patients	human eosinophils	all probability	exact calculation	enrollment year	a novel method	non-invasive method	pericardial fluid	clinical scores	seropositivity	response element	c-erbB2	the manufacturer	filipin staining	P-values	the origin	individual data points	phosphorylation status	intermediate filament profile	apical views	virus challenge	Readings	cDNAs	a safe manner	The supernatants	consortium database	an oral cancer tissue microarray	appropriate acquisition	vitro sampling	the women	prospective cohort studies	cell protein	TAT-G-Gpep treatment groups	the primary tumour	scan	this multivariate model	several different parameters	reduced-intensity conditioning regimen	a time domain fNIRS study	several variables	paraffin-embedded tumour tissue	multiple loci	human cytokines	cancer registration notification	these voxels	semi-automated border detection software	sequential samples	steroid use	Pediatrics	pulmonary function decline	the mineral coverage	clinical importance	vital statistics records	cytological examination	a vaginal plug	germline polymorphisms	tumor-infiltrating leukocytes	the cause-specific mortality	statistical parametric maps	subcortical structures	reactivation	ocular samples	fluorochrome labels	clinical samples	outcome measurements	unilateral total knee arthroplasty	Rs1-induced bone formation	non-Māori perspectives	neurodegenerative disorders	these samples	the error pattern	lavage fluid	excellent temporal resolution	pooling	myocardial perfusion	lymphopenia	staining	the microCT measurement	mesencephalic structures	growth plate thickness	Several lines	restrictions	overexpression	lung histology data	useful prognostic marker	pretherapy	technical support	culture medium	echo analysis	disease response	each point	the sequencing fragments	an additional dataset	the rhombomeric raphe units	independent component analysis	the assistance	the height threshold	continuous recording	human papillomavirus	a stratified analysis	gathering	asymptomatic cardiac arrhythmias	prompt separation	acoustic transmission	–1002	the central aortic pressure	salvage	supine	protein extraction	mis	the scan time	untransformed data	TNF-α levels	acoustic reflex patterns	proinflammatory	the nuclear dye	a large panel	transplant conditioning	c-erbB2/neu gene	individual components	diagnostic modalities	surgeries	standardized post-bronchodilator spirometry	international cases	plasma miRNA	temporal trends	statistical significance	The subclass	study groups	digital system	initial findings	hormonal replacement therapy	cancer registry data	intramuscular injection	retention	inpatient service	hearing aid items	the following phases	bands	suprapubic cystostomy drainage	nucleated cells	colorectal cellular transformation	speed response	healthcare system	hematopoiesis	lung tissues	the twenty	additional subjects	the genomics	iodinated contrast medium	meningeal irritation	Categorical variables	p62	the gene activation profiles	the proportional hazards model	df	platelet alpha-granules	within-subjects contrasts	ice	a heart rate variability	the questionnaire	Reverse-transcriptase polymerase chain reaction	an adverse 30-day outcome	preload assessment	the total cohort	p.G2019S mutation	A rejection episode	O-linked glycosylation	chromatin state identifies	paper	time trends	the study design data collection	estrogen receptor distribution heterogeneity	predictive value	model-free baseline	pulmonary vein flow	the computerized selective attention task	the clonal origins	echocardiographic data acquisition	the stocked sample	maximal exercise test	statistical computing	relapsers	optional time-points	final results	focal perfusion abnormality	the human genome Nature	reflections	promoter activity	the mean signal variations	data processing	empirical antiviral treatment	probabilistic models	biomolecular interaction analysis system	pQCT	The Sequenom-iPlex genotyping	carboxyfluorescein diactetate succinimydl ester	the cytoplasm	an independent bladder tumor data set	myocardial blush	urine tests	critical review	the published literature	statistical analysis	cytoarchitectonic probabilistic atlas	grades	magnification x200	cDNA sequence	an analog interface	gene copy number	engine emissions	claim database	artifacts	the function	autopsied cases	neuronal cell death	post-docetaxel plasma/serum samples	kinematics	the representation	Urinary deoxypyridinoline	Functional imaging	continuous decline group	the qRT-PCR gene expression data	multiple myeloma patients	univariate n=3	treatment characteristics	Egyptian respiratory adenovirus isolates	baseline uptake	the tissues	repeat elements reveals	document number	the mRNA level	nationwide experience	the contrast agent	productivity	an aye–aye brain	glucocorticoid-induced osteoporosis	duplication	observers	a definite benefit	the calculated mechanical parameters	Osteopromotive potential	compartment	a large cohort	t test	manuscript	the abstracts	contribution	all brain slices	histopathologic factors	genetic lineage	the protein levels	the independent-samples two-sided t test	chromosome	non-culprit attenuated plaques	the protocol	underwent plasmapheresis	a Drill-Down LC-MS/MS Approach	resorption pits	individual patient data	protein streaks	neutrophil-to-lymphocyte ratio	multi-subject diffusion data Neuroimage	a volume conductor	homocysteine inhibition	the implementation	standard deviations	tubuloglomerular feedback regulation	a brain atlas	mutation c.475C	each interview	the restriction	the automated complete blood count	memory scores	primary data	parameter measurements	the model group	microsurgery	chronic gastrointestinal toxicity	measure	the expression level	robust expression	the baseline scans	the mouse habenula	significant overall trend	left ventricular geometry	t-tests	possible clinical applications	acute myocardial infarction	mucosal flora	fMRI data sets	a 10-year all-comers	the purified 4.8-kDa protein	common mutation	a colorectal cancer	the specific immune response	rCBF	profile data	asymmetry	peptides	the normal karyotype cohort	potential involvement	the entire series population	the intellectual content	waves	descriptive cytogenetic information	an age period cohort	the diagnostic value	epiphysis	multivariate analyses	request	the isolations	drug-active periods	channel genes	reverse line blot	study.Respir	parent-sibling analysis	outpatient stable chest pain patients	regional variability	Immunity	vivo surface electrocardiogram	snap-frozen tumor samples	energy	the anatomical network organization	each vertebral body	randomized clinical tnals	a significant interaction	the high-performance liquid chromatography	epidemiological modeling	storage	baroreflex sensitivity	invasive breast cancer	determine	deactivation	the long control region	the slides	research tool	intragroup	the matched cohort	other common clinical variables	cellular differentiation	a general population	this fMRI paradigm	peritoneal metastasis	a clinical service	influenza isolates	immune deficiency syndrome	lymphohaematopoietic cancers	time domain parameters	inception	other model-based analyses	a unitary disorder	familiarization	ill patients	the immunohistochemistry image	ploidy index	the mass spectrometry study	cross-sectional imaging	advanced studies	fibroblast cultures	two-tailed t-test	sICAM-1	false-negative cases	systemic inflammation	an exponential model	a general linear model	The present meta-analysis	the data extraction	progressive pneumonia	ultra-sensitive kit	normal compact osteonal bone	the influenza	menopausal status	university	urine dipstick	the voxel-based morphometry	bovine tendons	laminar field potentials	tool	plot representation	set	sustained interferon gamma production	The surgical hemostasis	treatment efficacy	cut-off value	inflammatory regulators	the usefulness	invasive ductal carcinoma	the possible change process	bioinformatics	inflammatory	Hodder	angiotensin-converting enzyme inhibitor	the prospective trials	myeloperoxidase deficiency	data management	anti-TRAF6 antibody	radiations	the inconsistency	cerebral tumors	autosomal dominant cerebellar ataxias	The presentation	a recent magnetic resonance imaging	radioisotope cisternography	internal thoracic	the significance	the maximum-likelihood	volumetric system	utilization	print ]	severe valve disease	the reverse	Quantification	suppl abstr	cardiologic risk assessment	a standard error regression	expressed proteins	individual patient-level data	the pores	an initial t-test	electron imaging	a semi-quantitative approach	The supernatant	high-risk subgroup	study	sleep deprivation reveals	anti- Ma-2associated encephalitis	the optimum threshold	high vs low/int	primary testicular	the combined rectified activity	the secondary endpoints	cell cycle	hormonal influence	the spatial precision	septal motion	variance approach	functional brain imaging	national data	aerosols	this tumor type	the left ventricle	necropsy cases	kidney histopathology	quantitative information	fourteen cases	the 1-year follow-up	qualitative variables	this data	tandem repeats	electrophysiologic investigation	an average	the chromogranin	exons	serum cytokines	strand conformation polymorphism	the paper	cm3	the whole section	nonparametric parameters	pyramidal neurons	polar groups	each device	literature review	nasal steroid distribution	Voxel-based morphometry	normal at-risk breast tissue	scans	the ischemic boundary zone	α-SMA content changes	the polymerase chain reaction	medical management	modeling software	intracellular deposits	exhaustive paradigm	cytogenetic features	resp	interstudy reproducibility	prostate cancer risk	varianceAQ	6-month placebo-controlled trials	fluorescence intensity	drug effects	biochemical markers	the mean difference	the nasopharyngeal	sections	stereotactic body radiation therapy	panel	ventricular late potentials	lung mRNA	positive lymph nodes	a standard post-processing platform	the zero	the chromosome	applicable measurements	gene microarray data	vascular skin lesions	gap size	dual-energy X-ray absorptiometry data	bold text	those data	a results	The blood flow	all relationships	enteric infection	the specimens	non-overlapping myeloid immunophenotypes	ideas	uniform study	3.5-ml polypropene tubes	career	a large series	complete medical history	scalp	delayed bone formation	wounded warrior biopsies	clinical/physiological data collection	the coagulation reaction	the left kidney	annotated tumor samples	methylation level	the work time	microarray data management	validated models	] versus	disease-related variables	biplane	v1.44c	Spanish kindreds	proteomics	polymorphism reveals	spots	cell surface detection	the laboratory	those groups	a set	atlas	Point-mutation primers	the UK	diseased brains	Table	differential protein expression	the strain-stress curve	this ethnic group	package	estrogen receptor alpha target promoters	the molecular work	hypercoagulable tests	a brushing effect	genome scale models	recurrent events	a single global delay	this cluster	the predictive value	other variables	other unrelated cases	polymorphism site	prognostic impact	primary biliary cirrhosis patients	:1047	e	the gene	computer-aided endoscopic sinus surgery	lysates	a linear logistic regression technique	recent investigations	increased binding	vascular networks	reconstructions	interrelated variables	fraction	mmp7	primer extension	multi-subject diffusion data	multiple time scale entropy	each subject	Issues	symptom severity	and/or interpretation	acquisition	individual trials	three-year mortality	deteriorators	poor-quality spots	human saliva	Preservation	postictal transcriptional regulation	molecular mass	a local muscular level	study implementation	mucosal-associated intestinal microbiota	eyes	clinical use ”	search	hyperhomocysteinaemia	design	institutional experience	sudden sensorineural hearing loss	Cerebro-spinal fluid	recurrences	mPFC neurons	transbronchial cryobiopsies	an autophagy inhibitor	muscle fibres	noninvasive tests	individual studies	a hypothetical common ancestor	an excitation wavelength	multiple myeloma Nature	data-collection	unpublished data	these controversies	preserved ejection	tumour volume	important uses	the following primers	metabolites concentrations	flame photometry	multifocal prostate cancer lesions	comparative genomic hybridization	The interpretation	Tissue array immunohistochemistry	the protein infiltrate	wild-type	left superior temporal gyrus	indicator	log-rank statistic	The beta-weights	predicted grouping	this manuscript	consecutive rounds	μm2	serum cut-off levels	segment	cortical mechanisms	monoclonal antibodies	reference reagent preparation	transesophageal images	verbal behavior	motion	the literature	mitochondrial ultrastructure	a phase	human malignant ovarian tumors	anteroposterior view	the bone safety profile	reliable optimization	the strokes	distances	thermolysin	the trypsin digest	the epidural spinal cord compression scale	these datasets	The healthy volunteer	the neuroimaging analysis	a priori window	the retrospective validation series	ten cube specimens	correlated cancer sites	image reconstruction	the 6-month adherence measurement period	cellular fractions	the murine	inflammatory gene expression	important intellectual content	the decision	formulation vaccine recommendations	iNOS protein levels	An initial compilation	a small series	functional imaging	small-angle X-ray scattering	prospective collection	variance model	non-parametric ordinal variables	count variables	database management	bone-dominant vs non-bone-dominant recurrence.58	multidimensional image display	tail	encephalitis cases	ocular gene expression	the beamformer weights	reversible tracer binding	p value	apoptotic pathways	The interval	the prostate	the bone marrow	weighted global connectivity	the signal	ventricular function	image morphology	anterior interbody fusion	the tibial proximal spongiosa	initial patients	the glial response	distant metastases	serum markers	pamphlets	class	the autoimmune state	the neurological examination	computational structural databases	the only variable	the transcription factor	Likert-type responses	classifiers	sample preparation	enterovirus	mixed bone metastases	brain inflammation	granulocyte	short chain	The prognostic value	cholangiocarcinoma.22	the regulatory region	understandable index	non-HDL-C levels	a main objective	healthy controls.6	line therapy	pathway	covariance difference	each mechanistic domain	Secondary analyses	post-Code	family members	the colocalization	the carotenoids	The parameters	the injected testes	independent favorable prognostic factors	repeated measures	non-significant trend	integration	copy-number changes	genetic material	the detection rate	the investigators.36	island methylation	A p value	electron micrograph interpretation	regulated genes	a temperature	laparoscopic versus	routine cerebrospinal fluid	other well-known cardiovascular risk factors	unobserved confounding	brain uptake	a total set	This discrepancy	the tumour markers	ciprofloxacin	the peptide	parietal bone osteoblasts	soft meningiomas	the program	translate	anthropometric variables	fluorescence-activated cell	streptococcus pyogenes isolates	family	scholarship	atrial activation	a ΔT1spleen threshold	the covariantes	the maximum score	intracellular	the proliferation pattern	continuous variables	chi-squared analysis	the bands	hospital characteristics	single cells	Clinical diagnosis	gross morphology	fluorescent intensity	The following primers	well-known antioxidants	such tests	the neuronal activation	mean difference	randomised clinical trials	late functional status	noteworthy observation	Some patients	expression levels	prophylactic pegfilgrastim	gastrointestinal cancer	cancellous bone	retrospective databases	the stable state	multiple levels	Independent t-tests	paniculata	dichotomous variables	socio-demographic characteristics	//icatb.sourceforge.net	the planning materials	western blotting	nicotine	genomic alterations	a strong correlation	the antioxidant properties	Fifty-six patients	the cluster-based multiple comparison correction	the codes	cryosection	sympathetic activity	the tolerability/patient preference results	jejuni strain	left atrial appendage occlusion	microsatellite	respiratory gases	chimerism	individual patients	anti-GFP antibody	the distance	the relative mRNA expression levels	assays	non-invasive urine test	Prolonged ventilation	human primary tumors	variance models	transcriptional activity	image work	the cryosections	parametric statistics	densitometric analysis a1	the manuscript	axonal injury	finite element	the subparts	Statistical advice	previous neurophysiological studies	apoptosis experiments	infarct resorption	investigators	incident cancers	case–control study	an overview	a hereditary colorectal cancer	right ventricular dyssynchrony	linear mixed modeling	the xenograft samples	pan-ubiquitin indicates	risk tissues	other ways	chronic ischemic heart failure	biopsy	fold change	this linear relationship	impaired systolic endocardial	any patient subgroup	‡Poisson regression	joint space	P-glycoprotein-mediated drug-drug interactions	reporter	this dataset	temporal lobe abnormalities	The ten	image analysis program	the computation	the table	the activated voxels	an adequate level	sixty‐six	strains	the developmental emergence	calcium score	immune response	complex dynamic data	an independent risk factor	snap-frozen tissue samples	input/output	blood sample	pediatric cancer patients	cardiac biomarkers	some value	the randomised trials	a sixth sample	the putative susceptibility locus	data transfer	low molecular weight copper complexes	birth data	attitudes towards	heart syndrome	cortical bone morphology	differentiated cells	microparticles reveals	–232	coronary artery flow velocity indexes	rs13118928	adult rat lung	cancer registry database	figure	exploratory comparison	the genealogical resource	frozen	the fractional anisotropy	inflammatory cytokines	the frontal systems	the same school	continuous ventricular tachycardia	multiple comparison test	Addition	any single miR	the impaired apoptosis	The mice	axons	factors	the cubital vein	western blot analysis	a representative Korean sample.19	compensative mechanism	the thrombophilic state	this family	specimen number	pulmonary vein	electrophysiological recovery	hair	shape variation	coordination	annotations	mesencephalic 5-HT nerve cell bodies	Findings	an unclear picture	variance/Scheffe	Focused ion beam-scanning electron microscopy	long time	medical questionnaires	the mutations	atlantoaxial fixation techniques	reexpansion	SDS-PAGE	principles	all hip fractures	the central motor pathways	recursive partitioning	biological replicates	microRNA gene expression	low risk patients	the bones	plasma	sudden unexplained death	logistic reasons	the risk area	the full ventricle	mitral inflow	library preparation	The challenge	informed consent	copy number	dynamic magnetic resonance imaging enhancement features	randomized studies	the human vascular cell adhesion molecule	some stent frames	factorial trial	data collection	way	cancer risks	breast cancer families	Physiological data acquisition	intraclass correlation	prevalent sites	independent expert readers	intestinal tissue	lesion numbers	hematopoietic stem cell	sequence alignment	peak velocities	the same period practice	the chromatin immunoprecipitation	Statistical Analysis	a joint implant register	total lung cDNA	cell morphology	enhancement patterns	acoustic shadowing	any significant effects	medication	the atena series	cytology	human frontoparietal polymicrogyria syndromes	DLX2-/DLX5+ patients	immunohistochemical analyses	peak delay	the cell infiltrate	annexin-V-positive cells	vacA	a subsequent unified structural equation modeling	multiplanar reconstruction analyses	reverse transcriptase polymerase chain reaction	an immunohistological study	crude odds ratios	aid failure	specimens	the biopsies	that compression	a region	22-year clinical experience	clinical use	structural inhomogeneities	underwent extensive clinical characterization	the long term safety	the Statistical Package	fatality	digitizer	the scarring	Supplementary Files	the low group	neoadjuvant chemoradiotherapy	non-cervical cancer	modeling	vital status data	orthodontic mini-implants	’ neuropsychological functions	mL cryotubes	other potential confounding variables	regional glucose metabolism	pre‐implant fMRI	careful diagnosis	important risk factors	gene rearrangements	-0.3219	additional participants	other studies	curve	small sample sizes	the reproducibility	the included studies	a shorter	downregulated groups	bronchoalveolar lavage tissues	admissions	the cancer cell biology	mOsm/kg	onset latency	the write‐up	the severe airway obstruction groups	the laboratory experiments	a positive signal	The numbers	positive segments	Setting	the per protocol	work-ups	diaphyseal bone mass	The novel missense substitutions	ischemic-reperfusion injury	a statistician	right ventricular pressure-volume loops	high-sensitivity	acute myocardial infarction study	a multiple regression type	mg kg−1 doses	malignant ovarian cancer effusions	the dorsal striatum	the records	serial normalized measurements Circulation	knockdown approaches	subject-specific prediction models	auditory sentence comprehension scores	a relative risk	nanostructured hydroxyapatite	methyl esterification	predictive validity	speech information	a standardized assay	data quality	flexible method	intensive surveillance	proportional hazards models	a significant side difference	somatic recurrent mutations	included women	the skill	paracellular-	the vehicle control	the coordination	spleen cells	a hospital claims	flow-sorted breast cancer cells	human metapneumovirus	morphism	the purposes	the primary tumor	adverse event	the proximal tibial metaphysis	the phagocyte respiratory burst	all test days	spasms	viral load	optimal rules	the hTR/CKS2	imbalances	the rudiment	standard biopsy forceps	deep sternal wound infections	no significant correlation	cell types	the conduct	indication	the cerebellum	general linear model	administrative data	induced sputum	exome sequencing	systolic function	the synovium	laser scanning	transcription polymerase chain reaction	the break point	quantitative pathology workstation	vimentin localization	tumour specificity	the primary end-point	relative expression	host institution	benign infantile epilepsy	variant sequence	indirect interactions	Logistic regression	cross-sectional studies	double transgenic mice	retrieval	underwent extensive behavioral testing	black bar	rank-sum test	endpoints	vascular endothelial cells	Technical expertise	primary efficacy endpoint	interquartile ranges	standard conventional methods	whole images	missense mutation	Meta-analysis	spectral software	control experiments	computerized files	a012724 .23813586	reverse-transcriptase polymerase chain reaction	plastic tissue-culture plates	surgical freedom	The proportion	repeated samples	a freeware	the tumor-bearing breasts	the imputation	trabecular bone dynamics	transient behavior	a death signal	low endpoint frequency	glial cell development	cell pellets	the real‐time	the clinical features	triple-negative breast cancer data	underestimation	brain segmentation	t=4.23d Abbreviation	proper study design	the temperature ramping	breast cancer specimens	binding assays	no significant association	these predictors	the cortical shell	unadjusted analysis	the connectivity	:609	plasma fibrinogen level	all migraineurs	p-EGFR	rotator cuff muscles	coordinate measuring machine	biochemical characterization	low-frequency	post hoc	○C	cell line specific	founder mutations	non-thermal injury	preparation	display	the research	osteoblast generation	chemiluminescent	a well-established single strand conformation polymorphism/heteroduplex	local/regional control	cardiac reoperations	anti–DC-STAMP	leptomeningeal biopsy results	myeloproliferative neoplasms	receiver operating characteristic	trial results	volume estimation	the upper alpha band	lymphocytic predominance	gastric cancer patients	secondary outcomes	a physiotherapy treatment protocol	n	meta-analysis	the eruption	:176	chondrocyte hypertrophy	manuscript development activities	the right hemisphere	projection	replicability	novel mutations	ap	50-52 ]	technical development	thymus	constitutes	therapy injection	30-week-old mice	the prospective multi-institutional clinical trial	lesion data sets	All random effects analysis	the multivariate	The general shape	the possible risk factors	strain changes	important threat	tissue acquisition	i	comprehensive genomic	appropriate statistical models	intrinsic ventricular conduction	The outcome	ear specific information	tau protein level	modules	all exons	anonymised buffy cones	statistical package version	longterm survival data	A serum albumin level	variance p	fracture patterns	all stages	paraneoplastic antibodies	disagreement	show	a 2273-woman cohort	the human extrastriate cortex	triceps	cellular inflammation	such biomarkers	saliva	inception cohort	messenger	a first‐level general linear model	flow cytometry	Analyses	brain infiltrating cells	blood-derived platelet concentrate	functional connectivity	facet joint morphology	subsequent histopathological evaluation	Wright-Giemsa-stained cytospins	the sounds	this region	Automation	active treatment	the adjacent segments	trace conditioning	correlation test	the thymic stromal lymphopoietin variants	–1671	airways resistance	drug levels	diabetic patients	osteogenic markers	propensity score matching	diagnostic biopsy tissue	blood investigations	microRNA expression patterns	transduction efficiency	immediate radical cystectomy versus	pancreatic cancer	whole lungs	multiple rounds	this display	different scales	cohort studies	process	batches	human cerebral cortex	EGCG-treated mice	the m-bcr breakpoint	heart rate variability signal	approaches	% mortality decrease	developmental neural antigen expression	osteocyte staining	presumed curative resections	control siRNA	p=0.0070	the equality	Significance	inter-group comparisons	deficiency.18	kinase inhibitor selectivity	a canaliculus	aPre	an exploratory	miR-146a	constructs	some similarities	the treatment efficacy	unstressed targets	hydroxyproline	endoscopic sphenopalatine artery ligation	the injured biceps muscle	meningeal irritation signs	age-related protein	Each well	functional data	a prospective randomized phase	high-dose recombinant erythropoietin treatment	examiners	the urinary proteome	endovascular versus	postoperative changes	human iliac crest biopsies	both gDNA	the critical revision	echocardiographic measurements	amp	acute phase	common data	the compound	the final version	severe hyponatremic patients	statistics software	histological differentiation grade	continuous flow	executive function impairment	the distal femurs	specific patient information	luciferase activity	senior authors	nonobese subjects	a small portion	drafts	divisions	Functional connectivity	involved bone	colorimetric method	scoring	cantonensis	tract volumes	the diagonal line	cognitive tests	potential prognostic factors	the same projection	the statistical software package	rGMV/rWMV	bone cells	trochanters	fellowship training	these data hence	metastatic tumor tissues	the mice	nucleocapsid gene	deviation	human hair	these polymorphisms	the above study patients	bead array	the outcome assessment	master regulators	a detection range m/z	endocardium	Spanish patients	myxoid liposarcoma	out- come	correlative analyses	statistical analyses	the skipping	thesis	cross-sectional study	n=38	randomization group	cell lines	aberrant cDNA product	metabolic activity	this head design	Surface	the studied markers	some beads	experimental conditions	voxel-by-voxel statistical parametric mapping	control groups	long-term outcomes	analogous pre-index variable	physiological loading	human embryonic stem cell differentiation	Theoretical/Mathematical modelling	an aspartyl protease inhibitor	normal distribution	influenza‐associated hospitalizations	other tumour markers	miR-21	gene structure	pMBMECs	protocol number	microscope	excitatory amino acid receptor expression	the first proper inhalation	all authors	clinical trial design	confident interval	a rodent model	brain-draining deep cervical lymph nodes	generalization	the transverse ligament	genotypes	all measurements	adult attention deficit hyperactivity disorder	surface marker expression	FITC-conjugated anti-CD45.2	gene copy number alterations	cerebellopontine angle tumor	disease-free survival	the lacunae	microcentrifugation	the time series data	all viruses	the stress-strain curve	a randomised trial	functional brain network	heart sections	the low concentrations	classification performances	monocytes	Further staining	osteolytic lesions	marigold Tagetes	complement fragments	perfusion images	EIF1S-based methods	diagnosis date	analysis mRNA	opposite polarity	telephone interviews	a positive correlation	a case control	digoxin	human breast cancer applications	further limitation	μCT	5-HTTLPR variants	single institutions	biases	a further data exploration	the high DNA content	statistical analysis package	software package	kinase	gene amplification	data acquisition	troponin ultra	referral criteria	reaction time	acylcarnitine profile	primary endpoint	prognostic variables	endometrial carcinoma	internet activity	nodal status data	active voxels	the study design	a 3-minute rest	domain-containing targets	:1065 –1076	vivo transduction	vehicle administration	signal attenuation	pharmacodynamic study	the mortality effect	a population pharmacokinetics	prostate tumours	multivariate	the corresponding distributions	carotid	those bladder cancer patients	the PHQ-9 scores	pairwise distance	raw data	the systolic	data sets	gait	TRISTAN	the interpretation	detection methods	nutritional assessment data	the respective non-malignant cells.6	the vascular tree	the study concept	the fifth stage	conception	breast cells	astrocyte alteration	cases	interest-type	hypercalciuria	brachial artery	the host response	vocal identity	tiotropium Tiotropium	These participants	body composition	available online	cine velocity	diffusion-weighted images	non-asthmatics	data analysis	endometrial carcinomas	bone tissue	an assistant	the other aliquot	p=0.025	the limited sensitivity	cyclin	total hemoglobin	multiple sclerosis trials	the simple thermodilution technique	the key secondary end point	the experimental group assignment	the qRT-PCR data	The field	Molecular Dynamics	the input data	attenuation profiles	proofreading	no malignant cells	subsequent editorials	electron microscopy	cancer-associated somatic mutations	the situation	level data	the placebo day	anti-chemokine/cytokine primary antibody	all deaths	mixed model	cortical width	prospective exacerbation studies	—	arterial blood gas measurement	histologic sections	intraventricular blood flow dynamics	regulatory element	forced expiratory time	left ventricular function	accurate diagnostic tool	fibrinogen degradation product	auto-HCT patients	the hierarchical clustering	plastic subsets	probabilistic mapping	non-synonymous substitutions	receptors/cell	the majority group	Sub-studies	the morphometric data	some respects	dr.rayeesdar	technical/gameplay issues	An ambiguity	sMRI	reporting	lung samples	nuclear medicine images	traditional univariate analysis	infectious causes	cardiac geometry	mutants	punction	wall motion	glucose reporting	the tail	such developmental ascription	Automatic periodic leg movement	chromatin immuno-precipitation assays	recurrence–free survival	The diagnostic evaluation	real-time polymerase chain reaction	breast cancer cases	overall treatment results	Smartnotebook	water maze data	cardiovascular autonomic function	the physical activity	subsequent data processing	gene expression mirrors	long-term transgene expression	cell death	the strategy	negative Chinese women	micro-array data	the intracellular localization	time t	clinical implications Seminars	the ubiquitin-conjugating enzyme	each type	single cytokeratin-positive cells	the pooled phase	quantitative phenotypes	clinical data collection	summarise	adjacent normal tissues	row	plan	auditory word processing	all available double-blind	an aqueous humor sample	the standards	The interview process	total cellular protein	mouse	tissue polypeptide	fracture	Stages	cardiac cycles	sides	pancreatic cancer tissues	a sputum sample	monocyte	epicardial torsion	the behavioral sciences	the weak counterclockwise vortex	clinical characterization	the host cell	mass fingerprint	:128	specific roles	technical assistance	//www.r-project.org/	the mixed fasting–nonfasting analysis	instantaneous left atrial volume –	western blots	all-cause hospitalization outcomes	the surgery-only group	arterial involvement	diverse patient populations	external pallidum	tumours	all data sources	hypoxia exposure	novel biomarkers	loco-regional control	the outcome measure	diol compounds	multiple cytokines	the significant prognostic factors	the outcome variables	IGF-1 signaling	An independent t-test	cytospins	a hot debate	vimentin protein expression levels	cf	afford mechanistic understanding	a basis	any mutation	serostatus	the mixed-effect model	filter plates	both target	cannabinoid content	the histological space	% variability	unknown genetic defect	erythroid dysplasia	Biochemical analytical assessments	thalamic versus	paraffin-embedded breast cancer tissue	viral gene fragments	order	ribonucleic acid	the entire breast.4–6	This kind	the data	the sixth lumbar vertebrae	frozen plasma	human anti-human responses	ovarian cancer susceptibility genes	morphometric analysis	hemispheres	whole-genome differential allelic expression data	estimator i.e	human brain gene expression	white matter lesions	Image acquisition	the synovial fluid	All methodologies	quantitative trait	This staining	variances	cytometric staining	the mRNA levels	related data.13,15,17	trabecular bone	chromosomal mapping	haematoxylin	sequential methods	initial data acquisition	the atrioventricular junctions	lung sections	the indicated references	no perfusion	data entry	hyperplastic stomach	every patient	final experiments	retinal endothelial tip cells	Quantitative polymerase chain reaction	facioscapulohumeral muscular dystrophy	immune spleen cells	the references	P-values ranging	continuous 15-minute recordings	breast cancer metastasis	individual hepatocyte growth factor receptor clusters	mvised form	early outcomes	mAb development	national mortality statistics Pediatrics	a cross-sectional national survey	human cardiac troponin	co-stimulatory receptor genes	the abundance	trypsin-Giemsa technique	these trials	causal indicators	miR-146a expression	*Chi‐square tests	no heterogeneity	human dopamine receptor subtypes	evident metastatic lesions	explant lungs	the medical literature	The apical 4- chamber	rapid development	secondary end points	biochemical indices	the intraventricular flow	parallel sequencing	mean change	Cardiac imaging	significant correlations	the task	CSSs	the robustness	a fundamental level	re-evaluation	challenging patients	thirty-two double-strand	All animal procedures	subsequent enhancement patterns	antigenemia	weekly records	bone-derived cells	all cell types	High-resolution micro-computed tomography	the limitations	the baseline score	the cardiac function	quality improvement projects	negative likelihood ratios	particles	target lesion calcification	No units	the indicated antibodies	the following colleagues	items Assumptions	the spatial order	study design	data interpretation	miRNA analysis	trend-line calculation	intravascular cells	these admissions	plasma cortisol	nucleotide position	gastric cancer tissues	the required number	the second level	paraffin-embedded intestinal tissue samples	cardiac cine	nonpalpable breast lesions	quality assurance	Human osteoclastogenesis assays	the predominant Jewish mutations	subsequent sequencing	infrared imaging	integrin subunits αv	target hub gene repression	control donors	problems	a log-rank test	brain tissue	molecular genetics	a narrative review	the experimental biochemistry work	regional variation	cox regression	matched pairs	prolyl endopeptidase	vitro blood–brain barrier models	an abnormal prion	xenografted athymic mice	and/	ammonium acetate buffer	the cell pellet	end results	recombinant-inbred strains	post-operative aortic regurgitation	All data entry	the chemokine receptor	prostate cancer susceptibility	spherical morphology	determinant factors	the hippocampal amnesic syndrome	metal ions	semiquantitative reverse-transcription–polymerase chain reaction	voluntary blood donors	bronchoalveolar lavage	30-day safety	invasive micropapillary differentiation	potential risk factors	a survival study	leukemic cells	Dalmatian dogs	all relevant data	physiological patterns	the mitotic spindle morphology	observational studies	twin sera	breast cancer cells	plasma calprotectin levels	winter5	some European countries	Side population	these categories	cardiac excision	laser-microdissected arteries	consensus statements	a careful descriptive study	the collected medium	The study complies	final draft	anatomical brain imaging	a mean age	workstations	counterparts	non-MI patients	the simplified reference tissue model	laser	relative gene expression	eANOVA	the last assessment	intensities	no mutations	coronary angiographic	minimal residual disease	genes	all further analysis	the component	post‐mortem	histopathologic prognostic factors	no specific findings	Neuroimaging	the local fibril organization	smoking status –	the disease localization study	data aquisition	different methods	the databasea	phospho-Akt hearts	rigorous baseline	sequence blast	PLS3-negative patients	psychosocial group therapy	expressions	the dual origin	subjects participation	substantial contributions	various studies	likely causal relationship	fluorescence detection	some psychometric measures	a large pooled data set	the software	reticulocytes	Genes	system performance measures	malignant tumor	unruptured intracranial aneurysms	image data	further details	versus off-pump	splits	the observed effects	these extended studies	The quality	subpopulations	function reveals	germinal center	several parameters	the basis	fMRI studies	functional class	the different skin sites	medium airways	segmental antigen challenge	The strength	passages	sorting	putative factors	adhesion sites	gene-level P-values	c.454-	early survivorship	v10	M	panels	all fMRI data sets	osteosarcoma	proinflammatory cytokines	fund raising	The result	g	ferritin	statistical tools	gDNA sequence	raw data Tumor volume	neuropsychological profile	each speed	a correlation coefficient	operator characteristic	pM	complete data	a diverse synapse population	the membrane proteome.21	global subplate volume increases	accounting	the arrays	Virus-specific response	phospho-ERK	serum proteins	**p <	datacollection	primary microglia shows	polychotomous response data	sleep quantity	electrodes	both sessions	participation	registry	protein	trabecular bone morphology	familial breast cancer	the sample processing	programme	The humerus	imaging technique	Malaysian women	positive population	multiple comparisons	All data acquisition	the whole-brain	ta	a large single-center cohort	left atrial anatomy	the annotation	fusion gene transcripts	offline analysis system	–593	non-silenced cell populations	–3697	gene polymorphisms	intracranial aneurysms	pCREB	1-9 year outcomes	this comprehensive dataset	female donors	the error measurements	qualitative data	accurate tool	testing procedures	the mismatch repair gene hMSH6	nuclear fraction	proportional hazards model	noninvasive tool	These samples	30-day readmission rates	a contribution	breast cancer cell lines	v11.0.1	cytogenetic analysis	Quantitative coronary angiography	sequence analysis	fMRI time series	reproducibility	liquid chromatography–mass spectrometry	cortisol collection	receiver operating characteristics	a false discovery rate	tissue segmentation	web-based data	nicotine-induced changes	histone	heterozygous mice	rFVIIa groups	the skeleton	motion correction	QCA	mouse platelet transcriptomes	stained tissue sections	ECG cases	data presentation	Genomics	the complication rate	bioinformatic analyses	lavage	patient prognosis	extraction	the functional contribution	bortezomib	oral cancer biomarkers	waist	each event type	founder effect	the prosthesis	The receiver‐operator	extratemporal surgical intervention	visual stimulation	review articles	parietal brain differences	absolute numbers	things	qualitative method	medical images	stroke patients Archives	cytokine	seronegative patients	labeled new bone formation	an independent prognostic factor	the global results	lymphatic vessels	item fit	distinct developmental language	variant	a complex pathological phenotype	two-by-two post-hoc analysis	copy number alterations	capillary tubes	frontal lobe dementia	contralateral afferent neurons	subacute	echocardiography values	Linear mixed-effects model	tunable resistive pulse sensing	the placebo group	left middle-temporal cortex	rank sums test	characteristic curve	hippocampal brain homogenates	interim analysis	nonsignificant association	lean mass	male breast cancer	A cerebrospinal fluid	fatty acid profiles	the ventral nerve roots	sensitivity analysis	covariance procedures	materials	the matched sample	primary care physicians	Blood samples	individual metabolites	the unique potential	etiologic groups	peripheral blood samples	unlabeled single-base extension	the binding	The acquisition	total testosterone	a balanced distribution	depression symptoms	sensitive speckle	Figures	A significant negative correlation	hospital discharge	hematoxylin-eosin	kidney calcium levels	bivariate analysis	the active tDCS group	regional wall motion score10	global longitudinal	neurological outcome	approvement	stromal syndecan-1 expression	µg	tunnel position	the oxygenation response	the mixed-effect model analysis	the first draft	α+ thalassemia heterozygotes	the human immune response	a dosage‐dependent manner	readers	The tissue microarrays	extreme acid survival	the predicted targets	Such high allele frequencies	prophylaxis versus treatment	osteoarthritic chondrocyte	the common mutation	technical triplicates	last donation	these effects	the paired trials	microarray-based comparative genomic hybridization	basal medium	the m/z	the study conduct	The worldwide problem	the rat organ	the cortical sources	cm-1	correlation polymicrogyria	the lesion length	positive samples	cytoskeleton-related factors	relations	proliferative activity	methylated alleles	Venous blood samples	potential determinants	vascular cell adhesion molecule	quantitative reverse transcriptase-PCR	multifocal bladder cancer	bisulfite genomic DNA sequencing	descriptive results	standard sample	metabolic myocardial imaging	a priori hypothesis towards regions	a threat	A noncompartmental pharmacokinetic	collection	calipers	sound features	murine hematopoietic stem cell transduction	descriptive characteristics	room temperature	myocardial inflammation	a backward	summary statistics	variables	cleaning	burden-of-headache studies	typical proinflammatory cytokines	the evaluable patients	combined experiments	acitivity	the injection site	the necrotic bones	fluorescence	modification	segmentectomy	rodent models	−	whole-cell patch voltage-clamp	the voxel-based morphometric	polymerase chain reaction -restriction fragment length polymorphism	therapeutic approaches	the technical assistance	functional activation	the second stage	thrombus formation	sulcation morphology	cardiac hypertrophy	whole sections	The resultant cells	% lymphocytes	static lung compliance	Fusion candidates	the continuous variables age	a contrast map	microwave-assisted acid digestion	rib	a software package	mucosal	segmentation	airway reactance	living cells	the same N-linked glycosylation	chance	neuroanatomical correlates	diastolic flow	the spastin gene	acid	vitro stimulation	intermediates	pleiotropic drug resistance	procedure- disease-	multiple sclerosis lesions	The score	external vesicle production	fMRI data	atrophy measures	meningococci	solutions	dose-ranging study	rotator cuff tears	the bone chip	vitro fertilisation	tissue inhibitor	206-subjects	the interesting results	absolute	cytokines levels	log-transformed urinary cortisol	the original analysis	liver metastasis	associated target genes	platform	colon cancer cell lines	all neurophysiologic data	gDNA controls	postmenopausal breast cancer	vitro production	estrogen cascade reveals	paired t-test	study concept	repertoire diversity	the metastatic sites	effector caspase activation	electron microscopies	multiple small studies	covariances	transcatheter closure	nucleotide change	histopathologic grading	editorial contributions	log-rank test	±3.0	testosterone status	mouse tendons	severity information	Cumulative survival curves	critical appraisal	frozen samples	mesenteric lymph	this method	ophthalmologic comorbidities	primary care settings	a mammogram	−1	abnormal flow	the microarray data	human bone biopsies	allele group	ramp test	LFS-related families number	real-time imaging	a signal value	regression model	administrative databases	tomography	composition	chi-square	tissue morphology	the human connectome	long-term independent prognostic information	ataxia mutants	the miRNAs	citrate/sucrose/DMSO buffer	cell receptor genes	B-lymphocyte subpopulations	binary outcomes	χ2-statistics	interactive multimodal	experimental conduct	many subjects	Immunohistochemical analysis	Description	mutant mice	subfamilies	essential hypertension	statistical method	propagation	polymorphic genotypes	genotyping	serotonin transporter gene polymorphism	GLM-based analysis	bp	this reflected standards	cytometry	sub-cloned products	absolute changes	neuroecological studies	electron transport chain activities	the subchondral region	intellectual support	statistical methods	genetic sequence	striatal subregions	arrays	a formalin effect	the basal ganglia	represent standard error	the reporting	–481	various interventions	twin	translocation	control-specific transcripts	specific item endorsements	the African-American face	gene influence	The processing	correlation coefficients	PK	code	real-time reverse-transcription	the structural causes	vocal affective information	glioblastoma multiforme	the regional blood oxygen	early quitters	an engineering laboratory	a multiple regression analysis	juvenile-onset	μL	previous functional imaging studies	the size	known numbers	microarray database	that seropositivity	specific mRNAs expression	peptide masses	the derivation study	descriptive statistics	th	adenomas	bone formation	multiple gene expression profiles	visual sample processing	lung function parameters	“ volume	cut-off points	promoter	plasma mass spectrometry	secreted proteins	preliminary results	DNA content	combined raw data	χ2-tests	the pleural fluid	a prospective multicentre cohort study	sorted cells	a linear relationship	candidate genes	the comparison	The main question	X-Strain software	phagocytosis experiments	anti-human monoclonal antibodies	All authors	undecalcified sections	special analysis	the plasma	Generation	human locomotion	homogeneous variances	prone	method	scan/CBT	combined pseudo-fracture	no upregulation	secPD-L1	randomized trials	the dimensional structure	iNOS protein	stone composition	indirect association	the preparations	Abstracts	randomised trials	the screening mammography program	administrative claims	blood collection	the different methods	the ventilatory equivalents	the sample preparation	no template control	a multinational cross-sectional survey	predictive clinical signs	the transcriptome	representative experiment	diffusion-weighted imaging parameters	low expressers	expression profiles	reagent	backup	leads	ductal carcinoma	–32	thematic coding	stem cell harvest	urinary tract	toolbox	leaflets	establishment	fluorouracil-based adjuvant therapy	the international standard method	breast cancer-susceptibility genes	the writing	gastric cancer samples	Self-assessments	insertion	yield	high ET-1 levels	A subsequent prospective	min	10-8 ]	a quarter century	human buccal epithelium	the substantia nigra	additional file	endonasal	10-year survival rates	recurrence-free survival	a public health risk	steroid hormone action	reversibility investigations	complete surgical staging	transthyretin	microarray data	the measurement	This finding	replication	dipyridamole stress echocardiography	a nonhomogeneous response	peptidyl-tRNA hydrolase	respondents	specific tracts	levodopa treatment	intact male rats	neuropsychological evaluation	lungs	This conclusion	radiation	lymphocyte cell-surface labeling	joint replacement	the average	Risk Factors	clinical trials	a student	ischemic myocardium	supervision	promoter lesion	synthesis	PC-3 cells	a single institution	The same regions	the oVEMP graphs	characterization	novel single nucleotide polymorphisms	acquisitions	the coordinating center	skeletal muscle	cancer antigen	all pathological characterizations	future work	reasons	early-stage breast cancer	A two-sided p-value	maximal power change	intergroup variance	adjuvant postoperative irradiation	human clear cell carcinoma	refs	human bone marrow	the core promoter region	the home	serum tandem mass spectrometry	this question	tibial pseudarthrosis	differential expression	a similarity index	a systemic description	image acquisition	the peptide extract	cervical neoplasia	profiles	the physical features	myocardial performance index	parametric data	the same institute	co-cultures	the clinic	integrity	source analysis	activation voxels	the long-term prognostic impact	paired rankings	bone health changes	some data sets	the investigation	non-inferiority	giant cells	relaxation rate curves	the transcriptional level	subjective sleep quality	procalcitonin	the transparent compounds	different connectivity values	hind legs	the sequence methodology24	=	multiple pathogenic isolates	the review	cryovials	the recruitment	enhanced expression	soft tissue profile	exploratory	situ hybridization	coronary artery bypass grafting	nuisance covariates	own experiences	amplifications	antigenic characterization	zygapophyseal joints	the process	the agreement	metabolic data	a 953B-Siemens/CTIPET camera	The tissue samples	thrombosis-associated risk markers	TS	dose coverage	prospective data	Immunohistochemistry	exclusion chromatography	+/PTX+ mice	monkey spinal cord	wild-type mice	segmental volume-time curves	The cerebral spinal fluid	subsequent stages	absolute humidity	non-invasive vagus nerve stimulation	immunocytochemistry	weighted linear regression	Two-dimensional difference gel electrophoresis	*Haplotypes	upstream regulators	repair	liver proteins	Initial draft	the afore-mentioned population studies	mouse hearts	interaction effects	treated patients	images	perfusion	subclinical psychosis	the breast cancer susceptibility gene	disease risk	vivo mutant p53	carbohydrate antigens	chirp	the breast cancer genes	isolates	spinal cord	biological sequences retrieval	inner medulla	lineage-negative cells	subject recruitment	acid-binding proteins	tumor subgroup	flow propagation velocity	arms	arthroplasty performance	the cortical bone compartment	all investigations	the only identified delineator	aldosterone synthase gene	unreported exacerbations	stepwise	the changes	treatment effects	tables	whole native pulmonary tissue	the next stage	a putative tumor suppressor	The design	the assessments	uncorrected data	bronchial cartilage	epicardial contours	surgical staging	valve structure	The method	the metaphyseal	residual volume/total lung capacity	The table lists genes	algorithm development	Trial design	rounds	5-LO activity	phase values	The authors	restless	cemented medial unicompartmental knee arthroplasty	a neoadjuvant trial	polymorphonuclear neutrophils	spreadsheet	representation	nonevaluable segments	mAbs	isolated hepatic stellate cells	linkage	lung tissue homogenate	execution	residual bind- ing sites	relapse incidence	cardiac dynamics	target gene	a non-parametric version	blood metal measurements	colorectal cancer	disease biomarkers	systematic errors	The weekly mean pain score	laboratory measures	the modified peptides	anti-Hu-associated paraneoplastic encephalomyelitis	blood type	multinational database	the mini_mapping10kv1_450 fluidics protocol	angle dependency	a significant increase	tubulin agents	an inherited speech	multiple acquisitions	independent experiments	cadmium-induced tubular proteinuria	expertise	factor-α Proceedings	systolic tissue velocities	the preload	performance alterations	standard deviation	spinocerebellar ataxia type	such trials	the collation	repeat testing	final efficacy	non-lacunar strokes	transferred patients	interpretation	disequilibrium	glyceraldehyde-3-phosphate dehydrogenase	vital importance	Upstream regulators	high-throughput public data	transporter-1 predicts survival	cardiologist	metabolic screening	computer software	transitional cell carcinoma	protocol/Retention	the project	non-consecutive subjects	heterozygosity	reads	health benefits	the variability	silico	a cut-off value	isolated angiitis	dyslexia candidate genes	p=0.305	agent	nucleus pulposus cells	substrate utilization	hereditary nonpolyposis	the homeobox	expressivity	outpatient service	renal cell culture models	unavailable imaging data	fluorescence-activated cell sorter	intra-class correlation coefficient	biomechanics	acquisition software	these tissues	differential scanning calorimetry	a medical advisory board member	cell panel	urinary fibronectin	subcutaneous fat trunk	The maximum score	prognostic relevance	X-Ray	developed clinical practice guidelines	11-17 ]	rigorous selection	T1-maps	single-strand conformation polymorphism	custom	elevation	image size standardising	endoscopies	statistical data	pre-dialysis pH	cocktail dual-color probe	integrated neural activity	re-drafted manuscript	medication-overuse headache patients	mutation ]	clinical significance	the reduced arthritis	a deviation analysis	microCT	visual cortical areas	hemodynamic responses	the access	extracraniofacial anomalies	incidences	variance	advanced flow parameters	Statistical analyses	calcium deposition	clusters	allelotyping	speckle-tracking measurements	:719	an exploratory manner	avidin column enrichment	the exact cut-off value	bronchial wall vascularity	any oligoclonal bands	lymphoma-specific survival	a patient cohort	mRNA	safety data	osteocalcin	the data sets	cervical cancer mortality	independent data monitoring	the last fluorescein isothiocyanate results	The characteristics	these regions	the therapy	categorical data	the content	regulatory interactions	the dystrophin gene	anti-phosphotyrosine antibodies	the paper A.	neurological examination findings	quantitative proteomics	the various methods	no systemic clinical design	the mammalian transforming growth	platelet	iCMs	Confocal microscopy	the representative value	complete mitochondrial genome	non-specific staining	decision	anaerobic threshold	the high resolution melt	colitis model	transcriptome	fractional anisotropy	Samples	convincing evidence	larvae	this research	available scientific literature	comorbidity indices	optical coherence tomography speckle	focal ischemia	the distributions	Delays	the generation	heart murmur	old mice	blood counts	promoter content	Potential Regulation	a population-based sample	pain-free walking distance	immunohistochemical distributions	the high-hemoglobin-F phenotype	vanadium	-11C-verapamil	arterial blood gas	residual analysis	manuscript review	the blink reflex	respiratory sounds	All analyses	the classification	a logistic regression analysis	the full cohort	volumetry	large prospective studies	the adjusted multivariate analyses	warfarin therapy	radiological data collection	the potential use	metalloproteinases	β-catenin occupancy	diabetic osteopenia	the draft paper	cases Annals	Western blotting work	the hydrolysis	lung volume	The reverse transcriptase-polymerase chain reaction	water	the rules	multiple-case	cases Archives	max velocity	A German Consortium	big city	survival outcomes	tumor susceptibility	the previous section	lexico‐semantic stimuli	colorectal cancer-specific death	virological tests	All regions	baseline assessment	distinct mice	the intervention	the cancer registry database	a potential explanation	manuscript drafting	adjusted odds ratio	proBNP predict	the intestinal microflora	slices	Western blotting	error data	the cluster size	the documented tidal dependence	statistical heterogeneity	robust standard errors	prefrontal cortex	the infarcted myocardium	all activities	gene transcription	respiratory crackles	tissue sections	a per-protocol	mineral density	rpm	sputum eosinophilia	the chances	nationwide Italian registries	transition dyspnoea index	pFAK	reviewing	the specific airway size	little data	principal components	the total feature set	the median value	specific conditions	different parameters	histogram parameters	standard-dose chemotherapy	programs	hyperpolarized helium-3 pulmonary MRI	baseline serum	independent prognostic factors	gene expressions	the plasma fraction	posttransplant chimerism	miRNAs	talus bone	immune infiltration	a fixed effects model	the other variables	gene chip data	comparative urine proteomics	Myocardial systolic segmental wall thickening	drusen change	all ages.219	parameters	the demonstration	a non-uptaken molecular control	fractional flow reserve	a gene expression	both femur	the frequency domain	FAS-completers	the clinical practice	scattered electron microscopy	81-directional motion-probing gradients	white histogram	laboratory data	co-expression network construction	ruderalis	The first trial	myofibroblast markers	a common ancestor	kit	the cross-sectional nature	linkage disequilibrium	q12	the other metabolic parameters	unexposed cultures	pathological data	cell receptor repertoire data	the cell population	SX	the latter position	undergraduate students	illiterate	inflammatory cell infiltration	the unique results	a significance level	walking	randomised trial	this trial	% reference limits	methods—nipple aspirate fluid	effector	the primary method	quartiles	immunohistochemistry	digitized mammograms	adverse events	transcranial dopplerography	cell lysates	the log-rank statistics	hepatic fibrosis	sample size requirements	continuous response	hypoxaemia	p210	dense genetic maps	histopathology examination	other urine	microangiopathy	a magnetization-prepared rapid gradient echo sequence	gap junction	this sample set	mitogens	The primers	calcium oxalate growth	Those patients	–392	survivin	baseline characteristics	the same dataset	maze procedure outcome	multicenter trials	extrapolation	year survival	agreement [ bias	residue	6-minute registrations	a Tuckey-Kramer test	the second part	the following rat	The quantitative metallic composition	female sex	surface integrins	p.His161Arg polymorphism	Confirmation	products	A correlation	A recent FISH	pepsin digestion	the maximum-tolerated dose	each femur	spite	the 4.8-kDa peak	cancer predisposition genes	diaries	inflammatory response	a low allele level	experimental spinal cord injury	human brain	non-paired t tests	article revision	electron microscope	prostate cancer	reactance	hypertrophied hearts	the samples	Representative dot plots	drafting	specific regions	cohort	Progression-free survival	the TV	the magnitude	a large consecutive series	cell-derived vesicles	decades	osteoclasts	a proof-of-concept randomised clinical trial	x2 tests	projection types	each moment	sera	an interaction term	mL freeze vials	individual aural rehabilitation	non-parametrical data	vascular stiffness	pipette solution	sub-cortical structures	congenital central hypoventilation syndrome	peroxisome-proliferator-responsive element motifs	a human ventricular model	psychometric testing	dead pups	Multiple correlation analysis	graded alcohols	a suspected inflammatory disorder	the subject factor	deceased patients	population studies	non-diagnostic vessels	affected area	human frontoparietal cortex	annotation	tissue culture supernatants	chemokine production	the short postlabeling delay	few positive expressions	correlation coefficient	the animal study	six-minute walking distance	structural equation modelling	efficiency	monocarboxylate transporter	matched samples	units-erythroid colonies	continuous variable	lung biopsies	a single surgeon	one-way factorial measures	transformation	eye movements	uterine cervix cells	technical supervision	status change	the whole trial population	Bcl-2–associated X protein	the objective	primary bone marrow osteoclasts	an upswing	lesion length	buffy coat fractions	other identified clinical risk factors	transverse sections	subdistribution hazard ratio	The above panels	avian influenza viruses	all statistical tests	this kind	p-H2A.X reactivity	each site	maximum compliance	the expression data	the beta-myosin heavy chain gene	gene locus	promoter methylation	research data collection	the aerobic group	basal	probabilistic sensitivity analyses	these fiber densities	the polymerase chain reaction technique	vascular endothelial growth factors	the only significant decreases	Experimental design	a variant type	Hsp90-targeted therapy	cigar smoke	a sound	water intakes	quantification	supraspinatus tendinopathy	strata	mutual information	gene amplification analysis	such patients	cardiovascular-cause mortalities	manuscript draft	the cell cycle	5-year survivors	intracellular cytokine staining	secondary events	the great potential	chemiluminescence immunoassay	the blots	fusion rate	axon distribution	each group	cervical cancer incidence	performance liquid chromatographic	technologies	proinflammatory activity	patients information	new refer	spib-depleted embryos	distinct classes	the same results	cell invasion assays	large data sets	myeloid	human brain identifies	limited regional neuronal synchronization	beta power	the log-linear range	screened populations	survey	time-series	a time-dependent covariate	genes pertinent	polygonal shapes	rheumatic heart disease prevention strategies	A similar trend	stringent data quality control	memory dysfunction	three-dimensional stem migration	proportional hazards	angiolymphatic invasion status	high vs low/ int	ocular melanoma	eNOS expression	human respiratory	obtained results	human dental pulp	Invasive micropapillary carcinoma	small studies	usage data	a single-institution experience	mean responses	generation	acute presentation	preventive treatment	the porosity	the interaction term	drug-active versus	event-free survival	ligands	iPSC-derived myocytes	glucose extraction differs	bronchial biopsy material	the early morning	convergence	gains	diastolic parameters	pixel-by-pixel homogeneity	supine position	immunohistochemistry staining	copy number variants	salient aspects	trigylceride	graph theory	sarcomeric genes	aberrant p16 methylation	second session	infarct border zone	the threshold	marginal zone	pre-processing	Iranian ministry	the drafting	idiopathic renal hypouricemia	epitopes	primary breast carcinoma features	this article	identical density	normal breast tissue	human brain function	additional sex combs	dispersive X-ray spectroscopy	pre-ECMO serum phosphorus concentration	the multi-node topological overlap measure	resistance-curve	axon guidance	bx high- performance liquid chromatographv	tumor cell nuclei	profiling	p16 methylation	luciferase-expressing donor cells	household income	the initial manuscript	seed regions	axin2 primer	Incorporation	lymphohematopoietic potential	multiple samples	comparative analysis techniques	further exploration	neuroimaging	integral plasma membrane	study supervision	colorectal cancer cases	aphasic patients Region	cholinergic innervation	the transcriptional coactivator	m/s	the cell lines	complete repairs	clinicopathologic factors	genomic sequence	dead cells	the covariates	the figures	synergistic effect	necropsy findings	next-generation sequencing	echocardiographic characteristics	predictive factors	case–control studies	the family	mutation types	bacterial DNA	analxsis	statistical package	publication	online supplementary material	age-related macular degeneration reveals	expression changes	Electrophysiological studies	metastatic tissue	shPVT1	the discriminatory character	null mouse	polymerase chain reaction	15-s onset delay	FWHM-based thresholding	short-term grant	The advantage	cell differentiation	cancers	the total cell count	an operation	software version	sophisticated statistical analyses	initial classification	a complex genetic disorder	:256–66	preprocessing	nipple aspirate fluid	the question	protein analysis	Statistical significance	cytokine induction profiles	inter-observer measurements	iKK protein expression	mammaglobin	An immunocytochemical method	speech sounds	angiographic coronary heart disease	the statistical design	signal processing	the classical network	patentability	graph properties	The DNA	assistance	The period	dynamic contrast	these participants	search program	report phases	postoperative outcomes	Three-dimensional motion reconstruction	liquid	each voxel	thoracic	behavioural data	co-labeled cells	subphenotypes	recording	correlation	a new stroke-specific outcome scale	the second test	the odontoblast layer	the subsequent use	thoracic idiopathic scoliosis	transcriptional profiling	lacZ expression	lymphocyte subsets	cognitive variables	mean corpuscular volume	clinical applications	serotonergic axons	major basic protein	the primary care records	major principles	homolog	murine macrophages	this retrospective study	the findings	bone integrity	hand-held dynamometry	gene coexpression network	metrics	male mice	cancer stratification	genomic data	inflammatory cell numbers	perindopril	The option	multivariate level	the respiratory measurements	large particles	the transcriptosome	the approximate data	all exon-intron boundaries	immunoglobulin superfamily expression	amygdala neuron number	the intestinal epithelial cell response	aureus skin infection	liquid chromatography-tandem mass spectrometry	rare finding	× magnification	delegation	patient data	stroke survivors	monosaccharide recognition	obstructions	estrogen receptor	heart progenitors	unpublished observation	clinical interpretation	A good correlation	the normal heart	classificatory technique	thrice	head penetration	anti-GR1 antibodies	other strategies	a band-pass	pores	white emboli	sample	the average responses	dopamine receptor immunoreactivity	eBioscience	the computational Euler-Langrangian particle delivery approach	an ocular melanoma cell line	the significance percentage value	the diseased animals	doxapram hydrochloride	the metastatic lymph	glioma	Complermentation	smear	high-mobility group	underwent scanning sessions	miR-146a reverse transcription	specific records	bars	first draft	absolute neutrophil count	molecular research data	known heart disease	global improvement	a brain network activation	lipid content	computer	this limitation	an interesting matter	clonotypes	all reference tissue extraction methods	low density lipoprotein receptor	each fifth value	a third-party payer perspective	headache episodes	clinicopathologic	wave latency	contractile force	µmol·L−1	costal margin	breast tumors	this atrial recording	A second level analysis	clinic-pathological correlations	frataxin levels	Method	rank order correlation	hematogones	murine colitis	melting	anti-Ma2-associated encephalitis	:1667	a genome-wide association	intracellular cytokine expression	a detection method	primers	cytokine gene expression	multivariate observations	visuospatial networks	buffy coat extraction	antibiotic prophylaxis	cervical stabilization systems	lung sounds	The possibility	human choroid plexus papilloma cells	logrank test	causal inference	a novel parvovirus	this timepoint	the linkage disequilibrium	the data set	the pulmonary compartment	multiple biomarkers	mutation tests	electric source imaging	rheumatological workup	human breast cancers	The appropriateness	the delay	no significant results	human bone sections	The print area parameter	ethnicity effects	lymphoblastoid cells	necrotic profile	mutation c.1582G	the electrical axis	flow data	immunoglobulins	chronic obstructive pulmonary disease phenotypes	onwards	fragments	different loci	mass spectrometer	concealment	aBMD	recurrent mutations carriers	tau	genes expression profiles	promoters	sugar	acetabular structures	post-infectious group	inversion time	the statistical significance criteria	resemble data	operating characteristic	the independent t-test	dose-effect relationships	the markers	appropriate	the modules	the channels	the original gene	mood variables	breast cancer progression	integrin-β1 trafficking	administrative claims data	the electroencephalogram	average vacuolation	the rat chondroitin	100-bp ladder	standardization issues	a recent report	a chi-square test	the mammograms	the hippocampus	Potential limitations	renal cell carcinomas	carcinomas	media coverage	affected provinces	orthotopic heart transplantation	new insights	a cell-survival signaling molecule Antioxidants	the primary unit	superior femoral neck	left ventricle	intrinsic functional brain connectivity	a cross-sectional study	treatable disorder	Chinese breast cancer patients	influenza particle accumulation	the pedigrees	breast	adult bone	the optimal level	interatrial defects	the avian‐like swine lineage	Possible Limitations	human blood	laboratory work	the secondary end point	subsequent multiple comparison tests	the data acquisition	this report	different stage	black participants	frozen sections	the purpose	consecutive resections	routine data	serous ovarian cancers identifies	the first tube	lifetime breast cancer risk	metatarsal bones	morphological parameters	countsAvascular necrosisThe costs	the amplitude	treated cells	tomography imaging	progressive removal	restriction fragment length	the fifth lumbar vertebrae	obese group	ruptured studies	recordings	:457 –481	simulation	a continuous spiral	surgeons	palsy	myocardial motion	hippocampal population spikes	cardiac arrhythmia	some subjects	pain ratings	unmatched cohort	disadvantage	baPWV	customized functions	psychosocial risk factors	inpatient services	preoperative embolization	prognostic factors	the follow-up period	long-term estrogen-deprived cells	mixed model approaches	smoker	narrowings	bacterial communities	poten- tials	immunostained cells	samples	variance test	mean±standard error	study design paper	human amniotic fluid	high- resolution	Three-dimensional stereotactic surface projection	infarct volume	negotiation	the molecular testing	The primary endpoint	prehospital arrest patients	the regional intensity	function parameters	aGVHD	a median	urinary stone protein	publication bias	total messenger	symptom index	All images	intra cavity thrombi	no definite conclusion	the power density	a paediatric population	the observed cellular response	microRNA expression	definitions	phantoms	collecting	potency measurements	sensor performance	Interpretation	new approaches	ventral striatum	cell surface markers	the statistical confidence	juvenile myoclonic epilepsy	irrelevant peptide	sample size software package-2008	independent variables	tumor recurrence	chromosomal arms	biologic assessments	microparticle generation	the malignancy-risk gene	frequentist methods	carotid artery	estrogen receptor gene expression	the manuscript draft	mucus production	the Student	ventricular repolarization	outpatient services	blood-brain barrier transport	eastern cooperative oncology group	policy	nuclei cells	the extraction sockets	fluid	the rich databases	ephrin-A5 shows	the overlap characteristics	the clinical details	the bowel microbiota	patient scans	exposure analysis	lung disease progression	calci- tonin gene-related peptide-like immunoreactivity	the internal consistency	placebo–control data	general approaches	secondary prevention trial data	the standard addition approach	An expert	factorial structure	this protocol	genetic variation	distributed parameters	further restriction	these small infarcts	post hoc analyses	manuscript writing	high loadings	vs oseltamivir/NTZ combination vs placebo	months data	the CD3-gated population	the human distal gut microbiome	the chi-square statistics	Sterility	regional cerebral development	transcription-polymerase chain reaction	the paired groups	surgical cases	a few centers	both dual-energy X-ray absorptiometry	excellent statistical analysis reliability	interpretetion	Quantitative measurement	alloimmunity	a normal situation	primer pairs	provide	immunoblots	comprehensive management	A receiver operator	mouse il10 promoters	the initial statistical assessments	pain survey	fMRI time-series	the colorectal cancers	vaccine effectiveness	inter- scan agreements	cellular composition	stromal cell cocultures	the geometry	the open source	a pre-treatment tumor specimen	interventions	Quantitation	biological samples	These results	molecular subtypes	non-pulmonary cancer incidence	ecological data	gene expression data Bioinformatics	multicenter	projections	deletion mapping	reversible radioligand	major hubs	Baltimore	significant time effects	n=123	viability	chi-square tests	the brain areas	the healthy volunteers	individual waveforms	Patch-clamp recording	audit trails	tryptase	possible risks	prostate cancer patients	heart sounds	magnetic resonance images	microarray	expression profiling	acute metabolic acidosis	the antigen	chronium	the reports	the reduced form	immuno- cytochemical	discrete variables	an aberrant glycoform	fibrinogen losses	all data processing	exemplary pictures	data produces color maps	lysoPC	radiologic data	Multiple runs	The unit	a small piece	the design	all factors	corpus callosum	resting‐state fMRI time series	myocardial remodeling	cell populations	the purified protein	nucleotide positions	The computed immunohistochemistry	obstructive sleep apnea patients	high-pressure liquid chromatography	yolk sac	the analysis plan	the wide application	independent samples	a common human polymorphism	a transfer pipette	final approval	a reference gene	liver cryosections	histological grading	data gathering	Pressure-Volume loops acquisition	moyamoya disease	change	sample size estimates	the statistical power	each experimental day	quantitation	this treatment plan	further investigation	transcription factor expression	mPGES-1 expression	newborn infants	ESK	cancer registrations	a control group	area values	the murine forelimb	the conception	no mutation	biological characterization	psychological experiments	genotypic studies	involved restriction fragment length polymorphism	scan analysis	bar=25 μm	24-hour weighted mean	variable number	the fecal microbiota profiles	authors	metastasis variants	particular ethnic groups	the variance	link	Data-handling	bone destruction	current experience	postbronchodilator spirometry	glucose-6-dehydrogenase deficiency	inflammatory cells	purulent fluid	nitric oxide immunoreactivity	a rigid surface	case series	no treatment	image-based drug profiling	primary renal cell carcinoma	questionnaire survey	autistic brain reveals	frontal cortex brain lysates	oxidative death	efficient molecular diagnostics Pharmacogenomics	bacterial composition analysis	confocal microscopy	post-operative variables	the cells	inhibition studies	a retrospective	interstitial mast cells	sampling	Fluorescence-activated cell	file	estrogen-related polymorphisms	Western blot	each continuous variable	Catastrophizing	statistical input	the scaling exponent alpha	the inclusion criteria	Sequences	few other studies	The cerebrospinal fluid	this research project	health surveys	% ethanol	whole blood	sample size	Dynamic contrast-enhanced ultrasound	structural parameters	s.d	digestion	NKG2D-expression	the micelles	communication training	electrophysiological studies	peripheral T-lymphocytes	the crude	Genome-wide analysis	the various groups	the neurodegeneration	a z-score normalisation procedure	the trabecular site	patient group	face	breath collection	tumor burden	immunoprecipitation	local recurrence	chemical constituents	the experimental fNIRS data	aka globin transcription factor	mRNA levels	the rhythm disorders	vivo visualization	multiple brain regions	costs	human herpes	focal brain ischemia	the implications	febrile neutropenia management	intraocular and/or cerebrospinal fluid	the heart rate	the p.R248W	an outbreak	the light chain isotype	signal substances	local antiviral treatment	rapid processing	The porosity	cyto-	regional mRNA distribution	indirect immunofluorescence	revascularization	complex datasets	a subsequent year	A mutation	brain sections	the raw data	o ’ clock position	univariate linear regression analyses	femora	algorithms	macrophage apoptosis	time reduction	tumour cells-biology	the expression levels	connective	continuous data	the suggested cut-off values	tract obstruction malformations	aortic media	intervention strategies	study outcomes	white matter skeleton	variance approaches	a novel SERPINA-1 mutation	member	source neuron fields	a ratio	calculations	tumour screening	maps	discrepant results	self-rated health	genome sequencing	1-12-2 mice	2-D tissue deformations	wave amplitude	gait data	the histomorphometric region	the present analysis	pulmonary perfusion	specific activation markers	the log-rank test	ectopic activation	cultures	normal bronchial mucosa	pancreatic cancer cells	the separate group analyses	These exclusions	tunable resistive pulse	financing	the data report	affected alleles	serial qualitative interviews	trabecular areas	missense variants	the cohorts	All male patients	an integration time	cryotubes	high resolution melt	organ bath fluid	the scales	purulent discharge	aBV	≥ pT3a	cohorts	haemophilia	best-fit models	haplotype analysis	the segmental analysis	an area	urinary levels	Image processing	micrometastasis	unclear parkinsonism	CABG procedures	the hematopoietic progenitor lineage	the experimental groups	both normal metaphase	≥31 days	different time points	reactive astrogliosis	rabbits	fibroblast growth factor receptor-1	the same samples	magnetic fields	:2325 –32 .10.1016/S0735-1097	post-BMT patient	left-lateralized posterior superior-temporal activation	this noisy dataset	The functional relationship	pathogenic mechanisms	homozygous deletions	the brain function	glucose	a clear segregation	completers	connexin36	an institutional experience	voxel‐based morphometry	the new results	cultured fibroblasts	underwent genetic counseling	a screening sample	Examples	mullerian adenosarcoma	reverse transcription	these estimations	handedness	cervical carcinoma	small-sized peripheral lung cancer	sonography versus	protein-coupled receptors	a single-component distribution	the percentages	ranks	Cerebrospinal fluid	warfarin use	the variable times	the block	phenotypic data	levels.21	multisite	medical charts	treatment effect	Rainero	the data collection	a black-box warning	n.a	host resistance	alternative strategies	animals	the maximum value	assigned treatments	p-IκBα/IκBα	The cohort	confidentiality	the spatiotemporal structure	expired gases	trabecular bone structure	sensitivity analyses	the significant cluster	island	compassion	The recording	the soil	a statewide experience	treated prostate cancer patients	blood groups	these women	the mouse brain atlas	a different software algorithm	48-week studies	the mean±s.d	The second line	important conclusions	local delivery	prostate cancers	binding assay	germline mutations	immunohistochemistry analysis	the rule	paired trials	the Latin American Section	unequal variances	the full range	normal tissue	history taking	a large database	structures	myocardial remodelling	the folate-related genes	osteoblast	These concerns	the random coil index	human albumin	bladder cancer exosomes	quantities	treatment covariates	period	the bisulphite modification	adenosine infusion	the scar area	IL-23-induced ear swelling	retrospective cohort	index measures	hepatotoxicity	the microscopy	all assessments	risk tables	Values	detailed heart rate variability	tricuspid flow	the discovery sample	coronary plaque burden	frontal bone osteoblasts	induced sputum levels	Haplotypes	this combination	a group comprising	Reports	SDS-polyacrylamide gel electrophoresis	the behavioral response distributions	dissemination	histopathology specimens	significant correlation	texture classification	a final cohort	the resection specimen	control samples	the video	left cingulum	multiple markers	the bone mineral structure	The experimental protocol	collagen-induced arthritis	paired t test	The serum samples	movement artifacts	iNOS	magnetic field interactions	peak acceleration	3- markers	sham mice	myxoid liposarcomas	gene expression data sets	iASD	gel electrophoresis	further definition	gene expression master mix	graphing	full set	interdialytic hyperkalemia	gene regulation	multiple haemodynamic functions	p53 status	Abbreviations	helper lymphocyte	urodynamic outcome	influenza circulation.5	potential mechanisms	the photos	further independent subjects	All data	a different stool consistency	micronucleus assays	intact vascular walls	the cysteine-rich luminal loop	β-catenin interaction	Version	digital oximetry	receptor activation	ventricular contractility	the histological categories	a new antibiotic chemoprophylaxis regimen	internal control	examples	the potency	the acquisition	hCDC4	strain gage measurements	single case-reports	visit rate	cancer transcriptome	the protein expression	the study	platforms	texture patterns	MRD-negative remissions	Main	sample size calculations	behavior involves	thrombi group	the continent	individual patient records	statistical power	artificial intelligence methods	groups analysis method	echo study	breast cancers	orthostatic headache	n %	gene expression patterns	age interact	specific probes	Statins	shock syndrome	new reagents	latent phenotypes	twenty‐one cases	mineralized cartilage	capillary tube formation	computational tools	the missense	histomorphometry	rodent	hippocampal morphology	the excellence	the Swedish population	proteins	paraffin	dyssynchrony	energy pathways Abbreviations	post-bronchodilator measures	the third quartile	the cystic fibrosis gene	a new type	a serum bank	cellular influx	categorical values	complex cancer genomics	mammographic densities	a large cross-sectional cohort	framework	study reports	thymidylate synthase polymorphisms	peer-reviewed publications	the prokaryotes	microparticles	early gastric cancers	media	al36	subdivision	ictal semiology	non-physicians	c-fos	intergenotype nt	different onset delays	surveillance	Hardy-Weinberg equilibrium calculator	experimental condition	the histology	the physical scale	stress	the inflammatory cells	functional brain networks	Detection	change versus	the brain temperature	MRI-defined tissue samples	gene expression dynamics inspector	several important limitations	cell pellet	activity data	cartilage	Previous micro-computed tomography	Similar findings	an external diameter	normal cervix	connectivity relationships	Proceedings	over-diagnosis	The banding positions	the blood pool	imaging system	Statistical Package	p =	functional pathways	the myeloid cells	ultrasound	the different analyzed variables	consistent approach	appropriate methods	the model	threefold	both methods	incidence rates	The complications	protein loading	vs. control	the unit	the acute phase response	subcellular fractionation	respiratory symptoms	temperature symptoms	metaphase cells	both events	multi-disciplinary prospective studies	mass-based method	serum potassium	//www.is.titech.ac.jp/∼shimo/prog/pvclust	anion transport	m/z	multivariate methods	that harmonization	cardiac storage	retroviral-insertion sites	a peripheral blood sample	culture	other EEG/ERP-based analytical methods	strain parameters	quantitative parameters	medical treatment versus surgery	biomolecules	the exploration	variance tests	the modification	tissues	experiment design	enzyme-linked immunosorbent assay	symmetric dimethylarginine	stable presentation	cell clones	clinical baseline variables	this alternative method	Terminations	vitreous samples	electrocardiographic waveforms	subsequent myeloperoxidase	response times	consecutive patients	the next steps	the structural micro-CT measurements	] Stridors	physiological indicator	a quantitative cerebral blood flow measurement	available gene chip data42	the isolated working heart function	an intention-to-treat	scaffolds	transcriptomic data	the production	*p <	The same kind	The exon arrays	μg	survival curves	a frequency	regression tree	cutoffs	white-matter hyperintensity	the spectral alignment	mass spectrometry	disease categories	the choroid	the scaffold	creatinine levels	reviewers	hepatic activation	mDCs	representative tracings	the cement cylinders	the first event	normal lung tissues	the adition	valvotomy	–225.19236239	significant differences	twenty-nine cases	the nanoparticles	inter-reader intraclass correlation coefficients	clinical pathways	adjuvant chemotherapies	respiratory rehabilitation	database preparation	gender index	minimum-norm	The amplification reactions	rectal bleeding	whole human saliva detects	the cluster stability	separate sectors	fibronectin content	data abstraction	dose effect relationship	an artificial pacemaker	documentation	the X-ray spectroscopy	marrow histopathology	the interstitium	a simple low-cost methodology	uterus	mechanical testing	the z-depth histogram	blood plasma	microflow histogram	p38MAPK	laser-microdissected paraffin-embedded tissues	a patients group	secondary hypotheses	p‐values	the calvaria	previous treatments	peripheral frequencies	cystectomy patients	the accuracy	C-reactive protein levels	left ventricular systolic function	solid	cut-off	the individual parameters	low stage	late‐onset cases	no reduction	immune complexes	reaction studies	s.e	cell isolation	oesophageal lead data	cytogenetic data	the members	fragment length polymorphism	three-dimensional iodine-related attenuation	antigenemia assay	liquid-chromatography–mass-spectrometry	other HAdV-14p1 strains	varicosities	planes	osteonectin-deficient mice	ratios	surplus cDNA	a high-resolution database	statistical software	mutation analysis	tasks	the relevant categorized covariables	cluster	histone lysine methylation variations	aqueous humor	the vertebral bone	the cDNA microarray analysis	these differences	unfavorable overall survival	each tissue sample	receiver	The antibodies	deidentified data	centres	the recommendations	a pinching effect	missense mutations	cell surface area	co-variance	intervention/ control	baseline variables	other placebo-controlled trials	help	the previous literature	respiratory bacterial species	local gray values	peritoneal macrophage	backscattered light	national representativeness	µA	glycosaminoglycan content	disease-specific survival	related techniques	Another interesting outcome	signal	miR-155	The robust multiarray average	clinical data	free survival	cell culture supernatants	an unsupervised analysis	The gene expression profile	variable genes	fiscal implications	significant 1000-fold permutation	the subcellular distribution	the first sample	voided-urine samples	Supernatants	bone markers	disease mortality	TRUS-guided biopsies	all affected individuals	replicates	The cut-off value	protein kinase specificity determinants	mitochondrial cardiomyopathies	full donor chimerism	consciousnessPhenomenology	all other structural variables	cardiac autonomic function	paravalvular aortic regurgitation	a baseline	survival time	rat	stationary sub-sections	the frontal eye field	members	a fluorescence-activated cell	a library	a scientific collection	cardiovascular risk factors	the reaction mixture	the phase	the coronary arteries	file formats	foci	recollection	microglia	multiple variables	Several resources	new bone area fraction	c-fos mRNA expression	visual search	white matter contrasts	an inverse solution approach	The Bland-Altman plots	microstructural integrity	Purification	previous reports	studied population	a DNA-based technology	the advective drop	A extraction	s recommendations	literature	right PC	the input	treatment duration	recurrent sudden sensorineural hearing loss	these methods	functional classes	refinements	epidermal innervation	pulmonary artery pressure	sample collections	image analysis	at-risk myocardium	bone metabolism markers	taxa	digital media	categorical variables	probability test	biopsied lesion enhancement patterns	the third national health	manual intervention	p53 mutations	item numbers	titers	hybridisation analysis	the primary data analysis	coronary blood flow spectrum	format	Limitation	left ventricular remodeling	median times	The study period	Optical Analysis	total number	peroxisome proliferator-activated receptor-gamma coactivator-1	quality status	electrolyte	organ cultures	biochemical risk failure	serum glucose levels	layer-specific genes	hypertrophic growth plate zones identifies differentiation markers	centrifugation	t-test	polygenomic breast cancers	p-ErbB2	seasonal incidence	hematopoietic regulatory networks	frontal-insula regions	normal cervical tissues	a principal investigator	rapid reconstruction	rainfall	protein complexes	the mutational spectra	antibody scans	cold virus infection	myocardial deformation	negative results	axis	a standard ultrasound machine	subcutaneous adipose tissue reveals differences	tibiae	Non-brain tissue	single-strand conformation polymorphism analysis	discussions	concussion	bacterial growth	the same parameters	the positive psychotic symptoms	conscious rats	clinical specimens	pictures	cell surface	A comparison	breast cancer survival	lateral decubitus	the cerebellar deficit hypothesis	zymosan-induced non-septic shock	intention	cardiac catheterization films	measureable central trabecular structure	a further source	alignment	gene exons	a homeostatic defect	repeat doses	cerebral vasculopathy	The final flavocoxid formulation	the constant comparisons	analysis/interpretation	the trunnions	treatment-refractory patients	datasets	manuscript revision	the field	gated myocardial perfusion	professional status	topography codes	version	this cystectomy population	TPO-treated groups	multiple	integrin-α9 versus	the beta subunit	nitrite	population	huge volume	respiratory variables	genomic characterization	the disability	clinical investigations	fit	cell responses	osteoblast differentiation	The proportions	:56	female children	statistical model	clinical evaluations	novel analysis methods	methodology	receiver operator	b lung	the human brain	verisi- militude	phylogeny	c.1276G	peripheral blood	mL whole-blood samples	fluorescent-activated cell	unique genes	major cardiac events	western blotting analysis	lung structure	Canberra	institutions	the patient-level	cloned mutation-specific 125-bp fragments	severe hyponatremia	spirometric tests	filtered responses	top loci	p=0.071	speakers	clinico-radiological findings	Micro-computed tomography	biosynthetic processing	observed outcomes	week control groups	the linguistic-cognitive level	this rate	the Korean version	structural data	clinical cases	consecutive adult patients	immunization studies	the ratios	connective tissue profile	significant factors	one-year mortality	the electrophysiological consequences	the intensities	miRNA assays	inflammatory genes	organelles	morphology parameters	Ag-specific monoclonal antibodies	stromal cell contamination	This study	the moment	Materials	cell expression	degradation product	the average response	5583-S cells	subtle trajectory differences	accurate short read alignment	hemostasis	endoscopic vein	bone marrow micrometastasis	functional deficits	rs72551386	smooth muscle actin	the downstream	postoperative effects/complications	a poor overall survival	Western blots	data acquistion	the primary angioplasty	primary sensorimotor cortex	the first test	XG	structure	cingulum	bronchial hyperreactivity	these alterations	smooth muscle content	the intraclass correlation coefficient	gastric cancer identifies	in-hospital mortality	electrocardiograms	a minimum	collagen content	cardiac surgical procedures	fusion proteins	special preparations	pneumonitis	pulmonary granulocytic infiltrates	the internet-based electronic data base	any significant difference	comparison studies	the non-mutated p68	right-hand columns	inferential statistics	All interviews	target genes	possible weakness	chemoresistance	this species	a negative serum	tail biopsies	tagged cardiac images	sequence data	the co-cultures	multiple cause-of-death data	the tissue response	literature search	host	abn	sPLA2 enzyme activity	the study conception	test subjects	the score	the primary gastroesophageal tumor	the same methods	western blot	Administration	dlPFC	blot analysis	this prediction	gas	Typical examples	clinical value	cardiovascular magnetic resonance	actual 5-year survivors	the coding	the culture dish	multidrug-resistance mechanisms	the genetic network	randomized screening trials	joint replacements	the genetic diversity	technologist abstract	the auditory study	splenocytes	frame phase stability	multiple parameters,6	the first step	gray-scale harmonic images	the retrospective collection	∆	figure preparation	open osteons	bisulfite sequencing	single-trial estimates	Regulation	other mutations	femur	ease	a primer	lipid profile	each session	the clinical stages	single centre studies	a locus	μg gastrocnemius	The last step	hepatoma	a unified multipoint approach	sBOLD	the first member	large airways	recurrence risk	the prospective collection	auditory event-related potentials	a comparative study	surgical groups	intracellular phospho-Erk activation	the combined rs3731055	epicardial borders	methacholine dose response curves	chronic myeloid leukemia	the entirety	an essential component	cell subsets	positive tumor immune cell infiltration	the optimal cutoff value	mid-ventricular maximum shortening	high-performance liquid chromatography	excessive accumulation	healthcare surveys	spatial distribution	butyrate	percutaneous subdural tapping	unpaired two-tailed t test	a serious condition	image domain	novelty	the region	these dose levels	apoptotic cells	quantitative trait mapping	free phenolic contents	antibody testing	myoepithelial cell carcinoma	acid–base variables	low frame rate	parental	amniocentesis	other intracellular proteins	hybrid nonresponder imputation	additional quantitative information	specified patient groups	data reduction	acute chest pain patients	the present data set	genetic polymorphism	skin distinguishes	the concussion group	V-positive monocytes	preoperative	respiratory functional abnormalities	neuropathological studies	house-keeping gene	bacterial isolation	miRNA functions	the candidates	population-wide comparison	the composition	the virtual reality system	the data entry	laboratory variables	a cut point	tumor area	renal hypouricemia	atrioventricular block	respiratory muscle interaction	full access	single cell mass cytometry	expiration	chemical methods	no other associations	neural network development	onset delay	an invalid result	the combined specificity	amyloid-β	aminotransferase concentrations	cell counts	the statistical analysis	non-improved participants	Japanese vital statistics	heterogeneity analysis	miRNA	visible hemolysis	the figure	the primate globus pallidus	parametric mapping	carrier	high-resolution melting	not-observational studies	the ultrasound	visualisation	delta	the data modeling	heart valves	central aortic blood pressure	functional endoscopic sinus surgery	a breast cancer cell line	standardization	synthesis Recordings	cDNA arrays	Poor-quality spots	primitive myeloid markers	electroencephalogram methodology	all images	Comparative genomic hybridization	the time–activity	the actual accuracy	small-study effects.	Fos-immunoreactive cells	acute cerebral infarction	quantitative real-time polymerase chain reaction	chi-squared test	opsonized phagocytosis	biopsied patients	a unitary single factor syndrome	the bone	brief	the femur	the diagnostic problem	post-bronchodilator spirometry	the literature search	immunofluorescence microscopy	the symptomatic group	due caution	The bands	observed changes	transmembrane proteins	diagnosis interaction	multiple logistic regression analysis	patient messenger	implicit structured sequence	the whole brain	methylation	facilitative glucose transporters	postoperative variables	incomplete observations	a renal glucose transporter	the haemagglutinin	a world series	relevant data	the pre-and post-training scans	purification	aggressive inflammatory response	contrast-enhanced power modulation images	a poor surgical outcome	the concentration trend	tumour morphology	subtype expression	sick patients	sinc interpolation	n =247	neural networks	apraxia	:612	social network monitoring	hemodynamic changes	molecular genetic studies	flow velocity profile	inflow effects	eicosanoid production	blood vessel formation	titin degradation	ear-nose-throat malpractice complaints	histone methylation reveals	human subjects	sudden hearing loss	door-to-needle time	baculovirus	the blinded results	monoclonal goat	Total leucocyte count	pleural fluid	a depth	native ΔT1spleen	critical part	periosteal surfaces	individual magnetic resonance brain images	parts	the human retrosplenial cortex	incomplete information	candidate reference genes	nodes	monocyte subsets	subclass	the international literature	an international clinical research community	event-related cortical activity	temporal trend	Linear mixed-effect model	sublines	depression scale	systems	critical input	2q35-q37.1 regions	study approval	methods	the primary endpoint	miRNA quantification	tissue depot formation	Acidified supernatants	β-Catenin	quality control	individual agents	per-vessel basis	prognostic features	this work	peritoneal cell populations	atypical onset ages	size marker	good prognosis	general quality control criteria	test	non-repeated-measures	aVBI	operations	the novel influenza	a RIG-I agonist	each species	Post-mortem studies	reagent kit	long-term benefit	common cancers	multivariate observations Proceedings	Representative dot-plots	pp38MAPK	the adenoma-to-carcinoma sequence	these tumor cell lines	potential windows	image pre-processing	a high overlap	peritoneal dissemination	a goal	trabecular number	serum bone turnover markers	Quantitative real time polymerase chain reaction	clinical stage groups	advanced tubular adenocarcinomas	an invaluable asset	spectrometry	vascular permeability	melanoma samples	radiation therapy oncology group	the past decade	good value	leptomeningeal biopsy	other outpatient services	bath salts	time course	A metabolic survey	mathematical background	marker combinations	total tau	q	the brainstem	musculoskeletal phenotypes	ed fungus	isolation	multichannel	calibration curve	short version	pre-treatment relapse rate	microCT imaging	region	the deterrents	evaluable cores	tonsillectomy	matrix metalloproteinase activation	dynamics	three-generation pedigree	non-cancerous epithelial cells	mechanistic level	invasive hMSCs	initial draft	polyADP-ribosylated proteins	the statistical exploration	the distinct genetic profile	variance47	the investigator	the cardiac electrical multipole series	the rheumatic diseases	systemic inflammatory interleukin-1β	myocardial homogenates	cytokine mRNA expressions	non-tg mice	myositis	:1562 –70	early gastric cancer	combined endoscopic	a strong linear correlation coefficient	inflammatory immune mediators	positive control	allele length	associated factors	the units	patient groups	The supportive care needs	digital screening mammography	neurological level	conduction studies	tissue biopsy	graphical representations	carbonylated proteins	a blinded fashion	The laboratory measurements	methylation analysis	supershift assays	each culture passage	the fiber gene	placements	bone densitometer	the transgenic mice	hIL-2	study drug	subjective experience	microspectroscopic	cyclic loading	febrile neutropenia occurrence	study participants	Income	purposes	serum autoantibody	endocardial contours delineation	decline,86	summer-type hypersensitivity pneumonitis	clinicopathological parameters	bone tissue development	validation cohort	product	user bias	clinicopathologic parameters	posterior whole-body bone	the revisions	case-control studies	fragment-length polymorphism	the confocal microscopy	dry	velocity gain	cytokine production	magnetic resonance imaging	the microdialysis experiments	microsatellite polymorphisms	propensity-matched patients	stress-induced change	The μCT images	3-D hemodynamics	major adverse cardiac events	the collection	weak staining	the uterine arteries	protein expression	boundaries	auditory	cancer management	immunocompromised patients	this table	biopsies	replication data	medians	covariance models	ginseng	skeletal cells	primary outcome	therapeutic trials	records/information	SMN	the interference	biased histamine	healthy young subjects	abstraction	old-age colitis	the next step	negative predictors	post hoc analysis	deficiency cases	the topological organization	valve function	linear prediction error	worldwide data	A limitation	gene expression data	the typical image	neural patterns	myocardial enzymes	some women	familial breast cancer cases	regional tissue blood flow measurements	watershed geomorphology	multiple regression	glomerular filtration rate	the molecular study	biopsy specimens	clinical perspective	mean differences	a comprehensive collection	nuclear patterning	Male gander	all experiments	both subsets	outcome evaluation	the classifier genes	proportional hazards regression	Spatial Statistics	urinary calcium	The high-resolution melting	interassay coefficients	a logistic regression procedure	pandemic influenza outbreak	microarray testing	tail clip	the bone phenotype	the articles	quantity	lung homogenates	parasite rates	coronary segments	average signal modulation	iodothyronine metabolites	total Costs	calcium phosphate	sample set	:293 –306	a recent study	anterior vOT	acquisition time	fast activity	complex protein mixtures	such test	electrocardiography	individual data	rigorous form	g/m2	sequence	preclinical sera	ponies	outcome interpretation	paired t-tests	the adverse prognostic significance	functional networks	controls	forward stepwise	hence	logistic regression	between-group differences	principal groups	tumor tissue	qualitative data collection	the multiple factors	cell proliferation	intrarenal pressure	tibial length	the linking	patient age	the last several years	college station	resorption assays	these cases	tissue blocks	gene promoters	fascicles	the primary auditory cortices	a value	single strand conformation polymorphism	patient serum samples	heart	the total score	autonomous requirement	this uncertainty	the individual gene analysis	Differential Item	a specialist breast	general analytical steps	experiment job	the eGFP signal	mortality data	live cells	Analgesic users	intracavitary pressure curves	A receiver	the images	patholgcal factors	umbilical cord	the humeri	the observed trends	overall survival	cardiac cycle events	exceptions	standard techniques	multiple studies	prion strain variation	a receiver	a single tissue section	suitable concentration	detection limit	comorbidity data	unaffected hands	non-invasive communication device	bronchoalveolar lavage fluid	the neuropsychological profiles	protein samples	retinal vascular occlusive disease	–903	split-mouth studies	the microarray profiling	the depiction	% correlation analyses	homozygous familial hypercholesterolemia	acute-onset	consistent abnormalities	this regard	variance assumption	gingival mucosa	the time series extraction	hours time point	the survival differences	the urinary sediment	the same square root transformation	the test phase	Additional observation	cell cultures	FACS-isolated populations	step	mammographic parenchymal patterns	This diagnosis	the intestinal wall	immune	cultivated vascular smooth muscle cells	Project design	pneumonia‐associated deaths	residuals	exact test	The mRNA levels	the weight vector	hypoxia-inducible factor	laboratory testing	% downregulation	intragenic microsatellite repeat polymorphisms	the corresponding sham groups	management	chi-square test	miR-146a expression levels	circadian variation	an atlas brain	The study design	subject	immunohistochemical staining	mtDNA	bacterial pathogens	receptor availability	Unit	the anticoagulated cohort	flow cytometric data	a part	gene family	a damaging fraud	the visual spectrum	homozygous neo+ animals	antibacterial prophylaxis	non-cancer outcomes	photographic documentation	the theoretical approach	each tube type	ultracentrifugation	colorectal tissue samples	a high negative predictive value	the marginal division	these criteria	plaque burden	mineralization	positive cell density	cm-1peak	parameter values	the article	an enormous amount	the control parameter	state	triple combinations	the left occipitotemporal cortex	neck pain patients	a common activation	the vastness	different laboratories	cardiovascular variables	12-week-old femurs	stress responses	any differences	Each session	mineral content	the resting-state networks	//www.ingenuity.com	the position	all data	unpaired t-test	the circumferential extent	intracellular drug uptake	ethnic subgroups	t helper subsets	the diagnostic odds ratio	different age groups	baseline visits	the growth plate	late-onset cases	prostate cancer families	epilepsy clinical research	striatal dopamine	serum samples	the ultrasound data	fundoscopy	Italian pedigrees	the contributions	the patient questionnaire data	data generation	proportional hazard analysis	exon	biosignals	regression models	hand	histologic	these genes	nasal secretion	the limit	//www.ncrr.nih.gov	the advice	aqueous humor samples	waldenstrom macroglobulinemia	:1154	primary androgen deprivation therapy	each myocardial segment	these factors	further downstream screens	the anti-inflammatory action	sphincter changes	n=454	this analysis	transcription	clinical dataset	number processing	freezer	r1	left-main coronary arteries	apolipoproteins measurements	low-level hepatitis	the preparation	influenza viruses	the wild type	pilocytic astrocytomas	the normal rat heart	real differences	lead field expansions	frontal lobes	socioeconomic factors	10-fold cross validation	tumor cells	insights	cell division cycle	long-term records	necrotic cells	either chromosome	wild-type patients	aorta wall stiffness	metabolic changes	infectious investigations	the meteorological factors	a “ poor ” two-ventricle repair strategy	stable cell lines	serum concentrations	glomerular gene expression	this survey	exhaled breath condensate equivalent	MGC-803 cells	recurrent colorectal cancer	antihypertensive combination therapy	stimulation assays	carotid bifurcation	promotion	propidium iodide	green fluorescence microscopy	whites,1	post-treatment biopsy samples	Visualization	capillary-to-myofibre ratio	each chamber	The serum	acetabular component orientation	an equine model	µm	cross-validation	single breath samples	chromatography	whole transcriptome sequencing	microsatellite instability	prescription	urinary biomarker candidates	the retrospective nature	the randomized phase	influenza-associated deaths	extraction sockets	mesothelin-expressing cells	qPCR	the gut	whole-lesion enhancement	handling	showing	mitral valve apparatus	percentile	cause-specific mortality	gastric cancer development	the time trend	each variant	the main neutralization	the cervical cancer cell lines	clonal composition	symptomatic complications	the cumulative risk	familial correlation	expression data	group comparisons	major depression	exchange	galectin-1 expression levels	differential effects	the DNA microarray	clinical asthma phenotypes	membrane protein degradation	likely needs	lacunar shape	myocardial repolarization	two-way random	a haemo- cytometer	a matrix stone	ear	The images	the prognostic value	the draft	free testosterone	sarcoidosis groups	continuous outcomes	thrombocyte particle count	twin families	aResults	medical literature	X-box binding protein	the cor- responding antigen	adhesion	downstream capillaries	the retinoblastoma locus	cytokine-measurements	exercise modes	death records	time-intensity-curve	p-values	membrane protein expression	45-90 mmHg	cerebral catheter angiography	additional antibodies	unblinded treatment	brilliant blue-staining	month study period	both combinations	mMRC2	fragmented vessels	compound-protein interactions Methods	defects	a maximal exercise test	high dose level	the helpful comments	each sample	behavioral responses	diagnostic options	lupus cohort	anti-β3 antibody	SM	the second heart sound	hits	multiple imputation	Amounts	animals/group	the next level	androgen deprivation	Copy numbers	skipping	proportional hazards analyses	control-specific genes	these uni-variable analyses	voxel-based morphometry	transmembrane domain	the smoke-free law	crosses	post-dialysis arterial pH	mouse airways	the time	breast tissue	ischemic mitral regurgitation	serological data	β-actin	four-dimensional magnetic resonance images	days gestation	family pedigree	4-month follow-up	signal pathways	*Significant difference	the amplification plot	music interventions	the optic radiation	the regressor	the mother	Erratum	a specific	sample volume	the present meta-analysis	mature data sets	rs1045485	primordial dwarfism reveals	fluid preparation	the bottom panel shows results	right femur	clots	laryngoscopic assessment	a hospital claims-made database	a layered pattern	the help	clinical experiments	relapse-free survival rate	fiber counts	inflammatory mediators	human monocyte chemoattractants	sleep architecture	long-term survival data	category descriptions	the only fair discriminatory performance	The histological groups	the hsCRP analysis outcome	cell quantification	uncultured primary clinical samples	this network	the spectral analysis	foam	countings	tobacco use	blood samples	methyl methacrylate	the sequences	urine proteomics	antibiotic resistance	methylation data	ms	a two-sided significance level	unnormalised data reveals	protocol basis	β-values	parturition	interferon-regulated genes	sarcomere non-uniformities	the molecular characterization	tumor volume	the databases	Margossian et al	nanoindentation	charac- terization	pigtail catheter	% variance	many institutes	overall survival time	innate immunity	characterise care pathways	Events detection	the various zinc finger families	fluorescence microfluorimetry	correlational clusters	EV	keratinocyte growth factor	calcium ionophore	pmol/l	isolated tricuspid repair	the independent samples	all other variables	simple nature	grey matter volume estimation	kind	the information	a hospitalised population	new mutations	the biopsy	false positive cases	post hoc correction	screening	early results	pedicle screw placement	hot spots	volcano spot filtering	sputum induction	n=8	the relation	all management	global longitudinal strain	inflammatory markers	these in-vivo results	the main branch	distal radius section	calcium scores	albuminocytological dissociation	circular data	the design alignment	integration sites	tissue microarray	manuscript preparation	diagnostic accuracy	G418-resistant population	other members	spirometric prediction equations.16 Participants	implications Archives	Sections	partial pressure	human osteoblastic cellular response	standard methods	kinetics	isotopomer modeling Metabolomics	a randomized phase	the entire manuscript	the cancellous bone parameter	prognostic factor analysis	colonies	statistic images	purity	fusions	these reports	cytokine/chemokine analysis	clonal chromosomal abnormalities	roflumilast/tiotropium therapy versus tiotropium monotherapy	contents	de-identified data	Membranes	consistent subgroup	urinary bladder carcinoma	overcorrection	mRNA methylation reveals	matrix-assisted laser desorption ionization	exon skipping	pedicle screw versus hook instrumentation	the indicated time	rRNA gene analysis	endomyocardial biopsies	insect cells	c.5682C	treatment allocation	dry ice	echocardiographic techniques	the inflammatory process	blood gas	functional neuroimages	The impairment	a double-blind	Real time	soft tissue regions	the nuclear index	murine liver fibrosis	potential differences	a preservative	diagnostic variables	co-inventors	General linear model	fixed propidium	the mediastinum	methodological variants	liquid nitrogen	stromal cells	lung tissue homogenates	proportional hazard model	nocturnal desaturation	full-length cDNA	pharmacy-based non-interventional studies	the subjective nature	any significant positive association	a statistical method	dipoles	the Western blot signals	ventilation heterogeneity	longitudinal strain	long-term outcome	audit	Image capture	the univariate	expression pattern	an important reduction	prepared manuscript	active echocardiography-based case finding	” state	routine clinical use	planning experiments	the horizontal axis	.26944254	All data variables	thoracic aorta	occupancy	the homologous peaks	novel groups	cells/mm	interviews	available kit	step-by-step digital interface	immunosenescence	metabolic risk factors	chlorpromazine	intubation	interesting observation	rhythm	no significant change	multiple donors	in-hospital death	randomized clinical trials	the methods	chips	the primary headaches	the DNA sequences	construction	instrument development	parametric	ring artifacts	the tracheobronchial tree	left atrial dilatation	psoriatic patients	Acquisition	the repolarisation	attentional control	urine samples	low-grade gliomas	cross	this degree	post hoc test	Japanese subjects	esophageal cancer	the international classification	analyses	no free mcherry protein	statistical trends	the masks	the protocol-defined hypotheses	The possible bias	erroneous peaks	child- hood cancer	serial changes	Chinese noninflammatory	left ventricular energetic performance	middle ear operation	the up-regulated genes	integrin subunits	dust collecting	failing hearts	planning	radical prostatectomy techniques	the femoral neck	disease entities	the initial diagnosis	square test	baroreceptor reflexes	mRNA decay	flow cytometer	stain samples	necropsy patients	-12	proton nuclear magnetic resonance	p53	the time domain	pathological variables	immune cell phenotypes	cytotoxicity	a societal perspective	The study protocol	tissue response	these outcomes	microhematuria	Schematic representation	the erythrocyte	arteritis	arrow	the estimates	vessels/slide	law	precursor cells	dry extracts	other components	additional studies	“ bad experience ”	uninfected controls	the 1-week state	rs104548	the significant region	dendrograms	spontaneous electroclinical seizures	The approach	PD-P1 status	the computer	the significant effects	sets	avian myeloblastosis virus reverse transcriptase	●	an α-granule secretion defect	foam block tests	network topography	post-mortem records	the tag lines	radiation exposure	non-stationary recordings	antigens	a cut	enrichment analysis	situ hybridisation	the research team	tissue burden	spatial extent	clinical grade	white matter	deletion	treatment period	sarcoidosis patients	Statistical analysis	vimentin levels	curves	all transplantation groups	sound level measurement uncertainty	reverse transcriptase	each administration frequency	3D-SSP display	cytosine methylation	inadequate image quality	each participant	whole animals	sufficient sensitivity	the gene expression analysis	rat-engineered heart tissue	fecal calprotectin levels	quantitative results	a last observation	the cellular phenotype	registry data management	metatarsals	dopOSCCI	endocytosis	unlabeled probes	the rats	genomics	surveys	surfaces	human cancer cells	blade plateversus	survivors	tumour DNA	this patient	poor quality	mortality group definitions	paired analysis	the myocardial scar	Simple logistics	head	individual psychosocial factors	loading	continuous aerosol	white crystalline powder	hospital admission	the coordinating site	low-resolution imaging	bioinformatics prediction	stained cells	syndecan-1	the morphology	microscopic inflammation	SN	Pi-Wei damp-hear syndrome	feces	case report	large european monoinstitutional experience	humoral rejection	preliminary findings	commercial ready-to-use primers/probe mixes	image	the endonasal	the prefrontal cortex	vs. tertile	* p	ovarian epithelial carcinoma	immunofluorescence	search engine	metastasis reveals	the requisite research data form	10-year nationwide outcomes	data extraction	unknown role	myoepithelial carcinoma	a subarachnoid haemorrhage	This method	morphological features	these questions	a “ blockade ”	rs3731055AG+AA	the genes	a basal level	laser-captured paraffin-embedded tissues	four-dimensional segmentation	sequencing	the gut microbiota	whole-bone cDNA	blood constituents	cancer microarray data improves gene expression	the other elements	c.3202	a displacement rate	tumor pathology	this large cohort	the univariable unmatched analysis	domain	active-controlled phase	xanthochromia	cardiac myxomas	trypsin	reverse transcription-polymerase chain reaction	unrelated bone marrow	the 70-gene list	partial pressure difference	the enumeration data	myocardial substrate metabolism	a second set	false positives	the latency	available software packages	Xcelera	tumor size	risk analysis	these diplotypes	Arterial blood-gas	the first day	ammonium acetate	the thrombosis model	observational data	literature reviewing	tumour cells	a new drug transporter	transformed values	receiver operator curves	a panel	atherosclerotic variants	the independent predictors	vivo studies	reduced toxicities	conduct	a clinical pathway	The primary aim	analytical approach	lung tissue	close contacts	blocks	the theta range	grant nos	articulation	cytokine responses	t tests	q-values	oscillatory responses	polyacrylamide gel electrophoresis	citrullinated protein/peptide antibodies	specimen collection	all stroke volumes	the internal validation process	a tail biopsy	epidemiological data	tumor markers	metabolic networks	ontology	conduction disorders	x ray	three-factor results	motivated subject	genetic linkage	clinical studies	significant prognostic information	undiluted samples	data files	diffusion measures	routine analysis	pairs	potassium leakage	phosphorylation	molecular data	μm	the diagnostic use	gradient-echo sequence	concomitant illnesses	viability assessment	the mineral content	an A-79175 standard curve	reveals	hsCRP distribution	79-B :254	inferior parietal lobule	slide	The expected 2.4-kb shift	the abundance ratio	trauma registry.43	an e-PAGE gel	brain connectivity networks	lung function outcomes	microstructural differences	:480	lung cancer dose–response relationships	investigated cells	the tendinopathic rat supraspinatus tendon	the impulse response function	the factor	Cell surface expression	intrahepatic dendritic cell subsets	small intestinal microcirculation	neat erythrocyte lysates	the clinical conduction	the binary images	substantial effects	the experimental protocol	cardiac muscle cell disorganization	power point	phase errors	dendritiform inflammatory cells	iodoacetamide	magnetic resonance brain images	a year	yohimbine uptake	aa substitutions	temporal parameters	the experimental unit/unit	observations	the first treatment day	subtle differences	the secondary endpoint	bias	induced sputum cells	other elements/minerals	bone properties	artefacts	proximal tibias	Units	mm	seventy	small piece	an internal standard	paired patient samples	new pathogenic epitopes	the average data	Descriptive statistics	the facial profile	the growth curves	the imbalances	exacerbation rates	JH	antiviral effectiveness	errors	validation dataset	Significant cluster	the relationships	the precuneus	the periodontium	a synthetic bone coating	unit	Propidium iodide	boul	metabolic	lyophilizer	progenitors	the thresholded results	Results	biochemical method	median follow-up	database	operating characteristics	females	microarrays	pressure measurement	signal intensity	the distribution	structural brain	the adenovirus surveillance program	double counting	potential studies	lipase levels	exclusion	PC v.7.0.1	all isolates	causal	a multicenter cohort	8-week-old femurs	allogeneic bone marrow transplantation	automated function imaging	laboratory animals	a manuscript	networks	experiments	antitumor effects	the coarctation site	time-lapse video	bold	sample processing	data quantification	bronchiolar lavage fluid	trial design	somatic mutation load	the within-male group-difference map	impedance cardiography	tricuspid annular motion	the portion	definite conclusions	all data entry	own material	reporter gene	transcription-PCR-purified plasma cells	minor responses	the bronchial wall	nicotine-associated protein expression	skin biopsies	community-acquired pneumonia	macrophage populations	a potential systemic inflammatory feature	–1032	histology findings	wounds	total callus	cutoff points	vector	different degrees	electro-acoustic specification	
low animal protein ingestion	

non–anginal pain	atypical chest pain	non-anginal chest pain h	typical angina	atypical symptoms	non-anginal chest pain	

median reduction	symptom control	main cause	carers	somatisation	a tibial fracture	the alveolar-capillary membrane	anesthesia overdose	suffocation	s pain	various sources	predictive model	initial call	husband	obstetric management	loneliness play	the relative importance	community integration	numerous factors	problem list category	these concerns	the numeric scale	disturbed sleep	an algorithm	the root cause	problem list categories	a multivariate logistic regression model	right lung collapse	social relationships	a delineating factor	the trajectories	relationship support	extreme distress	neuropsychiatric disorders	the exact level	a sign	AID-CNCR13 >	tachypneic	identifiable elements	important causes	a good understanding	the medical identification	significant emotional burden	online	acceptable alternative	course	local hospital	participant characteristics	The internal consistency	the accounts	a well-studied physiological index	thermal comfort	Definition	loss stigma	gastrointestinal symptoms	marital status	accessible computer-assisted behavioural analysis	1-year outcome	uncontrolled symptoms	non-oxygen-dependent chronic obstructive pulmonary disease patients	unemployment	psychometric instruments	feelings	illness cognitions	difficulties	denial	The measure	animal experiments	appraisals	a worldwide standard	rise	unmet needs	ter	surveillance behaviors	behavioral withdrawal	the concepts	infectious complications	overt signs	care treatment	dB	mammography utilization	impaired exercise capacity	a clinical setting	maladaptive coping styles	physical exam	psychiatric symptoms	consultations	partners	negative affect	suggested global indices	surfactant inhibition	test-related experiences	rate level	patient satisfaction	physiological signs	psychological symptoms	cancer-related self-efficacy	adjuvant breast cancer therapy	surveillance behaviours	≥15	depression thermometers	worry	maternal hypoxemia	effective communication	some measure	operators	abnormal motion	uncertainty	other developed countries	pain-related anxiety	parental divorce	unrelieved pain	social impairment	the timely detection	the unmet needs	disulfiram	a significant level	coping	the sixth vital sign	health informatics approaches	startle reactions	the processing	triage	related variables	the diagnostic phase	violence	p=0.02	deleterious insult	cohesion	other patient populations	peculiar behaviour	psychological distress	sympathetic-adrenal correlates	a single-item self-report measure	somatization	multiple pathways	behaviors	unpleasantness	global functioning postinjury	further assessment	pain rating scale	a guided self-help program	psychosocial support	other potential sources	personalised triage	mean =	The animals	a sense	physical symptoms	infrastructure utilities	’ level	that level	consultant	A prospective validation study	an increased awareness	callers	11-point scale	the tears	these symptoms	
further examples	methamphetamines	gamma-hydroxybutyric acid	

The slow degradation rate	the implantation	calcium aluminoferrite	a mineral dust consisting	bismuth oxide	respiratory manifestations	building construction	synthetic bone graft	histologic assessment	nano calcium sulfate	gypsum	vivo evaluation	
